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Abstract 
Oral Squamous Cell Carcinoma (OSCC) is the sixth most common cancer worldwide.  
The greatest cause of mortality and surgical morbidity is due to the common spread of 
tumour cells from the primary lesion to the lymph nodes of the neck.  This pathway is 
not unique to cancer: under physiological conditions, specific chemokine receptors on 
the surface of leukocytes mediate cell “homing” to tissues defined by gradients of 
complimentary chemotactic cytokines (chemokines).  The chemokine receptors CXCR4 
and CCR7 mediate leukocyte “homing” to secondary lymphoid tissue and have been 
demonstrated on the surface of a number of carcinomas of the aero-digestive tract.  The 
aim of this project was to determine the role of chemokine receptor expression and 
function in OSCC metastasis. 
 
CXCR4 mRNA expression (microarrays and semi-quantitative RT-PCR) and surface 
protein production (flow cytometry and immunocytochemistry) was significantly 
increased in some (but not all) established OSCC cell lines compared with primary oral 
keratinocytes grown in culture.  Examination of clinical samples using a novel, 
quantitative immunohistochemistry methodology demonstrated a positive association 
between CXCR4 staining of the cell membrane in primary OSCC lesions and 
histological evidence of lymph node metastases.  CXCR4 over-expression in a 
constitutively low expressing OSCC cell line (H357) was produced using stable 
transfection with the CXCR4 insert.  Stimulation of CXCR4-bearing OSCC cells with 
the ligand SDF was shown to mediate statistically significant increases in OSCC cell 
proliferation in-vitro using a number of complimentary techniques.  No effect on 
apoptosis was demonstrated.  The SDF/CXCR4 axis also mediated significant 
increases in tumour cell chemokinesis, chemotaxis and invasion as measured by a 
range of in-vitro assays. 
 
These results demonstrate a potential role for CXCR4 as part of a panel of prognostic 
markers for OSCC.  Therapeutic strategies aimed at the SDF/CXCR4 axis may be 
clinically beneficial if the problems of systemic toxicity can be overcome. 
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Literature Review 
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1.1 Oral Squamous Cell Carcinoma 
1.1.1 Definition 
Squamous cell carcinomas of the head and neck region are malignant tumours derived 
from the squamous epithelia of the upper aero-digestive tract.  Such a pathological 
definition is attractive in its simplicity.  However, it fails to address the exact 
anatomical location of disease and its considerable impact on presentation, diagnosis, 
treatment and prognosis.  Epidemiological observations have demonstrated a 
significant difference in Cancer Mortality to Incidence Ratios (CMIR) between, for 
example, carcinoma of the lip (0.065) and carcinoma of the upper oesophagus (0.96) 
which are both squamous cell carcinomas by pathological classification (Office of 
National Statistics 2006).1   One hypothesis is that this difference may be explained by 
clinical factors alone (such as delays in diagnosis and stage of disease at presentation).  
However, it is also possible that squamous cell carcinomas from different anatomical 
sites vary in their tumour biology.  Therefore, in order to minimise the effect of this 
potentially confounding variable, it is necessary to be more specific in the definition of 
oral squamous cell carcinoma (OSCC).   
 
OSCC accounts for over 90% of all oral mucosal malignancies (Daley and Darling 
2003).  For the purpose of this thesis I have defined OSCC as squamous cell carcinomas 
arising from the tongue, gum, floor of mouth, palate, oropharynx, tonsil, piriform sinus 
and hypopharynx.  These match the anatomical areas as defined in the diagnostic 
codes C01-06, C09, C10, C12 and C13 from the International Classification of Disease 
(Tenth Revision, 2007 Version) (ICD-10) outlined in Table A1.1, Appendix 1 (World 
Health Organisation 2007).  By this definition I have excluded carcinomas of the lip, 
salivary glands, nasopharynx, oesophagus, larynx and trachea (ICD-10 codes C00, C07, 
C08, C11, C14, C15, C32 and C33) although the metastatic patterns of squamous 
carcinoma of the lip will be compared briefly with OSCC using 
immunohistochemistry.  Overall, approximately 40% of head and neck squamous 
carcinomas occur at sites defined “oral” as above (Stewart and Kleihues 2003).  Further 
                                                     
1  Cancer Mortality to Incidence Ratios (CMIR) are calculated by dividing the number of 
patients registered as dying of a particular disease by the number diagnosed with the same 
condition within the same year.  United Kingdom data from 2003 are presented in the example. 
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subdivisions of OSCC by aetiology, tumour stage and prognosis are used to inform the 
clinical decision-making process and these are discussed below.   
 
1.1.2 Epidemiology 
Oral cancer and its treatment is a significant cause of morbidity and mortality amongst 
the population both in the United Kingdom and worldwide. In Asia and the Indian 
subcontinent, OSCC is the most common malignancy with a lifetime prevalence 
approaching 20-30% (Parkin, Pisani et al. 1993).  Although accurate data derived from 
cancer registries are not available from these countries, the World Health Organisation 
has estimated that squamous carcinoma of the head and neck is the sixth most 
common malignancy worldwide (Stewart and Kleihues 2003; Warnakulasuriya 2009).2  
In the United Kingdom, OSCC is much less common: the most recent epidemiological 
data derived from cancer registries show that 4,337 patients were diagnosed with the 
disease in 2005.3  However, two worrying trends in the United Kingdom incidence of 
OSCC have been described.  Firstly the incidence within the immigrant Asian 
population is disproportionately high (Warnakulasuriya, Johnson et al. 1999).  
Secondly the incidence in younger adults has nearly doubled over the last three 
decades (Figure 1.1) (Llewellyn, Johnson et al. 2001; Warnakulasuriya 2009).  
Furthermore, similar changing patterns of incidence in younger patients (defined as 
adults under 45 years of age) have been demonstrated in Scotland (Macfarlane, Sharp 
et al. 1996; Warnakulasuriya 2009), Europe (Levi, La Vecchia et al. 1995; Annertz, 
Anderson et al. 2002) and North America (Davis and Severson 1987; Schantz and Yu 
2002).  Based on these epidemiological observations it is tempting to hypothesise that 
these trends are restricted to the Developed World.  However, data from developing 
countries suggest that this is not the case as similar observations have been made in 
both the indigenous and migrant populations from the Indian Subcontinent (Gupta 
1999; Warnakulasuriya, Johnson et al. 1999).  This suggests that the factors influencing 
incidence rates are not geographically related.  More recent evidence suggests that this 
trend may be due to OSCC following exposure to Human Papilloma Virus (HPV) 
(D'Souza, Kreimer et al. 2007). 
                                                     
2  The precise global incidence and prevalence of OSCC is uncertain primarily due to poor 
registration data in the highly endemic areas of South Asia. 
3   Data derived from http://info.cancerresearchuk.org/cancerstats/types/oral/incidence/. 
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Figure 1.1:  Percentage change in incidence rates of oral cancer in British men, 1975-6 / 2004-5.  
Source: http://info.cancerresearchuk.org/cancerstats/types/oral/incidence/ 
 
OSCC is a highly lethal condition.  Its calculated CMIR for the United Kingdom in 2005 
was 0.33 for men and 0.36 for women.4  There are two principal reasons for the high 
lethality of this disease.  Firstly; a significant proportion of patients present late with 
advanced disease.  In these cases important anatomical structures may have been 
breached or tumour cells spread to multiple distant organs with the consequence that 
curative treatment is not possible.  Secondly, for those patients that present early, 
treatment often fails to achieve disease control.  The commonest cause of treatment 
failure is recurrent disease, either at the site of the original (primary) lesion or at a 
distant (secondary) site.  If widespread dissemination has occurred then disease 
control is often impossible and further treatment may only be palliative.  
Consequently, in order to affect a cure in patients presenting early, it is vital to identify 
and address all the disease that is present, however small.  In the diagnostic phase 
                                                     
4   Derived from data Office for National Statistics. Cancer Statistics registrations: Registrations 
of cancer diagnosed in 2005, (England. Series MB1 no.36. 2008) presented at 
http://info.cancerresearchuk.org/cancerstats/types/oral/incidence/. 
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clinicians continually face the uncertainty that stems from the fact that small volumes 
of tumour cells (at either primary or secondary sites) are very difficult to detect.5 
  
 
1.1.3 Clinical features 
OSCC often presents as a painless white patch or ulcer within the oral mucosa.  The 
most commonly affected areas are the floor of the mouth and both the lateral border 
and ventral surface of the tongue (Shah 1990).  These are often referred to as the 
“sump” areas and are thought to be at particular risk because of the combined effect of 
gravity increasing the concentration of carcinogens in saliva and the thin oral mucosa.  
The typical clinical features of OSCC are of a primary lesion arising from within the 
squamous epithelium (oral mucosa) with a wide spectrum from mild dysplasia 
through to frank carcinoma.  It should be stressed that, clinically, many OSCC lesions 
fail to demonstrate sequential progression from dysplasia to carcinoma unlike the well 
documented sequence of adenoma to carcinoma progression in colorectal 
adenocarcinoma.  Carcinoma in situ is defined as full thickness (or almost full 
thickness) architectural disturbance in the viable cell layers accompanied by 
pronounced cytological atypia while invasive carcinoma is defined by penetration of 
the basement membrane below the basal layer of keratinocytes (Barnes, Everson et al. 
2005; Gandolfo, Pentenero et al. 2006; van der Waal 2009).  OSCC, like any carcinoma, 
has the potential to spread both locally (by direct invasion) and to distant sites 
(metastasis).  Distant metastasis may involve the local lymph nodes or more remote 
body tissues.  Oncological principles governing curative treatment determine that 
disease at any of these locations must be addressed adequately.  However, the 
significance of subclinical micrometastases on clinical symptoms and overall survival 
remain debatable (vide infra). 
 
                                                     
5  In the absence of clinically or radiologically detectable metastatic disease, the indication for 
primary treatment (surgery or radiotherapy) of the ispilateral neck is set an arbitrary threshold 
of 20-40% (Weiss, Harrison et al. 1994; Okura, Aikawa et al. 2009). 
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1.1.4  The impact of tumour metastases on patient prognosis and 
treatment 
OSCC can spread locally (by the direct invasion of adjacent tissues), regionally to the 
cervical lymph nodes (via lymphatic channels) or to distant sites via the bloodstream.  
It is clear from epidemiological data that metastatic involvement of the cervical lymph 
nodes (CLN) is the single most important prognostic indicator of survival for patients 
with OSCC (Shah 1990; Persky and Lagmay 1999; Woolgar, Rogers et al. 1999; Rogers, 
Brown et al. 2009).  Data from Liverpool (UK) demonstrate a disease-specific five-year 
survival rate from presentation from primary disease alone, CLN metastases within the 
capsule and extra-capsular CLN metastases of 81%, 64% and 21% respectively 
(Woolgar, Rogers et al. 1999; Rogers, Brown et al. 2009).  Data from the same area has 
shown that the presence of distant metastasis reduces the treated five-year survival to 
less than 20% (Jones, Roland et al. 1994). 
 
The main modalities for curative treatment of OSCC are surgery and radiotherapy.   
These may be used to treat lesions in the mouth and metastatic deposits in the neck.  
Both treatment modalities carry significant morbidity and risk of complications.  
Consequently, the treatment recommended should be sufficient to control the disease 
but avoid over-treatment and unnecessary suffering.  However, incomplete removal of 
tumour cells will result in the failure of curative treatment.  OSCC recurrence in the 
neck may occur if tumour deposits in the cervical lymph nodes remain outside the 
primary treatment field.  Therefore, in order to offer appropriate treatment, it is 
critically important that clinicians are accurately able to determine the extent of disease 
dissemination at the time of diagnosis.     
 
 
1.1.5 Diagnosis of OSCC metastases 
Current detection strategies for metastatic deposits are limited to clinical and 
radiological examination.  The critical determinant of the clinical usefulness of each 
diagnostic test is its sensitivity.  Sensitivity is defined as the number of true positive 
results divided by the combined number of true positives and false negatives.  A 
highly sensitive test will return few false negative results and consequently prevent the 
clinician from under-treating the disease in the neck.   
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1.1.5.1  Clinical history and examination 
Primary OSCC lesions are frequently symptomatic although features may be subtle 
(Marshall and Mahanna 1997).  However, OSCC metastases are frequently 
asymptomatic.  For example, pain is poorly predictive of lymphatic (Shah 1990) and 
distant (Carlson and Ord 2002) tumour spread.  Cervical lymph nodes are readily 
accessible to clinical examination by digital palpation.  It might be predicted that the 
examination of the neck by skilled clinicians would provide accurate detection of 
metastases.  This is not the case.  Clinical examination has a false negative detection 
rate of between 30 to 50% when compared with subsequent histological examination of 
the surgical resection specimen (Woolgar and Scott 1995; Hodder, Evans et al. 2000; 
Greenberg, El Naggar et al. 2003).  There is considerable variability in reported 
findings between clinicians, even when clearly palpable disease is present in the neck 
(Alderson, Jones et al. 2001).  What is required is a reliable non-invasive method for the 
detection of small cervical lymph node metastases. 
 
 
1.1.5.2 Radiological assessment 
Radiological assessment marginally improves diagnostic sensitivity in those patients 
with impalpable lymph nodes (Woolgar 1999).  The technique of ultrasound-guided 
fine needle aspiration cytology (FNAC) produces the highest sensitivity (Hodder, 
Evans et al. 2000; Stuckensen, Kovacs et al. 2000).  However, there are three significant 
limitations in the methodologies of these series.  Firstly, when treatment of the neck is 
based on the ultrasound findings, a considerable proportion of patients with no 
detectable CLN metastases either clinically (cN0) or radiologically (rN0) do not 
undergo elective neck dissection preventing the comparison with histological findings.  
Secondly, the cohort of patients with no clinical or radiological evidence of lymph node 
metastases (cN0 and rN0) is seldom compared to lymph node positive patients 
preventing specific analysis of the former, clinically important, group. Finally, 
prospective studies looking at survival data do not take into account the implications 
of other factors (such as tumour thickness) on prognosis and thus it is possible that 
their results may be explained by other factors associated with the tumour (Rogers, 
Brown et al. 2009).  Consequently, it is likely that the quoted sensitivity for ultrasound-
guided FNAC (85-90%) is not representative of the accuracy of the technique in the 
cN0 patient.  Furthermore, it should not be forgotten that for every hundred cN0 
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patients staged using this technique, at least ten will have their neck metastases 
missed.  This is an unacceptable rate of treatment failure. 
 
Conventional radiological techniques (ultrasound, CT and MRI) focus on the detection 
of anatomically abnormal lymph nodes.  With the advent of Positron Emission 
Tomography (PET) scanning it has been possible to investigate functional changes in 
cellular glucose metabolism that may be associated with high cell turnover such as that 
associated with tumour growth.  Unfortunately initial results have been disappointing 
with sensitivities reaching only 70% (Stuckensen, Kovacs et al. 2000). The role of 
PET/CT in the management of first presentation OSCC is therefore restricted to 
detection of unknown primary lesions and staging advanced tumours (Wong and 
Batty 2009).  
 
The accurate detection of OSCC tumour metastases is fundamental for treatment 
planning and patient prognosis.  There are significant limitations to the use of current 
clinical and radiological screening modalities due to their high false-negative detection 
rates.  Considering that metastatic cells are derived from the primary tumour it is 
possible that a better understanding of the molecular mechanisms of tumour 
metastasis may enable the scientific assessment of the primary tumour to aid the 
clinical prediction of distant dissemination.   
 
 
1.2 The observed clinical behaviour of OSCC metastases 
1.2.1 OSCC spread to cervical lymph nodes. 
The most frequent site of OSCC spread is to the CLN.  Overall, approximately 45% of 
patients presenting with OSCC have CLN metastases at the time of diagnosis (Shah 
1990; Woolgar 1999; Okada, Mataga et al. 2003).  Two predominant patterns of OSCC 
dissemination to the CLN have been described by Woolgar based on the histological 
examination of surgical resection specimens (Woolgar 1997; Woolgar 1999; Woolgar 
2007).  Firstly, the majority of tumours appear to spread to the “first echelon” of the 
CLN and then sequentially down the deep CLN chain by a progressive “overflow” 
mechanism (Woolgar 1999).  According to this model the pattern of lymphatic 
dissemination is predictable and treatment can be targeted once the lowest lymph node 
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basin has been determined.  However, a second pattern of tumour spread has also been 
observed from clinical specimens in which lymphatic deposits were seen to spread in a 
non-sequential manner and “skip” lymph nodes (Woolgar 1999).  In a series of 277 
patients with OSCC, CLN “skipping” was demonstrated in 15.8% of cases (Byers, 
Weber et al. 1997).  Other studies suggest this is an overestimate with only 2/89 (2.2%), 
5/192 (2.6%), 21/526 (3.9%) and 14/226 (6.2%) patients demonstrating skipping (De 
Zinis, Bolzoni et al. 2006; Dias, Lima et al. 2006; Woolgar 2007; Lodder, Sewnaik et al. 
2008).  Despite the technical limitations of these studies, the clinical observation of 
lymph node skipping supports the hypothesis that CLN metastasis does not follow a 
sequential path and may be a common event in the early pathogenesis of certain 
OSCCs.6  This has significant implications not only for our understanding of tumour 
biology, but also for patient outcomes based on sentinel node biopsy and elective 
surgical treatment of the N0 neck, both of which are currently undergoing clinical 
investigation.7 
 
The reason for this dichotomy is not clear.  One possible hypothesis is that the pattern 
of lymph node metastasis is entirely determined by the position of the primary lesion 
within the mouth.  OSCC-derived skip metastases to the lower CLN levels have been 
demonstrated with primary lesions arising in the tongue (Byers, Weber et al. 1997; 
Woolgar 2007).  In a series of 339 patients Dias et al identified skip metastases in 7/222 
(3.1%) tongue lesions but none out of 117 floor of mouth lesions (Dias, Lima et al. 
2006).  It is possible that metastatic deposits entering the lymphatic channels from the 
tongue may bypass the upper cervical lymph nodes. However, clinical evidence does 
not support this hypothesis.  The location of the first (sentinel) lymph node within the 
first CLN basin for OSCCs can be determined using lymphoscintography.  For all 
primary tumours (including tongue tumours) the sentinel lymph node was located in 
upper cervical chain (Stoeckli, Pfaltz et al. 2002).  Consequently, the variable patterns of 
cervical lymph node metastasis may not be attributable to differences in primary 
tumour location.  However, it is possible that the observed patterns of lymph node 
metastasis are due to other features of the primary tumour including size (horizontal 
diameter) or thickness (vertical depth of invasion).  The hypotheses that attempt to 
                                                     
6 The detection of micrometastases is limited by factors including surgical lymph node yield 
and assiduous histological examination of multiple fine microscope sections.  Completely 
accurate investigation would require analysis with molecular methods of tumour cell detection. 
7 Sentinel European Node Trial (SENT) and Selective Elective Neck Dissection (SEND) studies 
respectively. 
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explain the association between these attributes of the primary tumour and the 
observed patterns of metastasis are outlined below. 
 
Cervical lymph node metastases are more commonly associated with larger primary 
tumours (Okada, Mataga et al. 2003).  The correlation between increasing vertical 
invasion and an increased incidence of lymph node metastasis in OSCC has been 
demonstrated by several groups (Mohit-Tabatabai, Sobel et al. 1986; Spiro, Huvos et al. 
1986; Yuen, Lam et al. 2002; O-charoenrat, Pillai et al. 2003; O'Brien, Lauer et al. 2003; 
Sheahan, O'Keane et al. 2003).  In melanoma, the depth of invasion of the primary 
tumour correlates with both lymph node metastasis and survival (Breslow 1970).  In 
OSCC, a histological depth of invasion greater than 5mm was associated with an 
increased risk of cervical metastasis (relative risk 2.4) and decreased disease specific 
survival (O-charoenrat, Pillai et al. 2003).  As yet there are no published data 
investigating the relationship between depth of invasion and skip metastases in OSCC. 
 
One hypothesis, based on anatomical principles, would suggest that more host tissue 
structures are encountered as tumour invasion progresses in both horizontal and 
vertical directions.  These structures include arteries, veins and lymphatic channels.  
Their relative density increases with vertical distance from the mucosal surface. In 
theory, invasion of any of these vascular structures would provide a possible conduit 
for the passage of malignant cells to distant sites.  However, clinical evidence does not 
support this theory in OSCC.  Direct vascular invasion is uncommon, occurring in just 
over 5% of cases (Fagan, Collins et al. 1998).  Perineural invasion is more common 
(occurring in approximately 25-50% of cases) and is associated with lymph node 
metastasis, extracapsular spread, distant metastasis and disease-specific mortality 
(Fagan, Collins et al. 1998; Rahima, Shingaki et al. 2004).  Nevertheless, nerve fascicles 
are not hollow and do not provide a direct conduit for the passage of malignant 
deposits to distant sites.  Therefore, what this may represent is a manifestation of a 
more aggressive tumour phenotype (with the ability/predilection to spread along 
nerves) rather than a direct causal relationship. 
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1.2.2 OSCC distant metastasis to distant body sites. 
Data based on the incidence of symptomatic lesions indicate that the incidence of 
distant metastases is approximately 1% (Crile 1906; Ferlito, Shaha et al. 2001; Carlson 
and Ord 2002).  However, it is possible that this may be a significant underestimate of 
the overall prevalence of distant metastases as a large proportion of lesions remain 
asymptomatic.  The small amount of data available in the literature suggests that this is 
the case.  An exhaustive histological examination of all body tissues made at autopsy 
demonstrated that the overall incidence of distant metastases in patients with OSCC 
was shown to vary between 24 and 47% (Kotwall, Sako et al. 1987; Slootweg, Hordijk et 
al. 1996 ; Jennings and Bradley 2002 ).8  This suggests that distant metastatic deposits 
are common in OSCC but do not ubiquitously assume a clinically significant size.  This 
finding has two important consequences.  Firstly, metastases, too small to cause 
symptoms, often fall below the size detection threshold of clinical and radiological 
examinations.  As a result, distant metastatic tumour burden may be frequently 
underestimated.  Secondly, it appears that distant metastatic deposits may frequently 
become established in OSCC, but often fail to grow, unlike those in the cervical lymph 
nodes.  One possible explanation is that the development of metastatic lesions is 
dependent on the host tissue microenvironment.  Further clinical evidence supporting 
this hypothesis comes from the observation that the distribution of OSCC distant 
metastases is not random.  A pattern emerges that favours the lungs (56-80%), bone 
(16-31%), liver (10-31%) and mediastinal lymph nodes (34%) (Kotwall, Sako et al. 1987; 
Shingaki, Suzuki et al. 1996).   
   
The clinical behaviour of OSCC metastases is an intriguing paradigm:  the growth of 
OSCC deposits is favoured in the cervical lymph nodes more than certain distant sites.  
In roughly a third of tongue tumours, the metastatic distribution in the cervical lymph 
node chain is not sequential despite the uniformity of the location of the sentinel node.  
These observations suggest that tumour spread is not entirely determined by 
anatomical considerations.  It is possible that the interaction between the tumour cell 
and the host tissue microenvironment plays a key role in determining metastatic 
progression. 
 
                                                     
8 It has been estimated from one series that, although diagnosed with advanced head and neck 
cancer, approximately a third of these patients did not die of their disease (Jennings and 
Bradley, 2002).  
 33
1.3 Hypothetical models of metastatic dissemination 
Historically, the potential interaction between malignant cells and their host has been 
the subject of much consideration.  Two dominant theories of metastatic dissemination 
have emerged and each contributes to the modern understanding of metastatic 
mechanisms. 
 
 
1.3.1 “Mechanisms of Circulation” hypothesis 
Until the 1970s it was widely believed that metastatic dissemination was primarily 
determined by the anatomical structure of the vascular system.  This “Mechanisms of 
Circulation” hypothesis was originally proposed by James Ewing in 1928 and outlined 
how the delivery of malignant cells was channelled by the existing lymphatic and 
vascular channels in the adjacent tissue (Ewing 1928). 
 
On first inspection, it appears that the clinical evidence from OSCC would support this 
theory: invasion of the lymphatic channels by OSCC primary lesions is more common 
than vascular invasion and this accounts for the greater incidence of lymph node 
metastases compared with distant dissemination (Shah 1990; Fagan, Collins et al. 1998; 
Ferlito, Shaha et al. 2001).  However, the “Mechanisms of Circulation” hypothesis does 
not explain several features of OSCC metastasis based on clinical observations.  Firstly, 
it does not explain the occurrence of “skip” metastases in the cervical lymph node 
chain found in up to 30% of patients (Byers, Weber et al. 1997; Woolgar 1999).  
Secondly, it does not explain the relative preponderance (16-30%) of distant bony 
metastases compared with the fraction (5%) of the circulatory flow received by the 
bone as determined experimentally (Tothill and MacPherson 1986; Kotwall, Sako et al. 
1987; Shingaki, Suzuki et al. 1996).  These observations in OSCC are consistent with 
clinical and experimental evidence in other tumours that suggests that metastatic 
dissemination cannot be explained by mechanical factors and random distribution 
alone (Hart and Fidler 1980).  
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1.3.2 “Soil and Seed” hypothesis 
The “Soil and Seed” theory of metastatic dissemination was originally proposed by 
Stephen Paget in 1889 (Paget 1889).  He recorded the disparity between organ blood 
flow and the incidence of distant metastases in breast cancer and concluded that the 
development of a tumour metastasis at a specific location was due to an interaction 
between the disseminated tumour cells (“seed”) and the local tissue microenvironment 
(“soil”).  Clinical observation of epithelial tumours such as breast, bronchus, renal, 
thyroid and prostate carcinomas reveals that they commonly metastasise to bone 
(Coleman 1997).  The incidence of bony metastases in these tumours is 
disproportionably greater than the volume of the circulatory blood flow directed to 
bone. 
 
By inference, Paget’s theory predicts that distant metastases will not develop if the 
interaction between the tumour and local tissue is not favourable (Paget 1889).  
Consequently, the “Seed and Soil” theory predicts that the metastatic process is not 
100% efficient.  Indeed, there is compelling clinical and experimental evidence that 
carcinoma metastasis is highly inefficient.  Experimental evidence comes from the 
injection of viable tumour cells into the circulation of nude mice.  These results 
demonstrate that less than 0.1% of tumour cells are still viable 24 hours after injection 
and under 0.01% of these tumour cells form metastatic deposits (Fidler 1970).  Clinical 
evidence includes the palliative treatment of ovarian carcinoma by peritoneo-venous 
shunting.  Using this technique, malignant ascites is delivered directly into the jugular 
vein and, via the right heart, to the pulmonary capillary bed.  However, patients 
treated in this way only rarely demonstrate metastases outside of the peritoneal cavity 
at autopsy (Tarin, Price et al. 1984). 
 
Observational studies in OSCC indicate that only a minority of distant metastases 
develop into lesions of clinically significant size.  At autopsy the incidence of 
microscopic distant metastases approaches 50% (Kotwall, Sako et al. 1987).  However, 
only 1% of distant metastases become large enough to cause symptoms (Crile 1906; 
Carlson and Ord 2002).  These findings suggest that the vast majority of the metastatic 
deposits that initially invade at distant sites fail to proliferate substantially to form 
clinically significant lesions. 
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1.3.3 Contemporary perspectives on metastatic dissemination. 
Paget’s and Ewing’s original hypotheses were amalgamated by Sugarbaker (1979), 
based on a review of clinical cases.  He proposed that regional metastasis could be 
attributed to anatomical factors (such as venous or lymphatic drainage), but distant 
metastases were site specific and supported a “seed/soil” hypothesis (Sugarbaker 
1979). 
 
However, it may be that this dichotomy between the mechanisms underpinning 
lymphatic and distant metastases is over-simplistic.  The “mechanical” delivery of 
malignant cells to the local lymph nodes does not circumvent the possibility of 
interaction between the tumour cell and the host microenvironment at this point.  One 
of the principal functions of peripheral lymph nodes is to present foreign antigen to the 
immune system in order to coordinate a response.  Therefore tumour cells within the 
peripheral lymph nodes must evade the host immune response and undergo 
significant proliferation in order to produce the lymphatic deposits observed clinically.    
 
Metastases are formed by a complex sequence of cellular events initiated by the 
delivery of primary tumour fragments to distant locations by the circulation.  This 
multi-step process has been summarised by Fidler and is listed in Table 1.1 (Fidler 
2003).  This parallels Darwin’s theories of natural selection: each tumour cell is 
required to “adapt” to each new tissue environment.  The “selective pressure” from 
each environment results in an overall “positive selection” of only those tumour cells 
capable of survival at each stage.  The overall low “efficiency” of metastasis parallels 
that of the natural selection of species. 
 
It is unlikely that tumour cells develop all of these cellular processes de novo (Fidler 
2003; Zlotnik 2004).  The sequential progression through dysplasia to invasive 
carcinoma is caused by an accumulated genetic instability rather than the sudden 
development of entirely novel signalling pathways.   These observations support the 
hypothesis that tumour cells subvert physiological homeostatic mechanisms to achieve 
survival and dissemination.  Indeed, tumour cells are not unique in their affinity for 
particular body tissues.  There are considerable similarities between steps (5) to (7) of 
the metastatic process listed above and the pathways of physiological leukocyte 
“homing” to distant tissue sites including peripheral lymph nodes.  These parallels 
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suggest that it is reasonable to investigate the validity of the mechanisms of leukocyte 
“homing” as a model for metastatic dissemination. 
 
 
Table 1.1: Multi-step process of metastatic dissemination  
 
Step Process 
1 Proliferation & angiogenesis of the primary tumour 
2 Detachment & invasion of local vascular structures 
3 Malignant embolisation 
4 Transport through the circulation 
5 Arrest in distant organs 
6 Adherence to vessel wall 
7 Tumour extravasation & invasion 
8 Establishment of tumour microenvironment 
9 Metastatic tumour proliferation & angiogenesis 
Adapted from (Fidler 2003). 
 
 
1.4 Physiological pathways of lymphocyte homing and 
dendritic cell uptake by lymph nodes 
1.4.1  Physiological lymphocyte homing 
Peripheral lymph nodes play a pivotal role in the coordination of the immune 
response.  This is not due to random chance encounters between participating 
leukocytes but rather due to a carefully coordinated sequence of molecular events.  The 
targeted circulation and re-circulation of leukocytes to specific tissues is known as 
“homing”.  The mechanisms controlling the “homing” phenomenon are best 
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understood in lymphocytes.  Butcher and Picker (1996) describe the “homing” process 
as “a multi-step sequential engagement of adhesion and signalling receptors” and their 
proposed model of lymphocyte-endothelial interaction has gained wide acceptance.  
This is summarised in Table 1.2 and outlined in Figure 1.2. 
 
 
Table 1.2:   Multi-step pathway of lymphocyte homing  
 
Step Mechanism 
1 Transient adhesion to the endothelial surface 
2 Lymphocyte rolling on the endothelial surface 
3 Lymphocyte activation 
4 Firm adhesion 
Adapted from (Butcher and Picker 1996) 
 
The initial contact between the circulating lymphocyte and the target tissue occurs at 
the endothelial cell surface of the post-capillary high endothelial venules.  The delivery 
of the lymphocyte to this location is determined by the circulatory flow.  The transient 
adhesion of this initial contact is mediated via weak binding between “homing 
receptors” expressed on the lymphocyte cell surface and “addressin” molecules on the 
endothelial cell surface (Figure 1.2a).  Homing receptors belong to the selectin or 
integrin families of adhesion molecules and the expression of both homing receptors 
and addressins is tissue specific (Alon and Feigelson 2002).   
 
 
1.4.1.1  Addressins and homing receptors mediating the initial stage of 
lymphocyte homing 
Unstimulated, naïve T-lymphocytes preferentially re-circulate to secondary lymphoid 
tissue (SLT) (von Andrian and Mempel 2003).  SLT comprises of the peripheral and 
mesenteric lymph nodes, spleen and Peyer’s patches of the small intestine.  The surface 
homing-receptor L-selectin (CD62L) is found on naïve T cells and mediates transient 
adhesion at the post-capillary endothelial surface of the lymph node by binding to 
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Peripheral-Node Addressin (PNAd) (Table 1.3).  Intravital microscopy in mice reveals 
L-selectin-mediated rolling of naïve T-lymphocytes on subcortical lymph node 
capillaries expressing PNAd (von Andrian 1996).  In oral mucosal-associated lymphoid 
tissue, lymphocyte homing appears to be mediated by L-selectin / PNAd (Csencsits, 
Jutila et al. 2002).  Naïve lymphocytes expressing L-selectin may also bind to 
carbohydrate residues on MAdCAM-1 (Bargatze, Julita et al. 1995).  MAdCAM-1 is the 
addressin expressed on gut endothelium although naïve T-lymphocytes are not 
preferentially taken up at this site.  This suggests that there is a second mechanism that 
also confers a degree of tissue specificity downstream of the homing 
receptor/addressin interaction. 
 
 
 
Table 1.3:   Known Lymphocyte Homing-receptor and Endothelial Addressin 
interactions by tissue type. 
 
Tissue 
Type 
Tissue 
Endothelial 
addressin 
Lymphocyte 
Homing 
Receptor 
References 
Peripheral 
lymph node 
PNAd L-selectin 
(Salmi, Hellman 
et al. 1998) 
Secondary 
Lymphoid 
Oral-
associated 
lymphoid 
tissue 
PNAd L-selectin 
(Csencsits, Jutila 
et al. 2002) 
Skin E-selectin CLA (Hwang 2001) 
Gut MAdCAM-1 Integrin α4β7 (Briskin, Winsor-
Hines et al. 1997) Epithelium 
Oral mucosa Unknown 
Integrin αeβ7 
CLA 
(Walton, Macey 
et al. 1998) 
Legend: PNAd: Peripheral lymph node addressin, CLA: Cutaneous Lymphocyte Antigen, 
MAdCAM-1: Mucosal associated cell adhesion molecule-1. 
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The homing-receptor/addressin mediated adhesion is transient and weak. Under 
physiological flow conditions, vascular shear stress propels the lymphocytes along the 
endothelial surface (Figure 1.2b).  This greatly enhances the likelihood of the rolling T 
cell encountering chemokines ligands produced on the endoluminal surface.   
Endothelial cell-derived chemokines bind to specific receptors expressed on the 
lymphocyte surface (Figure 1.2c).  The release of chemokines by endothelial cells is 
tissue specific.  Similarly, the expression of chemokine receptors by lymphocytes 
defines the chemokines they will respond to.  Consequently this mechanism 
determines a second level of specificity on the lymphocyte / endothelium interaction.  
Peripheral lymph node endothelial cells constitutively express the chemokine CCL21 
which binds to its receptor CCR7 expressed on the surface of naïve T-lymphocytes 
(Blades, Manzo et al. 2002; Phillips and Ager 2002; Stein, Soriano et al. 2003).  The 
endothelial chemokine/chemokine receptor interactions that control lymphocyte 
homing to the skin and gut have also been characterised (Table 1.4).  It appears that the 
chemokine receptor binding is the key determinant of tissue specificity.  However, the 
chemokine receptors involved in lymphocyte homing to the oral mucosa are, as yet, 
unknown.   
 
Naïve T cells express low levels of the integrin heterodimers αLβ2 (LFA-1), α4β1 (VLA-
4) and α4β7 (LPAM), which bind ICAM-1, VCAM-1, and MAdCAM-1, respectively  
(Springer 1995).  Of these, the interaction of αLβ2 with ICAM-1 is particularly 
important for T cell entry into pLN and T cell interactions with antigen-presenting cells 
(APCs).  
 
 
Table 1.4:  Characterised tissue-specific endothelial chemokines and their 
corresponding lymphocytic chemokine receptors. 
 
Tissue Endothelial Chemokine 
Lymphocyte Chemokine 
Receptor 
Peripheral lymph node CCL21 CCR7 
Skin CCL17 CCR4 
Gut CCL25 CCR9 
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 Chemokine mediated lymphocyte activation is mediated by cell-surface G-protein-
coupled chemokine receptors.  Tissue specific chemokines /  chemokine receptor 
binding induces a conformational change in the expression of integrins on the surface 
of the lymphocyte and firm (but reversible) adhesion to endothelial integrins (Figure 
1.2c) (Stein, Rot et al. 2000).  The firm activation-dependent binding of the lymphocyte 
to the endothelial cell surface is a pre-requisite for the lymphocyte to leave the 
circulation (extravasation) and enter the tissue stroma (diapedesis). 
 
Following activation in SLT, effector T-lymphocytes develop the capability to home 
selectively to non-lymphoid tissues including epithelial surfaces.  This expedites 
antigen recognition.  Activated T cells decrease expression of the L-selectin homing 
molecule and the chemokine receptor CCR7.  It has been postulated that differential 
expression of integrins defines the homing properties of activated T lymphocytes to 
non-lymphoid tissue.  The integrins α4β1 and α4β7 appear to be reciprocally expressed 
(Erle, Briskin et al. 1994).  The homing receptor / addressin pairs for memory T-
lymphocyte homing to the skin (E-selectin/Cutaneous Lymphocte Antigen [CLA]) and 
the gastrointestinal tract (MAdCAM-1/α4β7) have been determined (Table 1.3).  The 
lymphocytes that home to the oral mucosa have been characterised and shown to 
express the integrin αeβ7 and the homing-receptor CLA (Walton, Macey et al. 1998).  
However, the addressin involved is, as yet, unknown.  
 
The pattern of lymphocyte homing to peripheral lymph nodes and other specific sites 
is dependent on the combination of a number of complimentary molecular 
mechanisms.  Failure at any one stage results in the return of the lymphocyte to the 
circulation.  The stimulation of functional lymphocyte chemokine receptors by tissue-
specific chemokines constitutively expressed by the endothelium is a key component 
of the homing mechanism.  The uptake of lymphocytes from the circulation in this way 
mirrors the delivery of metastatic tumour cells to distant organs.  The possibility that 
this “homing” mechanism shares molecular similarities with the metastatic process of 
OSCC and other carcinomas has prompted further investigation (Sections 1.6 and 1.5 
respectively). 
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Figure 1.2:  Schematic representation of the four principal steps of lymphocyte homing. 
Initially transient binding of the T-lymphocyte homing receptor to complementary addressins 
on the endothelial surface occurs mediating transient arrest (panel a).  Tissue specific addressin 
/ homing receptor binding is outlined in Table 1.3.  Vascular shear force is resisted by transient 
binding of the T-lymphocyte homing receptors to complementary endothelial addressins 
allowing the lymphocyte to “roll” along the endothelial surface (panel b).  Endothelial 
chemokines bind to complementary chemokine receptors on the lymphocyte surface resulting 
in G-protein activation and a change in the expression profile of cell adhesion molecules. 
Activated chemokine receptors on the lymphocyte surface mediate a change in the expression 
profile of cell adhesion molecules.  These mediate firm adhesion to the endothelial surface 
(panel c).  Tissue specific chemokines / chemokines receptor binding is outlined in Table 1.4.   
Legend: T-Lφ = T lymphocyte, HR = homing receptor, Ad = addressin.  Adapted from (Butcher 
and Picker 1996). 
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1.4.2  Dendritic cell homing to peripheral lymph nodes 
Dendritic cells are bone marrow-derived leukocytes that are specialised in the capture 
of antigen and its presentation to lymphocytes via a multi-step pathway (Table 1.5).  In 
this way dendritic cells play a key role in the initiation of the primary immune 
response.  Dendritic cells present in the epidermis are known as Langerhans cells and 
are the best studied dendritic cell population.  Immature Langerhans leave the 
peripheral circulation and enter the epidermis.  If antigen capture is successful then the 
Langerhans cells undergo a functional maturation and move to the peripheral lymph 
nodes cells in order to present antigen to naïve T-lymphocytes.  It has been shown that 
Langerhans cells continuously leave the epidermis in the afferent lymphatics.  
However, local activation by inflammatory stimuli considerably increases the number 
of cells released (Brand, Hunziker et al. 1992).  This suggests that the multi-step 
pathway involved with dendritic cell release is controlled by active mechanisms. 
 
Immature Langerhans cells (ILCs) homing to the skin use a mechanism that mirrors the 
homing-receptor / addressin / chemokine pathway described in Section 1.4.1 above. 
Langerhans cell maturation is triggered by the capture of antigen and is mediated by 
the pro-inflammatory cytokines TNFα and IL-1.  Upon maturation, dendritic cells 
significantly alter their chemokine receptor expression profile.  They downregulate the 
chemokine receptors CCR6, CCR1, CCR5 and CXCR1; while significantly upregulating 
the chemokine receptors CCR7 and to a lesser extent CXCR4 and CCR4 (Lin, Suri et al. 
1998; Sallusto, Schaerli et al. 1998; Forster, Schubel et al. 1999).  The hypothesis that 
CCR7, CXCR4 and CCR4 all play an equal role in the physiological homing of 
dendritic cells to peripheral lymph nodes is not supported by experimental evidence.  
Only in the CCR7 -/-  knockout mouse do dendritic cells lack the ability to home to 
peripheral lymph nodes (Dieu, Vanbervliet et al. 1998; Sallusto, Schaerli et al. 1998; 
Forster, Schubel et al. 1999).  This suggests that CCR7 plays the most important role the 
homing of mature dendritic cells to peripheral lymph nodes. 
 
Immature Langerhans cells (ILCs) and skin-homing lymphocytes constitutively 
express an isoform of the homing-receptor P-selectin glycoprotein ligand-1 (PSGL-1) 
that contains the CLA epitope (Kieffer, Fuhlbrigge et al. 2001).  Intravital microscopy 
demonstrates that the CLA isoform of PSGL-1 mediates rolling on the addressins E-
selectin and P-selectin which are expressed on dermal HEVs (Fuhlbrigge, King et al. 
 43
2002).  ILC precursors constitutively express the chemokine receptors CCR6, CCR1, 
CCR5 and CXCR1 (Jakob, Ring et al. 2001).  ILCs can access the epidermis in the 
inflamed and un-inflamed states.  Uptake of ILCs to the uninflamed epidermis is 
mediated by the stimulation of CCR6 by the constitutive chemokine MIP-3α (CCL20) 
(Charbonnier, Kohrgruber et al. 1999).  However, at inflammatory sites, ILCs may 
access the epidermis independent of PSGL-1 and are recruited along gradients of the 
inflammatory-type chemokines.  These including IL-8 (CXCL8) binding to CXCR1, 
RANTES (CCL5) to CCR5, MIP-1α (CCL3) to CCR1 and CCR5, and MCP-3 (CCL7) to 
CCR1 (Jakob, Ring et al. 2001; Pendl, Robert et al. 2002).   
 
 
 
Table 1.5:   Multi-step pathway of dendritic cell recruitment by lymph nodes 
 
Step Process 
1 Attraction to inflammatory sites 
2 Antigen capture 
3 Maturation & chemokine receptor switch 
4 Reduction of adhesion 
5 Migration  
6 Uptake by lymph node 
 
 
 
 
The chemokine receptor CCR7 binds two chemokines: Secondary Lymphoid-tissue 
Chemokine (SLC, CCL21) and the EBV-induced Chemokine-1 (ELC, CCL19) that bind 
with equal affinity to induce chemotaxis (Yoshida, Imai et al. 1997; Campbell, Bowman 
et al. 1998; Yoshida, Nagira et al. 1998).  SLC is constitutively produced by the 
lymphatic endothelial cells in peripheral tissue and by the stromal cells of the 
peripheral lymph node T-cell zones.  ELC is produced by dendritic cells and stromal 
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cells in the T-cell areas of lymphoid tissue.  There is good evidence that CCR7 plays a 
key role in the recruitment of Langerhans cells to peripheral lymph nodes in the 
inflamed and un-inflamed states (Ohl, Mohaupt et al. 2004).   
 
Blockade of SLC activity with neutralising monoclonal antibodies inhibits the 
migration of Langerhans cells to the draining lymph nodes (Saeki, Moore et al. 1999).  
Investigation of the spontaneous mouse mutant named PLT (paucity of lymphoid 
tissue) reveals no measurable SLC expression in their secondary lymphoid tissue 
(Gunn, Kyuwa et al. 1999).  Interestingly, despite no SLC expression, these mice 
demonstrated normal entry of Langerhans cells into lymphatic vessels although 
reduced accumulation in the regional lymph nodes.  The explanation for this 
observation was found to be a second gene in the mouse genome that encodes a SLC-
like protein which is predominantly found in the lymphatic endothelium of non-
lymphoid tissue.  The PLT mice lack the SLC gene but demonstrate normal production 
of the second SLC-like protein (Vassileva, Soto et al. 1999).  In sites of chronic 
inflammation, Langerhans cells that are not fully mature may only be recruited to 
peripheral lymph nodes if CCR7 expression has been induced (Geissmann, Dieu-
Nosjean et al. 2002).  The migration of T-cells and DCs from non-lymphoid tissue to 
draining lymph nodes appears to be more dependent on CCR7 expression than 
integrins (Forster, Schubel et al. 1999; Ohl, Mohaupt et al. 2004; Lammermann, Bader et 
al. 2008).  However, it has been shown recently that blockade of the sphingosine 1-
phosphate receptor 1 (S1P1) prevented migration of T cells into afferent lymphatics by 
increasing firm adhesion mediated by both αLβ2 and α4β1 integrins (Ledgerwood, Lal 
et al. 2008).  
 
The role of CXCR4 in dendritic cell migration is less clear.  Functional CXCR4 
expression has been demonstrated on both immature and mature dendritic cells, 
(Sallusto, Schaerli et al. 1998; Delgado, Finkel et al. 1998).  Mature dendritic cells 
express CXCR4 and are responsive to its ligand SDF (Lin, Suri et al. 1998; Delgado, 
Finkel et al. 1998 ; Tchou, Misery et al. 2001).  However, it is not clear whether this is 
due to an upregulation of expression following stimulation with TNFα and IL-1b (Lin, 
Suri et al. 1998; Sallusto, Schaerli et al. 1998), granulocyte-macrophage colony 
stimulating factor (Tchou, Misery et al. 2001) or due to the persistence of expression 
levels present in the immature state (Delgado, Finkel et al. 1998).  SDF is constitutively 
produced by fibroblasts in the bone marrow, lymph node, and lungs (Blades, Manzo et 
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al. 2002; Ratajczak, Majka et al. 2003).  One interpretation of the experimentally-derived 
data regarding the response of CXCR4-expressing dendritic cells to SDF is that this 
chemokine/receptor interaction may play a role in the spatial co-ordination of antigen 
presentation within the lymph node substance (vide infra). 
 
Dendritic cells entering the afferent lymphatics are transported to the subcapsular 
sinus of the draining lymph node.  Both SLC and ELC are constitutively expressed 
within the T-cell zone of secondary lymphoid tissue.  In addition ELC is produced by 
dendritic cells resident in the paracortical T-cell zone and it has been suggested that 
this may facilitate the correct positioning of newly arriving migratory dendritic cells 
recruited from peripheral tissues (Jakob, Ring et al. 2001).  SLC is also expressed by 
inter-digitating dendritic cells and high endothelial venules of secondary lymphoid 
tissue where it promotes adhesion and chemotaxis of naïve T lymphocytes (Gunn, Ngo 
et al. 1998; Gunn, Tangemann et al. 1998). 
 
CCR7 phenotype defines subsets of T cells that mediate two distinct aspects of 
immunological memory.  CCR7-negative memory cells (TEM, effector memory T cells) 
express receptors for migration to inflamed tissue and have immediate effector 
function.  CCR7-positive memory cells (TCM, central memory T cells) express lymph 
node homing receptors, efficiently stimulate dendritic cells and differentiate into TEM 
cells on secondary stimulation (Sallusto, Lenig et al. 1999).  Interestingly, central-
memory T-lymphocytes may access lymph node compartments by a SDF-mediated 
mechanism independent of CCR7 expression (Scimone, Felbinger et al. 2004). 
 
In summary, the mechanism of physiological lymphocyte homing (Section 1.4.1) is a 
good anatomical analogue for the dissemination of distant metastases.  However, it 
does not accurately represent the route of tumour spread to the peripheral lymph 
nodes.  Dendritic cells mirror this process more closely as they home to peripheral 
lymph nodes via afferent lymphatic channels (Section 1.4.2).  It has become apparent 
that, although the delivery of dendritic cells to the draining lymph nodes is defined by 
anatomical pathways, their uptake there is not a random process.  Dendritic cell 
homing is carefully controlled by the interaction between chemokines and their 
receptors.  Evidence is accumulating that CCR7 and CXCR4 play specific roles in this 
process.   
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1.5 Chemokines and their receptors 
The role of chemokines in lymphocyte and dendritic cell homing has been outlined 
above.  In this section an overview of the chemokine superfamily is presented and 
evidence for their role in tumour metastasis is discussed.  The superfamily of 
chemotactic cytokines (commonly abbreviated to chemokines) bind to specific cell 
surface seven-transmembrane domains of G-protein coupled receptors of the 
rhodopsin family (Lindley, Westwick et al. 1993).  Since their first identification in 
1977, over forty human chemokines and eighteen chemokine receptors have been 
described (Walz, Wu et al. 1977).  Their initially confusing nomenclature was 
simplified by the Nomenclature Committee of the International Union of 
Pharmacology (Murphy, Baggliolini et al. 2000; Zlotnik and Yoshie 2000; Murphy 
2002).  This classification is based on chemokine structure.  
 
 
1.5.1 The classification & nomenclature of chemokines and their 
receptors 
The majority of chemokines have four conserved cysteine residues and have been 
classified according to their number and spacing (Murphy, Baggliolini et al. 2000; 
Zlotnik and Yoshie 2000; Murphy 2002).  There are two major groups: firstly the C-C 
group (28 members) with the first two cysteine residues adjacent, and secondly the C-
X-C group (14 members) with the first two cysteines separated by one variable amino 
acid.  The remaining chemokines form the C group (two members) and the C-XXX-C 
group (one member).  Chemokine ligands are denoted with an “L” and a specific 
number.  The classification of chemokine receptors mirrors that of their ligands.  
Chemokine receptors are denoted with an “R” and a specific number (Figure 1.3). 
 
A dichotomous functional classification for chemokines has also been proposed 
comprising an inflammatory (or inducible) group and a homeostatic (or constitutive) 
group.  Inflammatory chemokines tend to bind promiscuously to multiple receptors, 
while homeostatic chemokines tend only to bind to other homeostatic chemokine 
receptors located on the same chromosome.  Interestingly the human genes for 
chemokines in the inflammatory group cluster to the chromosomes 4 (C-X-C group) 
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and 17 (C-C group) while those for the homeostatic group are widely scattered 
throughout the genome. 
 
 
 
 
Figure 1.3:  Human chemokines and their receptors.  A schematic representation of the binding 
characteristics of human chemokines and their receptors.  Some receptors demonstrate 
promiscuous binding to multiple ligands while others are more specific.  The former can be 
described as inflammatory (inducible) and the latter as the homeostatic (constitutive) groups. 
Reproduced with permission from (Balkwill 2004). 
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1.5.2  The structure and function of chemokines and their receptors 
With the exception of CX3CL1, chemokines lack transmembrane domains and are 
secreted by cells.  However, chemokines are able to bind to cell membrane 
glycosaminoglycans that allows them to form chemotactic gradients.  It is important to 
note that chemokines are the secreted messengers while their receptors are the effector 
units.  Consequently, the chemokines secreted by a cell will mediate a paracrine effect 
on other cells.  Meanwhile, the cell’s response to external chemokine stimuli is 
determined by its chemokine receptors expression pattern and the associated G-protein 
elements.  Significant interaction between chemokine receptors at the secondary 
messenger level explains the ability of chemokines to play a role in a variety of cellular 
processes.  Stimulation of differing chemokine receptors co-expressed on the same cell 
by different chemokine ligands can result in the same response.  Conversely, a single 
chemokine receptor may sort signals from different ligands to different signalling 
pathways (Zhang, Youn et al. 1999).   
 
 
1.5.2.1  CXCR4 structure, function and associated signalling pathways 
CXCR4 is a protein of 352 amino acids (molecular weight 42 kDa) that belongs to the 
superfamily of seven-transmembrane G-protein coupled receptors (Figure 1.4).  Its 
only known ligand is Stromal Cell-Derived Factor-1 (SDF) also known as CXCL12 
according to the universal nomenclature for chemokines and their receptors (Murphy, 
Baggliolini et al. 2000; Murphy 2002).   
 
Under homeostatic conditions, transcriptional control of CXCR4 expression is 
predominantly regulated by the positive transcription factor Nuclear Respiratory 
Factor-1 (NRF-1) (Moriuchi, Moriuchi et al. 1997) with a potential role for a second, 
positive transcription factor SP-1 (Wegner, Ehrenberg et al. 1998).  NRF-1 activity is 
increased by interaction with the human T lymphocyte virus type 1 (HTLV-1) 
transactivator protein (Tax) that may, in turn, increase the subjects susceptibility to 
HIV infection via CXCR4 binding (Moriuchi, Moriuchi et al. 1999).  The principal 
negative regulatory factor in basal CXCR4 expression thought to be Yin Yang-1 (YY1)  
(Moriuchi, Moriuchi et al. 1999).  Patients infected with human herpes virus-6 (HHV-6) 
show decreased surface CXCR4 levels, possibly due to decreased association between 
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c-Myc and YY-1 resulting in increased YY-1 binding (Hasegawa, Yasukawa et al. 2001).  
In pathophysiological states a significant number of signalling molecules have been 
shown to have an effect of CXCR4 transcription including calcium, cyclic AMP, 
interleukins (1β, 2, 4, 7, 10 and 15), growth factors (including TGF-1β, EGF, VEGF and 
basic fibroblast growth factor) and pro-inflammatory mediators such as TNF-α and 
IFN-γ (Busillo and Benovic 2007).  Some or all of these mediators of CXCR4 
transcription control may play an important role within the tumour/host 
microenvironment (Section 1.5.5) (Rubin 2009). 
 
 
 
 
Figure 1.4:  Schematic representation of the structure of the CXCR4 receptor.  Legend:  ** 
Asn11 glycosylation site for post-translational control;  shaded residues represent 25 potential 
phosphorylation sites, * denote cysteine residues involved in disulphide bonding;  IC = site of 
initial SDF/CXCR4 interaction; SBP = secondary binding pocket created by a conformational 
change in CXCR4 following initial SDF binding; UZ = Ubiquitination zone mediating 
internalisation; GPBS = G-protein binding site (contains multiple potential phosphorylation 
sites).  Adapted from (Alkhatib 2009) 
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The post-translational modification and control of CXCR4 have been extensively 
investigated.  Two potential glycosylation sites have been identified within the 
extracellular domain of CXCR4 although only one of these (Asn11) appears to be 
involved in mammalian cells (Figure 1.4) (Zhou and Tai 1999; Chabot, Chen et al. 
2000).  Glycosylation of CXCR4 is important for SDF binding as mutation at the Asn11 
site has been shown to reduce ligand association and decrease downstream signalling  
(Wang, Babcock et al. 2004).  Tyrosine sulphation is another important post-
translational modification that has been shown to affect SDF binding (Farzan, Babcock 
et al. 2002).  Three extracellular tyrosine residues have been shown to undergo 
sulphation by tyrosyl protein sulphotransferase situated in the trans-golgi apparatus.  
However, their functional significance has yet to be determined. 
 
Members of the G-protein coupled receptor superfamily typically undergo either 
homo- or hetero-dimerisation within the cell membrane.  This may occur with or 
without ligand binding and, although extensively studied (particularly within the field 
of HIV research), the exact functional significance of this oligomerisation is still 
unclear.  However, it seems most likely that homodimerisation may play a role in non-
classical activation of signalling pathways (such as JAK/STAT) independent of G-
protein function. 
 
Interaction between SDF and CXCR4 is thought to occur in two stages.  Initially, 
contact between SDF (residues 12-17) and CXCR4 (residues 2-36) results in a 
conformational change in the receptor (Figure 1.4) (Huang, Shen et al. 2003).  This, in 
turn, allows interaction between SDF (residues 1-8) and an exposed binding pocket 
formed by a combination of the second and third extracellular loops (Figure 1.4).  
Cleavage of the N-terminal residues of either SDF or CXCR4 by proteases associated 
with the inflammatory response will disrupt ligand binding (Valenzuela-Fernandez, 
Planchenault et al. 2002).  Inflammatory mediators may also play a role in increasing 
CXCR4 binding sensitivity.  This is thought to occur through changes in the 
distribution of the receptor in the cell membrane, predominantly by incorporation in 
lipid rafts (Wysoczynski, Reca et al. 2005).   
 
CXCR4 signalling has been shown to occur through G-protein dependent and 
independent mechanisms.  However, the majority of CXCR4-mediated cell functions 
are pertussis toxin sensitive, suggesting the G-protein based signalling pathways 
 51
predominate. Ligand binding results in a conformational change in the cytoplasmic 
domain of CXCR4 and association with intracellular heterotrimeric G-proteins.   Upon 
ligand binding the Gα protein subunit exchanges GDP for GTP.  This, in turn, induces 
a conformational change in the Gα subunit exposing the interacting domains for the 
Gβγ subunits and initiating signalling.  CXCR4 is able to bind multiple Gα isoforms 
although the functional significance of this is still unclear (Maghazachi 1997).  
However, chemotaxis and inhibition of adenylyl cyclase by CXCR4 are pertussin toxin 
sensitive suggesting a role for the Gαi and Gαo subunits.  CXCR4-mediated chemotaxis 
has been shown to be dependent on the activation of Rho-GTPases via Gαi subunits 
(Hart, Jiang et al. 1998).  The Gβγ subunits also play an important role in CXCR4 
signalling through their effects on multiple cascades including adenylyl cyclase, ion 
channels, signalling kinases, phospholipase-Cβ and direct activation of 
phosphoinositide 3-kinase (PI3K).  The protein p101 regulates PI3K through 
association with Gβγ subunits resulting in transcription control of several pro-
apoptotic and pro-survival genes.  Interestingly PTEN, the negative regulator of PI3K, 
is frequently deleted or mutated in cancer (Salmena, Carracedo et al. 2008).   
 
CXCR4 signalling is regulated by a combination of desensitisation, internalisation and 
degradation.  Homologous desensitisation is mediated by G protein-coupled receptor 
kinase phosphorylation of serine or threonine residues.  Twenty-one serine and 
threonine residues predominantly within the C-terminal tail and third intracellular 
domain act as potential phosphorylation sites (Figure 1.4) (Marchese, Paing et al. 2008). 
Following receptor activation, signal transduction is reduced (desensitisation) by 
phosphorylation of these residues.  This permits binding with arrestin-2 and arrestin-3 
(Figure 1.5).  This effectively uncouples the receptor from further G protein activation 
and targets it for internalisation (Krupnick and Benovic 1998).  Truncation of the C-tail 
of CXCR4 containing the potential phosphorylation sites enhances receptor activity 
and reduces internalisation (Haribabu, Richardson et al. 1997).  However, it appears 
likely that arrestin binding may not only play a role in signal truncation, but also in the 
co-ordination of signalling cascades, particularly the G-protein independent pathways 
involving p38 and ERK (Lefkowitz and Shenoy 2005).  CXCR4 also undergoes 
heterologous desensitisation mediated by a second messenger dependent protein 
kinase such as protein kinase-C (PKC).  Potential PKC phosphorylation sites include 
multiple serine residues in the C-tail.  Activation of PKC by phorbol esters increases 
phosphorylation and internalisation of CXCR4 (Signoret, Oldridge et al. 1997).   
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CXCR4 undergoes ligand-dependent degradation mediated by the E3 ubiquitin ligase 
atrophin-interacting protein-4 (AIP4).  Endosomal sorting of CXCR4 is inhibited by 
cytokine independent survival kinase (CISK) that favours receptor recycling (Figure 
1.6).  AIP4 is required at multiple steps of the degradation process (Marchese, Paing et 
al. 2008).  Ubiquinated CXCR4 is collected within HRS-postive microdomains together 
with AIP4.  Ubiquination of one of three lysine residues in the C-tail appears to mark 
the internalised receptor for degradation.  Mutation of these lysine residues appears to 
reduce degradation without affecting internalisation (Marchese and Benovic 2001).   
 
 
 
 
Figure 1.5:  An outline of the signal transduction pathways and regulation of CXCR4.  
SDF/CXCR4 interaction leads to the activation of multiple G-protein dependent signalling 
cascades.  Two G-protein independent signalling pathways have also been demonstrated 
(JAK/STAT and p38/ERK). Adapted from (Busillo and Benovic 2007). 
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Originally two isoforms of SDF were described: the predominantly expressed SDF-1α 
(89 amino acids) and the less common SDF-1β (93 amino acids).   Both SDF-1α and 
SDF-1β bind CXCR4 with similar affinity (Kd equals 7.5nM and 13.7 nM respectively) 
(Hesselgesser, Liang et al. 1998).  More recently an additional four SDF isoforms (δ, ε, φ 
and γ) have been described (Yu, Cecil et al. 2006).  For example SDF-1γ has been shown 
to be a weaker CXCR4 agonist than SDF-1α but more potent at blocking HIV binding 
due to its efficient internalisation of CXCR4 (Altenburg, Broxmeyer et al. 2007).  These 
functional isoforms are differentially distributed across tissues although their 
biological significance has yet to be fully determined. 
 
 
Figure 1.6.  CXCR4 trafficking within the endosomal-lysosomal system.  Activated CXCR4 
undergoes ubiquitination by the E3 ubiquitin ligase atrophin-interacting protein-4 (AIP4).  
Cytokine independent survival kinase (CISK) inhibits endosomal sorting of CXCR4 and favours 
receptor recycling.  Legend: ESCRT = endosomal-sorting complex required for transport; MVB 
= multivesicular bodies; Ub = ubiquitin; Vps4 = vacuolar protein sorting.  Adapted from 
(Marchese, Paing et al. 2008; Alkhatib 2009). 
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1.5.3 Chemokine receptor distribution and function on normal non-
haematopoietic cells 
Chemokine receptors are mainly distributed on the surface of leukocytes.  However, 
they have also been demonstrated on a wide range of normal cell types including 
endothelium (Pablos, Amara et al. 1999), neurones (Gupta, Lysko et al. 1998) and 
keratinocytes (vide infra).  The significance of chemokine receptor expression by non-
haematopoietic cells is unclear.  One possibility is that they play a role in 
developmental processes due to their involvement in directed cell migration.  Indeed, 
there is good evidence for chemokine receptor involvement in organogenesis, 
vascularisation and neural development (Tachibana, Hirota et al. 1998; Zou, Kottmann 
et al. 1998; Van Der Meer, Goldberg et al. 2001 ).  Chemokine receptor knockouts 
display phenotypes of variable severity.  CXCR4 is the only chemokine receptor whose 
murine knockout is fatal in the perinatal period due to ventricular septal defects, 
defective gastric vasculogenesis, abnormal cerebellar development, abnormal bone 
marrow myelopoiesis and defective B-cell (but not T-cell) lymphopoiesis (Zou, 
Kottmann et al. 1998).  This suggests that this chemokine receptor is critical in the 
normal development of the vasculature as well as its haematopoietic components.  
Evidence supporting this hypothesis has been demonstrated for development of the 
intestinal microcirculation (Heidemann, Ogawa et al. 2004).   
 
In addition to its role in vasculogenesis CXCR4 surface protein has been demonstrated 
in certain normal human epithelia.  Low levels of CXCR4 protein has been shown in all 
layers of normal oral epithelium except for the lamina propria (Jotwani, Muthukuru et 
al. 2004). Other authors investigating normal oral epithelia as controls have 
demonstrated similar findings (Delilbasi, Okura et al. 2004; Moutsopoulos, Nares et al. 
2007), although not universally so (Katayama, Ogino et al. 2005).   Positive CXCR4 
staining of has been shown in a proportion of specimens of normal breast epithelia 
(Salvucci, Bouchard et al. 2006) but this finding is poorly reproducible  (Muller, Homey 
et al. 2001; Kato, Kitayama et al. 2003).  Similar contradictory findings have been 
demonstrated for prostatic (Sun, Wang et al. 2003),  ovarian  (Scotton, Milliken et al. 
2001) and colonic (Jordan, Kolios et al. 1999; Dwinell, Eckmann et al. 1999 ; Ottaiano, di 
Palma et al. 2005) epithelia.  The reasons for these discrepancies are not clear although 
the presence of inflammation in these “normal” specimens may be a confounding 
variable due to ingress of CXCR4-labelled leukocytes or the upregulation of CXCR4 
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within the lamina propria.  The latter has been demonstrated in specimens 
representative of chronic periodontitis (Jotwani, Muthukuru et al. 2004). 
 
There is some experimental evidence of chemokine receptor expression on normal skin 
keratinocytes.  CCR3 expression was demonstrated on normal skin keratinocytes in-
vitro but not in-vivo (Wakugawa, Nakamura et al. 2001).  However, strong upregulation 
of CCR3 (Wakugawa, Nakamura et al. 2001), CCR4 (Zheng, Nakamura et al. 2003) and 
CCR6 (Homey, Dieu-Nosjean et al. 2000) expression was seen in inflammatory skin 
conditions such as psoriasis and atopic dermatitis.  The inference that the expression 
pattern of oral keratinocytes is similar to that of their skin counterparts suffers from a 
lack of direct experimental evidence.  Instead data come indirectly from the 
investigation of HIV infectivity in the oral mucosa.  It has been shown that the R5 
strain and the X4 strain of HIV (using CCR5 and CXCR4 as co-receptors respectively 
infected oral gingival cells in-vitro  (Feng, Broder et al. 1996; Liu, Zha et al. 2003 ; 
Moore, Rahemtulla et al. 2003 ).  Treatment with alcohol increased the surface 
expression of CXCR4 and increased X4-HIV strain infectivity (Chen, Zha et al. 2004). 
 
In summary, chemokine receptors are expressed on a variety of haematopoietic cells 
and contribute to the co-ordination of the immune response.  They are also expressed 
by normal non-haematopoietic cells including keratinocytes, particularly under 
inflammatory conditions where they signal via a multitude of pathways.  The 
expression of functional chemokine receptors by carcinoma cells would make them 
potentially responsive to chemokine gradients defined by the inflammatory process 
including those that mediate leukocyte homing to secondary lymphoid tissue. 
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1.5.4  Evidence for the role of chemokine receptors in the 
chemoattraction of tumour metastases. 
Direct evidence for the expression of chemokine receptors by normal epithelia is 
scarce.  However, chemokine receptor mRNA expression and protein production has 
been demonstrated by a number of carcinoma systems, including breast, prostate, 
pancreas, lung, ovarian and OSCC (see below).  Cumulative experimental and clinical 
evidence indicates that the involvement of chemokine receptors in neoplastic 
progression can be divided into three broad categories (Zlotnik 2004).  Firstly there is 
compelling evidence for the involvement of two chemokine receptors (CXCR4 and 
CCR7) with metastatic dissemination in a number of carcinoma systems.  Secondly, 
there are some chemokine receptors (such as CCR10) that may be involved with tissue-
specific metastasis.  Thirdly, there are some chemokine receptors (such as XCR1 and 
CCR9) that appear not to be associated with metastasis at all.  These observations are 
compatible with the “chemoattractant” hypothesis of metastasis.  The extrapolation of 
evidence from physiological homing mechanisms and the observed behaviour in 
clinical specimens suggest that chemokine receptors may play a role in the metastasis 
of carcinoma cells to specific tissues.   However, considering the multi-step model of 
metastatic dissemination previously outlined in Section 1.1.3 (Fidler 2003) it is possible 
that chemokine receptors may be implicated in other mechanisms that contribute to 
metastasis.  These include tumour angiogenesis, proliferation and invasion. However, 
the evidence for the role of chemokine receptors in these pathways is limited to in-vitro 
observations while the overwhelming majority of in-vivo data supports the 
“chemoattractant” hypothesis.     
 
In neoplasia it is possible that chemokine receptor activation may be achieved in a 
number of ways: mutations within the promoter region or changes in transcription 
factor levels may result in the deregulation of CXCR4 mRNA expression.  Alternatively 
single nucleotide polymorphisms (SNP) within the CXCR4 coding sequence may 
confer changes in protein function (Petersen, Glashoff et al. 2005). An association 
between one or more abnormal CXCR4 SNP containing allele and an increased risk 
(Odds Ratio 2.66) of Stage III/IV OSCC disease (Teng, Liu et al. 2009).  Finally, tumour 
cells expressing wild-type chemokine receptor may bind chemokines produced within 
the host/tumour microenvironment.  These chemokines may be derived in an 
autocrine or paracrine fashion.  Autocrine production of chemokine by tumour cells 
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will also exert an effect on those neighbouring host cells that bear a complimentary 
receptor.  The production of the chemokines by tumour cells forms a complex tissue 
microenvironment in which the host immune response may be modulated (Mosser 
2003; Mantovanni, Allavena et al. 2004).  However, it must be remembered that it is the 
expression of functional chemokine receptors that determines the responsiveness of the 
tumour cell to the microenvironment. The primary focus of this project is the 
expression of chemokine receptors by OSCC tumour cells and consequently the 
delineation of their response to factors that may be present in the host/tumour 
microenvironment.  The production of chemokines by OSCC tumour cells would be an 
interesting subject for investigation but falls outside the scope of this project.   
 
 
1.5.4.1 Evidence for the role of chemokine receptors in lymphatic metastasis. 
The chemokine receptors most commonly over-expressed by carcinomas are CCR7 and 
CXCR4 (Zlotnik 2004).  CCR7 plays a key role in the physiological homing of 
lymphocytes and dendritic cells to peripheral lymph nodes.  Consequently it may be 
hypothesised that the lymphatic spread of tumour cells is mediated by the expression 
of CCR7.  There is some in-vitro data and observational evidence to support this theory.  
Investigation of carcinoma cell lines in-vitro has demonstrated an increase in the 
expression of the chemokine receptor CCR7 in the majority of breast, gastric and 
oesophageal carcinoma cell lines compared with primary cultures of epithelial cells 
(Muller, Homey et al. 2001; Mashino, Sadanaga et al. 2002; Ding, Shimada et al. 2003).  
The CCR7 receptors expressed by these cell lines were functionally active: 
demonstrating calcium flux, actin polymerisation, migration and invasion in response 
to the chemokine SLC (CCL21). 
 
Immunohistochemical analysis of clinical samples from the digestive tract reveals that 
CCR7 expression is not ubiquitous.  CCR7 protein was shown to be expressed by 90% 
of oesophageal carcinoma cells (Ding, Shimada et al. 2003) and 22 to 66% of gastric 
carcinomas (Mashino, Sadanaga et al. 2002; Kwak, Hur et al. 2005).  The literature on 
the clinical correlations of CCR7 expression by gastric tumours remains unclear.  
Mashino et al (2002) found that primary gastric tumours staining positive for CCR7 
were more likely to be associated with lymphatic invasion, lymph node infiltration and 
reduced patient survival.  Kwak et al (2005) found no association between CCR7 
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expression and lymph node metastasis and, indeed, demonstrated that patients with 
CCR7 positive primary tumours had a better overall survival compared with their 
CCR7 negative counterparts.   Examination of colorectal carcinomas found no 
association between CCR7 staining and lymph node metastasis or patient survival 
(Schimanski, Schwald et al. 2005).  These contradictory findings may be due to 
experimental factors such as methodological inconsistencies, small study numbers or 
poor clinico-pathological correlation.  Alternatively, it is also consistent with the 
hypothesis that CCR7 expression alone does not determine the metastatic potential of 
gastric carcinomas. 
 
It has been shown that CCR7 mRNA expression by non-small cell lung carcinoma 
(Takanami 2003) and oesophageal (Ding, Shimada et al. 2003) carcinoma cells, 
positively predicts lymph node metastasis.  Again, for gastric carcinomas, results from 
the literature are conflicting regarding this association (Yan, Zhu et al. 2004; Kwak, Hur 
et al. 2005).  However, a methodological flaw of all of these studies was that the 
detection of CCR7 was based on the RT-PCR of homogenised tissue samples.  
Therefore it is possible that this difference is due to the recruitment of CCR7-positive 
host leukocytes into the tumour microenvironment and not due to increased CCR7 
expression by the tumour cells.  In the investigation of chemokine receptor expression 
in tissue samples it is important to separate tumour cells from host inflammatory 
infiltrate prior to analysis.  Consequently, despite the methodological flaws in some of 
these studies, it seems unlikely that CCR7 expression is uniquely responsible for the 
mediation of lymphatic metastases in carcinomas of the upper aero-digestive tract.  A 
role for other chemokine receptors is possible.  One that is associated with 
physiological leukocyte homing to lymph nodes is CXCR4. 
 
The role of CXCR4 in metastatic progression has been studied in a number of 
carcinoma systems.  Renal, breast and lung carcinoma cells showed significantly higher 
expression of CXCR4 compared to adjacent normal tissue (Muller, Homey et al. 2001; 
Schrader, Lechner et al. 2002; Takanami 2003).  Breast carcinomas with higher 
expression of CXCR4 showed more extensive lymph node metastasis (Kato, Kitayama 
et al. 2003; Liu, Lang et al. 2009).   Interestingly, in the study by Takanami (2003), both 
CCR7 and CXCR4 expression was associated with lymph node metastasis, although 
only CCR7 mRNA expression was an independent predictive factor.  These data 
suggest that CCR7 and CXCR4 may play a dual role in lymphatic metastases in some 
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tumour types.  Further evidence for this theory is provided by investigation of 
lymphoma subtypes.  Hodgkin’s disease of the classical type locates predominantly in 
the inter-follicular areas of the lymph node and was found to express both CXCR4 and 
CCR7, whereas the nodular lymphocyte-predominant type is regularly associated with 
the follicular structures and expressed CXCR4 but not CCR7 (Hopken, Foss et al. 2002).  
Lymphoid infiltration by Adult T-cell leukaemias appears to be CCR7 mediated 
(Hasegawa, Nomura et al. 2000). 
 
 
1.5.4.2  Evidence for the role of chemokine receptors in distant metastasis 
Clinical observation of carcinomas of the breast, bronchus, kidney and prostate reveals 
their affinity for metastasis to the lung, liver and bone.  One hypothesis is that this 
affinity could be mediated by the CXCR4/SDF axis.  Supporting evidence comes from 
the demonstration that SDF is preferentially expressed in human lymph nodes, lung, 
liver and bone marrow at the mRNA and protein levels (Muller, Homey et al. 2001; 
Phillips, Burdick et al. 2003).  Experimental data show that primary human osteoblastic 
cell cultures express SDF (Taichman, Cooper et al. 2002).  As stated earlier cell lines 
derived from breast, prostate and renal carcinomas express CXCR4.  Interventional 
studies reveal that the CXCR4/SDF axis does play a role in tumour metastasis.  
Treatment of nude mice with neutralising anti-CXCR4 monoclonal antibodies 
significantly reduced the metastatic burden of CXCR4-positive breast carcinoma cells 
to the lung and peripheral lymph nodes (Muller, Homey et al. 2001) and CXCR4-
positive prostate carcinoma cells to the bone (Sun, Schneider et al. 2005).  Abrogation of 
distant non-small cell lung carcinoma metastases in nude mice was achieved by 
blockade with anti-SDF monoclonal antibodies (Phillips, Burdick et al. 2003).   
 
However, experimental evidence has shown that the role of CXCR4 in the 
development of distant metastases is not purely related to its chemoattractive 
properties (see Section 1.5.5 for further discussion).  The development of pulmonary 
metastases following intravenous injection of colonic carcinoma cells was studied in 
nude mice (Zeelenberg, Ruuis-Van Stalle et al. 2003).  They observed that, 24 hours 
after inoculation, CXCR4-negative tumour cells colonised the lungs with the same 
efficiency as CXCR4-positive cells.  However, CXCR4-negative cells failed to 
proliferate and form macrometastases while CXCR4-positive cells grew exponentially 
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from approximately day six.  These findings suggest that CXCR4 does not mediate the 
arrest of tumour cells in the pulmonary vasculature but does promote subsequent 
proliferation of the secondary tumour deposits.  This group used an interesting 
technique to prevent CXCR4 surface expression.  They transfected wild-type colonic 
carcinoma cells that produced CXCR4 with a vector containing SDF tagged with a 
KDEL sequence that anchored it to the nuclear membrane.  Consequently the free 
bioactive end was able to bind CXCR4 preventing its association with the cell 
membrane.  It is possible that the overexpression of SDF may have altered the cell 
phenotype in a way that alters its metastatic potential.   
 
Studies using an alternative technique of gene silencing supports the theory that 
CXCR4 mediates metastatic tumour progression in breast carcinomas (Lapteva, Yang 
et al. 2005; Liang, Yoon et al. 2005).  Both groups used small-inhibiting RNA (siRNA) to 
induce CXCR4 knockdown and they demonstrated that pulmonary metastases were 
reduced in mice inoculated with CXCR4-deficient tumour cells.  However, these 
experiments did not differentiate between the chemoattractant and non-
chemoattractant mechanisms of CXCR4 action. 
 
A role for chemokine receptors has been postulated in other tumour types.  Melanoma 
cells express the chemokine receptor CCR10 as well as CCR7 and CXCR4 in-vitro.  
CTACK (CCL27), the ligand for CCR10, is preferentially expressed in the skin (Muller, 
Homey et al. 2001).  The common sites for melanoma metastasis include satellite 
lesions to the skin.  These may be mediated by CCR10 expression by melanoma cells.   
 
 
 
1.5.5 The role of CXCR4 in mechanisms of tumour metastasis not 
involving chemoattraction. 
Experimental data in ovarian, renal, prostate, colon and breast carcinoma cell lines 
have demonstrated that CXCR4 mRNA is not ubiquitously translated in-vitro.  (Muller, 
Homey et al. 2001; Scotton, Milliken et al. 2001; Taichman, Cooper et al. 2002; 
Zeelenberg, Ruuis-Van Stalle et al. 2003; Schimanski, Schwald et al. 2005).  In these cell 
lines, SDF-mediated signalling has been shown to result in ligand-induced receptor 
endocytosis, intracellular calcium mobilisation, actin polymerisation, chemotaxis, 
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increased cell-to-cell adhesion, trans-endothelial migration and invasion of the 
extracellular matrix.  However, as outlined above (Section 1.5.4.2), direct in-vivo 
evidence of a role for CXCR4 in the pulmonary dissemination of colonic carcinoma 
cells via a non-chemoattractive mechanism has been described (Zeelenberg, Ruuis-Van 
Stalle et al. 2003).  Given the multistage process of tumour metastasis (Table 1.1) it is 
possible that chemokine receptors may play a role in a multitude of these steps (Fidler 
2003).  This is discussed below. 
 
1.5.5.1  The role of CXCR4 in tumour proliferation and apoptosis. 
Over-expression of CXCR4 has been shown to mediate the proliferation of prostate 
carcinoma cells in-vitro and in-vivo (Darash-Yahana, Pikarsky et al. 2004).  
Subcutaneous injection of transfected prostate carcinoma cells containing the CXCR4 
insert into NOD/SCID mice yielded primary and secondary tumours significantly 
larger than controls lacking the CXCR4 insert.  Similar experimental evidence has 
demonstrated a similar pro-proliferative effect of CXCR4 in anaplastic thyroid 
carcinoma (De Falco, Guarino et al. 2007), salivary mucoepidermoid carcinoma (Wen, 
Zhu et al. 2007), breast (Wendt, Cooper et al. 2008) and epithelial ovarian carcinoma 
(Kajiyama, Shibata et al. 2008).  Pathways thought to be involved include MAP/Erk 
kinase (Darash-Yahana, Pikarsky et al. 2004; Yang, Lee et al. 2007), ERK1/2 and AKT 
(De Falco, Guarino et al. 2007).  However, direct empirical testing of the precise 
pathways involved is limited by the relatively crude pharmacological antagonists 
available and the complex interaction of the multiple downstream signalling pathways 
activated following SDF binding to CXCR4. 
 
Net tumour growth is the outcome of cell proliferation and cell death.  While cell 
necrosis can occur due to anoxia, the ability to evade programmed cell death 
(apoptosis) is another possible mechanism by which tumours may expand.  Two 
reports have recently demonstrated a regulatory role for CXCR4 in bcl2-mediated 
apoptosis in thymic dendritic cells (Hernandez-Lopez, Valencia et al. 2008) and 
prostatic carinoma cell lines (Porvasnik, Sakamoto et al. 2009).   However, Pan and 
colleagues found no effect of SDF-blockade on renal cell carcinoma apoptosis (or 
proliferation) either in-vitro or in-vivo (Pan, Mestas et al. 2006).  The role of 
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SDF/CXCR4 has been examined in anoikis (Wendt, Cooper et al. 2008).9  They found 
that autocrine SDF production inhibited tumour formation in non-adherent colorectal 
carcinoma cells by the induction of caspase 3/7-mediated apoptosis.  Their data 
suggest that endogenous (but not exogenous) SDF stimulation yields tonic ERK1/2 
phosphorylation leading to apoptosis.  In this way their findings differ from those of 
others by suggesting that it is the suppression of autogenous SDF production that is 
the key step in metastatic progression for the colorectal cells examined.  Without 
further work to determine if this effect can be demonstrated in other cell lines, it is 
impossible to tell if these findings are limited to the cell system examined. 
 
The exact role of the SDF/CXCR4 axis in tumour proliferation and apoptosis is not as 
clear-cut as these data from different carcinomas suggest.  The limitations of in-vitro 
findings are that manipulation of individual variables may not accurately reflect the 
complex tumour/tissue microenvironment found in-vivo.  The limitation of animal 
model data is that the primary endpoint measured (relative tumour size) is inevitably a 
result of a combination of factors of which proliferation is one.  Supportive evidence of 
a role of the SDF/CXCR4 axis in other components of the metastatic pathway should 
be sought. 
 
 
1.5.5.2  The role of CXCR4 in tumour angiogenesis  
The effect of CXCR4 stimulation on tumour growth has been reported in a number of 
carcinoma systems.  As discussed in Section 1.5.5.1, continued cell proliferation 
requires the development of a new blood supply (neo-angiogenesis).  SDF stimulation 
results in increased vascular endothelial growth factor (VEGF) production by CXCR4-
overexpressing prostate carcinoma cells (Darash-Yahana, Pikarsky et al. 2004).  One 
possible mechanism by which CXCR4 upregulation might be controlled in response to 
tissue hypoxia is via hypoxia-inducible factor-1α (HIF-1α) mediated signalling in a 
number of different cell types including endothelial and tumour cells (Schioppa, 
Uranchimeg et al. 2003).  HIF-1α mRNA is stabilised under hypoxic conditions 
whereas under conditions of normal oxygen tension HIF-1α mRNA is degraded via the 
von Hippel-Lindau (VHL)-E3 ubiquitin ligase complex (Staller, Sulitkova et al. 2003).  
                                                     
9 Anoikis is the term used to describe programmed cell death due to lack of contact with the 
extracellular matrix. 
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Through this mechanism, mutations in the VHL protein have been shown to be 
associated with high CXCR4 expression and poor prognosis in renal cell carcinoma 
(Staller, Sulitkova et al. 2003 ; Pan, Mestas et al. 2006).    
 
HIF-1α mediated control of CXCR4 expression is not the only role of the SDF/CXCR4 
axis in tumour angiogenesis.  Activated carcinoma-associated fibroblasts (CAFs), 
bearing a myofibroblast phenotype, have been shown to promote the growth of breast 
carcinoma cells by the recruitment of endothelial progenitor cells (EPCs) via a 
mechanism at least partly mediated by SDF (Orimo, Gupta et al. 2005).  A role for EPC 
recruitment in tumour angiogenesis has been demonstrated in-vitro and in-vivo (Lyden, 
Hattori et al. 2001).   By the activation of fibroblasts it is possible that tumour stroma 
parallels the physiological response of tissues to injury including the release of SDF 
(De Falco, Porcelli et al. 2004).  Unlike the response to injury, CAFs remain 
permanently activated, for example by establishing autocrine stimulation by TGF-β.  
However, the role of CAFs in tumour progression is not limited to neo-angiogenesis 
and, recently, a direct effect on carcinoma cell proliferation has been described.   This is 
outlined below. 
 
It has been shown that the tumour/tissue microenvironment plays an important role in 
the initiation and promotion of carcinogenesis.  Transforming Growth Factor-β (TGF-β) 
signalling in fibroblasts has been shown to control the oncogenic potential of adjacent 
epithelia in squamous cell carcinoma of the forestomach (Bhowmick, Chytil et al. 2004).  
This is in addition to the autocrine activation loop outlined above and was initially 
thought to be achieved through a multitude of fibroblast-derived growth factors 
including the transforming-, hepatocyte-, insulin-like, epithelial- and fibroblast- 
growth factor families (Bhowmick, Neilson et al. 2004).   
 
More recently a role for complex interplay between SDF and TGF-β has been 
described.  Breast CAFs have been shown to produce significantly more SDF than 
primary breast carcinoma cells in-vitro (Orimo, Gupta et al. 2005).  This release into the 
tumour/tissue microenvironment has been shown to exert a paracrine pro-
proliferative effect on breast tumour growth that can be increased by over-expression 
of SDF or decreased by the downregulation of CXCR4 expression by siRNA (Orimo, 
Gupta et al. 2005).  Co-culture experiments have revealed that activated carcinoma-
associated fibroblasts (CAFs) stimulate the proliferation of transformed (but not 
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normal) epithelia and, conversely, CAFs (but not normal fibroblasts) stimulate the 
proliferation of transformed epithelia.  In prostatic cell lines, it has been demonstrated 
that TGF-β regulates localisation of CXCR4 to the carcinoma cell membrane and its 
subsequent response to CAF-derived SDF (Ao, Franco et al. 2007).  Some preliminary 
data outlining the possible association between CXCR4 and EMT in OSCC cells in-vitro 
has been described and this is discussed in Section 1.6.2.4. 
 
 
1.5.5.3  CXCR7: a second receptor for SDF 
The receptor RDC1 was originally cloned in 1990 (Libert, Passage et al. 1991) but its 
role as a second receptor for SDF was not described until 2005 (Balabanian, Lagane et 
al. 2005).  RDC1/CXCR7 shares many similarities with CXCR4 including a high affinity 
for SDF, ligand-mediated receptor internalisation, acting as a HIV-1 co-receptor and 
possible interaction between the two receptors (Shimizu, Haraguchi et al. 1999; Sierro, 
Biben et al. 2007).  However, some differences have been noted, not least the inability 
of CXCR7 to associate with G-proteins via the intracellular domains (Balabanian, 
Lagane et al. 2005).  CXCR7 is highly implicated in developmental processes 
(particularly of the haematopoietic system) although, unlike CXCR4, its double 
knockout is not lethal (Sierro, Biben et al. 2007).  It has been proposed that the principal 
function of CXCR7 in organogenesis is through its role as a decoy receptor delivering 
ligand for lysosomal degradation (Pruenster and Rot 2006).   
 
From these observations it might be expected that CXCR7 does not mediate functional 
responses in tumour cells.  This is not the case.  CXCR7 over-expression has been 
shown to promote tumour growth in nude mice (Raggo, Ruhl et al. 2005) and has been 
demonstrated in a number of human carcinoma cell lines (Burns, Summers et al. 2006).  
Investigation of prostate carcinoma specimens has revealed an association between 
CXCR7 expression and tumour aggression, survival pathways and the release of pro-
angiogenic factors such as VEGF and CXCL8 (Wang, Shiozawa et al. 2008).  Other 
groups have found that the interaction between CXCR4 and CXCR7 varies between 
cell lines (Meijer, Ogink et al. 2008).  In colon carcinoma cells, proliferation was 
dependent on CXCR7 activity whereas in pancreatic carcinomas both CXCR7 and 
CXCR4 mediated proliferation in-vitro.  However, either over-expression or 
 65
downregulation of CXCR7 had no effect on invasion into Matrigel or tumour growth in 
nude mice (Meijer, Ogink et al. 2008). 
 
These data are part of a rapidly increasing literature investigating possible roles for 
CXCR7 in carcinoma progression.  It is not clear at present what is the precise 
intracellular function for CXCR7 although it appears from these preliminary findings 
that it may differ between cell types.  CXCR7 certainly acts as a competitor for SDF 
binding and may exert some of its effects on the SDF/CXCR4 pathway by targeting the 
ligand for lysosomal destruction.  However, a more complex interplay between the 
receptors or their downstream signalling pathways cannot be excluded and further 
work is required to delineate this more clearly. 
 
 
1.5.6  Summary 
Chemokines receptors are G-protein linked cell surface receptors that have been shown 
to be associated with many important physiological roles including embryonal 
development, lymphocyte homing, inflammation and tissue repair.  Two family 
members (CXCR4 and CCR7) are central to many of these processes.  The wide tissue 
distribution of CXCR4, its fatal murine knockout and its discovery on murine stem 
cells lends support to the hypothesis that CXCR4 is a human stem cell marker. 
 
There is increasing evidence that carcinomas develop the ability to subvert many of 
these physiological signalling pathways to promote tumour-associated characteristics 
including proliferation, migration, invasion, angiogenesis and EMT.  For all of these 
processes it has been shown that the SDF/CXCR4 axis does not act alone, but rather as 
an (important) player within the tumour/tissue microenvironment.  The prominent 
role of CXCR4 in the biology of both stem cells and carcinoma cells supports its 
possible role as a cancer stem cell marker (Kucia, Wojakowski et al. 2006).   
 
 
 66
1.6  Chemokine and chemokine receptor expression in oral 
squamous cell carcinoma. 
The vast majority of evidence relating to roles for chemokines and their receptors in 
OSCC progression has focussed on CCR7 and CXCR4.  This is discussed in Sections 
1.6.1 and 1.6.2 respectively.  With regards to chemokines, CXCL8 (Interleukin-8) has 
been shown to increase OSCC cell growth in-vitro (Christofakis, Miyazaki et al. 2008), 
and has been suggested as a possible serum biomarker for the disease (St John, Li et al. 
2004).  Laboratory data suggest that CXCL8 plays a role in many tumour processes and 
large scale clinical studies are still awaited to substantiate the sensitivity and specificity 
of the marker.10  Quantitative evaluation of salivary CXCL8 levels have demonstrated a 
considerable overlap between OSCC patients and disease-free controls suggesting its 
use as a screening tool would not be helpful (Arellano-Garcia, Hu et al. 2008).  From 
these findings it would be possible to hypothesise that, due to the complexities of 
chemokine and chemokine receptor signalling, the manipulation of individual 
molecules from these families would not be associated with relevant changes in OSCC 
tumour behaviour.  The evidence presented below shows that for (at least) CCR7 and 
CXCR4 this is not the case. 
 
 
1.6.1  Evidence supporting a role for CCR7 in OSCC 
As previously described (Section 1.2.1), clinical observation of OSCC reveals that 
cervical lymph node metastasis is common.  Distant metastasis may be common at the 
microscopic level (Kotwall, Sako et al. 1987) but is uncommon at the macroscopic level 
(Ferlito, Shaha et al. 2001; Carlson and Ord 2002).  Given the weight of evidence in the 
literature favouring the importance for CCR7 expression in lymphatic homing, it is 
reasonable to hypothesise from these clinical observations that CCR7 is more 
important in OSCC metastasis than CXCR4.  Indeed, there is some evidence in the 
literature that supports a role for CCR7 expression in HNSCC.  Wang et al (2004) 
investigated CCR7 expression in four pairs of cell lines derived from the primary 
lesions and lymph node metastases of squamous carcinomas of the larynx and pharynx 
(Wang, Xi et al. 2004).  Although they claim that CCR7 mRNA expression was higher 
                                                     
10  In this small series (n=32) the sensitivity and specificity of the association of raised salivary 
CXCL8 levels with OSCC were reported as 86% and 97% respectively (St John, Li et al. 2004) . 
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in the metastatic cells than in those derived from the primary lesion, their non-
quantitative results show similar expression levels.  Interestingly, CCR6 expression 
appears to reduce in the metastasis-derived cell lines.  Their examination of 
homogenised fresh-frozen HNSCCs revealed similar levels of CCR7 expression in the 
primary lesion and lymph node isolates.  Again CCR6 expression was reduced in the 
latter.  One methodological criticism is that no attempt was made to exclude host 
stromal cells the lymph node isolates.  Consequently it is impossible to determine if the 
CCR7 expression demonstrated was derived from host leukocytes or neoplastic cells.  
 
The same group also investigated CCR7 mRNA expression in sub-clones of an OSCC 
cell line that had metastasised to the lymph nodes in three successive passages in nude 
mice (Wang, Xi et al. 2004).  Using semi-quantitative RT-PCR they showed that CCR7 
expression was increased with successive passage.  However, preliminary evidence 
from another group does not support this finding (Uchida, Begum et al. 2003).  They 
demonstrated that CCR7 was universally downregulated in four OSCC cell lines 
including two that readily metastasised to local lymph nodes in nude mice.  
Furthermore they showed that CXCR4 mRNA expression was increased in extracts 
from lymph nodes with OSCC metastatic involvement compared with primary lesions 
and gingival tissue from patients undergoing third molar surgery.  However, their 
findings are subject to the same methodological criticism as before: tissue biopsies 
were taken whole and homogenised and no attempt was made to account for the 
relative contributions to the overall levels of CXCR4 mRNA from resident lymphocytes 
or tumour cells found in the tissue samples.  Furthermore it is possible that the control 
tissue overlying the third molar teeth that required removal (and therefore assumed to 
be symptomatic) was not representative of normal mucosa.  Inflammation has been 
shown to increase CXCR4 labelling in oral keratinocytes as outlined above (Section 
1.5.3). 
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Evidence for the localisation of CCR7 protein in OSCC samples has been produced 
using immunohistochemistry by two groups (Tsuzuki, Takahashi et al. 2005; Shang, 
Liu et al. 2009).  Both papers demonstrated CCR7 staining of OSCC cells in primary 
and CLN secondary deposits in 60 to 66% of clinical specimens examined.11  Both 
groups also demonstrated CCR7-positive tumours were associated with statistically 
significant increases in large primary disease (T3/4), lymph node metastases (pN+) 
and advanced disease (Stage III/IV) although no attempt was made to address the 
confounding effects of these variables (Tsuzuki, Takahashi et al. 2005; Shang, Liu et al. 
2009).  These results are suggestive that increased CCR7 production is associated with 
advanced disease and in one cohort this was associated with an increased risk of local 
recurrence and a reduced disease-free and overall survival (Tsuzuki, Takahashi et al. 
2005).  Some in-vitro data to support a causative role for CCR7 in metastatic disease 
was also reported with increased invasion through an extracellular matrix analogue 
(Matrigel) in response to the CCR7 ligand CCL21 (Shang, Liu et al. 2009).  Knockdown 
of CCR7 using siRNA significantly decreased CCR7-mediated migration, invasion and 
proliferation of OSCC cells in-vitro (Shang, Liu et al. 2008).12  It has been shown that 
CCR7-mediated PI3K/Akt signalling protects OSCC cells from cisplatin-induced 
apoptosis and increases tumour cell survival.  This mechanism may explain the 
observation of significantly less tumour growth in CCR7 ligand-deficient (plt) mice 
compared with normal controls (Wang, Seethala et al. 2008).  In conclusion, the small 
amount of preliminary data available on CCR7 production by OSCC cells suggests that 
this chemokine receptor is a reasonable candidate for mediating tumour metastasis. 
 
 
                                                     
11 Both groups used similar methodology.  Briefly, CCR7 positive tumours were defined as 
having >=30% of OSCC cells that stained for CCR7.  The threshold was determined empirically 
but set at an arbitrary value once assessment had been made by two independent and blinded 
observers (Tsuzuki, Tkahashi et al. 2005; Shang, Liu et al. 2009).  
12 This description is based on the abstract as the original article is written in Chinese and 
therefore its validity and scientific rigour cannot be tested independently of the journal’s peer 
review process (Shang, Liu et al. 2008).   
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1.6.2  Evidence supporting a role for CXCR4 in OSCC 
1.6.2.1  CXCR4 protein in OSCC clinical specimens 
A series of studies using immunohistochemistry to investigate CXCR4 expression in 
OSCC clinical specimens have been published over the last six years (Table 1.4).  Two 
small preliminary series both demonstrated strong CXCR4 staining in cells that had 
metastasised to the cervical lymph nodes although, probably because of small numbers 
(18 and 23 respectively), no statistically significant associations with clinico-
pathological features were demonstrated (Uchida, Begum et al. 2003; Delilbasi, Okura 
et al. 2004).  In a larger series (61 patients) CXCR4 staining was demonstrated in 57% of 
primary lesions and 75% of lymph node metastases (Almofti, Uchida et al. 2004).  
Positive CXCR4 staining was significantly associated with the mode of invasion, 
lymphatic metastasis and reduced 5-year disease-free survival by univariate analysis.  
Association of the latter was no longer significant on multivariate analysis, most likely 
due to the confounding effect of lymph node status on prognosis (Almofti, Uchida et 
al. 2004).  A significant relationship between CXCR4 staining in OSCC cells within the 
primary lesion and lymph node metastases was also demonstrated in another large 
series (90 patients) although only 30% of primary tumours were judged to be CXCR4 
positive (Ishikawa, Nakashiro et al. 2006).  
 
O’Donnell et al (2005) investigated the expression profiles of a small number of 
primary and secondary OSCC lesions.  They found no significant difference in CXCR4 
mRNA expression between specimens although their methods used tissue 
homogenates rather than microdissection of tumour tissue (O'Donnell, Kupferman et 
al. 2005).  Examination of the same specimens using immunohistochemistry found no 
subjective difference in CXCR4 staining between primary and secondary lesions.  
However, the validity of these findings can be questioned as no appropriate controls or 
description of the assessment methods used were given. 
 
Xu et al investigated 91 OSCC specimens and reported expression of CXCR4 in 57 
(62.6%) of them (Xu, Li et al. 2006).  The same findings were re-reported 3 years later  
(Meng, Wuyi et al. 2009).  Furthermore they also described an association between 
CXCR4 expression and lymph node metastasis, tumour size and histological grade 
although it is not clear whether these are univariate or multivariate analyses.  Lee 
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investigated 74 cases and demonstrated CXCR4-positive staining in 45 (61%) primary 
lesions (Lee, Jin et al. 2009).13  Multivariate analysis revealed that positive CXCR4 
staining, recurrence and large tumour size (T3/4) were independent, significant 
predictors of poor overall survival.  Of these, CXCR4 demonstrated the most striking 
effect.  However, the duration of follow-up was not specified although interpretation 
of the Kaplan-Meier curves infers that the majority of patients were followed for less 
than 5 years. 
 
In a small series of advanced OSCC (predominantly tongue and floor of mouth lesions) 
no significant difference was demonstrated between CXCR4 staining in primary 
lesions, lymph node metastases or survival (Oliveira-Neto, Silva et al. 2008).  However, 
these results may have been skewed by the selection of cases with advanced disease 
and poor overall survival.  In a large series of predominantly early OSCC, 20/85 (23%) 
of primary lesions were found to express CXCR4 (Ishikawa, Nakashiro et al. 2009).14  
Qualitative reporting of the findings suggested that staining was strongest at the 
invasive front.  Positive CXCR4-staining of primary lesions was associated with lymph 
node metastasis. 
 
In summary, this accumulation of published literature demonstrates that CXCR4 
protein staining is present in OSCC primary lesions.  Collectively there is a trend for 
increased CXCR4 staining to be associated with more advanced disease, lymphatic 
metastases and reduced patient survival.  However, these data have numerous 
shortcomings. There are a number of potential methodological inconsistencies both 
between studies and between observers.  Selected samples vary in their site, size, stage, 
differentiation and overall treatment.  These potentially confounding variables were 
often poorly controlled for both methodologically and statistically.  All of the 
published studies used consecutive runs for immunohistochemistry (none of the 
specimens were run concurrently).  The best method to overcome this potential bias 
would be to use tissue arrays with comprehensive pathological information.  None of 
the published studies used this methodology.  
                                                     
13 CXCR4 staining was graded into 4 categories by two independent blinded observers relative 
to the intensity of interstitial infiltrates (Lee, Jin et al. 2009).  
14 Specimens were graded on a 4 point scale with 0 and 1 defined as negative and the remainder 
as positive.  The number of observers, blinding or definition of the grading levels was not 
supplied (Ishikawa, Nakashiro et al. 2009). 
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Table 1.4: Synopsis of the published literature on the association of CXCR4 production by 
OSCC clinical specimens.   
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Uchida 2003 18 SNS Not stated 8/10 (80%) None 
Almofti 2004 61 SNS 35/61 (57%) NT 
LN metastasis (UV) 
Mode of invasion (UV) 
Reduced survival (UV) 
Delabasi 2004 23 Tongue 23/23 (100%) 
9/9 
(100%) 
No significant 
associations 
O’Donnell 2005 26 SNS 16/16 (100%) 
10/10 
(100%) 
No significant 
associations 
Xu 2006 
Meng 2009 91 SNS 
57/91 
(62%) NT 
LN metastasis (NK) 
Tumour size (NK) 
Histolol Grade (NK) 
Ishikawa 2006 90 SNS 27/90 (30%) NT LN metastasis (UV) 
Oliveira-Neto 
2008 41 
Tongue 
FOM Not stated NT None 
Hong 2008 26 SNS 15/26 (58%) NT 
PCNA labelling index 
(UV) 
Lee 2009 74 SNS 45/74 (61%) NT Reduced Survival (MV) 
Ishikawa 2009 85 SNS 20/80 (23%) NT LN metastasis (UV) 
 
Legend: FOM = floor of mouth, SNS = site not specified, NT = not tested UV = Univariate 
analysis, MV = multivariate analysis, NK = type of statistical analysis not stated. 
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1.6.2.2  CXCR4 in OSCC cell migration and invasion. 
A high, constitutively expressing CXCR4 cell line has been shown to invade through 
the ECM-analogue Matrigel in response to SDF (Yoon, Liang et al. 2007).  This effect 
was attenuated by incubation with the pharmacological CXCR4-antagonist TN14003.  
Over-expression of CXCR4 was induced in an OSCC cell line by transfection including 
the CXCR4 insert (Uchida, Begum et al. 2004).  CXCR4 over-expression was associated 
with an increase in migration towards SDF.  However, these findings were not 
substantiated with blockade of the SDF/CXCR4 axis and the negative control 
experiments were performed with wild-type (rather than transfected cells lacking the 
CXCR4 insert) (Uchida, Begum et al. 2004).  The migration of a constitutively CXCR4-
expressing OSCC cell line (in the absence of exogenous SDF) was shown to be 
increased by transfection with the SDF coding sequence (Uchida, Onoue et al. 2007).  
This effect was attenuated by the pharmacological CXCR4-antagonist AMD3100.  
However, the scratch wound assays from which these findings were derived were not 
performed with growth-arrested cells and therefore do not differentiate between 
differences in cell motility or anchorage-dependent cell proliferation. 
 
CXCR4 knock-down in OSCC cells using RNAi has been shown to reduce cell invasion 
through Matrigel in-vitro (Hong, Pai et al. 2009).  However, no evidence has yet been 
published looking at the effect of CXCR4 over-expression on cell invasion through 
ECM analogues with appropriate controls (Uchida, Begum et al. 2004).  Work focussing 
on possible mechanisms of bone invasion by OSCC cells in-vivo has suggested an 
important role for IL-6 (Tang, Chuang et al. 2008).  This group has shown constitutive 
production of SDF by osteoblasts in-vitro.  They also demonstrated that SDF increased 
IL-6 production by OSCC cells by a mechanism that was blocked by antibodies, 
antagonists or RNAi towards CXCR4.  They hypothesised that, as IL-6 has been 
implicated in osteoclastogenesis, this mechanism may be involved in bone invasion by 
OSCC cells within primary lesions in-vivo (Tang, Chuang et al. 2008).  What is unclear 
from these data is whether this may play a role in the metastatic dissemination of 
OSCC, although clinical observation reveals that distant, lytic bone deposits are an 
uncommon manifestation of the disease. 
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1.6.2.3  CXCR4 protein in OSCC cell proliferation  
Over-expression of CXCR4 in a constitutively low-expressing OSCC cell line yielded 
more lymph nodes metastases following orthotopic injection in nude mice compared 
with untransfected controls (Uchida, Begum et al. 2004).  Serial passage of metastatic 
OSCC sub-clones following orthotopic inoculation into nude mice has been shown to 
be associated with an increase in CXCR4 mRNA and protein (Yoon, Liang et al. 2007).  
Treatment of mice in which CXCR4-positive subclones had been implanted in the 
submandibular region with the CXCR4 antagonist TN14003 resulted in a significant 
reduction of early primary tumour growth and associated lung metastases (Yoon, 
Liang et al. 2007).  While this evidence seemingly supports a role for CXCR4 in the 
growth of primary and secondary OSCC lesions, it has some flaws.  Firstly, in the 
former experiments, the effect of transfection alone was not determined (Uchida, 
Begum et al. 2004).  Secondly, in the latter experiments, the original sub-clones were 
selected out through serial animal passage (Yoon, Liang et al. 2007).  Therefore, it is 
possible that other factors have been upregulated through this artificial process.  This 
may limit the translation of these data to the clinical setting. 
 
Other factors, such as the delivery of viable tumour cells to the systemic circulation, 
may define the pattern of metastatic dissemination of CXCR4-expressing OSCC cells.  
Orthotopic injection of constitutively CXCR4-expressing OSCC cells transfected with 
the SDF coding sequence resulted in increased lymphatic metastases without changing 
the volume of the primary disease or detectable distant metastases (Uchida, Onoue et 
al. 2007).  However, when the same cells were injected intravenously the volume of 
lung metastases was significantly higher in clones containing the SDF insert compared 
with those that did not.  These data suggest that differing patterns of metastasis result 
from cells directly entering the systemic venous system (and thus delivered directly to 
the pulmonary capillary bed) compared with the conventional delivery to the regional 
lymphatic nodes. 
 
While the majority of the published literature on CXCR4 function in OSCC tumour 
growth has focussed on animal studies, there is a paucity of in-vitro data regarding its 
effect on proliferation.  This is an important question to answer.  CXCR4 knock-down 
in OSCC cells using RNAi has been shown to be associated with a significant reduction 
in real-time proliferation in-vitro (Hong, Pai et al. 2009).  The effect of CXCR4 over-
expression on proliferation or apoptosis has yet to be investigated in OSCC. 
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HIF-1α labelling was demonstrated in 51/85 (60%) of predominantly early stage OSCC 
primary lesions (Ishikawa, Nakashiro et al. 2009).  Of the 20/85 lesions that labelled 
positively for CXCR4, 18 showed staining for both HIF-1α and CXCR4.  HIF-1α 
labelling was not associated with any of the clinicopathological features recorded 
(Ishikawa, Nakashiro et al. 2009).  However, other authors have demonstrated an 
association between HIF-1α staining and both prognosis and lymph node metastasis 
although this was in a series of predominantly late stage OSCC cases in which the 
prognosis was poorly defined (Uehara, Sano et al. 2009).15  Manipulation of OSCC cell 
lines in-vitro demonstrated an increase of HIF-1α and CXCR4 mRNA and protein in 
response to hypoxia that was abrogated by knock-down of HIF-1α expression by RNAi 
(Ishikawa, Nakashiro et al. 2009).  While these data suggest a role for HIF-1α in the 
control of CXCR4 production in OSCC the exact mechanism is unclear. 
 
 
1.6.2.4  CXCR4 in the epithelial-mesenchymal transition of OSCC cells. 
Epithelial-mesenchymal transition (EMT) is a process that occurs during embryonic 
development and is typified by an increase in motility and invasiveness associated 
with the loss of E-cadherin expression.  Over-expression of the Snail zinc-finger protein 
has been shown to induce EMT in OSCC cells in-vitro with an associated increase in 
SDF and CXCR4 expression (Taki, Higashikawa et al. 2008).  Serial passage of 
metastatic OSCC cells through nude mice resulted in a change in morphology 
mirroring EMT with a concomitant reduction in E-cadherin and increase in CXCR4 
expression (Yoon, Liang et al. 2007).  OSCC cells showing features of EMT 
demonstrated an increased migratory response and upregulation of CXCR4 expression 
in response to SDF stimulation or TGF-ß1 (Taki, Higashikawa et al. 2008). TGF-ß1 
production by tumour cells has been shown to induce differentiation of fibroblasts into 
activated myofibroblasts.  These then regulate tumour growth and invasion via 
complex cytokine networks.  Oral mucosal fibroblasts have been shown to produce 
SDF and hepatocyte growth factor (HpGF) in-vitro (Daly, McIlreavey et al. 2008).  This 
was increased in response to stimulation with Interleukin-1α (IL-1α) or OSCC-
conditioned media and reduced by incubation with TGF-ß1.  SDF and HpGF both 
increased OSCC cell invasion through Matrigel and in fibroblast-free organotypic 
                                                     
15 Poor prognosis was defined as death (at an unspecified point) within the follow-up period of 
4-16 years. 
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cultures, although the pattern of invasion in the latter was different compared with 
fibroblast-conditioned media (Daly, McIlreavey et al. 2008).  In conclusion, these 
reports suggest that EMT in OSCC cells is associated with an aggressive tumour 
phenotype and increased CXCR4-mediated functional responses secondary to 
interactions with (activated) fibroblasts within the tumour/tissue microenvironment.  
What is not clear is whether CXCR4 upregulation is the cause or effect of EMT. 
 
 
1.7 Summary 
Chemokine receptors are mediators of physiological leukocyte recruitment to 
peripheral lymph nodes and distant sites.  The uptake of dendritic cells to local lymph 
nodes is dependent upon the surface expression of the chemokine receptor CCR7.  
Evidence from a number of carcinoma systems supports the chemoattraction theory of 
metastasis.  Investigation of a number of carcinomas of the aero-digestive tract 
suggests that tumour cell expression of CCR7 facilitates lymphatic metastasis while 
CXCR4 expression is most frequently associated with distant metastasis.  However, it 
is possible that CXCR4 may mediate metastasis by mechanisms additional to its 
chemoattractant effect.   
 
Although the literature on chemokine receptor expression by OSCC has accumulated 
over the last decade, the findings remain inconclusive.  Reported results from in-vitro 
studies have suggested a role for CXCR4 in cell motility and tumour growth.  
However, the precise effect of CXCR4 over-expression remains unclear.  Studies have 
so far failed to differentiate between effects on cell chemokinesis, chemotaxis and 
invasion, and can be criticised for their lack of appropriate negative controls (see 
above).   
 
Different groups have reported an association between CXCR4 or CCR7 upregulation 
with lymph node metastasis.  Clinical observation reveals that significant metastatic 
deposits are formed frequently in the cervical lymph nodes but rarely at distant sites.  
Nevertheless, micrometastases at distant sites are common at autopsy.  Emerging 
evidence indicates that the importance of the chemokine network in tumour 
progression is not limited to directed cell migration.  Given its clinical distribution of 
OSCC spread, the chemokine receptor expression profile of OSCC is intriguing.  
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Investigation of the modulation of the chemokines network by OSCC in vitro and in 
vivo may provide considerable insight into the control of metastatic dissemination. 
 
 
1.8 Plan of investigation 
1.8.1 Overall Study Aim 
To investigate the role of chemokine receptors in the metastasis of oral squamous cell 
carcinoma. 
 
 
1.8.2 Overall Study Hypothesis 
Genetic changes in oral squamous cell carcinomas result in the over-expression of 
those functional wild-type chemokine receptors associated with physiological 
leukocyte homing to secondary lymphoid tissue.   Metastatic cells delivered to the 
cervical lymph nodes via established lymphatic channels that bear these chemokine 
receptors undergo stimulation by the chemokines constitutively produced there.  This 
chemokine receptor-mediated activation favours neoplastic growth and dissemination 
by increasing tumour cell migration, invasion, proliferation and survival. 
 
 
1.8.3 Outline of Investigation 
Initially this hypothesis will be investigated by the examination of chemokine receptor 
mRNA expression in cultured normal oral keratinocytes and established OSCC cell 
lines using microarrays.  Interesting results will be verified using semi-quantitative RT-
PCR and further investigated at the protein level using immunocytochemistry, flow 
cytometry and examination of clinical specimens using a novel technique of semi-
quantitative immunohistochemistry.  Chemokine receptors that demonstrate 
upregulation in OSCC lines (compared with normal oral keratinocytes) will be selected 
and stably transfected into a constitutively low-expressing OSCC cell line.  These 
transfected cell lines (and appropriate controls) will be investigated using functional 
assays of chemokinesis, chemotaxis, proliferation and invasion.   
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Chapter 2: 
Materials and Methods 
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2.1 Cell Culture 
2.1.1  Established cell lines derived from oral squamous cell carcinomas. 
1.  H357 
The  cell  line  H357  was  derived  from  a  well  differentiated  oral  squamous  cell  
carcinoma  from  the  tongue  of  a  74  year  old  male (Prime, Nixon et al. 1990).  The  
original tumour  was  less  than  4  cm  in  diameter  with  regional  lymph  node   
involvement  but  no  distant  metastases.  It has been shown that orthotopic 
inoculation of H357 cells into the floor of the mouth of athymic mice does not result in 
tumourigenesis (Prime, Eveson et al. 2004). 
 
2.  TR146 
The  continuous  cell  line  TR146  was  derived  from  a  human  neck  metastasis  
originating  from  a  buccal  carcinoma (Rupniak, Rowlatt et al. 1985).  These cells were 
originally a gift to the laboratory from Cancer Research UK 
 
3.  FaDu 
The FaDu  cell  line (ATCC, HTB-43)  was  established  in  1968  from  a  punch  biopsy  
of  a  hypo-pharyngeal  tumour  removed  from  a  56  year  old Hindu  patient 
(Rangan 1972).  The  established  line  was  found  to  contain  bundles of  tono-
filaments  in  the  cell  cytoplasm  and  desmosomal  regions  were  prominent  at  cell  
boundaries. 
 
4.  CAL27 
The CAL27 cell line (ATCC, CRL-2095) was established from tissue taken prior to 
treatment from a  56  year  old  Caucasian  male  with a squamous  cell  carcinoma of  
the middle of the tongue (Gioanni J, Fischel JL et al. 1988).  CAL27 cells are epithelial, 
polygonal with a highly granular cytoplasm.  Immunocytochemical studies show 
strong positive staining with anti-keratin antibodies. 
 
5.  SCC4 
The  SCC4  cell  line  (ATCC,  Number  CRL-1624)  was  derived  from  a  squamous  
cell  carcinoma  of  the  tongue  of  a  55  year  old  male (Rheinwald and Beckett 1980).   
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6.  SCC25 
The  SCC25  cell  line  (ATCC,  Number  CRL-1628)  was  derived  from a  squamous 
cell  carcinoma  of  the  tongue  of  a  70  year  old  male (Rheinwald and Beckett 1980).  
 
 
2.1.2  Established non-cancerous oral cell lines. 
1.  Human Gingival Fibroblasts 
Primary human gingival fibroblasts (HGFs) were obtained from the departmental 
archive of frozen cells (Dept. of Oral Pathology, Clinical and Diagnostic Oral Sciences, 
Queen Mary University London).  These cells were obtained from clinically healthy 
gingival tissues at the time third molar extraction and originally frozen in 1995 after 
their seventh passage. 
 
2.  Primary Normal Oral Keratinocytes 
Primary normal oral keratinocytes (NOKs) were acquired from the departmental 
archive of frozen cells (Dept. of Oral Pathology, Clinical and Diagnostic Oral Sciences, 
Queen Mary University London).  They were taken from normal oral mucosa at the 
time of third molar surgery in 1995 and frozen at the time of first passage. 
 
 
2.1.3  Established non-oral cell lines and feeder cells 
1.  Primary Normal Skin Keratinocytes 
Primary normal skin keratinocytes (NSKs) were a gift from Professor Alan Storey 
(Department of Cutaneous Research, Queen Mary University London).  They were 
established from normal skin taken at the time of breast reduction surgery in 2002 and 
frozen at the time of first passage.  
 
2. NIH 3T3 Swiss embryo fibroblasts 
These murine fibroblasts were obtained from the European Collection of Cell Cultures 
(ECACC, 93061524). 
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2.1.4  Cell culture and passage 
Established OSCC cell lines were taken and grown in 75cm2 plastic tissue-culture flasks 
under sterile conditions in a mycoplasma-free incubator at 37˚C in a humidified 
atmosphere with 5% CO2.  Specialised growth media (Table A2.1, Appendix 2) were 
supplemented with 10% Fetal Bovine Serum (FBS) where appropriate.  Cells were 
passaged at early confluence using Trypsin/ Ethylenediaminetetraacetic acid (EDTA) 
solution (Invitrogen 25300-054).  Cells were grown in quadruplicate to 90% confluence 
as determined by light microscopy.  The doubling time for each cell line was calculated 
using proliferation assays (see Section 2.1.6).  
 
Primary cultures of NOKs and NSKs were incubated with specialised growth media 
(Table A2.1, Appendix 2) under similar conditions to those outlined above with the 
addition of a feeder layer of growth-arrested fibroblasts.  These feeder cells were 
prepared by the incubation of NIH-3T3 murine fibroblasts with 10 μg/ml Mitomycin C 
(Sigma, M4287) for 2 hours in a humidified atmosphere at 37˚C with 5% CO2 in the 
dark.  The cells were then washed 3 times with sterile PBS, passaged, counted and 
seeded at a density of 2x106 per T75 flask.  These growth-arrested fibroblasts were 
allowed to adhere to the flask for 4 hours prior to the addition of the primary 
keratinocytes. 
 
 
2.1.5  Mycoplasma testing and treatment 
Samples were checked weekly for mycoplasma contamination using a combination of 
three complimentary techniques: immunofluorescence, polymerase chain reaction and 
ELISA.   Cells identified as mycoplasma-positive were treated with courses of BM 
Cyclin (Roche, 799050) until testing negative, and then for a further two weeks 
(according to the manufacturer’s recommendations).  After initial treatment, 
mycoplasma contamination was not subsequently detected in tissue culture samples.  
Specimen methodologies and results are given in Section A2.2 (Appendix 2). 
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2.1.6  Determination of cell growth kinetics by MTT assay. 
Cell proliferation assays were performed for each cell line to determine their growth 
kinetics under optimal conditions.  In this way the time to the end of the logarithmic 
growth phase was calculated for a known seeding density and culture surface area.  
This technique is described in detail in Section 2.8.2.  Briefly, cells were passaged and 
mixed well to form a final cell density of 25x103/ml in appropriate media.  Two 
hundred microlitres of this cell suspension were added to each of 12 wells on a 96 well 
plate.  Seven identical plates were prepared in total and incubated at 37ºC in a 
humidified atmosphere with 5% CO2.  A time course at 24-hour intervals was 
performed.  Mean absorbance for blank wells was subtracted from each recorded value 
and the mean and standard deviation for each set of 12 replicates was calculated.  The 
growth profile of each cell line was plotted against time and the exponential growth 
phase defined.  The gradient of the exponential function was calculated across this 
period and the accuracy of fit determined using the Root Mean Square (RSQ).  The 
results are summarised in Table A2.2 (Appendix 2). 
 
 
2.2  Microarrays 
2.2.1  Overview 
Two sets of microarray experiments were performed using the Affymetrix platform.  
Sample handling was very similar in each case.  However, by the time of the second 
round of experiments, the Affymetrix U133A arrays had been superseded by the 
U133v2.0 hardware (with associated small changes in the preparation protocol).  For 
simplicity the protocol based on the U133A system is described with a short 
addendum containing the U133v2.0-based changes.   
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The analysis of samples using microarrays was performed using the following steps: 
 
1. Growth of cell lines in culture 
2. Extraction and purification of tRNA 
3. tRNA clean-up and DNase treatment  
4. Quantification of tRNA 
5. Double-stranded cDNA synthesis 
6. Clean-up of double-stranded cDNA 
7. Synthesis of biotin-labelled cRNA 
8. Clean-up of cRNA 
9. cRNA fragmentation 
10. Preparation for hybridisation 
11. Microarray hybridisation 
12. Data processing and analysis 
 
 
2.2.2  Growth of cell lines in culture 
In the first set of experiments six established OSCC cell lines (CAL27, FADU, H357, 
TR146, SCC4 and SCC25), primary normal oral and primary normal skin keratinocytes 
(NOK and NSK respectively) were taken and grown in cell culture as outlined 
previously.  Cultured cells were grown in 100mm Petri dishes with 10% FBS to just 
before the end of the logarithmic growth phase as determined by proliferation assays.  
Samples from the SV cell line were prepared in an identical manner and were a kind 
gift from Dr Joanne Stewart (Clinical and Diagnostic Sciences, Queen Mary University 
London). 
 
For the second set of experiments H357 cells transfected with and without the CXCR4 
insert were stimulated with and without Stromal-cell Derived Factor (SDF).16  The 
effect of culture under conditions of high (20%) and low (2%) oxygen tension for 24 
hours was also investigated using a hypoxic incubator by kind permission of Professor 
Ian McKenzie, Queen Mary University London. 
  
                                                     
16  For this experiment SDF concentrations of 1 and 100ng/ml were used compared with no 
stimulation. 
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2.2.3  Extraction, purification and quantification of total RNA 
Methodologies using various agents for the extraction of RNA from cultured cells were 
compared.  These included using Ultraspec (Biotecx, BL10050), RNAwiz (Ambion, 
9736), RNAbee (AMS Biotechnology, CS-104B) and TRIzol (Invitrogen, 10296-028).  On 
the basis of spectrophotometric and electropherographic analysis of quality and 
quantity the method using TRIzol and double precipitation was found to produce the 
best yields.  
 
Cell culture medium was removed and the cells were washed once with sterile PBS.  
Care was taken to aspirate all the PBS.  Five hundred microlitres of TRIzol was added 
for each 25cm2 of cell growing surface.  The TRIzol was distributed over the entire 
surface of each flask and incubated for 20 minutes at room temperature.  The cells were 
mechanically disrupted using a cell scraper and the lysate collected in nuclease-free 
Eppendorf tubes in 750µl aliquots.  One hundred and seventy five microlitres of 
chloroform (Sigma) was added to each aliquot, vortexed briefly and each added to 
heavy phase lock gel tube (Eppendorf, 0032 007.953) that had been previously 
centrifuged at 8,000g for 30 seconds to pellet the gel.  The samples were then spun at 
8,000g for 2 minutes and subsequently each colourless upper aqueous layer was 
carefully transferred to an Eppendorf tube. 
 
The RNA was precipitated by the addition of 500µl of isopropanol and 1µl of glycogen 
(Ambion, 9510) for 20 minutes at room temperature.  An RNA pellet was obtained by 
centrifugation at 12,000g for 10 minutes at 4°C.  The supernatant was removed and the 
pellet was washed with 500µl of 75% ethanol followed by centrifugation at 7,500g for 5 
minutes at 4°C.  The supernatant was removed and the pellet was allowed to air dry 
for 10 minutes at room temperature.  The RNA was dissolved in 200µl of RNAse free 
water (Ambion, 9934) for 10 minutes at 65°C.  A second salt precipitation of RNA was 
performed by the addition of 20µl of 3M sodium acetate (Sigma, 57899), 500µl of 100% 
ethanol and 1µl of glycogen to each tube at -20°C overnight.  An RNA pellet was 
subsequently produced by centrifugation at 12,000g for 20 minutes at 4°C.  Washes 
with 500µl of 80% ethanol followed by centrifugation at 12,000g for 10 minutes at 4°C 
were performed twice.  The supernatant was carefully removed and the pellet was 
allowed to air dry for 10 minutes at room temperature.  The RNA was dissolved in 
50µl of RNAse free water at 65°C for 10 minutes. 
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2.2.4  Total RNA clean-up and DNAse treatment 
Total RNA clean-up was performed using an RNeasy kit (Qiagen, 74104) according to 
the manufacturer’s instructions.  One hundred micrograms of total RNA was made up 
to a volume of 100µl with RNase free water in an Eppendorf tube.  To each tube 350µl 
of 1% β-mercaptoethanol (Sigma) in the supplied buffer RLT and 250µl of 100% ethanol 
was added and mixed by pipetting.  The tube contents were then added to a spin-
column placed over a 2ml collection tube.  The column was centrifuged at 8,000g for 15 
seconds at room temperature and the flow-through was discarded. 
 
On column DNase digestion was performed using the RNase-free DNase kit (Qiagen, 
79254).  Three hundred and fifty microlitres of the supplied buffer RW1 was added to 
each spin column and these were centrifuged at 8,000g for 15 seconds and the flow-
through discarded.  Ten microlitres of DNase I stock solution, gently mixed with 70µl 
of buffer RDD, was added to each column and was incubated for 15 minutes at room 
temperature.  A further spin-wash with 350µl of buffer RW1 was performed. 
 
Each column was washed with 500µl of buffer RPE and spun at 8,000g for 15 seconds 
at room temperature and the flow-through discarded.  This was performed twice.  The 
columns were replaced with new collection tubes and allowed to air dry by 
centrifugation at 8,000g for 1 minute.  The collection tubes were replaced with clean 
Eppendorf tubes with care being taken to avoid ethanol carryover and contamination.  
Thirty microlitres of RNase-free water was placed on to the column membrane, 
incubated for 2 minutes at room temperature and spun at 8,000g for 1 minute.  This 
elution was performed twice.  
 
 
2.2.5  Quantification of tRNA 
Spectrophotometry was performed using an UVmini-1240 instrument (Shimadzu, 
Japan).  The 260/280Ǻ absorbance ratio was found to be critically dependent on buffer 
pH.  Dilution in un-buffered diethyl pyrocarbonate (DEPC) treated water produced 
variable absorbance ratios.  This problem was overcome by performing all dilutions 
with sodium-diphosphate (Sigma, P8135) buffer.  A working solution of sodium-
diphosphate spectrophotometry dilution buffer (SDSDB) in nuclease-free water was 
prepared fresh for each batch of samples.  Baseline correction for 1x SDSDB was 
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performed prior to all measurements.  One microlitre RNA samples were added to 99 
µl of 1x SDSDB and mixed thoroughly.  For each sample the values for absorbance at 
260Ǻ (A1) and 280Ǻ (A2) were recorded.  The amount of RNA contained in each 
sample was calculated by the formula: 
Amount (µg/µl) = A1 x 4 
 
Final RNA quality was assessed using spectrophotometry and a RNA 6000 Nano 
Assay chip with an Agilent 2100 Bioanalyser (both Agilent Technologies).  The latter 
was performed using the Nano LabChip kit (Agilent, 5065-4476) according to the 
manufacturer’s protocol:  Briefly, 65 µl aliquots of Nano gel matrix were spin-filtered at 
1,500 g for 10 minutes at room temperature.  One microlitre of Nano dye concentrate 
was added to each aliquot, vortexed and spun at 13,000g for 10 minutes at room 
temperature.  Each chip was primed with 9 µl of the gel-dye mixture using the 
supplied syringe pressuriser for 30 seconds.  Five microlitres of the Nano marker were 
added to each of the wells and 1µl of heat denatured ladder (Ambion, 7152) to one 
control well.17  All samples were heat denatured in a similar way and 1µl aliquots were 
added to each of the sample wells.  Finally, prior to reading, the loaded chip was 
covered with an adhesive film and vortexed on a specific shaker (IKA, MS2-S8) for 1 
minute at 2,000 rpm.   
 
Samples of suitable quality and quantity were selected by examination of the 
electropherograms produced by the Agilent 2100 Bioanalyser.  A typical 
electropherogram of a suitable sample is shown in Figure 2.1.  The ratio of the height of 
the 28S peak relative to that of the 18S peak was calculated.  Evidence of good RNA 
quality was demonstrated by a ratio of 28S to 18S peak height of greater than 1.0. 
 
 
                                                     
17  Heat denaturation was performed by incubation at 70°C for 2 minutes 
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Figure 2.1: Electropherogram of a typical RNA sample.  Electropherogram of a typical 
RNA sample produced by analysis by an Agilent 2100 Bioanalyser showing absorption peaks at 
18S and 28S.  This example shows RNA of suitable quality for microarray analysis 
demonstrated by a greater absorption (peak height) at 28S compared with 18S. 
 
 
2.2.6  Double-stranded cDNA synthesis 
Double-stranded cDNA was synthesised using the Superscript ds-cDNA Synthesis Kit 
(Invitrogen, 11917-010) according to the manufacturer’s instructions.  Ten micrograms 
of total RNA (tRNA) of known concentration were taken and added to 100 pmol of 
high performance liquid chromatography (HPLC) purified T7-(dT)24 primer 
(Invitrogen) on ice.18  The reaction volume was made up to 11 µl with RNAse free 
water (Ambion, 9937) and mixed by pipetting.  The reaction mixture was incubated at 
65°C for 10 minutes to break any RNA secondary structures present and their 
subsequent re-formation was inhibited by placing the tubes immediately on to ice.   
 
Initially, single-stranded cDNA was synthesised by the following method: A master-
mix comprising of 4µl of the supplied 5x First Strand Buffer, 2µl of 0.1M DTT and 1µl 
of dNTPs (10mM each) for each sample was prepared on ice.  Seven microlitres of this 
master-mix were added to each tRNA sample the reaction was incubated at 42°C for 2 
minutes.  Subsequently four hundred units of Superscript II reverse-transcriptase were 
added to each sample, mixed gently and incubated at 42°C for one hour.  
 
                                                     
18  The sequence of the T7-(dT)24 primer (Invitrogen) was GGCCAGTGAATTGTAATACGA 
CTCACTATAGGGAGGCGGTTTTTTTTTTTTTTTTTTTTTTTT 
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The second strand of cDNA synthesis was then performed: A master-mix was 
assembled on ice by the addition of 91µl of RNAse free water, 30µl of 5x Second Strand 
Buffer, 3µl of dNTPs (10mM each), 10 units of E. coli DNA ligase, 40 units of E. coli 
DNA Pol I and 2 units of E. coli RNase H for each sample.  Following gentle mixing, 
130µl of the master-mix was added to each sample and the reaction was incubated at 
16°C for 2 hours.  Ten units of T4 DNA polymerase were then added and incubated at 
16°C for a further 5 minutes.  Finally 10µl 0.5M EDTA (pH 8.0) was added. 
 
 
2.2.7  Clean-up of double-stranded cDNA 
To each sample of double-stranded cDNA prepared above was added 162µl of buffer-
saturated phenol.19  The samples were then vortexed briefly and transferred to a light 
phase-lock gel tube (Eppendorf, 0032 007.961) that had previously been spun at 8,000g 
for 30 seconds to pellet the gel.  The samples were then centrifuged at 8,000g for 2 
minutes at room temperature and the upper aqueous layer was transferred to a new 
nuclease-free Eppendorf tube. 
 
To each tube was added 75µl of 7.5M ammonium acetate (Sigma, A2706), 4µl of 
glycogen (Ambion) and 375µl of 100% ethanol followed by gentle mixing.  The samples 
were centrifuged at 12,000g for 20 minutes at room temperature.  The supernatant was 
carefully removed leaving the pellet behind; 500µl of cold 80% ethanol was added and 
then spun at 12,000g for 5 minutes at 4 °C.  This ethanol washing was performed twice.  
All the ethanol supernatant was carefully removed and the pellet was allowed to air 
dry for 10 minutes at room temperature.  The pellet was finally resuspended in 12 µl of 
nuclease-free water. 
 
 
2.2.8  Synthesis of biotin-labelled cRNA  
Synthesis of biotin-labelled complementary RNA was performed using the Bioarray 
high yield RNA transcript labelling kit (ENZO, Affymetrix, 900182) according to the 
manufacturer’s instructions.  A master-mix was assembled at room temperature 
                                                     
19 Buffer-saturated phenol was prepared as follows: 65 µl of alkalin buffer (10mM Tris HCl, 
1mM EDTA pH 8.0) was added to 1ml of phenol-chloroform-isoamyl alcohol in the ratio 25:24:1 
(Ambion, 9732), vortexed for 2 minutes and then centrifuged briefly. 
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comprising of (per sample): 10µl of nuclease-free water, 4 µl of 10x HY reaction buffer, 
4µl of biotin-labelled ribonucleotides, 4µl of DTT, 4µl of RNase inhibitor mix and 2µl of 
T7 RNA polymerase.  Twenty-eight microlitres of master-mix were added to each 12µl 
sample prepared above and the reaction was incubated at 37°C for 5 hours with gentle 
mixing by tapping every hour. 
 
 
2.2.9  Clean-up of cRNA  
Clean up of the biotin labelled cRNA produced above was performed using the 
RNeasy KIT (Qiagen, 71404).  Each sample was made up to 100 µl by the addition of 60 
µl of nuclease-free water.  Three hundred and fifty microlitres of buffer RLT and 250µl 
of 100% ethanol were added and mixed thoroughly by pipetting.  The reaction was 
added to a spin-column placed over a 2 ml collection tube.  The column was 
centrifuged at 8,000g for 15 seconds at room temperature and the flow-through was 
discarded.  The column was washed with 500µl of buffer RPE and spun at 8,000g for 15 
seconds at room temperature and the flow-through discarded.  This washing stage was 
performed twice.  The columns were replaced with new collection tubes and allowed 
to air dry by centrifugation at 8,000g for 1 minute.  Thirty of RNase-free water was 
placed on to the column membrane; incubated for 2 minutes at room temperature and 
spun at 8,000g for 1 minute into a fresh nuclease-free Eppendorf collecting tube.  This 
final elution step was performed twice.  One microlitre of the eluted cRNA was 
analysed using the spectrophotometer.  The minimum concentration of cRNA required 
was 0.6 µg/µl.  Samples with concentrations below this value (but with total yields 
greater than 40 µg) underwent a salt and ethanol precipitation as described in Section 
2.2.3 above. 
 
A 1% agarose gel was prepared:  100 ml of 10x TAE buffer (Invitrogen, 15558-026) was 
diluted with 900ml DEPC-treated water.  One gram of agarose (Helena Biosciences, 
8201-07) was dissolved in 100 ml of 1x TAE buffer by microwave heating for 30 
seconds twice followed by the addition of 60 μg of Ethidium Bromide (Sigma, E8751).  
The gel was poured, allowed to set and covered in 700ml of 1x TAE buffer in the gel 
tank. 
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Five hundred nanograms of each cRNA sample were denatured by heating at 70 ºC for 
10 minutes in denaturing loading buffer (Sigma, S4268).  Samples were mixed with 2 μl 
of gel loading buffer (MBI Fermentas, SM0321) and loaded on to the gel alongside a 
DNA ladder (Generuler 100bp Plus, MBI Fermentas, SM0321).  The gel was run for at 
100V for 30 minutes.  Samples were checked for quality (the appearance of a smear 
from 100bp to 2kb with a brighter region from 500bp to 1kb) as demonstrated in Figure 
2.2. 
 
 
 
 
Figure 2.2:  1% agarose gel showing typical band pattern of cRNA quality.  Gel 
electrophoresis of six samples of fragmented cRNA (lanes A-F) run against a 1kb ladder (lane 
G).  All samples except lane C are suitable for subsequent microarray analysis as demonstrated 
by a smear from 100bp to 2kb with a brighter region from 500bp to 1kb. 
 
 
2.2.10 cRNA fragmentation 
RNase free, filter-sterilised 5x fragmentation buffer was prepared: 200mM Tris-acetate 
pH 8.1 (Sigma T1503), 500mM Potassium acetate (Sigma, P5708) and 150mM 
Magnesium acetate (Sigma, M2543).  Thirty micrograms of cRNA and 8 µl of 5x 
fragmentation buffer was made up to 40 µl with nuclease-free water and incubated at 
94 ºC for 35 minutes.   An aliquot of 250 ng of fragmented cRNA was taken from each 
sample and run on an Agilent 2100 Bioanalyser using a RNA 6000 Nano Assay chip (as 
outlined in Section 2.2.5 above).   
 
A     B    C    D    E     F     G 
500bp 
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2.2.11 Preparation for hybridisation 
Preparation of the hybridisation cocktail for each sample was performed using the 
Gene Chip Eukaryotic Hybridisation control kit (ENZO, Affymetrix, 900299).  Vials of 
the 20x Eukaryotic Hybridisation Controls and Control Oligo B2 were heated at 65 ºC 
for 5 minutes, vortexed and spun briefly.  Two buffers were prepared as outlined 
below: 12xMES and 2x Hybridisation Buffer. 20,21  For each sample a master-mix was 
prepared on ice: 5 µl of Control Oligo B2 (3nM), 15 µl of 20x Eukaryotic Hybridisation 
Controls, 3 µl of Herring sperm DNA (10mg/ml), 3 µl Acetylated BSA (50mg/ml), 150 
µl of 2x hybridisation buffer and 15 µg of fragmented cRNA.22  The total reaction 
volume was made up to 300 µl with nuclease-free water. 
 
 
2.2.12 Microarray hybridisation 
The hybridisation cocktail was heated to 99 ºC for 5 minutes followed by 45 ºC for a 
further 5 minutes, and then centrifuged at maximum speed for 5 minutes to remove 
any insoluble material.  Initially, small aliquots of the hybridisation cocktails were run 
on control microarrays to confirm that the sample quality was suitable for the genome-
wide arrays.  Briefly, each control microarray was brought up to room temperature, 
filled with 200 µl of 1x hybridisation buffer, and placed in the probe array oven at 45 ºC 
for 10 minutes at 60 rpm.  The buffer solution was removed from the array cartridge 
and replaced with 35 µl of the hybridisation cocktail.  The array was incubated in the 
probe oven at 45 ºC for 16 hours at 60 rpm.  Each control array was scanned and the 
hybridisation of sample genes across the array were analysed for signal level and 
consistency.  All samples passed this level of quality control.   
 
Subsequently, each genome-wide microarray (Affymetrix, U133a) was prepared in a 
similar fashion and incubated with 200 µl of the hybridisation cocktail under the same 
conditions.  Duplicate samples from each cell line were hybridised separately.   
                                                     
20 12x MES Buffer (1.22M MES, 0.89 [Na+]):  64.61g MES Hydrate and 193.3g MES Sodium Salt 
made up to 1 litre with molecular biology grade water then 0.2µm filtered and pH checked (6.5 
to 6.7). 
21 2x Hybridisation Buffer (100mM MES, 1M [Na+], 20mM EDTA, 0.01% Tween-20):  8.3ml 12x 
MES Buffer, 17.7ml 5M NaCl, 4.0ml 0.5M EDTA, 0.1ml 10% Tween-20 and 19.9ml molecular 
biology grade water stored at 4ºC protected from light. 
22 Final working concentrations of the supplied Eukaryotic Hybridisation Control preparation  
include bioB (1.5pM), bioC (5pM), bioD (25pm) and cre (100pM). 
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2.2.13 Data processing and analysis 
The hybridised array was scanned using the Affymetrix image-reading system and 
raw data for each probe position was tabulated against the Affymetrix U133A 
sequence number.  All data underwent a series of quality checks before any analyses 
were performed:  Firstly, the expression levels of multiple probes for Affymetrix 
control genes distributed across the array were compared to determine whether the 
microarray had hybridised completely and evenly.  Only raw expression data from 
arrays that had hybridised correctly were entered into the analysis programme 
(GeneSpring v6.0SE, Agilent Technologies).  Secondly, the range of expression values 
for each array was compared against background to filter out absent signals.  Thirdly, 
the values of all positive signals on each array were plotted against a normal 
distribution to ensure the data were parametric.  Expression levels for individual genes 
were then normalised around a mean value of 1.0 to produce a Normalised Expression 
Value (NEV).  This allowed comparison between samples.  Finally, the software was 
used to calculate correlations between the samples.   
 
In the first set of microarray experiments data from duplicate samples were available.   
Initially, the raw data sets were renamed using a unique, randomised and blinded 
identification number.  The analysis software was asked to determine the pattern of 
similar samples and these statistical correlations were compared with the biological 
cell line of origin once the blinding was removed.  
 
Values for genes with multiple addresses on the microarray were arithmetically 
averaged.  The mean and range of each duplicate sample pair was derived from the 
GeneSpring software and plotted on a logarithmic scale.  Individual gene expression 
levels in OSCC cell lines were compared with those from normal oral keratinocytes by 
calculation of the relative NEV by the following formula: 
 
Relative NEV  =  NEV in OSCC cell line 
NEV in normal oral keratinocytes 
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The relative NEV and range of the duplicate samples were plotted on a logarithmic 
scale.  Fold change (plus direction) was calculated from the Relative NEV in the 
following way:  
 
If Relative NEV > 1.0   → Positive Fold Change = Relative NEV 
If Relative NEV < 1.0  → Negative Fold Change = 1 / Relative NEV 
 
Statistical comparison was performed using Analysis of Variance (ANOVA).  To 
reduce the likelihood of chance statistical correlations (false-positive results) post-hoc 
tests were employed.  The most stringent of these was the Bonferroni correction. 
 
 
2.2.14 Variations in the U133A and U133v2.0 Protocols 
Some additional steps were included in the U133v2.0 protocols: 
1. Eukaryotic Poly-A RNA spike-in controls were added to the sample total 
RNA at the beginning.  These included various in-vitro synthesised 
polyadenylated transcripts for B.subtilis genes23 that are absent in eukaryotic 
samples but which have specific probe sets on the final arrays. 
2. DMSO to a final concentration of 10% was added to the hybridisation 
cocktail 
3. Data underwent normalisation using a GC-RMA pre-processor 
(incorporated in Genespring 6.0 SE). 
4. Signal filtering was performed at a threshold calculated by multiplying the 
mean background reading by four (according to the manufacturer’s 
recommendations) 
 
 
2.3 Quantitative Reverse-Transcription Polymerase Chain Reaction 
2.3.1  Overview 
Samples were prepared for semi-quantitative reverse-transcription polymerase chain 
reaction (sqRT-PCR) as follows: 
                                                     
23 These include lys, phe, thr and dap at final concentrations (ratio of copy numbers) of 1:100000, 
1:50000, 1:25000 and 1:6667 respectively 
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1. Growth of cell lines in culture 
2. Extraction and purification of total RNA 
3. total RNA clean-up and DNase treatment  
4. Quantification of total RNA 
5. total RNA reverse transcription 
6. Quantitative polymerase chain reaction 
7. Data processing and analysis 
 
Sample selection and preparation was identical to Steps 1-4 of the microarray protocol 
outlined in Chapter 2.  However, four replicate samples from each cell line were 
analysed by sqRT-PCR, each run in triplicate. 
 
 
2.3.2 Total RNA Reverse Transcription 
Two protocols were used for performing reverse transcription.  Initially samples were 
prepared using the multi-step protocol based on the Moloney Murine Leukaemia Virus 
(M-MLV) reverse-transcriptase chemistry.  Subsequently the one step reaction using 
the iScript cDNA Synthesis kit (Bio-Rad, 170-8891) was preferred due to its simplicity 
and cost.  The iScript method had the added advantage of containing both oligo-(dT) 
and random hexamer primers making the cDNA produced suitable for both 
conventional and real-time PCR.  Both methodologies are outlined below. 
 
 
2.3.2.1 Moloney Murine Leukaemia Virus reverse transcriptase method. 
Two micrograms of DNase-treated total RNA was taken and made up to a reaction 
volume of 13µl with nuclease-free water.  One microgram of random hexamer primers 
(Promega, C1181) was added; incubated at 75°C for 5 minutes and immediately cooled 
on ice for 5 minutes.  A master-mix was assembled on ice containing (per sample) 5µl 
of reaction buffer (Promega M5313), 5 µl of combined nucleotide pool and 1 unit of 
Moloney Murine Leukaemia Virus reverse transcriptase (MMLV-RT) enzyme 
(Promega, M368B).  Eleven microlitres of the master-mix were added to each sample 
and incubated sequentially at room temperature initially for 10 minutes and then at 
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40°C for 50 minutes.  Finally the sample volume was made up to 100 µl by the addition 
of 75µl of nuclease-free water.  For each cell line a negative control reaction was 
performed in which the 1µl of MMLV-RT enzyme was replaced by an equal volume of 
nuclease-free water.  All other reagents and reaction conditions remained the same. 
 
 
2.3.2.2 iScript cDNA Synthesis method 
Again, two micrograms of DNase-treated total RNA was taken and made up to a 
reaction volume of 15µl with nuclease-free water.  A master-mix was prepared 
containing (per sample) 4µl of 5x iScript Reaction Mix and 1µl of iScript Reverse 
Transcriptase.  Five microlitres of the master-mix were added to each 15µl sample.  The 
samples were incubated at 25°C for 5 minutes, then 42°C for 30 minutes and finally 
85°C for 5 minutes.  If a greater volume of cDNA product was required then the 
reaction volume was increased with the components scaled-up proportionally.  In a 
similar fashion to before, a no reverse-transcriptase negative control reaction was 
performed by the substitution of the iScript Reverse Transcriptase with 1µl of nuclease-
free water. 
 
 
2.3.3 Quantitative polymerase chain reaction 
Quantitative RT-PCR (relative or absolute) requires reference to a normalised standard.  
For comparison between cell lines, relative quantitative comparison against a standard 
endogenous internal standard (18S RNA) was performed.  The Taqman primer/probe 
sets used (Assays-on-Demand, Applied Biosystems) consist of a pre-optimised pair of 
sequence-specific PCR primers and a sequence-specific probe with a FAM reporter dye 
at the 5’ end and a non-fluorescent quencher at the 3’ end.  In the unbound state the 
quencher lies in close physical proximity to the reporter negating its fluorescence.  
However, when bound the quencher/reporter complex separates and the reporter 
fluoresces when laser stimulated.  Fluorescence is proportional to the concentration of 
amplicon in the sample.  Samples in which the reverse transcription step had been 
omitted were used as negative-controls. 
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A master-mix was assembled as follows for each sample: 1.25 μl FAM-labelled 
sequence-specific primer/probe set, 1.25 μl VIC-labelled 18S RNA primer/probe set, 
12.5 μl Taqman Universal Master-Mix (Applied Biosystems) and 8 μl PCR grade water 
(Ambion).  Each reaction was assembled by the addition of 23 μl of master-mix to 2 μl 
of each cDNA sample.  Four samples were analysed per cell line and each sample was 
run in triplicate.  PCR was performed using an ABI Prism 7700 light cycler (Applied 
Biosystems) with the following programme: 50ºC for 2 minutes, 95ºC for 10 minutes, 
then 60 cycles of denaturing at 95ºC for 15 seconds followed by annealing and 
extension at 60ºC for 60 seconds.  Initially the expression of CXCR4 and CCR7 was 
investigated using Assays-on Demand FAM-labelled fluoroprobes for CXCR4 
(4333458, Hs 00607978) and CCR7 (4331182, Hs 00171054).   
 
Data were interpreted using the software supplied with the Applied Biosystems 7700 
light cycler.  Amplification threshold (Ct) was set according to the software’s 
suggestion for each of the FAM and VIC dye layers.  For each individual well the 
difference in Ct values (ΔCt) between the FAM (chemokine receptor) and VIC (18S 
RNA) reporters was calculated according to the following formula: 
 
ΔCt =  Ct FAM – Ct VIC 
 
The mean ΔCt values for each triplicate well were calculated.  Comparison of cell lines 
to normal oral keratinocytes was performed by calculation of the ΔΔCt value for each 
cell line.  Finally the fold change between cell lines was calculated and plotted against 
a logarithmic scale. 
 
ΔΔCt (CELL LINE) = mean ΔCt (CELL LINE) – mean ΔCt (NOK) 
 
Fold Change (CELL LINE) = 2 -ΔΔCt (CELL LINE) 
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2.4 CXCR4 stable transfection 
2.4.1  Overview 
The aim of this procedure was to produce a transfected OSCC cell line with a high 
stable expression of CXCR4 mRNA.  This was achieved as follows:  
 
1. Selection of cell lines and preparation of reagents 
2. Transformation of competent cells and clonal expansion 
3. Clonal screeing for presence of the insert 
4. DNA extraction from clones 
5. Plasmid ligation 
6. Colony screening 
7. Extraction and purification of CXCR4 plasmid DNA 
8. Transfection 
9. Clonal selection under antibiotic selection 
10. Characterisation of transfected cell line 
 
 
2.4.2  Selection and preparation of reagents. 
The CXCR4 coding sequence received had been inserted into the pcDNA3 DNA 
plasmid (Invitrogen) using the restriction enzymes EcoR1 and Xba1.  This was a kind 
gift of Dr Hagen Kulbe and Dr Julia Wilson (Translational Oncology Laboratory, 
Cancer Research UK, Queen Mary University London).  The pcDNA3.1 plasmid 
(Invitrogen) was selected for these experiments in order to provide appropriate 
restriction enzyme digest sites and both DNA and protein tags for construct labelling.  
 
Bacterial culture was performed using the LB medium.24  The base Lysogeny Broth 
(LB) was supplemented with filter-sterilised Ampicillin to a final concentration of 
100µg/ml.  Briefly, these were prepared by pouring 16ml of Ampicillin-supplemented 
molten agar into sterile Petri dishes, allowing it to solidify and then incubated, 
inverted, at 37°C in a dry oven for 30 minutes to remove any condensation.  Agar 
                                                     
24  Lysogeny Broth was produced by adding 10g Bacto-tryptone, 5g yeast extract and 
10g NaCl to 800ml of water.  The pH was adjusted to 7.5 with sodium hydroxide and 
the volume then adjusted to 1L before autoclaving. 
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plates used for blue/white screening were prepared by spreading 100 µl of 0.1M 
dioxane-free isopropyl-β-D-thiogalactopyranoside (IPTG, Promega, V3955) and 20 µl 
of 50 mg/ml of 5-bromo-4-chloro-3-indolyl-β-D-thiogalactopyranoside (X-Gal, 
Promega, V3941) on to each plate and allowing the solutions to absorb for 30 minutes 
at 37°C.  Stocks of bacterial clones were preserved by mixing 800µl of culture media 
with 200 µl of sterile 100% glycerol and freezing at -80°C.   
 
 
2.4.3 Transformation of competent cells, clonal expansion and 
determination of transformation efficiency 
Transformation was performed using JM109 competent cells (Promega).  Initially, 
200µl of competent cells were thawed and mixed carefully without pipetting.  The 
bacterial suspension was divided into two equal aliquots and transferred to pre-chilled 
12 ml tubes.  Fifty nanograms of DNA were added to one aliquot and 0.1ng of 
Competent Cells control DNA (Promega) added to the other.  Both tubes were 
immediately returned to ice for 10 minutes, then exposed to heat shock (42°C for 
exactly 45 seconds) in a water bath, and then returned to ice for a further 2 minutes.  
Nine-hundred microlitres of cold (4°C) culture media were added to each tube 
followed by incubation at 37°C for 1 hour on a rotational shaker at 225 revolutions per 
minute (rpm).  Serial dilutions (x1, x10, x100 and x200) were performed for the 
transformed cells and spread on to sterile agar plates.  The control reaction was diluted 
x100 and plated in-triplicate.  All plates were incubated overnight at 37°C in a dry 
oven.   
 
The reaction involving Competent Cells Control DNA acted as a positive control and 
allowed calculation of the transformation efficiency by use of the following equation: 
 
Transformation efficiency (cfu/µg) =        mean cfu on control plate       x      1000ng/µg 
ng of Competent Cells Control DNA plated 
 
After overnight incubation, single colonies were selected from plates with an 
appropriate colony density and added to 9ml of Ampicillin-supplemented LB broth in 
sterile universals.  These clonal cultures were incubated at 37°C for 24 hours on a 
rotational shaker at 225 rpm.   
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2.4.4 Clonal screening for presence of the target sequence. 
Screening of single-clone cultures for a target sequence was performed using 
conventional polymerase chain reaction (PCR).  Five microlitres of the bacterial culture 
were added to sterile RNase and DNase-free thin-walled Eppendorf tubes and boiled 
at 100°C for 10 minutes.  Each tube was spun briefly and 45µl of the PCR master-mix 
added to each tube.  The PCR master-mix comprised of (per 50µl reaction): 1µl each of 
sense and anti-sense primers (100pmol/µl), 1µl of dNTP (each 200 µM), 5µl of 10x 
reaction buffer, 0.5µl DNA polymerase, and 37.5µl of RNase and DNase-free water.  
PCR parameters were set at 94°C for 2 minutes followed by 40 cycles of 94°C for 1 
minute, 60°C for one minute and 72°C for 1 minute, with a final incubation at 72°C for 
10 minutes at the end of the reaction.  The PCR products underwent electrophoresis on 
a 1% agarose gel at 100V until sufficient band separation was achieved.  Their size was 
determined by comparison with a DNA ladder using the Kodak imaging detection 
system and software.   
 
 
2.4.5 DNA extraction from clones 
Bacterial clones identified as positive for the target sequence by PCR underwent DNA 
extraction using the Miniprep technique (Qiagen, 27104).  Duplicate two millilitre 
samples were transferred from the clonal bacterial suspensions to Eppendorf tubes 
under aseptic conditions.   Each column was spun on a bench centrifuge at 8,000 rpm 
for two minutes at room temperature to pellet the bacteria.  The supernatant was 
discarded and the bacterial pellet resuspended completely in 250µl of Buffer P1 
supplemented with RNaseA.  Following the addition of 250µl of Buffer P2, each tube 
was carefully mixed by gentle inversion.  Finally 350µl of Buffer N3 was added and 
each tube inverted again.  The tubes were then spun at 8,000g for 10 minutes at room 
temperature and the supernatant carefully collected and added to spin columns.  The 
columns were spun at 8,000g for 60 seconds, washed with 500µl of Buffer PB, spun 
again, washed with 750µl of Buffer PE and spun finally for 2 minutes with the flow-
through discarded after each spin.  Fifty microlitres of Buffer EB was added directly to 
the membrane of each spin column, incubated for one minute and spun as above for 
one minute.  The DNA concentration in this final sample was measured using a 
UVmini-1240 spectrophotometer (Shimadzu, Japan) in a similar fashion to the RNA 
quantification described in Section 2.2.5.  For each sample the values for absorbance at 
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260Ǻ (A1) and 280Ǻ (A2) were recorded.  The amount of DNA contained in each 
sample was calculated by the formula: 
DNA Amount (µg/µl)  =  A1 x 5 
 
 
2.4.6 Restriction enzyme DNA digestion 
Restriction enzyme digestion of plasmids was performed at a number of stages during 
the transfection procedure.  For each reaction, although the DNA substrate, enzyme, 
buffer and possibly conditions differed, the way in which the reactions were prepared 
was standardised.   The enzymes, buffers and conditions used are outlined in Table 2.1.  
A typical reaction was assembled as follows: 1 µg of DNA substrate was taken and 
made up to a total volume of 17.3 µl with nuclease-free water.  To this was added 2 µl 
of Restriction Enzyme 10x buffer, 0.2 µl of acetylated bovine serum albumin (Promega, 
R396D) and, after mixing by pipetting, 0.5 µl of restriction enzyme.  Incubations were 
performed at the optimum temperature for 4 hours.  Five microlitre samples of the 
reaction products were then mixed with 1 µl of 6x loading buffer (Fermentas, R0611) 
run on 1% agarose electrophoresis gels at 100V against either 100bp (Fermentas, 
SM0421) or 1kpb (Fermentas, SM0311) DNA ladders as appropriate.  On the occasions 
that incubation with two restriction enzymes was performed (for example EcoR1 and 
Xba1) a suitable combination buffer was used.  For this example the MultiCore buffer 
was used (Promega, R999A). 
 
 
Table 2.1:   Restriction enzymes, associated buffers and experimental conditions used 
during the transfection procedure. 
Restriction 
Enzyme 
Promega 
Reference 
Buffer 
System 
Promega 
Buffer 
Reference 
Optimum 
Incubation 
Temperature / °C 
EcoR1 R6011 H R008A 37 
Xba1 R6181 D R004A 37 
Bcl1 R6651 C R9921 50 
Sal1 R6051 D R004A 37 
Nco1 R6513 D R004A 37 
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2.4.7 Construct isolation and extraction. 
The pcDNA3-CXCR4 containing plasmid and the pcDNA3.1vB empty vector were 
double-digested with the restriction enzymes EcoR1 and Xba1 at 37°C for 8 hours in 
the appropriate buffer solution in triplicate.  The clone map, PCR primers and 
restriction enzyme sites are shown in Figures A2.3, A2.4 and A2.5 (Appendix 2).  The 
reaction products were run on a 1.0% agarose gel at 100V until sufficient band 
separation had occurred.  The bands were identified under ultraviolet light, excised 
from the gel using a sharp scalpel, and transferred to a nuclease-free Eppendorf tube of 
known mass.  The DNA was extracted from the gel using the QIAquick gel extraction 
kit (Qiagen, 28704). 
 
The tubes containing the excised gel fragments were weighed and the mass of their 
contents was calculated.  For each 100mg of gel, 300µl of yellow QG buffer was added 
to each tube.  The mixture was incubated at 50°C for 10 minutes (with vortexing every 
couple of minutes) until the gel had dissolved.  Any colour change in the QG buffer at 
the end of this dissolution step was corrected with the addition of 10µl aliquots of 3M 
sodium acetate (pH 5.0) until a yellow colour was restored.  An equal volume of 
isopropanol was added to each tube in order to maximise yield of DNA fragments 
>4kbp.  The contents were added to a spin column in 800µl aliquots and centrifuged 
for one minute.  All centrifugation steps were performed at 8,000g for one minute at 
room temperature.  The spin column membrane was washed with 500µl of buffer QG 
to remove all traces of agarose and spun again.  Finally, the column membranes were 
washed with 750µl of buffer PE, spun and then spun again over an empty collecting 
tube.  Elution of the DNA was performed using 50µl of buffer EB that was allowed to 
stand for one minute prior to centrifugation.  Final DNA concentration was 
determined using a spectrophotometer as outlined above. 
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2.4.8 Construct ligation 
The optimal molar ratio of insert (CXCR4) to vector (opened pcDNA3.1vB) was 
investigated.  The mass of insert DNA required for each reaction was calculated 
according to the formula given below where kbp insert = 1.086 and kbp vector = 5.454: 
 
Insert mass (ng)  =  mass of vector (ng) x kbp of insert     x     ratio 
            kbp of vector 
 
The ratios investigated were 1:3, 1:1 and 3:1 insert to vector respectively.  Ligation was 
performed by adding the required amounts of CXCR4 insert DNA and pcDNA3.1vB 
vector DNA made up to a total volume of 17.5 µl with nuclease-free water.  To this was 
added 2 µl of x10 T4 DNA ligase buffer and 0.5 µl of T4 DNA ligase (Promega, M1801).  
A negative control reaction was also prepared where 0.5 µl of nuclease-free water was 
substituted for the T4 DNA ligase.  The reaction mixtures were then incubated at 37°C 
for 15 minutes.  To determine the effect of the insert : vector molar ratios on ligation 
efficiency, the reaction products were investigated using the T7 forward and BGH 
reverse PCR primer pairs.  These were preferable to CXCR4 primers as the latter would 
have been non-specific for free or incorporated inserts within the reaction mixture. 
 
 
2.4.9 Preparation of constructs for transfection. 
The pcDNA3.1vB-CXCR4 plasmid was prepared as detailed above.  It was transformed 
into competent JM109 cells, as previously described, and single colonies were taken 
and expanded by overnight culture in liquid media.  The pcDNA3.1vB empty-vector 
negative control plasmid was also taken and similarly expanded.  All clones were 
screened by PCR using primers for CXCR4 and T7F/BGHR to ensure the presence of 
the CXCR4 insert.  Clones identified as positive by PCR were then grown up, the DNA 
extracted by the mini-prep technique and subjected to digestion by a panel of 
restriction enzymes.  This was to confirm the copy number and orientation of the 
inserts in each plasmid.   
 
A large amount of the analysed pcDNA3.1Vb-CXCR4 plasmid DNA was then 
produced using the Maxi-prep plasmid kit (Qiagen, 12162).  For this, a starter culture 
of the confirmed clones was grown in 9ml of LB media on a rotational shaker at 225 
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rpm at 37°C for 8 hours.  Subsequently, 200 µl of the starter culture was added to a 
further 100ml of fresh, warmed LB media and incubated overnight at 37°C at 225 rpm.  
A bacterial pellet was then formed by centrifugation at 6,000g for 15 minutes at 4°C, 
after which the supernatant was discarded.  The pellet was re-suspended in 10ml of 
Buffer P1 to which RNase A had been added to a final concentration of 100 µg/ml.  Ten 
millilitres of Buffer P2 was then added to the tube, mixed by inversion, and incubated 
for 5 minutes at room temperature.  Finally, 10 ml of Buffer P3 (pre-chilled to 4°C) was 
added to the tube and incubated on ice for 20 minutes.  At the end of the incubation the 
tube was gently mixed, centrifuged at 20,000g for 30 minutes at 4°C, and then the 
colourless supernatant containing the plasmid DNA removed and stored on ice.  The 
centrifugation was then repeated for a further 15 minutes and the supernatant 
removed and stored.  Ten millilitres of Buffer QBT was applied to the filter membrane 
and was allowed to flow through completely under gravity.  The DNA-containing 
supernatant was then applied to the membrane and allowed to flow through under 
gravity.  Two, 30 ml washes of Buffer QC were then applied.  The DNA was then 
eluted from the membrane by the addition of 15 ml of Buffer QF collected in a non-
polycarbonate 50 ml tube.  Ten millilitres of room-temperature isopropanol was added 
to the tube, mixed and centrifuged at 15,000g for 30 minutes at 4°C.  The supernatant 
was carefully removed and discarded, taking care to leave the DNA pellet 
undisturbed.  This was then washed with 5 ml of 70% ethanol and centrifuged again 
for 10 minutes.  The supernatant was again removed and the pellet allowed to air dry.  
The DNA was dissolved in nuclease-free water and the quantity and quality were 
assessed using a spectrophotometer as outlined in Section 2.4.5.  Finally, the DNA was 
made up to a concentration of 1 µg/µl and stored at -20°C. 
 
 
2.4.10 Beta Galactosidase Assay and Cell Visualisation 
Optimum conditions for the transfection reaction were determined using the β-
Galactosidase reporter assay (E2000, Promega) and the pcDNA3.1-lacZ positive control 
plasmid.  The assay chemistry is based on the lacZ-encoded β-Galactosidase that 
hydrolyses the colourless o-nitrophenyl-β-D-galactopyranoside (ONPG) to o-
nitrophenol which is yellow.  Standards were prepared according to the 
manufacturer’s instructions:  a 1:10,000 dilution of 1µg/µl β-Galactosidase was 
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produced and used to prepare standards ranging from 1.0 to 6.0 milliunits β-
Galactosidase made up to 150µl with x1 Reporter Lysis Buffer (RLB).   
 
For optimisation reactions, wild-type H357 cells were transfected with pcDNA3.1-lacZ 
DNA using the Transfast reagent (vide infra).  Negative controls were performed using 
the Transfast reagent alone, without the addition of pcDNA3.1-lacZ DNA.  Six wells 
per experimental condition were used.  The cells were then incubated for a further 48 
hours before the β-Galactosidase reporter assay was performed.  At the end of this 
period, the growth medium was aspirated and the cells were gently washed twice with 
Mg2+ and Ca2+ free PBS.  After careful aspiration of the PBS, 200µl of RLB was added to 
each well and incubated for 15 minutes at room temperature with gentle agitation.  
Following this, the wells were scraped and the lysate transferred to a 1.5ml Eppendorf 
tube on ice.  Each tube was vortexed for 15 seconds and then centrifuged at 13,000g for 
2 minutes at 4°C.  One hundred microlitres of supernatant from each sample was 
carefully removed and used fresh.  In a clean 96-well-plate, 50µl of sample, standard or 
negative control was added in duplicate to separate wells.  A further 50µl of 2x Assay 
Buffer was added to each well, mixed by pipetting, covered and incubated at 37°C.  
After 30 minutes the reaction was stopped by the addition of 150µl of 1M sodium 
carbonate solution and the absorbance at 420nm read using a microplate reader.  The 
reading for each sample duplicate was averaged, and the mean and standard deviation 
calculated for the six wells from each experimental condition.  Statistical analysis was 
performed using the ANOVA test with post-hoc Bonferroni correction for multiple 
testing.  
 
Visualisation of in-situ staining for β-Galactosidase activity was also performed.  Wild-
type H357 cells, transfected with the pcDNA3.1-lacZ control plasmid, were grown in 
sterile six well plates without antibiotic selection (vide infra).  A pcDNA3.1vB empty-
vector mock transfection was also performed to act as a negative control.  Once 
confluence was approached, the cells were washed with PBS and fixed with 2ml per 
well of glutaraldehyde solution for 15 minutes.  The fixative was removed, and the 
cells washed three times with PBS.  One millilitre of 50 mg/ml X-Gal solution 
(Promega, V3941) was added to each well.  The cells were incubated at 37°C for eight 
hours until visible blue staining was seen.  The X-Gal solution was then removed and 
replaced with PBS prior to photographing. 
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2.4.11 Transfection Optimisation  
Wild-type H357 cells were seeded on to 24-well-plates in normal growth media 
supplemented with 10% FCS at a sufficient density to achieve 80% confluence after 24 
hours.  Transfection was performed using the TransFast reagent (E2431, Promega).  
This reagent is comprised of the synthetic cationic lipid, N,N [bis (2-hydroxyethyl)-N-
methyl-N-[2,3-di(tetradecanoyloxy) propyl] ammonium iodide, and the neutral lipid, 
DOPE.  On the day before the transfection procedure the TransFast reagent was 
thawed, 400 µl of nuclease-free water was added and the mixture was vortexed for 10 
seconds.  Finally the prepared reagent was stored at -20°C overnight.  On the following 
day, the prepared reagent was warmed to room temperature and spun at 300g briefly 
prior to use.   
 
The transfection procedure was performed by combining empirically-determined 
volumes of the TransFast reagent, plasmid DNA and serum-free media.  Initially this 
mixture was incubated for 15 minutes at room temperature.  After this time, the 
growth medium was aspirated from the cells and replaced with the pre-mixed 
TransFast/DNA/serum-free media.  The cells were then incubated at 37°C and 5% 
CO2 for an empirically determined time period, after which the mixture was removed 
and replaced with pre-warmed normal growth media supplemented with 10% FCS.  
Three experimental variables were investigated in order to determine the optimal 
conditions for transfection: 1) charge ratio of TransFast reagent to DNA, 2) amount of 
DNA added per well, and 3) the cell exposure time to the TransFast/DNA/serum-free 
media mixture.  All experiments were run three times.   
 
The influence of charge ratio on transfection efficiency was investigated.  The charge 
ratios were manipulated by varying the ratio of TransFast reagent volume to plasmid 
DNA volume within the TransFast/DNA/serum-free media mixture to which the cells 
were exposed for one hour.  Charge ratios of 1:1, 1.5:1 and 2:1 (TransFast reagent 
volume to pcDNA3.1-lacZ volume) over a range of starting DNA concentrations (0.2 
and 0.8 µg per well) were investigated.  A DNA-free negative control was also 
included.  Six wells were used for each experimental condition and each well was 
analysed in duplicate for its β-Galactosidase reporter assay activity. 
 
The effect of the starting amount of DNA on transfection efficiency was determined.  
The concentration of pcDNA3.1-lacZ DNA in the TransFast/DNA/serum-free media 
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mixture was varied between 0.2 and 2.0 µg per well, and a DNA-free negative control 
arm was also included.  A charge ratio of 1:1 was used and the cells were exposed to 
the transfection mixture for a total of one hour.  Again, six wells were used per 
experimental condition and each well was measured in duplicate for its β-
Galactosidase reporter assay activity.   
 
The relationship between the exposure time of cells to the TransFast/DNA/serum-free 
media mixture and transfection efficiency was investigated.  A charge ratio of 1:1 was 
used with 1.5 µg of pcDNA3.1-lacZ DNA added per well.  Exposure time was varied 
between 30 minutes and 2 hours.  Six wells were used per time period and the β-
Galactosidase reporter assay activity was measured in duplicate for each well.   
 
 
2.4.12  Transfection procedure 
A suitable wild-type OSCC cell line (H357) was selected on the basis of its low level of 
constitutional expression of CXCR4.  Production of a stably-transfected cell line was 
performed in the following stages:  
 
1. Determination of wild-type H357 killing by the antibiotic G418 
2. Transfection of the pcDNA3.1vB-CXCR4 plasmid 
3. Clonal selection and expansion 
 
The effect of the antibiotic G418 sulphate ([Geneticin], Invitrogen, 10131) on wild-type 
H357 cells was determined using the MTT cell viability assay (as described in Section 
2.8.2).  The aim was to determine the G418 concentration that resulted in 90% cell death 
after 72 hours of exposure to the agent as per the manufacturer’s instructions.  Briefly, 
1 x 104 cells and 200µl of fresh medium containing 10% FCS were seeded into each well 
of a 96-well-plate and allowed to incubate overnight at 37°C and 5%CO2.  G418 stock 
solutions were made up by serial dilution in growth media to yield a range of final 
concentrations of 100 to 1600µg/ml when was added to each of the pre-incubated 
wells.  Twelve wells per treatment concentration were used in addition to a no-
treatment control of 10µl of growth media alone.  Time points of 24, 48 and 72 hours 
were measured and the mean and standard deviation cell survival was calculated and 
expressed as a percentage compared with the no-treatment control.  A two-tailed 
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homoscedastic student t-test was used to compare the effect of increasing G418 
concentration on cell survival. 
 
Wild-type H357 cells were seeded at densities of 3, 4 and 5 x 105 in six well plates in 
duplicate.  All cells were incubated overnight with normal growth media under 
optimal conditions.  The following day, the wells with healthy cells at 80% confluence 
(as estimated by light microscopy) were selected.  The TransFast reagent was also 
prepared 24 hours before use as previously described.   
 
Optimum conditions for the transfection reaction were determined empirically using 
the pcDNA3.1-lacZ control plasmid and the β-Galactosidase reporter activity assay as 
described in Sections 2.4.11.  The results of these experiments are outlined in Appendix 
5.  Three transfections were performed: experimental (pcDNA3.1vB-CXCR4), mock 
(pcDNA3.1vB empty-vector) and negative control (no DNA), each with duplicate 
wells. Transfection parameters were determined empirically from optimisation 
experiments and scaled up to the 6 well plate format.  A 1:1 molar charge ratio of 
TransFast reagent for 1.5µg of DNA per well was used.  Sufficient mixture was 
prepared for the experimental, mock and control wells, added to 2ml of serum-free 
media per well, and incubated for 15 minutes at room temperature.  The growth 
medium was removed from the selected wells and replaced with 2ml of the pre-
incubated TransFast/DNA/serum-free mixture per well.  The plates were re-incubated 
for 1 hour at 37°C and 5%CO2 after which the transfected wells were overlayed with 
normal growth media containing serum. 
 
The transfected cells were initially grown in non-selective media for 48 hours.  After 
this period, the cells were trypsinised and passaged as previously described into 10cm 
dishes.  Preliminary experiments had determined that a concentration of 1600µg/ml of 
the selective antibiotic (G418) was required to achieved 90% killing of untransfected 
cells (see Appendix 5).  Growth media supplemented with G418 to a final 
concentration of 1600µg/ml was then introduced to transfected cells and non-
transfected negative controls.  This selective growth media were changed every 48 
hours to remove dead and dying cells until colony formation could be seen.  When it 
was possible to visualise distinct single colonies by light microscopy their positions 
were marked on the surface of the dish.  The cells were washed twice in PBS and sterile 
paper cloning discs soaked in trypsin were applied to the marked colonies.  The 
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positions of the cloning discs were confirmed by light microscopy.  The dishes were 
incubated at 37°C for five minutes, after which the discs were removed and transferred 
into individual wells of a six well plate.  The selective growth medium was replaced 
and the plates were incubated under optimum conditions.   
 
In total, six pcDNA3.1vB-CXCR4 and six pcDNA3.1vB empty-vector clones were 
selected and expanded over a period of 3 weeks under antibiotic selection.  Of the six 
experimental clones (labelled H357-X4.1 to X4.6), all but one (H357-X4.3) survived.  All 
the mock-transfected clones (labelled H357-EV1 to EV6) survived.  Subsequently, all 
transfected cells were maintained in media supplemented with G418 at a concentration 
of 1600 µg/ml. 
 
 
2.4.13  Characterisation of the transfected cell lines. 
The newly transfected cells (with and without the CXCR4 insert) were characterised at 
the mRNA and protein levels.  Determination of CXCR4 mRNA expression by 
transfected cells was performed using semi-quantitative real-time RT-PCR as described 
in Section 2.3.  Briefly, six mock-transfected clones (H357-EV1 to EV6), five CXCR4-
transfected clones (H357-X4.1, 4.2, 4.4, 4.5 and 4.6) and wild-type H357 cells (H357-WT) 
were grown to 90% confluence (as determined by light microscopy) in appropriate 
media under optimal conditions.  Four separate replicates of each clone were taken, the 
cells washed with PBS, and the total RNA harvested by the method previously 
outlined in Section 2.2.3.  The total RNA obtained was DNase treated using the RNase-
free DNase kit (Qiagen, 79254), a component of the RNeasy kit (Qiagen, 74104) as 
outlined in Section 2.2.4.   The amount of total RNA was measured using a 
spectrophotometer and 2 µg of each sample was used to manufacture cDNA using the 
iScript cDNA synthesis kit (Bio-Rad, 170-8891) as described in Section 2.3.2.2.  No 
reverse-transcriptase control reactions were included for each clone.  Each sample was 
analysed in triplicate wells for CXCR4 by real-time PCR as outlined in Section 2.3.3.   
The relative expression of CXCR4 mRNA in each clone compared with wild-type H357 
cells was calculated.  Statistical comparison between clones was performed using the 
ANOVA test.  The whole experiment was performed twice.   
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Determination of CXCR4 protein production by transfected cells was performed using 
flow cytometry and fluorescence immunocytochemistry as outlined in Sections 2.5 and 
2.6 respectively. 
 
 
2.4.14  Cell maintenance, FACS sorting and clonal re-selection 
Stock cultures of all transfected cells (with and without the CXCR4 insert) were 
maintained in normal growth media supplemented with the selective antibiotic G418 
to a final concentration of 1600µg/ml.  After freezing, storage and subsequent thawing, 
the H357-X4.1 and H357-X4.2 clones underwent FACS sorting on the basis of their 
CXCR4 expression.  Briefly, cells were prepared for FACS analysis as outlined in 
Section 2.4 although, in addition, this was done under strict aseptic conditions.  For 
each clone a total of 8.5 million cells were harvested.  Eight million cells were labelled 
with the anti-CXCR4 primary monoclonal antibody and the remaining 500,000 with an 
isotype control.  After completion of the washing and secondary antibody stages (vide 
infra) the CXCR4-labelled cells were resuspended with 2mls of cold PBS in a sterile 
FACS tube and kept on ice in the dark.  FACS analysis of CXCR4 labelling was 
performed using a FacsAria platform running the FacsDiva software package (both 
Becton Dickinson) as outlined below.  Cells from the central population of CXCR4-
positive cells were sorted and collected in a fresh, sterile FACS tube.  Cells from each 
clone were resuspended in warmed growth media supplemented with the antibiotic 
G418 (1600 µg/ml) and plated using serial doubling dilutions into successive wells of a 
24 well plate. 
 
Cells were incubated under standard conditions of 37°C and 5%CO2 overnight to allow 
attachment and then washed gently with warmed PBS and fresh selective growth 
media added.  Wells containing cells at clonal density were identified by light 
microscopy, photographed and allowed to expand over a period of three weeks with 
passaging as required.   
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2.5 Flow cytometry 
Established and transfected OSCC cell lines, primary oral and skin keratinocytes and 
human gingival fibroblasts were examined with flow cytometry.  Conventional cell 
lines were grown in T25 flasks normal growth media containing 10% FBS and 
passaged at early confluence (approximately 80%) as determined by light microscopy.  
Early-passage primary cell lines were initially seeded with growth-arrested fibroblast 
feeder cells (as described in Section 2.1).  Several methodological steps were performed 
to ensure that the feeder cells did not affect the results:  Firstly, primary cells were 
cultured for each passage for a sufficient time to ensure that the majority of fibroblast 
feeder cells had died and become detached.  This was confirmed by visual inspection 
for fibroblastoid morphologies prior to passage.  Secondly, keratinocytes and 
fibroblasts could be differentiated on the basis of size and granularity and separate 
analyses of the appropriately gated populations were performed (see results).  Finally, 
pure mono-populations of the feeder cells were examined for relevant chemokine 
receptor expression by flow cytometry. 
 
Once 80% confluence had been attained, the growth media were gently aspirated and 
the cells washed in warmed, sterile PBS.  The PBS was aspirated and the cells 
incubated with 1ml of non-enzymatic dissociation buffer (Sigma) at 37ºC and 5% CO2 
until dissociation had occurred (typically 5 to 10 minutes).  The samples were washed 
with 1ml of warmed PBS and centrifuged at 300g for 6 minutes.  The supernatant was 
aspirated gently and the samples were resuspended in 200μl of cold PBS.  Each sample 
was divided into aliquots of 100μl in clean Eppendorf tubes.  For each sample, one 
aliquot was incubated with 50μl of 1:50 dilution primary anti-chemokine receptor 
mouse anti-human immunoglobulin monoclonal antibodies.  Commercially available 
antibodies were used for these experiments: one clone raised towards CCR7 (MAB197, 
R&D Systems) and two separate clones raised against CXCR4 (MAB172 and MAB173, 
R&D Systems).  To investigate CXCR4 protein production by flow cytometry two 
monoclonal antibodies with different binding sites were selected.  Both antibodies had 
been validated for this technique by the commercial compant and one (MAB173) has 
been widely used in the published literature on CXCR4.  The second experimental 
aliquot was incubated with 50μl of isotype control monoclonal antibody diluted 1:50 in 
cold PBS under the same conditions to act as a negative control.  All reactions were 
incubated for 30 minutes on ice in the dark.   
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Following these incubation steps, the samples were centrifuged at 1,500g for 60 
seconds, the supernatant removed and resuspended with 200μl of cold PBS to wash the 
cells.  The samples were centrifuged again and the PBS removed.  A 1:300 dilution of 
the secondary antibody (conjugated 488 anti-mouse IgG) was prepared in cold PBS.  
The pellet of cells was resuspended in 50μl of secondary antibody for 15 minutes on ice 
in the dark.  This incubation was followed with two washes with 200μl of cold PBS.  
The samples were finally resuspended in 200μl of cold PBS.  Finally, just prior to 
analysis, 100μl aliquots of cold propidium iodide (Sigma, P4864) were added to each 
sample.  Flow cytometry was performed using an FACS-Calibur instrument (BD 
Biosciences) and accompanying Cell Quest software.    
 
Brief sampling of each negative control aliquot allowed the analysis parameters to be 
set for each cell line.  Firstly a plot of forward scatter (cell size) against side scatter 
(granularity) was performed.  Cells within the central distribution were selected (gated 
R1) and the remainder discounted for the purpose of the analysis.  Secondly, for R1-
gated cells, the propidium iodide fluorescence intensity was plotted against the 
chemokine receptor antibody fluorescence intensity.  Cells with an intact surface 
membrane that excluded propidium iodide were selected (gated R2).  Finally, a plot of 
cell count against chemokine receptor antibody fluorescence intensity for R2-gated 
cells was produced and overlaid against a similar plot for the matched isotype control 
labelled cells.  Mean fluorescence values for chemokine receptor labelling and isotype 
controls were calculated and recorded.  Analysis was based on a minimum of 10,000 
counts from the R2-gated cell population. 
 
 
2.6 Fluorescence immunocytochemistry and confocal microscopy 
Sterile glass coverslips 13mm in diameter were taken and placed in individual wells of 
sterile 24 well cell-culture plates.   Cells were seeded at low density in supplemented 
media for 48 hours as before.  The cells were washed twice with PBS and fixed in cold 
3.7% paraformaldehyde at pH 7.4 (15 minutes), permeablised in 1% Triton X-100 (5 
minutes) and incubated in blocking buffer (30 minutes) with three washes in PBS 
between each step.  Primary anti-chemokine receptor monoclonal antibodies were 
diluted to optimal concentrations in blocking buffer (1% BSA and 10% FBS in PBS) and 
incubated with the cells overnight at room temperature.  Negative controls with no 
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primary or substituted isotypes were performed for each cell line.  Each sample was 
washed three times in PBS and then incubated with a bovine-anti-mouse secondary 
antibody directly conjugated to Texas Red at 1:200 dilution for an hour at room 
temperature.  After washing three times with PBS, 1ml of 1:1000 dilution DAPI in PBS 
was added to each well for 5 minutes at room temperature in the dark.  Each sample 
was washed a final three times in PBS and mounted in aqueous immuno-mount, sealed 
with clear resin and stored at 4ºC in the dark.  Non-fluorescence immunocytochemistry 
was performed using the same protocol with a DAB finish as outlined in Section 2.7. 
 
Conventional microscopy was performed using a fluorescence microscope (Zeiss) and 
digital image capture (Nikon).   Images were carefully labelled, stored on a memory 
card, transferred to PC and opened using the Powerpoint software package (Microsoft 
Corporation).  A 5µm graticule was also photographed under plain light at all 
magnifications used in order to provide a standard reference for scale. 
 
Confocal microscopy was performed using a laser illuminated confocal microscope 
(Zeiss) with accompanying image control software.  Scout images were taken and the 
plane of focus defined.  Serial scans through the focal plane were taken at increments 
recommended by the software package.  Image folders were carefully labelled, 
recorded on to CD and transferred to PC.  Image analysis was performed using the 
satellite image reformatting software package provided by the manufacturer (LSM 5 
v.3.2, Zeiss).  Reconstructed images were then imported into Powerpoint.  In a similar 
way to before, a 5µm graticule was used to provide a standard reference for scale. 
 
 
2.7  Immunohistochemistry 
Immunohistochemistry was performed on tissue sections collected from the pathology 
archive of St Bartholomew’s and The London NHS Trust. Clinical specimens were 
used with approval of the East London and The City Research Ethics Committee 
(ELTC P1/04/016).  Anonymous pathology reports are summarised in Table A2.1 
(Appendix 2).  Head and Neck Tissue Arrays (A219II, Accumax) were also 
investigated.  The layout of the tissue array used is shown in Figure A2.1 (Appendix 2).  
Clinicopathological features of the specimens available on the tissue array are outlined 
in Table 4.1 (Chapter 4). 
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Specimen handling protocols basically involved the following steps: 
 
1. Specimen selection and section cutting  
2. Section rehydration and antigen retrieval 
3. Blocking non-specific binding 
4. Incubation with primary antibody 
5. Incubation with secondary antibody 
6. Colour preparation and counterstaining 
7. Dehydration and mounting 
 
In detail:  The recorded minimum data set for head and neck tumour specimens were 
taken and salient information was entered into a spreadsheet (Excel, Microsoft Office).  
Specimens were selected based on their clinico-pathological parameters and the 
available complete diagnostic pathology reports checked for consistency.  Blocks of 
formalin-fixed, paraffin embedded tissue were obtained from the pathology archives, 
orientated and cut into 5µm sections on to SuperFrost glass slides using a microtome.  
Positive control specimens were prepared in a similar way.  Sections were stored 
vertically and air dried before baking in a dry oven at 65°C for 90 minutes. 
 
The specimens were then processed in standard histological water baths and racks 
using solutions at room temperature (unless otherwise specified).  To de-wax the 
specimens the slides were incubated in xylene for 15 minutes twice followed by two 
rinses in 100% ethanol for 10 minutes each.  Endogenous peroxidise activity was 
blocked by incubation with 1% Hydrogen Peroxide in methanol for 30 minutes.  
Samples were then rehydrated by successive incubation in reducing concentrations of 
ethanol (100%, 75% and 50% respectively) for 5 minutes each, followed by 5 minutes in 
pure distilled water.  Other methods of antigen retrieval were evaluated empirically 
using positive control specimens.25  The most effect method was determined to be 
microwave pressure cooking as follows:  A working concentration of Antigen 
Unmasking Solution (H3300, Vector Laboratories) was prepared by the addition of 
15ml of concentrate to 1600ml of distilled water in a microwave-proof pressure 
chamber.  This was heated in a microwave at full power for 15 minutes until the 
solution was bubbling.  Sections were immersed in the boiling unmasking solution, the 
                                                     
25  Other methods of antigen retrieval used were EDTA, citrate or protease-based. 
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pressure chamber sealed and returned to the microwave.  The chamber and its 
contents were heated at full power until the pressure indicator demonstrated that 
maximum pressure had been achieved.  Cooking was then continued for a further 
period.  Empirically, 2 minutes was determined as optimal.  After heating the pressure 
was released and the chamber cooled as quickly as possible with cold water without 
contaminating the samples.  Sections were then washed quickly in distilled water 
followed by PBS. 
 
A volume of PBS containing 0.1% BSA Fraction V (Sigma) was prepared fresh.  
Blocking buffer was prepared by adding 150µl of horse serum (Vector Laboratories) to 
10ml of PBS/BSA.  Samples were incubated in blocking buffer for 20 minutes at room 
temperature and then rinsed in PBS/BSA.  Avidin and biotin blocking was achieved by 
incubation for 15 minutes each with Solution A and Solution B of the avidin-biotin 
blocking kit (Vector laboratories) respectively, with a PBS/BSA wash between stages.  
Sections were then rinsed with PBS/BSA followed by blocking buffer.  Each slide was 
dried peripherally and encircled by a hydrophobic barrier (Immedge Pens).   
 
The working concentration of each primary antibody was determined empirically.  
Primary antibody was diluted in blocking buffer and each section was flooded.  An 
isotype control mouse IgG2a antibody was used as a negative control at a working 
concentration of 3µg/ml.  All sections were sealed in a humidified chamber and 
incubated overnight at 4°C.  After this period the slides were washed in three changes 
of freshly prepared wash buffer for 5 minutes each time with gentle agitation on a 
rotational shaker.26  Free liquid was then removed from around each slide and each 
section was flooded with a working dilution of biotinylated horse anti-mouse 
secondary antibody.27  This was incubated for 1 hour at room temperature followed by 
rinsing with three changes of wash buffer for 5 minutes each time.  Again excess liquid 
was removed and Vectastain ABC solution (Vector Laboratories) was added (which 
had been prepared 30 minutes prior to use according to the manufacturer’s 
instructions) and incubated for one hour at room temperature.28 
 
                                                     
26 Wash buffer: 0.15M sodium chloride and 0.05% Tween 20 in PBS 
27 Working dilution of secondary antibody: 50µl in 10ml PBS/0.1% BSA 
28 Vectastain ABC solution:  100µl of Solution A was mixed with 5ml of PBS and then 100µl of 
Solution B was added.  The prepared solution was allowed to stand at room temperature for 30 
minutes prior to use. 
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The slides were then washed with PBS for 10 minutes with gentle agitation as before 
and then incubated with DAB solution (Vector Laboratories) prepared according to the 
manufacturer’s instructions29 for a maximum of 5 minutes.  Colour development was 
stopped by the removal of the DAB and rinsing with PBS.  Haematoxylin 
counterstaining was performed by adding filtered Gill’s haematoxylin stain for 3 
minutes, rinsing in tap water to produce a blue colour change then dipping briefly 
twice in acidified alcohol and rinsing in tap water again.  Sections were then 
dehydrated by the sequential washing in increasing concentrations of ethanol (50%, 
70%, 90% and 100% twice) and xylene twice for 5 minutes each.  A small volume of 
xylene-based mountant (Immunomount) was added to each slide and a glass coverslip 
applied.  For diagnostic purposes one section from each tissue block was stained with 
haematoxylin and eosin.  This was performed by the rehydration of sections and 
staining with haematoxylin as described above.  An additional incubation with eosin 
for 45 seconds was then performed.  The slides were then rinsed in water, dehydrated 
and mounted as described above. 
 
Tissue array specimens were prepared using an identical immunohistochemistry 
protocol and were then subjected to a number of post-processing steps.  These are 
outlined in Appendix 4. 
 
 
2.8  Proliferation Assays 
2.8.1  Overview 
Three complementary techniques were used to perform proliferation assays: 
 
1. 3-(4,5-dimethylthiazol-2-yl)-2,5,-diphenyl tetrazolium bromide (MTT). 
2. Resazurin (Alamar Blue).   
3. Bromodeoxyuridine (BrdU) 
 
Two of the three methodologies (MTT and resazurin) are based on the biochemical 
transformation of compounds added to the cell supernatants by living cells.  The BrdU-
                                                     
29 DAB solution:  Initially, 100µl of supplied buffer was mixed with 5ml of distilled water.  Then 
200µl of DAB was added, mixed and followed by 100µl of hydrogen peroxide. 
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based technique is based on uptake of the compound by proliferating cells which 
incorporate it into their DNA.  In this way these methodologies selected are 
complementary.  
 
 
2.8.2  MTT assay 
This tetrazolium-based assay is dependent on the observation that the reduction 
potential of proliferating cells is greater than that of non-proliferating cells.  The 
tetrazolium salt (yellow) is reduced to form formazan crystals (violet) which are 
insoluble in water.  When the reaction product is dissolved in solvent (such as DMSO), 
the cells are killed.  This limits the MTT assay to the measurement of one time-point 
only.  However, data generated are representative of the proliferation activity of cells 
over their period of incubation with MTT, rather than cumulative as is the case with 
Alamar Blue (vide infra).  
 
MTT assays were performed in a 96 well-plate format as follows.  Cells were passaged 
as previously described and mixed well to form a final cell density of 2.5 x 104/ml in 
appropriate media.  Two hundred microlitres of this cell suspension were added to 
each experimental or negative control well.  A similar volume of media alone (no cells) 
was added to a final row on the plate to determine background absorption.  Several 
identical plates were prepared and incubated overnight at 37ºC in a humidified 
atmosphere with 5% CO2 to allow the cells to adhere.  After this period the wells were 
aspirated gently and washed twice with warmed PBS.  Finally 200μl of fresh media 
containing the appropriate experimental conditions were added and the plates 
returned to the incubator.   
 
An MTT stock solution was prepared as follows: MTT powder (Sigma, M2003) was 
dissolved in sterile PBS to a stock concentration of 10 mg/ml, filter sterilised and 
stored at 4ºC protected from light.  At each selected time point 20 μl of the MTT stock 
solution was added to each well (including no-treatment controls and media-only 
blanks).  Care was taken to prevent contamination of the stock solution.  Each well was 
careful mixed by pipetting.  The plates were return to the incubator for four hours 
protected from light.  At the end of this period the growth media were carefully 
aspirated and the plates blotted dry with paper towels.  Two hundred microlitres of 
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DMSO (Sigma, D5879) was added to each well and incubated at room temperature for 
one hour protected from light.  For cells grown on opaque 96-well plates (vide infra) a 
final pipetting step was performed to transfer 100 μl of the DMSO/cell lysate mix from 
each well to a fresh transparent 96-well plate suitable for absorbance readings.  
Absorbance at 570nm was measured using a Titertek Multiskan Plus II microplate 
colourimeter (Life Sciences International).  Absorbance readings were entered into a 
Microsoft Excel spreadsheet and the mean absorbance for blank wells was subtracted 
from each recorded value.  Using the SPSS statistical package, a P-P plot of the 
experimental data was prepared to compare against the normal distribution (vide infra).  
Subsequently, the mean and standard deviation for each set of experimental replicates 
were calculated and compared using the ANOVA test.  Significant differences (p<0.05) 
between groups were further investigated with post-hoc testing using the Bonferroni 
correction. 
 
 
2.8.3  Alamar Blue Assays 
The reaction chemistry of resazurin-based assays is based on the reduction of the 
starting compound (blue and non-fluorescent) to resorufin (pink and highly 
fluorescent) in the cell supernatant (O'Brien, Wilson et al. 2000).  For each experimental 
condition, serial fluorescence measurements may be taken without disturbing the cell 
culture environment.  Consequently there are two significant advantages of this 
technique over MTT assays:  Firstly, that time-series data can be generated for each 
well; and secondly that the cell seeding density can be checked for consistency across 
the plate prior to the commencement of the experimental treatments. 
 
Assays were performed using opaque, sterile 96-well plates.  The optimum number of 
cells per well and duration of experiments were determined empirically.  Plates were 
set up with 5 x 103 cells per well in 200µl of normal growth media supplemented with 
10% FCS and 5% Alamar Blue (BUF012B, Serotec) by volume.  A blank row of media 
only (no cells) was prepared on each plate.  Initially plates were incubated overnight at 
37ºC in a humidified atmosphere with 5% CO2 to allow the cell populations to adhere.  
After this incubation period, the fluorescence emission (at a wavelength of 590nm) of 
each well was measured following excitation (at a wavelength of 530nm) using a 
 117
fluorescence microplate reader.   Readings were tabulated using the accompanying 
software and exported to the SPSS statistical software package.  
 
Each 96-well plate was analysed for consistency in cell seeding density prior to setting 
up any experimental conditions.  This quality-control check was performed using two 
quick statistical tests.  Firstly, the spread of the data was compared with the normal 
distribution by plotting the observed against expected cumulative probabilities (P-P 
plot).  Secondly, if the data were normally distributed (P-P plot conforms to a straight 
line), then baseline fluorescence values for each forthcoming experimental group were 
compared using the ANOVA test.  If no significant difference (p<0.05) could be 
demonstrated between groups then the plate was used for further experiments.  Plates 
that did showed baseline differences between groups were discarded.  Typical P-P 
plots and group comparisons are shown in Figure A2.4 (Appendix 2). 
 
Selected plates were then washed carefully twice with warmed, sterile PBS.  A stock 
solution of cell culture media, FCS (varied empirically) and 5% Alamar Blue was made 
up for all experimental wells including cell-free blanks.  This was maintained at 37ºC 
and protected from light.  Experimental treatments and negative controls were 
prepared using aliquots of this stock solution, and 200µl were added to each well.  The 
number of replicate wells required for each treatment condition was determined 
empirically.  Serial fluorescence measurements were taken at two hours and at regular 
time points to a maximum of 72 hours as detailed above.  At the end of the 
experimental time period it was still possible to perform MTT assays on these cells.  On 
these occasions, the supernatants were aspirated and the cells washed twice with 
warmed PBS.  Fresh media containing 1mg/ml MTT were added to each well and the 
assay was performed as described in Section 2.8.2. 
 
 
2.8.4  BrdU Incorporation Assay 
BrdU is a halogenated analogue of thymidine and is taken up by any cell undergoing 
DNA synthesis during the time of exposure.  Following treatment with putative 
mitogens cells are pulsed with BrdU, fixed and then immunostained using antibodies 
raised against the BrdU label. 
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In these experiments, assays were performed in transparent, sterile 24-well-plates.  
Cells were passaged as previously described and seeded at a density of 5 x 104 per well 
in 500µl of basal growth media supplemented with FCS to a final concentration of 10%.  
Cells were incubated under standard conditions overnight, then aspirated and washed 
with warmed, sterile PBS.  A further 500µl of basal growth media supplemented with 
0.1% FCS and SDF (varying in concentration between 0 and 100ng/ml) was then 
added.  Incubation was continued for a further 48 hours under standard conditions.  
The growth media were then removed and replaced with warmed basal growth media 
supplemented with 0.1% FCS and BrdU to a final concentration of 10µM.  Incubation as 
before was then continued for a further empirically-determined period after which the 
media were aspirated, the cells washed with PBS and then fixed in 4% 
paraformaldehyde for 20 minutes.  The wells were then washed twice with PBS and 
stained immediately. 
 
To prepare the cells for staining PBS was first aspirated from each well and the cells 
permeabilised with 0.2% Triton for 10 minutes and then washed with PBS.  To 
denature the DNA 4M hydrochloric acid was added for 10 minutes followed by 
washes with PBS pH 8.5 for 10 minutes with 2 changes then with PBS pH 7.6 for 20 
minutes with 4 changes.  Wells were then washed briefly with double-distilled water 
and then incubated with mouse anti-BrdU monoclonal antibody (Clone Bu20a, M0744, 
Dako) at room temperature for 2 hours.30  Cells were then washed with PBS for 15 
minutes with 3 changes and then incubated with an anti-mouse FITC-conjugated 
secondary antibody at 1:80 dilution for 1 hour at room temperature protected from 
light.    Cells were then washed with PBS for a further 15 minutes with 3 changes and 
then counterstained with DAPI at a final concentration of 1µg/ml in PBS for 15 
minutes in the dark.  After a final brief PBS wash a drop of aqueous Immunomount 
was added to each well and a glass coverslip applied.  Plates were stored at 4ºC in the 
dark until visualisation. 
 
Images were stored as photomicrographs taken with an inverted fluorescence 
microscope (Nikon) at x100 total magnification.  Three non-overlapping positions were 
selected for each well and two photomicrographs taken at each position: one to record 
DAPI staining and the other to record FITC activity.  All images were carefully 
                                                     
30 Antibody final concentration of 7mg/L (1:80 of supplied solution) in PBS supplemented with 
0.5% Tween 20 and 1% BSA (final concentration). 
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labelled, stored on a memory card, transferred to a PC and then opened in the 
Photoshop CS software package (Adobe Corporation).  A rigorous method was 
employed to ensure that accurate cell counting was performed.  All DAPI-stained 
nuclei were counted using a screen-tool that highlighted counted cells (to ensure no 
double counting occurred).  Over the three images taken per well a total cell count of 
over one thousand was sought.  From the images of FITC activity it was important to 
ensure that cells undergoing active division (concentrated bright signal) were 
differentiated from background (dull diffuse signal).  To achieve this 10 cells clearly 
undergoing cell division were identified and the colour saturation profile was recorded 
using the on-screen tool.  The mean and standard deviation of green saturation was 
calculated for the ten cells and the programme was used to filter the image according 
to the lower standard deviation less 20%.  The image generated was visually inspected 
to ensure no artefacts were present or cells were missing.  Finally a count was made of 
the cells identified in this way in a manner similar to that employed above. 
 
For each well the number of cells labelled with BrdU and the total number of cells 
analysed were recorded.  The results from replicate wells were combined 
mathematically.  Statistical comparison for individual treatments was performed using 
an online Chi-Squared test generator.31  For data derived from dose-response 
experiments a Chi-Squared test for trend was performed using the MedCalc statistics 
software package (MedCalc Systems, Belgium).  Statistical significance was accepted at 
the 5% level.   
 
 
2.8.5  Statistical Analysis 
For the resazurin-based assay the measured fluorescence values were tabulated in 
Microsoft Excel.  The mean value for the blank wells was calculated and subtracted 
from the reading for each well.  These time-series data were analysed according to the 
method outlined by Matthews (Matthews, Altman et al. 1990).  The proliferation rate of 
cells in each individual well was calculated as follows:  The value for the measurement 
at the two-hour time point was defined as equal to 1; subsequent measurements of the 
each well were then calculated relative to this value.  A plot of relative fluorescence 
values against time revealed the duration of linear accumulation of resorufin.  This was 
                                                     
31  Found at (http://www.georgetown.edu/faculty/ballc/webtools /web_chi. html) 
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determined empirically as 48 hours.  Consequently, relative fluorescence values for the 
time points between 2 and 48 hours were selected and the gradient of the line 
calculated.  This was defined as the relative proliferation rate.  The conformity of these 
data to a straight line was checked by calculation of the square of the Pearson product 
moment correlation coefficient (R-square value).  Data with R-squared values less than 
0.95 were rejected.  These calculations were performed for each replicate well and were 
grouped by experimental condition.  Each group of data were then analysed for 
conformity to the normal distribution by P-P plots (vide supra) and, when appropriate, 
the mean and standard deviations calculated.  Experimental groups were compared 
graphically by plots of the mean and standard deviation.  Statistical comparison was 
performed using the one-way ANOVA test with determination of any significant 
differences between groups by post-hoc testing with the Bonferroni correction. 
 
A statistical power calculation was also performed to determine the required number 
of replicate wells to be able to differentiate between the effects of various experimental 
conditions.  This was done with an online statistics package using preliminary 
experimental data that had previously been analysed using SPSS.32  Firstly the 
conformity of the data to a normal distribution was checked.  Secondly, the variances 
were compared for equality against the F distribution using the Levene test.  Statistical 
conditions were selected to power the experiment to detect a two-tailed difference in 
the means between two experimentally-determined proliferation rates at the p<0.05 
significance level on 90% of occasions.  Mean and standard deviations from 
preliminary data were entered into the online algorithm and the predicted number of 
replicate wells noted. 
 
                                                     
32  Online statistical power calculation package available at http://calculators.stat.ucla.edu/ 
powercalc/ 
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2.9 Assays of cell motility 
Cell motility was assessed in-vitro using three complementary techniques: 
 
1. Gold Colloid Assays 
2. Wound Scratch Assays 
3. Transwell Assays 
 
Each assay investigated a subtly different aspect of chemokinesis, chemotaxis and 
invasion (as discussed in the results). 
 
 
2.9.1  Gold Colloid Assays 
The purpose of this assay was to measure the maximal movement of single cultured 
keratinocytes in response to a chemokine stimulus in the absence of a directional 
component.  The assays were performed on pre-prepared glass coverslips (13mm 
diameter) in a 12 well plate format.  Initially all coverslips and glassware were rinsed 
thoroughly in distilled water to remove all traces of detergent and dry-heat sterilised.  
A 1% BSA solution was prepared fresh and filter sterilised.  Coverslips were held in 
fine, sterile forceps, immersed in the 1% BSA solution, drained completely by blotting, 
immersed briefly in 100% ethanol and drained again.  They were then placed singly in 
individual tissue culture wells.  The coverslips were then coated with gold colloid as 
follows:  Firstly solutions of 0.387g of anhydrous sodium carbonate (451614, Sigma) in 
100ml of sterile distilled water and gold(III) chloride (318645000, Acros Organics) to a 
final concentration of 6.85mg/ml in sterile distilled water were prepared.  In a conical 
flask 15 ml of the sodium carbonate solution, 4.5 ml of the gold chloride solution and 
27.5 ml of sterile distilled water were added and mixed while heating to boiling point.  
To this 4.5 ml of a 0.1% formaldehyde solution was added, mixed and a colour change 
from red to purple observed.  One millilitre aliquots of this final mixture were added to 
each well containing a BSA coated coverslip.  The culture plate was covered and 
incubated overnight at 4˚C.   
 
Finally a wash buffer was prepared comprising of 500ml Hanks’ Balanced Salts 
Solution (HBSS) supplemented with 5ml penicillin/streptomycin, 10ml sodium 
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pyruvate and 10ml 1M Hepes buffer.  The gold colloid solution was aspirated from 
each well and the coverslips were rinsed twice with wash buffer.  One millilitre of 
wash buffer supplemented with Type 1 rat-tail collagen (354236, Becton Dickinson) to a 
final concentration of 15µg/ml was added to each well and incubated at 37˚C for two 
hours.  The wells were aspirated again and the coverslips rinsed with wash buffer 
once.  A total of 4,000 cells suspended in 1ml of growth media supplemented with 0.1% 
FCS and SDF to varying final concentrations were added to each well.  The culture 
plates were covered and incubated at 37ºC with 5% CO2 for 20 hours.  After this period 
the wells were aspirated, rinsed once with wash buffer and the cells fixed by the 
addition of 2ml of 0.1% formaldehyde in PBS to each well for 15 minutes at room 
temperature.  Cells were then stained for surface receptors using the protocol for 
fluorescence immunocytochemistry outlined in Section 2.6. 
 
Analysis was performed using photomicrographs of individual cells taken at x1000 
magnification under oil immersion.  Images were opened using the Image-J software 
package (NIH) and the area cleared of gold colloid particles around the cell was 
marked out (Figure 2.3).  The total area covered was recorded and converted into 
square micrometres using a formula derived from photomicrographs of a graticule at 
the same magnification.  Twelve individual cells from each treatment condition were 
measured and the mean and standard deviation calculated. 
 
 
 
Figure 2.3:  Method of determining area covered in gold colloid assays.  Cells were incubated 
on sterile coverslips coated with gold colloid for 20 hours as outlined above.  Photomicrographs 
were taken of single cells under oil immersion (a), scale bar represents 25µm.  The area cleared 
of gold colloid particles was drawn out (b), and the area calculated using NIH Image J software.  
Twelve cells per coverslip were analysed, tabulated and the mean +/- standard deviation 
calculated. 
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2.9.2  Scratch Wound Assays 
The purpose of this assay was to measure the maximal movement of confluent 
cultured keratinocytes in response to a chemokine stimulus (without a directional 
vector).  The assays were all performed in conventional, sterile 24-well plates.  Cells 
were trypsinised and passaged as described previously.  Varying concentrations of 
each cell type (typically 100x103, 200x103 and 300x103 per millilitre) were prepared in 
normal growth media supplemented with 10% FCS.  Different plates were prepared 
using the different concentrations with 500µl added to each well.  The plates were then 
incubated for 16 hours under standard conditions of 37ºC and 5% CO2.   
 
The following day, the plate with the most even cell distribution corresponding to 90-
100% confluence was selected and the others discarded.  This plate was then washed 
twice with sterile PBS and then incubated with serum-free media containing 10µg/ml 
mitomycin C and 0.5% BSA for 2 hours under standard conditions.  Two vertical and 
two horizontal scratches were created in each well with a sterile 200µl pipette tip using 
reasonable downward pressure.  This created eight areas for analysis in each well (as 
outlined in Figure 2.4).   
 
 
Figure 2.4:  Schematic representation of an individual well prepared for a scratch wound 
assay.  Briefly, a confluent culture was prepared in each well and then scratched twice in both 
the horizontal and vertical directions with a 200μl micropipette tip.  In this way eight individual 
areas for analysis were created within a single chamber.  For details see text. 
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Figure 2.5:  Schematic representation of the method employed to measure scratch wound 
closure.  Confluent cultures were prepared and scratched as previously outlined (Figure 2.4).  
Wells were incubated and photomicrographs were taken at various time points: for example 28 
hours (a), 24 hours (b) and 4 hours (c).  Comparison was made with baseline measurements 
taken at Tzero (d).  Residual wound distances (X) were measured at the same distance (m) above 
the intersection in all images and were calculated as a percentage of (Tzero). 
 
 
The wells were then washed three times with sterile, warmed PBS and aspirated 
carefully.  Serum-free growth media supplemented with 0.5% BSA with or without 
treatments was added to each well to a total volume of 500µl.  Positive and negative 
controls were included on each plate and each experiment was repeated a minimum of 
three times.  A photomicrograph was recorded from each of the eight areas for analysis 
(shown in Figure 2.4) using an inverted microscope (Nikon) at x20 magnification.  Each 
area in each well was photographed sequentially at the outset (Tzero) and at pre-
determined intervals over a 28 hour time period.  From each experiment, four or five 
images were obtained for each area.  These images were analysed together at the end 
of the experiment using the Image-J (NIH) software package.  The final image was 
analysed first and the minimum distance (in pixels) between the two sides of the 
wound was measured (Figure 2.5).  The distance (M) this occurred above the 
m 
x 
m 
x 
a) T28 b) T24
m 
x 
c) T4
m 
x 
d) T0
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perpendicular line of the second scratch was also recorded.  For images taken of this 
area taken at previous time points the distance between the sides (X) was measured at 
point (M) above the intersection (Figure 2.5).  In this way distances between the closest 
points of the wound edges were recorded over various time periods including Tzero.  
These were expressed as a percentage of the value for Tzero.  For each experimental 
condition the mean and standard deviation for the eight areas were plotted against 
time.  If a wound was found to have completely closed then the value for that time 
point was defined as 0%. 
 
 
2.9.3  Transwell Assays 
2.9.3.1  Overview 
Assays of cell migration and invasion were performed using the Transwell assay 
system.  These were performed in a sterile 24-well plate format using polycarbonate 
membranes with 8 µm pore sizes (Falcon 353097, Becton Dickinson).  A diagram of the 
assay system is shown in Figure 2.6.  Essentially, cells under investigation were added 
to the upper chamber at a known density.  Cells adhered to the upper surface of the 
basal polycarbonate membrane that contained pores of known diameter.  Here they 
were exposed to chemotactic stimuli contained within the growth media added to the 
lower chamber.  Over a period of time a proportion of the cells migrated through the 
membrane pores to reach the lower surface of the membrane.  At the end of the 
experiment the number of cells that had reached the lower surface was determined.  
Cell migration was studied in this way or, alternatively, cell invasion was investigated 
by the addition of material (such as Matrigel) to the upper surface of the membrane. 
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2.9.3.2  Membrane coating and blocking 
The effect of coating the polycarbonate membrane with various matrix proteins was 
investigated.  Solutions of 50µg/ml rat tail collagen type 1 (BD Biosciences, 354236) 
and 10µg/ml fibronectin (Sigma, F2006) were prepared.33  To coat the lower surface of 
the polycarbonate membranes, 250µl of the working solutions were added to the lower 
chambers and the inserts introduced (with care not to trap air below the membrane).  
The upper surfaces were coated by the further addition of 50µl of the working 
solutions to the upper chamber, again with care not to introduce any air.  The plates 
were then incubated at 37ºC in a humidified atmosphere with 5% CO2 for two hours.  
Finally, the working solutions were removed and the membranes were washed gently 
with sterile PBS. 
 
 
Figure 2.6.  Diagram of the Transwell assay system.  Briefly, polycarbonate membranes with a 
defined pore size were prepared either as supplied (cell migration) or supplemented with an 
extracellular analogue (such as Matrigel).  Media containing a known concentration of cells 
were added to the upper chamber while cell-free media containing a known concentration of 
the chemoattractant were added to the lower chamber.  Cells were allowed to adhere and the 
apparatus was incubated for a defined period under optimal conditions.  The upper surface of 
the membrane was then cleaned mechanically and the cells adherent to the lower surface were 
fixed, stained and counted.  For further description see text. 
 
                                                     
33 Rat tail collagen type 1 solution (BD Biosciences, 354236) was prepared: the stock solution 
(3.12 mg/ml) was diluted in 0.02N acetic acid to a final concentration of 50µg/ml then filter 
sterilised and stored at 4ºC.  Fibronectin solution(Sigma, F2006) was prepared: as follows  the 
stock solution (1 mg/ml) was diluted in sterile PBS to give a final concentration of 10µg/ml. 
Upper chamber 
Lower chamber 
Polycarbonate membrane 
Media containing added cells 
Optional Matrigel 
Adherent migrated cells 
Media containing chemoattractant 
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Migration buffer was prepared fresh as follows:  Dulbecco’s Modified Eagle Medium  
(Cambrex, BE12-604F) and HAM nutrient mixture F12 (Cambrex, BE12-615F) were 
mixed in a 3:1 ratio, supplemented with 0.5% bovine serum albumin (0.25g/50ml) and 
filter sterilised.  Both sides of the polycarbonate membranes were then blocked with 
migration buffer.  Six hundred microlitres of migration buffer were added to the lower 
chamber and 100µl to the upper (again ensuring no air bubbles).  The membranes were 
returned to the incubator for a further hour. 
 
 
2.9.3.3  Preparation of cells and wells. 
Cells were grown in 25cm2 flasks to 80% confluence as determined by light 
microscopy.  The growth media were aspirated and the cells washed in warmed, sterile 
PBS.  One millilitre of non-enzymatic cell dissociation solution in PBS (Sigma, C5914) 
was added to each flask and the cells returned to the incubator until they were no 
longer adherent.  Passage was performed as previously described and the cells finally 
resuspended at a density of 1 million per millilitre in freshly prepared, warmed 
migration buffer.  The contents of the upper chamber were aspirated and 100µl of the 
cell solution (containing 1 x 105 cells) was added to the upper chamber.  The 
chemoattractant to be tested was diluted in migration buffer to the required 
concentrations with the appropriate negative controls.  Three hundred microlitre 
aliquots were added to the lower chambers and the inserts were gently lowered into 
place, again ensuring no air bubbles were trapped.  The plates were then returned to 
the incubator. Three replicates were included for each experimental condition 
including negative controls.  When included, pharmacological antagonists and 
bioneutralising antibodies (and isotype controls) were added to the upper chamber in 
the concentrations stated.  Positive controls were performed with the addition of 10% 
FCS to the lower chamber. 
 
At the end of the incubation period the plates were transferred to the fume cupboard.  
The migration buffer from the upper and lower chambers was removed and the cells 
fixed in 10% formalin for 10 minutes at room temperature.  The formalin was then 
aspirated and the cells stained with a solution of 0.5% crystal violet in 10% ethanol for 
10 minutes.  After staining the cells were immersed in water for 10 seconds.   The 
upper surface only was then dried firmly with first a dental roll and then a cotton bud 
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to remove all remaining adherent cells in the upper chamber.  The lower surface was 
carefully preserved untouched.  After rigorous cleaning of the upper surface the 
polycarbonate membrane (with stained adherent cells on the lower surface only) was 
excised using a fresh scalpel and fine forceps.  Each membrane was briefly air dried, 
immersed in xylene and then mounted under a glass coverslip in non-aqueous resin on 
a clean, labelled, standard microscope slide.  Gentle downward pressure was applied 
with the forceps on the coverslip to flatten the membrane and exclude any air bubbles.  
The mounting resin was allowed to harden overnight. 
 
 
2.9.3.4  Cell counting and data analysis. 
Stringent methods were used to reduce observer bias during data collection:  Firstly, all 
experimental wells were allocated a random identification number by an independent 
observer.  A record of these numbers and their associated experimental conditions was 
kept separately and securely.  The matching microscope slides were re-labelled with 
this number in a way that retained the blinding of the person doing the counting.  The 
blinding was only removed once all data recording and analysis had been performed.  
Secondly, all membranes were photographed using a digital camera and a 
photomicroscope.  Images were taken from randomly selected, non-overlapping fields 
at x200 original magnification.  The edges of the membrane were excluded because 
mechanical cleaning of the upper surface always left a small zone of adherent cells 
around the peripheries.  Each membrane yielded approximately 20 images which were 
carefully labelled, downloaded on to computer and printed out. 
 
Image printouts were checked for quality and clarity.  Intact cells were marked and 
counted.  Cellular material remaining only in a membrane pore was not included in 
the count.  The total number of cells per image was recorded on a Microsoft Excel 
spreadsheet.  The total number of images counted per membrane was determined by 
means of cumulative mean plots produced in Microsoft Excel in real-time.  Essentially 
this method calculates the cumulative mean and standard deviation of the data as they 
are recorded.  Further images were counted until the changes in the calculated mean 
were less than 5% for at least two iterations.  A simple computer model of the process 
was generated to test the methodology (Figure 2.7).  It showed that the cumulative 
mean varied by less than 5% of their value after 10 data had been included.  This 
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occurred for the six datasets generated with varying means.  This model was 
supported by experimentally-derived data which, in the majority of cases, involved 
counting cells on approximately ten images.  The cumulative mean from the count of 
each membrane was taken and averaged for the three replicate wells.  Although from 
multiple images, the cumulative mean for each well represents only a single data point.   
 
 
Figure 2.7:  Computer modelling of cumulative mean plots.  Twenty integer values were 
randomly generated by computer to conform to a normal distribution of mean (x) and standard 
deviation 0.25(x).  Six datasets were produced where x=10, 20, 40, 80, 160 and 320.  Cumulative 
means were calculated and the percentage change plotted against the iteration number.  Results 
show that in all cases the cumulative mean varies by less than 5% of its value before the tenth 
iteration. 
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Chapter 3: 
Characterisation of 
established OSCC cell 
lines 
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3.1   Introduction 
The role of chemokine receptors in leukocyte homing has been well established.  The 
specific chemokine receptors CXCR4 and CCR7 have been specifically implicated in 
the mechanism of homeostatic selective re-circulation of T-lymphocytes.  Their role in 
tumour metastasis has also been supported by evidence in breast, prostate, gastric and 
oesophageal carcinomas.  More recently some preliminary work has been published on 
the role of CXCR4 and CCR7 in the dissemination of OSCC.  The limitations of the 
methodologies of these studies have previously been discussed (Chapter 1) and, 
therefore, the role of any chemokine receptors in the metastatic pathways of OSCC has 
yet to be fully elucidated.  Established OSCC cell lines provide a useful tool to 
investigate chemokine receptor mRNA expression and protein production in-vitro.  
They provide a population of tumour cells distinct from the adjacent tissue stroma 
found in clinical biopsies.  Consequently the mRNA and protein levels of a whole 
range of chemokine receptors can be determined with a view to manipulation of gene 
expression and investigation with functional assays as required.  The aim of the work 
presented in this chapter is to determine the expression of chemokine receptor mRNA 
in established OSCC cell lines and to investigate associated protein levels where 
appropriate. 
 
 
3.2   Chapter Hypotheses 
1. The mRNA expression of chemokine receptors associated with the lymph node 
homing dendritic cells (CCR7 and CXCR4) varies between OSCC cell lines and 
primary keratinocytes. 
2. CXCR4 surface protein production reflects mRNA levels in established OSCC 
cell lines. 
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3.3  Chapter Aims & Objectives 
3.3.1  Overall Aim 
To determine the pattern of chemokine receptor mRNA expression and protein 
production in primary keratinocytes and selected, established OSCC cell lines. 
3.3.2  Specific Objectives 
1. To perform a quantitative screening of chemokine and chemokine receptor 
mRNA expression in primary keratinocytes and OSCC cell lines using 
microarrays. 
2. To compare the mRNA expression of selected chemokine receptors in OSCC 
cell lines using the second technique of semi-quantitative, real-time RT-PCR. 
3. To determine an OSCC cell line that constitutively expresses CXCR4 mRNA at 
low levels. 
4. To determine the surface expression of CXCR4 protein on normal oral 
keratinocytes in culture and in-vivo. 
5. To compare the surface expression of CXCR4 and CCR7 protein on established 
OSCC cell lines 
 
 
3.4  Results 
3.4.1  Microarrays 
3.4.1.1  Experimental overview 
Microarray analysis was performed on established OSCC cell lines and primary 
normal oral and skin keratinocytes grown to early confluence under optimum 
conditions (including media supplemented with 10% FCS).  To ensure good quality 
data were generated, the efficiency of microarray hybridisation was determined prior 
to analysis.  Where available, data from duplicate samples were compared and 
combined.  The expression of chemokines and chemokine receptors in primary 
keratinocytes and in established OSCC cell lines was determined and compared.   
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Eighteen arrays from 9 cell lines were processed.  Sample data were analysed for 
quality according to the four criteria outlined in Section 2.2.13.  Signals from internal 
controls identified two arrays that had failed to hybridise correctly (one each from 
SCC25 and CAL27).  Consequently data from these arrays were excluded from the 
analysis and the SCC25 and CAL27 cell lines were analysed on the basis of one array 
each.  Data quality and replicate matching was performed as outlined in Section 2.2.13 
and the results are presented in Appendix 3. 
3.4.1.2  Chemokine Receptor mRNA expression by Primary Cultures of 
Normal Oral and Skin Keratinocytes 
 
A comprehensive microarray screening of the expression of all known chemokine 
receptors (CCR1-10, CXCR1-6, XCR1 and CX3CR1) was performed on seven 
established oral cell lines (H357, TR146, CAL27, FADU, SCC4, SCC25 and SV) and 
primary cultures of normal oral and skin keratinocytes as outlined above.  Normalised 
expression values (NEV) were calculated for each gene in each sample as described in 
Section 2.2.13.  The NEV for the chemokine receptors in normal oral and skin 
keratinocytes are represented in Figure 3.1.   
 
For normal oral keratinocytes, these data show that there was only a small degree of 
variability (0.31 to 1.70) in expression levels for the majority of chemokine receptors.  
CXCR1 displayed a greater than three-fold reduction in expression compared with the 
normalised mean.34  Taking a two-fold change in expression as significant, this was the 
only chemokine receptor in normal oral keratinocytes to show a significant change in 
expression away from the normalised mean.  For normal skin keratinocytes, again only 
a small degree of variability in the expression of chemokine receptor mRNA was 
demonstrated.  However, the NEVs of four chemokine receptors were found to lie 
outside a two-fold change from the normalised mean: CCR3, CCR6 and CXCR5 were 
expressed at relatively low levels (NEV 0.37 0.22 and 0.39 respectively).  CXCR1 (NEV 
= 2.04) was the only chemokine receptor expressed at relatively high levels.   
 
In summary, chemokine receptor mRNA expression in NOK demonstrated no striking 
variation from the norm.  Expression in NSK cells showed more variability but no 
consistent pattern was observed when compared with NOK.  These results 
                                                     
34 A reduction in expression expressed as fold-change was calculated as the reciprocal of the 
NEV.  In the case of CXCR1 this was 1.0/0.314 = 3.18 or just over a three-fold change. 
 134
demonstrated the expression of chemokine receptor mRNA in laboratory cultures of 
normal keratinocytes for comparison with similar data derived from established OSCC 
cell lines. 
 
 
 
Figure 3.1:  Normalised expression of chemokine receptor mRNA by normal oral and skin 
keratinocytes.  Normal oral keratinocytes (NOK) from third molar surgery (Section 2.1.2) and  
normal skin keratinocytes (NSK) taken during breast reduction surgery (Section 2.1.3) were 
taken and cultured in four parallel flasks.  Normalised chemokine receptor mRNA expression 
was determined by microarray analyses run in duplicate.  Bars represent the mean (range) of 
the duplicate samples.  For NOK only one mean chemokine receptor NEV (CXCR1) lies more 
than two-fold from the normalised mean.  For NSK, this occurs with four chemokine receptors 
(CCR3, CCR6, CXCR1 and CXCR5).  The raw data are given in Table A3.1 (Appendix 3). 
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3.4.1.3  Chemokine Receptor mRNA expression by Established OSCC cell 
lines. 
Seven established oral cell lines (H357, TR146, CAL27, FADU, SCC4, SCC25 and SV) 
were analysed by microarray as outlined above.  The mean NEVs for all known 
chemokine receptors in all the cell lines were calculated as outlined in Section 2.2.13.  
These values are represented in Figure 3.2 with the raw data given in Table A3.2 
(Appendix 3).  Compared with the normalised mean, CXCR4 demonstrated the highest 
chemokine receptor mRNA expression in the oral cell lines tested.  This occurred in 
two OSCC cell lines, SCC4 and SCC25 (NEV 8.3 and 10.1 respectively).  The normalised 
expression of CXCR4 was essentially unchanged in the remaining five cell lines (NEV 
range 0.76 to 0.85) which was very close to the values obtained for NOK and NSK 
(NEV of 0.96 and 0.80 respectively).  The expression of the chemokine receptor CCR7 
was significantly decreased in the SCC25 cell line (NEV 0.27).  In the remaining cell 
lines relative CCR7 expression did not significantly differ from that of normal oral 
keratinocytes. 
 
Apart from the high expression of CXCR4 mentioned above, only two other chemokine 
receptors were expressed more than two-fold above the normalised mean:  CCR5 in the 
SCC4 cell line and CXCR2 in FADU cells (NEV 3.7 and 2.5 respectively).  All other 
changes in chemokine receptor expression in oral cell lines were reductions compared 
with the normalised mean.  TR146 cells expressed CCR1 and CCR3 at low levels (NEV 
0.45 and 0.47 respectively) while the expression of CCR3, CCR6 and CCR8 was 
similarly low in FADU cells (NEV 0.35, 0.43 and 0.27 respectively).  The CAL27 cell line 
also expressed CCR8 at low levels, but also CXCR1 and CXCR5 (NEV 0.24, 0.26 and 
0.36 respectively).  CXCR5 was also expressed at low levels by H357 cells (NEV 0.48).  
The SV40 transformed cell line [SV] demonstrated a unique profile of chemokine 
receptor expression with low levels of CCR4, CXCR1, CXCR2 and CX3CR1 detected 
(NEV 0.29, 0.19, 0.29 and 0.34 respectively).  CX3CR1 was also expressed at low levels 
by SCC4 cells, in addition to CXCR3 (NEV 0.48 and 0.49 respectively).  Finally, XCR1 
was expressed at lower levels in all OSCC cell lines, reaching significance in SCC4, 
SCC25 and TR146 (NEV 0.26, 0.30 and 0.43 respectively).  A representation of the 
relative expression of all chemokine receptors in all oral cell lines compared with NOK 
is given in Table 3.1. 
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Figure 3.2:  Chemokine Receptor mRNA Expression by Established OSCC Cell Lines.  Solid 
bars represent the chemokine receptor NEV (averaged for duplicate samples where applicable).  
For description of results see text.  The raw data are given in Table A3.2 (Appendix 3). 
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In summary, these data indicate that CXCR4 upregulation was the most striking 
change in chemokine receptor expression in some, but not all, OSCC cell lines.  This 
was not demonstrated in the normal oral or skin keratinocytes tested.  Most other 
changes that occurred in chemokine receptor expression involved reduction in mRNA 
levels compared to normalised means.  Interestingly CCR7, one of the chemokine 
receptors strongly associated with physiological leukocyte homing to lymph nodes, 
was not upregulated in oral cell lines or normal keratinocytes.  The expression of 
chemokine mRNA by NOK, NSK and established OSCC cell lines was also determined 
and the results are presented in Section A3.3 (Appendix 3). 
 
 
 
Table 3.1:  Significant Changes of Chemokine Receptor Normalised Expression Values in 
Established OSCC Cell Lines.   
 SCC4 SCC25 CAL27 H357 FADU TR146 SV 
CCR1      ▼  
CCR2        
CCR3     ▼ ▼  
CCR4       ▼ 
CCR5 ▲       
CCR6     ▼   
CCR7  ▼      
CCR8   ▼  ▼   
CCR9        
CCR10        
CXCR1   ▼    ▼▼ 
CXCR2     ▲  ▼ 
CXCR3 ▼    ▼   
CXCR4 ▲▲ ▲▲      
CXCR5   ▼ ▼    
CXCR6        
XCR1 ▼ ▼    ▼  
CX3CR1 ▼      ▼ 
This table is derived from data presented in Table A3.4 (Appendix 3).  Legend: ▲ = 
upregulation 2-5 fold, ▲▲ = upregulation greater than five-fold, ▼= downregulation 2-5 fold, 
▼▼ = downregulation greater than five-fold. 
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3.4.2 Chemokine receptor mRNA expression levels determined by 
semi-quantitative Reverse Transcription Polymerase Chain 
Reaction. 
  
Semi-quantitative RT-PCR was used to determine the relative expression of chemokine 
receptor mRNA by cultured cells using an alternative methodology.  Complimentary-
DNA synthesised from the same RNA used in the microarray analyses was 
investigated with additional replicates included.  Data normalisation against an overall 
expression level for multiple genes was not possible for sqRT-PCR results.  
Consequently the expression levels of each mRNA species in NOK was defined as 
equal to one and expression in all other cell lines was calculated relative to this to yield 
semi-quantitative results.  Compared with NOK, CXCR4 mRNA expression was 
significantly higher in all cell lines examined with the exception of NSK, TR146 and 
H357 (Figure 3.3).  Expression in skin and oral keratinocytes showed no significant 
difference.  Two cell lines (SCC4 and SCC25) demonstrated CXCR4 upregulation of 
more than 1,000-fold compared with NOK (p<0.001).  Three further cell lines (SV, 
FADU and CAL27) showed significant upregulation of CXCR4 (compared with NOK) 
although the magnitude of this increase varied considerably (93, 25 and 5 times 
respectively).  The mRNA expression of other chemokine receptors by OSCC cell lines 
was also measured by sqRT-PCR for comparative purposes.  The relative expression of 
CCR7 by NSK and OSCC cells lines demonstrated no significant differences from NOK 
(Figure 3.4a).  NOK and NSK demonstrated very similar levels of CCR7 mRNA 
expression.  Although CCR7 mRNA expression was less in the SCC4 and SCC25 cell 
lines and increased in the remaining OSCC cell lines, none of these differences were of 
a sufficient magnitude to achieve statistical significance.  CCR4 mRNA expression 
showed some variation between cell lines (Figure 3.4b).   
 
Expression by primary skin keratinocytes was nearly ten-fold greater than by primary 
oral keratinocytes (p<0.001).  The SCC4 and SV cell lines were the only established 
OSCC cell lines in which CCR4 mRNA expression was significantly altered, compared 
with NOK (p<0.001).  In SCC4 cells, CCR4 expression showed a three-fold increase, 
while in SV cells a five-fold decrease in expression was demonstrated, compared with 
NOK.  The remaining cell lines investigated (SCC25, FADU, CAL27 and untransfected 
H357 cells) showed no significant alteration in CCR4 mRNA expression compared 
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with NOK.  Expression of XCR1 mRNA showed significant differences in most cell 
lines compared with NOK (Figure 3.4c).  Expression in NSK was ten-fold less than in 
NOK (p<0.001).  In most of the established OSCC cell lines, XCR1 mRNA was also 
significantly reduced compared with NOK:  in the TR146, SCC4 and SCC25 cell lines 
expression was reduced 20-, 30- and 100-fold respectively (p<0.001), while in the 
FADU and H357 cell lines expression was reduced two- and three-fold respectively 
(p<0.05).  XCR1 mRNA expression was increased in the CAL27 and SV cell lines two- 
and five- fold respectively (p<0.05), compared with NOK. 
 
 
 
Figure 3.3:  Expression of CXCR4 mRNA by normal keratinocytes and OSCC Cell Lines.  
Relative CXCR4 mRNA expression in normal keratinocytes and OSCC cell lines cultured under 
optimal conditions to the end of their logarithmic growth phase.  Results show two high-
expressing OSCC cell lines (SCC4 and SCC25), three expressing at intermediate levels (SV, 
FADU and CAL27) and two (H357 and TRI46) expressing similar levels to normal oral and skin 
keratinocytes.  All OSCC cell lines except H357 and TR146 demonstrated significantly more 
CXCR4 mRNA expression than normal oral and skin keratinocytes (ANOVA with Bonferroni 
correction for multiple testing).  Mean (solid bars) and range (lines) of four replicates (each 
measured in triplicate) are shown expressed as relative fold change compared with CXCR4 in 
normal oral keratinocytes.  Graph shows the cumulative results of two experiments performed.  
Legend: *** = p<0.001, * p<0.05, ns = not significant. 
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Expression of the chemokine XCL1 was also determined by sqRT-PCR (Figure 3.4d).  
XCL1 was selected for investigation as it is the XCR1 ligand and thus made a 
receptor/ligand pair, as well as being a representative of the chemokines also 
investigated by microarray (Appendix 3).  Interestingly, XCL1 expression was less than 
NOK in only NSKs (30-fold, p<0.001).  XCL1 expression in OSCC cell lines was 
increased compared with NOK: in five cell lines (SCC4, SCC25, SV, CAL27 and TR146) 
this increase was relatively small (two-to three-fold, p<0.05).  However, in the H357 
and FADU lines the increase was seven- and 21-fold respectively (p<0.001). 
 
To investigate the relationship between the microarray results and the sqRT-PCR data 
obtained from similar samples, a simple graphical representation of the raw expression 
data was produced.  From this it was determined that the range of magnitude of the 
sqRT-PCR results was much greater than that demonstrated by the microarrays.  To 
investigate this further the expression values for all the genes examined by both 
methods (CXCR4, CCR7, CCR4, XCR1 and XCL1) were pooled.  Following a log(10) 
transformation of both data sets, a clear linear relationship of gradient 0.32 between the 
results was demonstrated (Figure 3.5).  This relationship was maintained over the 
entire range of expression levels exhibited.  Using linear regression the Root Mean 
Square (R2) value was calculated as equal to 0.645 suggesting a probability value of less 
than 0.001. 
 
In summary, there was a high concordance between the log-transformed mRNA 
expression values derived by the two independent methods (sqRT-PCR and 
microarrays).  CXCR4 was the chemokine receptor expressed at the highest level by 
some, but not all, the established OSCC cell lines, compared with NOK.  There was no 
significant variation in CCR7 mRNA expression.   
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Figure 3.4:  Messenger RNA expression by Normal Keratinocytes and OSCC Cell Lines.  All 
cells were cultured under optimal conditions to the end of their logarithmic growth phase.  
Panels represent CCR7 (a), CCR4 (b), XCR1 (c) and XCL1 (d) mRNA expression in cell lines 
relative to NOK.   For a detailed description of the results see text.  Mean (solid bars) and range 
(lines) of four replicates (each measured in triplicate) are demonstrated for each cell line.   
Statistical significance was determined using ANOVA with the Bonferroni correction for 
multiple testing.  Legend: NOK = normal oral keratinocytes; NSK = normal skin keratinocytes; * 
= p<0.05, ** = p<0.01, *** = p<0.001.  Panels represent the cumulative results of three 
experiments performed. 
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Figure 3.5: The relationship between RT-PCR and microarray values for chemokine and 
chemokine receptor relative expression values.  Relative expression values for the chemokine 
receptors CXCR4, CCR7, CCR4 and XCR1, and the chemokine XCL1 were determined by both 
microarrays and qRT-PCR.  A scatterplot of the Log(10) values yielded a linear relationship of 
best fit (Root mean square = 0.645, linear regression p<0.001) with gradient of 0.32. 
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3.4.3 CXCR4 and CCR7 protein production by primary keratinocytes 
and gingival fibroblasts. 
Following initial investigation at the mRNA level, CXCR4 and CCR7 surface protein 
production by primary oral and skin keratinocytes was determined initially using flow 
cytometry.  Cells were passaged using growth-arrested fibroblast feeder cells as 
previously described (Section 2.1.4) and grown until 80% confluence as determined by 
light microscopy.  The data plots for CXCR4 and CCR7 labelling of primary normal 
oral and skin keratinocytes, and untransformed human gingival fibroblasts (HGFs) are 
given in Figure 3.6.  No significant CXCR4 or CCR7 labelling was demonstrated for 
either normal oral or skin keratinocytes.  In HGF cells, CXCR4 labelling was marginally 
higher compared with isotype antibody controls (Mean Fluorescence Values [MFV] 
7.26 and 4.17 respectively).  No surface CCR7 was detected on HGFs by flow 
cytometry.  Although very few cells with a fibroblast-like morphology were seen in the 
cultures prior to dissociation, the presence of contaminating feeder cells could not be 
excluded.  Therefore, further analyses were performed to compare CXCR4 expression 
in a mono-population of 3T3 feeder cells and combined culture with primary oral and 
skin keratinocytes (Figure 3.7).  Results showed no CXCR4 labelling of the 3T3 
population grown in isolation or in combination with the primary keratinocytes.  
Furthermore, when differentiated by relative size, neither component of the combined 
keratinocytes/feeder cell culture demonstrated significant CXCR4 labelling. 
 
To investigate further these flow cytometry findings of CXCR4 labelling in NOK, a 
second, complementary technique was employed.  Two anti-CXCR4 monoclonal 
antibodies (MAB172 and MAB173, R&D Systems) were used for flow cytometry while 
the latter was used for immunocytochemistry.  Primary oral and skin keratinocytes 
(together with control mono-populations of fibroblast feeder layers) were examined 
using immunocytochemistry.  No significant staining for either CXCR4 or CCR7 was 
demonstrated compared with isotype antibody controls.  However, HGFs revealed 
very weak staining for CCR7 and a slightly stronger signal with CXCR4, compared 
with isotype and no primary antibody controls (Figure 3.8).  This finding is in 
concordance with the low level of CXCR4 labelling of HGFs demonstrated by flow 
cytometry (Figure 3.6, panel E).  However, the very low level of CCR7 immunostaining 
in HGFs (Figure 3.8, panel B) was not replicated using flow cytometry (Figure 3.6, 
panel F). 
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Figure 3.6:  Flow cytometry of CXCR4 and CCR7 in 
primary keratinocytes and human gingival fibroblasts.  
Cells were grown to 80% confluence, passaged and 
incubated with anti-CXCR4 (A, C and E) or anti-CCR7 
(B, D and F) monoclonal antibodies or isotype controls.  
Data plots of cell counts against fluorescence intensity for NOK (A and B), NSK (C and D) and 
HGF (E and F).  Table shows Mean Fluorescence Values (MFV).  No significant CXCR4 or CCR7 
labelling was demonstrated by either oral or skin keratinocytes.  HGF cells demonstrated a very 
low density of CXCR4, but not CCR7.  One representative experiment shown of two performed.  
Legend: NOK = primary normal oral keratinocytes; NSK = primary normal skin keratinocytes; 
HGF = untransformed human gingival fibroblasts. 
Antibody MFV 
Cell Type NOK NSK HGF 
Isotype 14.16 5.22 4.17 
CXCR4 14.17 7.16 7.26 
Isotype 7.34 3.65 5.06 
CCR7 7.78 4.57 4.62 
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Figure 3.7: CXCR4 labelling of primary cultured keratinocytes and their feeder fibroblasts.  
Primary oral and skin keratinocytes were cultured with growth-arrested 3T3 fibroblasts under 
optimum conditions.  At 80% confluence and maximal fibroblast detachment the cells were 
dissociated and labelled with anti-CXCR4 monoclonal antibodies (clone 173) prior to flow 
cytometry.  Monocultures of 3T3 cells were used for comparison.  The normal size distribution 
of 3T3 cells was determined from pure cultures (G) and only a population of cells outside of this 
(population P1, panel G) was defined.  The P1 population was selected from primary cultures of 
oral and skin keratinocytes (A and D respectively).  Comparisons between labelled cells (C and 
F respectively) and unlabelled controls (B and E respectively) demonstrated that very low levels 
of oral and skin keratinocytes labelled positively for CXCR4 (4.3% and 3.1% respectively, panel 
I).  3T3 cells did not demonstrate CXCR4 labelling (H). One representative experiment shown of 
two performed.  Legend: NOK = normal oral keratinocytes; NSK = normal skin keratinocytes. 
3.1 NSK 
0 3T3 
4.3 NOK 
Positive (%) Cells 
A) B) C) 
D) E) 
I) 
F) 
G) H) 
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Figure 3.8:  Human gingival fibroblast expression of CXCR4 and CCR7.  Human Gingival 
fibroblasts were cultured in optimal growth media supplemented with 10% FCS to 
approximately 80% confluence.  Cells were fixed and labelled using standard 
immunocytochemical methods outlined in Section 2.6.  Primary antibodies used were CXCR4 
(A); CCR7 (B); isotype control (C); and no primary antibody (D).  HGFs stained positively for 
CXCR4 and weakly for CCR7 with no significant non-specific binding demonstrated in negative 
controls.  Scale bar represents 100µm.  Representative images are shown from three experiments 
performed. 
  
 
  
In summary, no CXCR4 or CCR7 labelling for NOK or NSK was demonstrated by 
either flow cytometry or immunocytochemistry.  These findings concur with the low 
levels of CXCR4 and CCR7 mRNA expression displayed by these cells in culture.  
Again, these findings provide a baseline for comparison with established OSCC cell 
lines. 
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3.4.4 CXCR4 protein production by OSCC cell lines  
To determine their surface expression of CXCR4 protein, established OSCC cell lines 
were grown under optimal conditions to 80% confluence, dissociated and analysed 
with flow cytometry (Figure 3.9).  All OSCC cell lines tested demonstrated a 
homogenous distribution of size and granularity conforming to the normal 
distribution.  Less than 15% of the total number of cells stained strongly with 
propidium iodide and were gated out.  CXCR4 labelling was greatest on the SCC4 cell 
line (panel A) with a mean fluorescence value of 24.89 (compared with 9.64 for the 
isotype antibody control).  CXCR4 signal above background was also detected on 
SCC25 and CAL27 cells (panels B & C) with mean fluorescence values of 17.97 and 
14.48 respectively.  No significant CXCR4 labelling was detected on either TR146 or 
FADU cells (panels E & F).  The H357 cell line was also examined and the results are 
presented in Section 3.4.5. 
  
As before, immunocytochemistry was performed to investigate CXCR4 protein 
staining expression by these established OSCC cell lines (Figure 3.10).  The most 
significant CXCR4 staining was seen with SCC4 cells (Figure 3.10 (a)) compared with 
isotype controls (Figure 3.10 (f)).  SCC25 (Figure 3.10 (b)) and CAL27 (Figure 3.10 (c)) 
cells were seen to stain positively for CXCR4 but to a lesser extent than SCC4 cells.  The 
staining pattern in these three cells lines was diffuse and homogenous.  CXCR4 
staining in TR146 (Figure 3.10 (d)) and FaDu (Figure 3.10 (e)) cells was very weak, focal 
and heterogeneous in comparison.  Consequently it was demonstrated that cell lines 
positive for CXCR4 labelling by flow cytometry (SCC4, SCC25 and CAL27) also 
showed positive staining by immunocytochemistry.  Cell lines negative for CXCR4 by 
flow cytometry (TR146 and FaDu) showed only weak and heterogeneous staining.  
Two CXCR4 positive cell lines (SCC4 and CAL27) were cultured as described above 
and investigated with further immunocytochemistry experiments to try and visualise 
more clearly the distribution of CXCR4 protein within the cells.  Initially conventional 
fluorescent immunocytochemistry was performed on SCC4 and CAL27 cells grown at 
a low density on glass coverslips under optimum conditions (Figure 3.11 panels a-d).  
Results revealed that for both SCC4 and CAL27 cells the highest CXCR4 staining 
intensity was concentrated around the nuclei extending into the cytoplasmic 
compartment (panels a and b respectively).  Isotype antibody control experiments 
revealed no positive staining (panels h and i).  Compared with the outline of the 
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nuclear structures (highlighted by the DAPI counterstain - panels c and d respectively) 
the results were suggestive that CXCR4 protein expression was outside the nucleus.     
To determine the location of the staining within the cell more accurately confocal 
fluorescence microscopy was performed.  For both SCC4 and CAL27 cells this revealed 
diffuse staining for CXCR4 that appears to be associated with the cell membrane rather 
than the nucleus (panels e and f respectively).35    
                                                     
35 Computer reformatting and three-dimensional (3-D) reconstruction of the confocal data 
allows perspectives on the pattern of cell staining not possible with conventional microscopy.  
However, 3-D reconstruction images yield most information when manipulated on the 
computer screen and are only poorly represented by 2-D printouts and therefore have been 
omitted from this thesis. 
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Figure 3.9: CXCR4 surface protein production by OSCC cell lines.  Cells were grown to 80% 
confluence under optimum conditions.  Prior to analysis cells were incubated with anti-CXCR4 
antibodies (or isotype controls) and propidium iodide.  Cell count was plotted against 
fluorescence intensity for: SCC4 (A); SCC25 (B); CAL27 (C); TRI46 (D); and FADU cells (E).  
Table shows Mean Fluorescence Values (MFV) for anti-CXCR4 (clone 173) and isotype control 
antibodies.  SCC4, SCC25 and CAL27 cells demonstrated CXCR4 labelling in excess of isotype 
controls.  CXCR4 protein was not detected on the surface of TR146 and FADU cells.  One 
representative experiment shown of two performed.  Legend: anti-CXCR4 antibodies (green 
line); isotype controls (purple shading). 
SCC4 SCC25 
A) B) 
C) D) 
CAL27 TR146 
E) 
FADU 
MFV Cell 
8.16 4.65 FADU 
6.03 4.89 TR146 
14.48 4.16 CAL27 
17.97 7.27 SCC25 
24.89 9.64 SCC4 
CXCR4 Isotype  
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Figure 3.10: CXCR4 immunocytochemistry of established OSCC cell lines.  Established OSCC 
cell lines were cultured under optimum conditions on sterile glass coverslips until 80% 
confluent.  Cells were fixed, permeablised and stained using monoclonal antibodies against 
CXCR4 (clone 173) conjugated to Texas Red.  Convential light microscopy revealed strong 
staining for the SCC4 cell line (a) and, to a lesser degree, SCC25 (b) and CAL27 (c) cells.  Only 
very weak staining was seen for TR146 (d) and FaDu (e) cells compared with isotype antibody 
controls (f).  Representative images shown from three replicates performed.  Scale bar 
represents 100µm. 
a) b) 
c) d) 
e) f) 
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Figure 3.11:  CXCR4 staining of cultured SCC4 and CAL27 cells.  Representative images for 
SCC4 (panels a, c, e & h) and CAL27 (panels b, d, f and i) are shown using conventional (a-d, h 
& i) and confocal (e & f) microscopy.  Staining was performed using anti-CXCR4 monoclonal 
antibodies (a, b, e & f) with nuclear counterstain (c – i).  Isotype antibody negative controls were 
also performed (h & i).   Scale bar 20µm.  For results see text. 
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3.4.5 CXCR4 protein production by untransfected H357 cells 
To determine the surface expression of CXCR4 protein in the established H357 cell line, 
these cells were cultured under optimal conditions (including 10% FCS) until 80% 
confluence, then dissociated and prepared for flow cytometry.  Labelling with two 
anti-CXCR4 monoclonal antibodies was compared.  Both antibodies detected low 
levels of CXCR4 on the surface of untransfected H357 cells (Figure 3.12): MFV for 
clones 172 and 173 were 9.2 and 14.7 respectively compared with isotype controls 
(MFV = 4.4).  A similar pattern of results was obtained with a second, replicate 
experiment (panel H).  These data suggest that the CXCR4 receptor was produced on 
the surface of these cells at very low levels and further experiments were performed to 
investigate this.  Immunocytochemistry on permeabilised cells was used to visualise 
the pattern and location of CXCR4 protein (Figure 3.13).  Conventional peroxidase-
based staining for CXCR4 demonstrated clear staining of H357 cells (Figure 3.13 panel 
a) compared with isotype antibody controls (Figure 3.13 panel b).  At higher 
magnification, using fluorescent labels, staining could again be demonstrated (Figure 
3.13 panel c) although, following comparison with the nuclear counterstain (Figure 
3.13 panel d), the CXCR4 protein appeared to be associated with the nuclear structures 
rather than the cytoplasmic membrane.  Further examination of these experimental 
preparations with confocal microscopy revealed that CXCR4 labelling overlaid the 
nuclear membrane and nucleolar structures with a low intensity of cytoplasmic 
staining (Figure 3.13 panels e & f). 
 
Analysis of these data suggested that CXCR4 protein was produced at very low levels 
on the cytoplasmic membrane of untransfected H357 cells.  However, previous results 
had demonstrated that CXCR4 mRNA was expressed by these cells, and 
immunocytochemistry for the protein showed some staining of predominantly peri-
nuclear structures. From these results it was hypothesised that overexpression of 
CXCR4 mRNA would result in an increase in protein localising to the cytoplasmic 
membrane.  Experiments were designed to test this hypothesis and are described in 
Chapter 5. 
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C & D A & B E & F Panel 
17.12 10.83 8.15 2 
14.68 9.17 4.36 1 
173 172 Isotype Rep 
Mean Fluorescence H) 
R11
R12
R13
R14
R15
R16
A) B) 
C) D) 
E) F) 
G) 
Figure 3.12:  CXCR4 surface production by untransfected H357 cells.  Untransfected H357 
cells were cultured under optimum conditions until approximately 80% confluent, 
dissociated and labelled for analysis with propidium iodide and anti-CXCR4 monoclonal 
antibodies clone 172 (A & B), clone 173 (C & D) or isotype controls (E & F).  Only live cells 
were gated (B, D & F).  Low levels of CXCR4 labelling were demonstrated by both antibody 
clones (G & H).  Data from two replicate experiments are given (H) although only one is 
shown (A-G). 
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Figure 3.13:  CXCR4 staining in untransfected H357 cells.  Cells from the established H357 cell 
line were cultured under optimum conditions, fixed, permeablised using detergent and stained 
for immunocytochemistry using anti-CXCR4 monoclonal antibodies (MAB173, R&D Systems).  
Peroxidase-based methods revealed diffuse staining (a) compared with isotype antibody 
negative controls (b).  Using conventional microscopy fluorescence-based methods 
demonstrated that staining was less densely associated with the cytoplasmic membrane than 
with structures associated with the nucleus (c) as highlighted by the nuclear counterstain (d).  
Perinuclear staining may have been artificially increased by the use of detergents in preparation 
of the cells prior to labelling.  Confocal microscopy at 0.5µm intervals further delineated this 
predominantly peri-nuclear relationship of CXCR4 staining (e) with occasional expression 
within the cytoplasmic space (f).  Scale bar represents 100µm (a & b), 20µm (c-e) and 10µm (f). 
a) b) 
c) d) 
e) 
e) f) 
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3.4.6 CCR7 protein production by OSCC cell lines 
 
Parallel experiments to those outlined previously were performed to investigate the 
production of CCR7 by established OSCC cell lines.  Both flow cytometry and 
immunocytochemical techniques were carried out using commercially available 
monoclonal antibodies to the CCR7 receptor validated in the literature.  Three repeat 
experiments failed to demonstrate detectable CCR7 labelling on the surface of any of 
the cell lines tested by flow cytometry (Figure 3.14).   
 
Immunocytochemistry was performed to investigate these findings further.  These 
experiments showed barely detectable perinuclear CCR7 staining in permeabilised 
cells with fluorescence- or peroxidase-based methods (Figure 3.15).36  Isotype control 
antibodies demonstrated no labelling. 
                                                     
36 Immunofluorescence experiments are represented by results for untransfected H357 and 
CAL27 cells.  No CCR7 labelling was detected on any of the six established OSCC cell lines 
investigated. 
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Figure 3.14:  CCR7 surface labelling in established OSCC cell lines by flow cytometry.  Cells 
were grown to 80% confluence under optimum conditions.  Prior to analysis cells were 
incubated with anti-CCR7 antibodies or isotype controls followed by propidium iodide.  Cell 
count was plotted against fluorescence intensity for: SCC4 (A); SCC25 (B); CAL27 (C); TRI46 
(D); and FADU cells (E).  Mean fluorescence values were tabulated for anti-CCR7 and isotype 
controls.  Labelling in excess of isotype controls was not detected on the surface of any of the 
cells tested.  One representative experiment shown of three performed.  Legend: anti-CCR7 
antibodies (green line); isotype controls (purple shading). 
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Figure 3.15:  CCR7 labelling of H357 and CAL27 cells by immunofluorescence.  Cells were 
cultured under optimum conditions, fixed, permeablised and stained with anti-CCR7 
monoclonal antibodies using fluorescence-based reporters.  Untransfected H357 cells (a & b) 
and CAL27 cells (c-f) are shown.  Barely detectable perinuclear staining was demonstrated with 
anti-CCR7 antibodies (a & c) but not isotype controls (e).  Comparisons can be made with the 
DAPI nuclear counterstains of the corresponding areas (b, d & f).  Scale bar represents 20µm. 
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3.4.7 Summary of experimental results 
 
• Microarray samples that had been blinded and randomised were paired 
according to their biological cell line of origin by cluster analysis. 
• Microarray and sqRT-PCR measurements of relative mRNA expression 
demonstrated a linear association when their logarithmically-transformed 
values were plotted. 
• Little variability was shown in the levels of chemokine receptor mRNA 
expression by normal oral keratinocytes except for CXCR1 which is expressed 
at a lower level than other chemokine receptor family members. 
• The highest level of mRNA expression of all the chemokine receptors was 
demonstrated by CXCR4 in two of the OSCC cell lines tested.   
• CCR7 mRNA was expressed at similar or relatively lower levels in all the OSCC 
cell lines compared with normal oral keratinocytes.   
• H357 cells demonstrated similar levels of CXCR4 mRNA expression compared 
with normal oral keratinocytes.   
• CXCR4 or CCR7 protein production was not demonstrated by normal oral or 
skin keratinocytes. 
• Human Gingival Fibroblasts demonstrated some CXCR4 expression in vitro. 
• Three established OSCC cell lines (SCC4, SCC25 & CAL27) that showed CXCR4 
mRNA expression also demonstrated CXCR4 protein production associated 
with the cytoplasmic compartment. 
• CCR7 protein production was not demonstrated in any of the established OSCC 
cell lines examined. 
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3.5  Discussion  
A significant variation in chemokine and chemokine receptor mRNA expression and 
protein production was demonstrated between primary cultures of oral keratinocytes 
and established OSCC cell lines.  The quantitative and qualitative data produced were 
derived by several complimentary techniques.  Before the significance of the findings 
was examined it was important to review the strengths and weaknesses in each of 
these techniques particularly with respect to comparing the data generated for 
particular chemokine receptor mRNA species.  This is discussed in Appendix 3.   
 
 
3.5.1  CXCR4 mRNA expression and protein production by normal 
keratinocytes 
The results presented here have demonstrated that CXCR4 mRNA was expressed at 
low levels in NOK and NSK.  This is mirrored in the literature although similar 
experiments are often either small numbers of normal controls or part of studies 
focusing on HIV infection.  CXCR4 mRNA expression has been described in oral and 
gingival keratinocytes (Uchida, Begum et al. 2003; Chen, Zha et al. 2004).  These 
findings are substantiated by gene array studies on laser-capture specimens from 
normal oral mucosa (Moutsopoulos, Nares et al. 2007).  CXCR4 mRNA (and protein) 
have been demonstrated in cultures of normal colonic (Jordan, Kolios et al. 1999) but 
not salivary gland epithelial cells. (Moore, Rahemtulla et al. 2003)  In my experiments, 
both microarrays and sqRT-PCR were used semi-quantitatively with the expression 
levels in other cell lines calculated relative to NOK.  No absolute level of CXCR4 
mRNA expression was determined and this could be addressed by further work using 
carefully calibrated RNA standards.      
 
My results demonstrated that cultured normal keratinocytes did not label positively 
for CXCR4 protein with either flow cytometry or immunocytochemistry.  Liu et al 
demonstrated CXCR4 surface protein labelling in a small subset of normal oral 
keratinocytes derived from 3rd molar surgery (Liu, Zha et al. 2003).  Moore et al 
showed a greater proportion of positive cells in samples taken from periodontal flap 
surgery (Moore, Rahemtulla et al. 2003).  It can be assumed that there was significant 
inflammation present in the latter group of patients undergoing periodontal surgery 
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and that low grade inflammation was common in the 3rd molar region.  It was from a 
similar source that the NOKs used in these experiments were derived (Section 2.1.2).  
The effect of localized inflammation on CXCR4 expression and production in oral 
keratinocytes is not known.  My results demonstrated no upregulation of 
inflammation-induced chemokine receptor mRNA expression although no distinct 
pattern was seen.37  This could be investigated further by pathway analysis of the 
entire microarray dataset focusing on pro-inflammatory mechanisms.   Exposure of 
NOK to ethanol at low concentrations in-vitro increases CXCR4 surface protein (but not 
mRNA expression), although it is not known if this is secondary to a pro-inflammatory 
mechanism (Liu, Zha et al. 2003; Chen, Zha et al. 2004).   
 
My observational data on CXCR4 expression in NOKs did not address the question of 
whether these receptors were functional.  To do this would have required either careful 
passage without feeder cells or growth in a feeder-free environment.  The ability of 
CXCR4-tropic HIV-1 viruses to infect NOKs in culture (Liu, Zha et al. 2003; Moore, 
Rahemtulla et al. 2003 ) and the abrogating effect on this infection by co-culture with 
SDF (Chow, Yu et al. 2002) provides indirect evidence that a small number of normal 
keratinocytes express CXCR4 surface receptors at least capable of ligand binding and 
receptor internalisation.  Data on CXCR4-mediated downstream cell signaling in these 
instances were not documented. 
 
While CXCR4 surface protein was not detected on NOK or NSK in my experiments it is 
possible that functional protein is produced by these keratinocytes in-vivo.  If this is 
increased at sites of inflammation, together with the potential role of pro-inflammatory 
mediators in tumour progression, this would be an interesting field for further 
investigation (Balkwill and Mantovani 2001).  An initial step would be to investigate 
CXCR4 staining in clinical samples of normal and inflamed oral mucosa. 
 
 
 
                                                     
37 The normalised mRNA expression of inflammation-induced chemokine receptors CXCR1, 
CXCR2, CCR1, CCR2 and CCR3 were not significantly upregulated in NOKs (Section 3.4.1.2). 
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3.5.2  CXCR4 mRNA expression in established OSCC and other head 
and neck carcinoma cell lines 
CXCR4 mRNA was expressed at low levels in NOK and surface protein was not 
detected.  Considering the hypothesis that CXCR4 plays a role in OSCC tumour 
progression, it might be expected that the mRNA would be upregulated in OSCC cell 
lines.  My results show that CXCR4 mRNA was the only chemokine receptor to be 
expressed at significantly higher levels (ten-fold increase) in two out of six OSCC cell 
lines.  This upregulation in some, but not all, cell lines suggests that CXCR4 
overexpression is not ubiquitous in tumour progression.  Indeed a similar pattern of 
CXCR4 mRNA expression in established OSCC cell lines is described in the majority of 
the published literature:  high expression of CXCR4 mRNA was demonstrated in two 
out of three (Uchida, Begum et al. 2003), three out of six (Katayama, Ogino et al. 2005), 
three out of eight (Ishikawa, Nakashiro et al. 2006), but none out of 13 (Muller, Sonkoly 
et al. 2006) OSCC cell lines tested.  CXCR4 gene expression is a prerequisite of protein 
production and its absence in OSCC cells would not support (although not refute) the 
overall hypothesis of this thesis.  My findings, together with those from the literature, 
suggest that CXCR4 mRNA expression is not-ubiquitous in OSCC cells in-vitro.  This 
may be a reflection of the genome of the individual cell line or, alternatively, a change 
in the transcriptome in response to cell culture conditions.  It has been suggested that 
CXCR4 surface production is induced and maintained by the tissue/tumour 
microenvironment from observations of CT-26 colon carcinoma cells where CXCR4 
mRNA was strongly upregulated in-vivo but lost again following a few days of ex-vivo 
culture. (Zeelenberg, Ruuis-Van Stalle et al. 2003)  The effect of individual cell culture 
conditions on CXCR4 mRNA expression could be investigated empirically.  One 
variable of clinico-pathophysiological interest would be the effect of hypoxia 
particularly on CXCR4 mRNA expression (Uchida, Onoue et al. 2007). 
 
CXCR4 mRNA upregulation (compared with normal epithelia) has been demonstrated 
in other head and neck carcinomas cell lines including salivary adenoid cystic 
carcinoma (two out of four), thyroid (seven out of ten) and nasopharyngeal carcinoma 
(Moore, Rahemtulla et al. 2003 ; Wang, Xi et al. 2005; Muller, Sonkoly et al. 2006; De 
Falco, Guarino et al. 2007).  Interestingly, clinical observations demonstrate that 
adenoid cystic carcinoma is one of the few salivary tumours to demonstrate distant 
metastasis although it is not clear from these data alone what role CXCR4 plays in this 
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process.38  The finding of increased CXCR4 mRNA expression in a BCC-derived cell 
line (clinically a tumour that is locally invasive but very rarely metastasises) further 
clouds the picture of what role CXCR4 plays in epithelial tumour progression.  What is 
well established is that tumourigenesis is dependent on multiple factors within the 
tumour/tissue microenvironment (Balkwill and Mantovani 2001). 
 
Semi-quantitative analysis revealed a ten-fold increase in CXCR4 expression in the 
SCC4 and SCC25 cell lines, compared with NOK.  Upregulation of CXCR4 mRNA in 
primary thyroid carcinomas ranged from five to 65 times greater than in cultures of 
normal thyroid cells (De Falco, Guarino et al. 2007). Examination of other epithelial 
carcinomas has demonstrated CXCR4 upregulation one magnitude greater than found 
in OSCC.  For example,  the BCC-derived cell line BCC-1/KMC, CXCR4 was expressed 
72-fold more than all other chemokine receptors (Chen, Yu et al. 2006).  My data 
demonstrate that only CXCR4 mRNA was constitutively expressed at high levels in 
OSCC cell lines.  This pattern has also been described in the literature (Uchida, Begum 
et al. 2003).  However, Muller et al investigated a comprehensive panel of chemokine 
receptor mRNAs and found no discernable pattern amongst the OSCC cell lines 
examined (Muller, Sonkoly et al. 2006).  The exact mechanisms underpinning the 
differences in the magnitude of upregulation remain unclear.  What remains to be 
determined is whether this large range in upregulation observed in-vitro is 
representative of the in-vivo situation.  This could be addressed by laser-capture 
microdissection of small islands of tumour cells from clinical specimens and analysis 
with multiplexed semi-quantitative RT-PCR.  This was one of the original objectives of 
my experimental work as discussed earlier. 
 
In summary, low constitutive CXCR4 mRNA expression in NOK, with significant 
upregulation in some, but not all, established OSCC cell lines is consistent with the 
hypothesis that the SDF-CXCR4 axis is, in some way, involved with the malignant 
process.  However, at a mechanistic level, it is likely that CXCR4 mRNA expression 
levels would be poorly predictive of the behaviour of these cells in-vivo.  To test this 
hypothesis further, examination of CXCR4 protein production was required.   
                                                     
38 The observed clinical behaviour of adenoid cystic carcinomas is that they metastasise 
haematogenously (not via the lymphatics) to distant sites as a late event.  Here tumour deposits 
may enter a latent state and not produce clinically relevant lesions until quite some time after 
initial presentation.  The role of CXCR4 in this pattern of tumour behaviour is not clear (Muller, 
Sonkoly et al. 2006). 
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3.5.3  CXCR4 protein production by established OSCC and other 
carcinoma cell lines  
At first inspection, the relationship between CXCR4 mRNA expression and surface 
protein production appears simple: high levels of CXCR4 mRNA expression 
demonstrated by SCC4 and SCC25 cells were associated with positive labelling with 
flow cytometry and surface staining with immunocytochemistry.  Similar patterns of 
protein production (as determined by flow cytometry) have been reported in other 
OSCC cell lines expressing high levels of CXCR4 mRNA (Uchida, Begum et al. 2003; 
Katayama, Ogino et al. 2005; Ishikawa, Nakashiro et al. 2006); and in other high 
CXCR4-expressing carcinoma cell lines including salivary adenoid cystic (Muller, 
Sonkoly et al. 2006),  thyroid (De Falco, Guarino et al. 2007), basal cell (Chen, Yu et al. 
2006), renal (Schrader, Lechner et al. 2002) and non-small cell lung carcinoma (Su, 
Zhang et al. 2005) . 
 
Some cell lines (SV and FaDu) demonstrated CXCR4 mRNA expression at levels ten- to 
20-fold higher than NOK with sqRT-PCR but only very low levels of CXCR4 surface 
protein levels were detected with flow cytometry.  One explanation is that FaDu cells 
produce functional CXCR4 protein but this is only associated with the cell membrane 
at low levels.  The presence of low (but detectable) cytoplasmic staining of CXCR4 
protein in FaDu cells by immunocytochemistry supports this hypothesis and further 
investigation using confocal microscopy and co-staining with localising antibodies 
would provide more evidence.  Samara et al have demonstrated functional responses 
to SDF stimulation (calcium flux and cell adhesion) by FaDu cells in-vitro despite the 
expression of low amounts of CXCR4 mRNA (Samara, Lawrence et al. 2004).   This 
provides further evidence that mRNA expression levels are poorly predictive of cell 
behaviour.  Functional assays involving the FaDu cell line analysed in my experiments 
would determine whether these findings could be replicated. 
 
Muller et al showed small but detectable levels of CXCR4 protein with flow cytometry 
in OSCC cell lines with extremely low levels of mRNA expression (Muller, Sonkoly et 
al. 2006). Interestingly, despite surface protein labelling, these cells demonstrated no 
migratory response to SDF in Transwell chemotactic assays.  There are several 
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mechanisms that add to the complexity between mRNA transcription and functional 
protein production.  Firstly, abundant mRNA transcripts may not be translated; while 
another possibility is that CXCR4 undergoes a significant degree of post-translational 
control.  Immunocytochemistry revealed that the OSCC cell lines expressing high 
amounts of CXCR4 mRNA also labelled positively for CXCR4 protein.  Although this 
technique is not quantitative, there was a suggestion that low expressing cell lines 
stained less strongly for CXCR4 protein.  However, care must be taken in extrapolating 
these results as the transcriptomes of different cell lines may differ significantly (as 
demonstrated by microarray analysis) and it is this difference, rather than that of 
CXCR4 mRNA abundance, that may determine CXCR4 protein production.  A CXCR4-
transfected cell line would permit the investigation of this further by reducing possible 
confounding (genomic) factors. 
 
With regards to differences in post-translational control: this may result in CXCR4 
protein not reaching the cell membrane, not reaching it in a functional form, reaching it 
in a functional form but dimerising into a configuration not amenable to antibody 
binding, or reaching it and immediately being endocytosed by either ligand-dependent 
or independent mechanisms.  The staining of both the nuclear membrane and the 
cytoplasmic components of cells by anti-CXCR4 antibodies in permeablised OSCC cells 
suggest that the protein is manufactured but not always associated with the cell 
membrane.  Again, its location within cell compartments could be determined by 
confocal microscopy and co-labelling with localising antibodies.   
 
While cells with little CXCR4 surface labelling may be responsive to SDF stimulation, 
the converse may also be demonstrated.  CXCR4 protein associated with the cell 
membrane may be available for antibody binding but demonstrate no functional 
capacity.  The hepatocellular carcinoma cell line Hep G2 stains positively for surface 
CXCR4 but fails to undergo phosphorylation and internalisation upon ligand binding 
(Mitra, De et al. 2001).  Transfection of HepG2 with wild-type CXCR4 restored receptor 
function.  Even among other hepatocellular carcinoma cell lines that label positively for 
surface CXCR4 with rapid protein translocation from the membrane and cytoplasm to 
the perinuclear region following stimulation with SDF, not all cell lines demonstrated 
changes in migration and proliferation (Schimanski, Bahre et al. 2006).  Consequently, 
to determine the effect of CXCR4 mRNA expression on cellular responses to SDF 
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gradients, an experimental model was developed in which the overexpression of wild-
type CXCR4 mRNA was achieved by transfection (Chapter 5). 
 
In summary, established OSCC cell lines with high constitutive expression of CXCR4 
mRNA also demonstrated protein labelling with antibodies.  This localised to both the 
cell membrane and the perinuclear/cytoplasmic compartments.  Conversely, cell lines 
with low CXCR4 mRNA expression demonstrated significantly less protein labelling, 
little of which was associated with the cell membrane.  However, as demonstrated in 
the literature, surface protein labelling with monoclonal antibodies is poorly predictive 
of ligand-induced functional responses and these must be determined empirically 
(Chapters 6 & 7). 
 
 
3.5.4  CCR7 mRNA expression and protein production by normal 
keratinocytes, OSCC and other carcinoma cell lines  
The roles of the chemokine receptors CXCR4 and CCR7 in models of homeostatic 
leukocyte homing have been clearly defined.  Consequently pioneering investigations 
of similar mechanisms in carcinoma metastasis focused on both these receptors.  
Results from my experiments demonstrated low levels of CCR7 mRNA by microarray 
and sqRT-PCR with no significant variation between normal and neoplastic-derived 
oral cell lines.  Similar findings have been reported in other established OSCC cell lines 
(Uchida, Begum et al. 2003).  While Muller et al demonstrated a wide variation in 
absolute levels of CCR7 mRNA expression in ten primary OSCC tumours, her group 
reported no surface CCR7 labeling revealed by flow cytometry but a positive signal 
from the intracellular compartment and positive cytoplasmic staining with 
immunocytochemistry (Muller, Sonkoly et al. 2006).  I identified no CCR7 protein 
labeling on flow cytometry but some barely detectable perinuclear staining with 
immunocytochemistry.  While it is possible that CCR7 mRNA upregulation and 
increases in surface protein levels could be induced in-vivo, it has been shown in the 
literature that stimulation with either growth factors or pro-inflammatory cytokines 
did not induce surface CCR7 in OSCC cell lines (Muller, Sonkoly et al. 2006).   
 
Results from my experiments demonstrated low levels of CCR7 mRNA expression and 
no labeling of CCR7 protein.  One methodological criticism of these experiments is the 
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lack of a positive control cell line.  While an internal positive control was available for 
sqRT-PCR investigation of CCR7, there was no external positive control for either these 
or the protein assays.  A Hodgkin lymphoma-derived cell line, in which CCR7 
expression and surface protein are consistent features, has been described and would 
be suitable if available (Hopken, Foss et al. 2002).  Alternatively, CCR7-transfection of 
an established OSCC cell line might demonstrate CCR7 protein production, although 
this would be subject to the possible variation in post-translational control as discussed 
above.  However, CCR7 transduction of murine mammary carcinoma cells did result in 
detectable protein production (Croci, Nicoletti et al. 2007).  
 
The established OSCC cell lines investigated in these experiments did not demonstrate 
significant CCR7 mRNA expression or protein labeling.  However, CCR7 mRNA 
expression in other epithelial tumours of the aero-digestive tract varies widely with 
occasional cell lines demonstrating functional responses (Mashino, Sadanaga et al. 
2002; Ding, Shimada et al. 2003).  Interestingly, similar experiments have demonstrated 
substantial increases in CCR7 mRNA expression in lymph node metastasis-derived cell 
lines compared with those derived from their matched primary lesions (Muller, 
Sonkoly et al. 2006).  Indeed CCR7 expression has been shown to increase through 
successive passages of cell lines through nude mice (Wang, Xi et al. 2005; Wang, Zhang 
et al. 2005).  These findings suggest that, while constitutive levels of CCR7 expression 
may be low, they are upregulated during the process of lymph node metastasis.  
However, what is not clear from these data is whether CCR7 upregulation facilitates 
the progression of tumour cells to the lymph node, or whether CCR7 is induced by 
factors within the lymphoreticular microenvironment.  Data from leukocyte homing 
support the former although the extrapolation of these to carcinoma metastasis must 
be done with caution and further empirical evidence is desirable. 
 
XCR1 was expressed at lower levels in all OSCC cell lines compared with normal oral 
keratinocytes.  These findings are consistent with observations in the literature which 
suggest that XCR1 is rarely seen in tumour cells, predominantly due to its very limited 
physiological expression profile (Zlotnik 2004).  A more mechanistic hypothesis would 
be that tumours downregulate XCR1 in order to remain unresponsive to its ligand 
XCL1 (Lymphotactin).  XCL1 is constitutively produced by gamma-delta T-
lymphocytes that reside in the epithelial compartment and bear a dendritic phenotype 
(Boismenu, Feng et al. 1996).  In this way, downregulation of XCR1 would reduce 
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tumour cell responses to lymphocyte-derived XCL1 and facilitate evasion of the host 
lymphocytic response.  In reality, it is likely that this hypothesis is over-simplistic.  
XCL1 production by intraepithelial lymphocytes attracts neutrophils and natural-killer 
cells that express the XCR1 receptor (Huang, Li et al. 2001).  Consequently, it may be a 
reduction in XCL1 production (rather than XCR1) that is important in evading the anti-
tumour host response.  This is supported by evidence in solid tumours including 
myeloma where XCL1 transfection of tumour cells induced a dense neutrophil 
infiltration and lymphocyte-mediated tumour regression (Cairns, Gordon et al. 2001).  
Interestingly, my results showed that XCL1 was expressed at high levels by two OSCC 
cell lines (CAL27 and FADU) and at low levels by another two (SCC4 and SCC25).  It is 
possible to hypothesise that the former cell lines may have attracted a denser 
neutrophil infiltrate and greater lymphocyte-mediated tumour regression in-vivo than 
the latter pair.   
 
Together these results suggest that, even in cells with high expression of XCL1, there is 
low receptor expression and an autocrine pathway is not supported at an mRNA level.    
The role of the Lymphotactin-XCR1 axis has not been investigated in squamous cell 
carcinoma, particularly of the head and neck.  While this line of study would indeed be 
interesting, it lies outside the scope of this project.  
 
 
3.6  Conclusions 
The results presented in this chapter show that some (but not all) established OSCC 
cell lines constitutively produce CXCR4 (but not CCR7) mRNA and surface protein.  It 
was also observed that surface protein levels were higher in cell lines expressing 
greater amounts of CXCR4 mRNA.  Following these preliminary findings in 
observational studies it was decided to focus investigation on the chemokine receptor 
CXCR4.  It was hypothesised that the abundance of CXCR4 mRNA was a key 
determinant of surface protein levels and function.  Consequently, CXCR4 transfection 
of a constitutively low expressing established OSCC cell line was developed to test this 
(Chapter 5).  Functional assays were also performed to determine the response of 
constitutively high-expressing and CXCR4-transfected cells to SDF gradients (Chapters 
6 and 7).  However, the biological relevance of these in-vitro assays would only be 
confirmed if CXCR4 protein was observed in OSCC tumourigenesis in-vivo.  The 
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strongest mechanistic evidence for this would come from animal models (although this 
could not be justified at this stage without further preliminary data).  Consequently it 
was decided to do further observational investigation of CXCR4 in OSCC clinical 
specimens (Chapter 4). 
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Chapter 4:  
CXCR4 protein 
production in OSCC 
clinical specimens 
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4.1  Introduction 
Evidence from the literature has demonstrated a role for CXCR4 and CCR7 in the 
selective homing of leukocytes.  Animal studies have also shown that these chemokine 
receptors may play a part in the metastatic mechanisms of certain carcinomas.   Results 
presented in the previous chapter have demonstrated that CXCR4 (but not CCR7) 
protein is constitutively produced on the surface of cultured OSCC cells.  However, the 
distribution of CXCR4 surface protein in-vitro was found to be heterogeneous with 
only a minority of cells staining positively despite the relative upregulation of CXCR4 
mRNA expression compared with NOK.  Although derived from clinical specimens, it 
is not clear from in-vitro data alone whether the behaviour of these cell lines reflects the 
in-vivo situation, particularly as the tissue/tumour microenvironment is impossible to 
replicate under culture conditions.  Consequently, before undertaking assays of cell 
function, it was important to determine if CXCR4 staining was demonstrated in clinical 
specimens.  This could potentially be achieved using a number of complimentary 
techniques including immunohistochemistry, in-situ hybridisation and laser-capture 
microdissection with (multiplexed) sqRT-PCR.  By far the simplest of these was 
immunohistochemistry and, once published experimental protocols could be validated 
empirically, this was a useful technique to produce qualitative data on the distribution 
of CXCR4 protein within clinical specimens derived from archived histopathological 
specimens in which the lymph node status was known. 
 
To achieve this, samples were taken from archived, formalin-fixed, primary resection 
specimens and investigated with immunohistochemistry.  Lymph node status was 
defined by histological examination of the accompanying modified radical neck 
dissection using conventional, light microscopy based techniques.  However, the 
limitation of comparing results between specimens using this technique was quickly 
identified and a novel, quantitative assessment of staining using tissue arrays was 
developed, validated and used. 
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4.2  Chapter hypothesis 
Increased CXCR4 protein production in primary OSCC clinical samples is positively 
associated with histopathological observation of cervical lymph node metastases. 
 
 
4.3  Chapter Aims and Objectives 
4.3.1  Overall Aim 
To determine the pattern of CXCR4 production in clinical patient samples. 
 
 
4.3.2  Specific Objectives 
1. To develop a quantitative technique for the assessment of CXCR4 
immunohistochemistry staining of clinical patient samples. 
2. To investigate the relationship between clinico-pathological factors and 
CXCR4 staining of the nucleus and/or cytoplasm. 
3. To explore the association between CXCR4 protein expression and lymph 
node metastasis in head and neck squamous cell carcinomas. 
 
 
4.4  Results: CXCR4 protein staining in clinical specimens. 
4.4.1  Overview 
Initial experiments were performed to establish the validity and reproducibility of the 
CXCR4 immunohistochemistry protocol.  Following this, representative sections from 
primary OSCC lesions and their associated lymphatic metastases were then compared.  
Finally, a novel quantitative method of analysing staining intensity was developed, 
validated and used to investigate numerous specimens from squamous carcinomas 
arising in the head and neck (predominantly originating in the oral cavity and 
oropharynx). 
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4.4.2  Preliminary investigations 
Initially a series of CXCR4 positive control sections of human tonsil were prepared and 
various methods of antigen retrieval were examined empirically.  This included 
enzyme digestion, heating in a variety of buffer solutions and microwaving.  A tightly 
defined experimental protocol was derived and used in all subsequent experiments.  
Preliminary experiments were carried out with tissue blocks selected from the clinical 
resection specimens of ten patients.  Each specimen comprised of matched primary 
tumour and lymph node metastases excised from the same patient in continuity.   
Clinicopathological features of the specimens examined are outlined in Table A2.3 
(Appendix 2).  Where available, an examination of matched, adjacent, histologically 
normal mucosa was also performed.  Representative results and a discussion of these 
preliminary findings are presented in Section A4.1 (Appendix 4). 
 
The collective results from these preliminary investigations suggested that more 
CXCR4 protein was found in the cytoplasmic compartment of lymph node metastases 
compared with tumour cells from the matched primary lesions.  Where available, 
comparison with adjacent, histologically normal oral mucosa suggested that CXCR4 
staining was more intense in OSCC cells and that CXCR4 staining occurred in both 
primary OSCC lesions and their associated lymph node metastases.  The limitations of 
qualitative, immunohistochemical data are that results are not easily collated and batch 
sizes are often small.  Therefore, to address these issues, a method by which 
immunohistochemical slides could be prepared in batches and analysed quantitatively 
was devised.   
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4.4.3  Quantitative determination of CXCR4 expression in OSCC primary 
tumours 
4.4.3.1  Overview 
The aim of these experiments was to compare the CXCR4 protein distribution in a 
series of OSCC clinical specimens derived from a number of different patients.  In 
order to achieve a meaningful comparison between specimens two criteria had to be 
fulfilled.  Firstly, specimen preparation had to be identical in order to standardise 
antigen retrieval and antibody binding.  This was addressed using tissue arrays.  
Secondly, a quantitative method of assessing staining intensity was developed, 
validated and used to reduce inter-observer error in the assessment of staining 
patterns. 
 
 
4.4.3.2  Validation of the technique 
The method of immunohistochemistry analysis (as outlined in Section 2.7 and used in 
the preliminary experiments described in Section A4.1, Appendix 4) was optimised 
empirically.  Commercially available head and neck SCC tissue arrays were then taken 
and stained for CXCR4 protein with post-hoc processing as outlined in Section A4.2 
(Appendix 4).  Briefly, saturation measurements at nine standardised areas across the 
field of view were taken and the mean (standard error) values calculated.  Yellow 
saturation values were found to be the most sensitive marker of peroxidase activity.  
Results from samples with two replicates per array were compared, demonstrating a 
high level of concordance for both the nuclear and cytoplasmic compartments.  A 
random subset of 20 images were analysed on two separate occasions with a high 
concordance between results.   
 
 
4.4.3.3  Results of quantitative immunohistochemical analysis 
Only tissues from primary lesions were represented on the tissue arrays.  Pathological 
lymph node status was determined for each sample from the accompanying detailed 
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histology reports.39  A summary of clinicopathological variables for each specimen 
represented on the array is given in Table 4.1.  Their distribution on the array is shown 
in Figure A2.1 (Appendix 2).  Values for nuclear and cytoplasmic staining by tissue 
type were obtained and plotted (Figure 4.1).40   Each scatterplot point (panels a)i), b)i) 
and c)i)) represents the mean (95% confidence interval) for the measured cytoplasmic 
and nuclear staining intensity (horizontal and vertical axes respectively).  The bar 
charts (panels a)ii), b)ii) and c)ii)) represent the mean (standard deviation) cytoplasmic 
and nuclear staining intensity (light and dark bars respectively) for each specimen 
according to the tissue and nodal status.  All statistical comparisons were performed 
using the Student t-test.  Relationships that failed to reach statistical significance were 
not highlighted. 
 
For the seven specimens of lip tissue represented on the array (Figure 4.1 panels a)i) 
and a)ii)) the CXCR4 staining pattern was consistently different in primary lesions that 
had pathological evidence of lymph node metastasis (n=2) compared with tumours 
that had not spread (n=4).  These clusters were also distinct from the one specimen of 
normal lip mucosa represented on the array. Primary lip lesions with pathological 
evidence of CLN metastases (pN+) demonstrated significantly more cytoplasmic 
CXCR4 staining (p<0.05), but significantly less nuclear staining (p<0.001) compared 
with primary lip lesions without pathological evidence of CLN spread (pN0).  
However, statistical comparisons in this small subset of lesions must be interpreted 
with caution and validation of these changes was investigated with a larger sample of 
OSCC lesions. 
 
In total 26 specimens of oral tissue were represented on the array (Figure 4.1 panels b)i) 
and b)ii)).41  A clustering of normal (n=6), metastatic (n=11) and non-metastatic (n=9) 
tissue samples was demonstrated.  Normal oral tissues generally had the lowest 
intensity of both nuclear and cytoplasmic staining.  Compared with normal mucosa, 
primary OSCC lesions without lymphatic spread (pN0) demonstrated significantly 
more nuclear CXCR4 staining (p<0.01).  Primary OSCC lesions with pathological 
evidence of CLN metastases (pN+) demonstrated significantly more nuclear and 
                                                     
39 In 23/31 (75%) tumour specimens represented on the array the staging information was 
derived from histological reports following neck dissection.  On the remainder the staging was 
from a combination of clinical and radiological findings (Table 4.1). 
40  The methodologies used are outlined in Section 2.7 (Chapter 2) & Section A4.2 (Appendix 4). 
41  According to the ICD-10 definitions outlined in Appendix 1. 
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cytoplasmic staining of CXCR4 compared with normal controls (p<0.01 & p<0.05 
respectively).  In a similar pattern to the lip lesions described above, primary pN+ 
OSCC lesions showed significantly more cytoplasmic CXCR4 staining (p<0.05) 
compared with primary pN0 lesions.  Only one pN0 tumour clustered in the middle of 
the lymph node positive group and this was a moderately differentiated pT2 lesion of 
the floor of the mouth.   
 
Thirty one SCCs from all sites in the head and neck (with eight matched normal 
controls) were represented on the array (Figure 4.1 panels c)i) and c)ii)).42  A similar 
clustering pattern was observed to that described above for OSCC lesions.  
Interestingly, three of the four outlying specimens from the pN0 cluster comprised 
laryngeal, oesophageal and lip carcinomas.  Overall the pattern of staining intensities 
for normal, pN0 and pN+ HNSCCs was identical to that of OSCC described above.  
Particularly the intensity of cytoplasmic staining in primary pN+ HNSCC lesions was 
significantly greater (p<0.01) than for primary pN0 HNSCC lesions. 
 
 CXCR4 staining intensity data was reformatted according to disease stage (Figure 4.2, 
panels a)i) and a)ii)) and tumour size (Figure 4.2, panels b)i) and b)ii)).  Clusters were 
tighter based on disease stage (panel a)i)) compared with size of the primary tumour 
(panel b)i)).  Significantly more nuclear staining was observed for all disease stages (1-
4) compared with normal controls (p<0.05).43  No significant differences in nuclear 
staining were demonstrated between disease stages.  Cytoplasmic staining levels were 
similar in Stage 1 and Stage 2 disease (compared with normal controls).  However, the 
intensity of cytoplasmic staining was significantly greater in Stage 3 and Stage 4 
disease compared with the other groups (p<0.05).  Nuclear staining was significantly 
greater for all primary tumour sizes (T1-T3) compared with normal controls (p<0.05).44  
Only T3 lesions showed significantly increased cytoplasmic CXCR4 staining compared 
with normal, T1 and T2 lesions.  Although it was tempting to analyse trends of staining 
intensity associated with primary tumour site and grade of histological differentiation, 
there were insufficient replicates on the array to control for the important confounding 
variables of tumour size and nodal status. 
                                                     
42  Including all OSCCs and SCCs of the upper oesophagus, larynx and lip 
43  For disease stage and tumour size statistical comparisons were performed using ANOVA 
with post-hoc correction for multiple testing. 
44  No statistical comparison was possible for T4 tumours as only one T4 oral cavity SCC was 
represented on the tissue array. 
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A qualitative assessment of the CXCR4 staining patterns of OSCC lesions on the tissue 
arrays was also made (Figure 4.3).  This revealed that a homogeneous pattern was seen 
most often (panels b and d).  The distribution was also occasionally heterogeneous 
(panels a and c).  This was consistent for both the cytoplasmic and nuclear 
compartments.  Subjective assessment of laryngeal lesions (Figure 4.4) only revealed 
heterogeneous staining (panels a and b).  However, variability in both nuclear and 
cytoplasmic staining strength was seen (panels c and d) with the tendency that lesions 
with evidence of lymphatic metastases demonstrating a greater intensity of CXCR4 
staining (panels b and d). 
 
 
4.4.4  Summary of experimental results 
1. Qualitative assessment appeared to demonstrate more CXCR4 protein 
labeling in the cytoplasmic compartment of lymphatic metastases compared 
with tumour cells from matched primary lesions (Section A4.1, Appendix 
4). 
2. Quantitative assessment of CXCR4 staining in tissue sections was 
reproducible and concordant between matched samples. 
3. An increased intensity of CXCR4 staining (particularly cytoplasmic) in 
OSCC primary lesions was associated with pathological confirmation of 
lymph node metastases. 
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Table 4.1:  Summary of clinicopathological features for each specimen represented 
on the tissue arrays 
Site Age (years) Sex 
T 
Status 
N 
Status 
Method of 
Staging 
Disease 
Stage 
Normal 
Control 
Available 
Buccal 50 M 1 0 CL 1 Y 
Buccal 73 F 3 0 ND 3  
Buccal 68 F 2 1 ND 3  
Floor Of Mouth 64 M 3 0 ND 3 Y 
Floor Of Mouth 46 M 2 0 ND 2  
Floor Of Mouth 64 M 1 1 ND 3  
Gum 70 F 1 0 CL 1  
Hard Palate 61 M 2 0 ND 2  
Hypopharynx 55 M 3 1 ND 3 Y 
Hypopharynx 60 M 3 1 ND 3  
Hypopharynx 55 M 4 2c ND 4 Y 
Hypopharynx 61 M 3 2b ND 4  
Larynx 61 M 4 0 CL 4  
Larynx 79 M 4 0 ND 4  
Larynx 50 M 4 2c ND 4  
Lip 56 F 2 0 ND 4 Y 
Lip 89 M 2 0 CL 2  
Lip 62 M 4 3 ND 4  
Oesophagus 65 M 1 0 ND 1  
Oesophagus 56 F 2 0 ND 2 Y 
Oesophagus 71 M 1 0 ND 1  
Retromolar 59 M 2 0 CL 2 Y 
Retromolar 53 M 2 0 CL 2  
Soft Palate 68 M 2 0 CL 2  
Soft Palate 67 M 1 0 CL 1  
Tongue 68 M 2 1 ND 3 Y 
Tongue 73 M 2 2c ND 4  
Tongue 70 M 2 2c ND 4  
Tonsil 53 F 2 2b ND 4  
Tonsil 53 M 3 2b ND 4  
Tonsil 61 M 2 2c ND 4  
 
Legend: M = male, F = female, ND = neck dissection, CL = clinical 
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Figure 4.1:  CXCR4 staining intensity in SCC tissue array samples by tissue type and lymph 
node status.  Lip SCC (a), oral SCC (b) and all HNSCCs (c).  For details see text.  Legend N0 = 
CLN negative, N+ = CLN positive, * = p<0.05, ** = p<0.01, *** = p<0.001.  
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Figure 4.2:  CXCR4 staining intensity in oral SCC tissue array samples by disease stage and 
by primary tumour size.  SCC lesions from the oral cavity and matched normal controls were 
stained for CXCR4 and colour saturation data were collected blind to tissue of origin as 
described in Section 2.7.  Mean values (points) and 95% confidence intervals (error bars) were 
plotted by disease stage (a)i) and tumour size (b)i).   Mean (standard deviation) were calculated 
and plotted for cytoplasmic (light bars) and nuclear (dark bars) for each group of replicates 
represented.  Statistical comparisons were performed using ANOVA.  Results reaching 
significance (compared with normal controls) are highlighted.  Legend: * = p<0.05. 
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Figure 4.3:  CXCR4 immunohistochemistry of OSCC tissue array specimens.  Tissue arrays 
were taken and prepared as outlined in Section 2.7.  Immunohistochemistry was performed 
with monoclonal antibodies to CXCR4 (a-d) and isotype controls (e & f).  Sections of a 
pT1N0M0 SCC from the molar alveolus (a, c & e) and a pT1N0M0 buccal SCC (b, d & f) are 
shown.   Staining patterns in OSCC lesions were variably heterogeneous (a & c) or 
homogeneous (b & d).  Variation in the intensity of nuclear (c) and cytoplasmic (d) staining was 
also demonstrated.  Isotype antibody controls demonstrated no non-specific binding (e & f).  
Scale bar represents 250µm (a, b & e) or 50µm (c, d & f). 
a) b) 
c) d) 
e) f) 
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Figure 4.4:  CXCR4 immunohistochemistry of laryngeal SCC tissue array specimens.  Tissue 
arrays were taken and prepared as outlined in Section 2.7.  Immunohistochemistry was 
performed with monoclonal antibodies to CXCR4 (a-d) and isotype controls (e & f).  Sections of 
a pT4aN0M0 SCC (a, c & e) and a pT4N2cM0 SCC (b, d & f) from the larynx are shown.   
CXCR4 staining patterns in laryngeal SCC lesions varied in intensity (a-d) in both the 
cytoplasmic (c) and nuclear (d) compartments.  Isotype antibody controls demonstrated no non-
specific binding (e & f).  Scale bar represents 250µm (a & b) or 50µm (c-f). 
 
 
 
a) b) 
c) d) 
e) f) 
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4.5  Discussion  
Before interpreting these results it is important to analyse the strengths (and 
weaknesses) of the experimental methodologies used.  These are discussed in 
Appendix 4.  Due to numerous methodological inconsistencies within the literature, 
comparison of my results with those described in the literature must be performed 
with caution.  For completeness (and where possible) the relevant methodologies are 
summarised as footnotes. 
 
My results support the hypothesis that CXCR4 surface protein is produced at very low 
levels by occasional basal keratinocytes.  Matched normal controls represented on the 
tissue arrays demonstrated weak nuclear and cytoplasmic staining for CXCR4.  Similar 
findings have been reported for oral mucosa (Delilbasi, Okura et al. 2004; 
Moutsopoulos, Nares et al. 2007), prostatic epithelia (Sun, Wang et al. 2003) and in a 
proportion of normal breast epithelia by some (Salvucci, Bouchard et al. 2006) but not 
other authors (Kato, Kitayama et al. 2003).  However, other groups have reported no 
CXCR4 staining in normal oral mucosa (Katayama, Ogino et al. 2005).  The reasons for 
these apparent discrepancies are not clear.  Artefactual explanations include variations 
in experimental technique, particularly antigen retrieval and staining protocols.  One 
criticism of numerous published series is that they fail to include the appropriate 
positive and negative controls in order to exclude these confounding factors.   
Extravasated CXCR4-positive leukocytes within the epithelial compartment may be 
mistaken for keratinocyte labelling.  This could be addressed by the careful observation 
of cell morphology by experienced pathologists or the use of co-labelling for leucocyte-
specific surface markers.   
 
My examination of normal oral mucosa revealed focal staining of intra-epithelial cells 
with leukocyte morphology, as well as endothelial cells and occasional basal 
keratinocytes.   Similar findings have been described by other groups (Delilbasi, Okura 
et al. 2004; Moutsopoulos, Nares et al. 2007) although not universally so (Katayama, 
Ogino et al. 2005).  CXCR4 staining has been demonstrated in all layers of normal oral 
epithelium except for the lamina propria (Jotwani, Muthukuru et al. 2004).   In patients 
with chronic periodontitis, CXCR4-positive cells were also observed in the lamina 
propria although no consistent relationship between CXCR4 staining and 
inflammation was described (Jotwani, Muthukuru et al. 2004).  However, this 
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association does not explain the finding of CXCR4-labelled basal keratinocytes.  One 
possibility is that cells in different niches within the epithelial structure demonstrate 
different phylogenetic properties including some with stem cell characteristics 
(Mackenzie 2005).  In oral mucosa, epithelial stem cell populations localise to the rete 
ridges and are thought to be more autonomous than other epithelial stem cells which 
are more dependent on cell-to-cell interactions with non-epithelial cells (Tudor, Locke 
et al. 2004). While definitive oral epithelial stem cell markers remain elusive, the SDF-
CXCR4 axis has been implicated in many pathways associated with stem cell activity.  
(Kucia, Reca et al. 2005; Mackenzie 2005).  The transmission of the X4 strain of the HIV-
1 virus across intact epithelial surfaces facilitated by the CXCR4 surface protein co-
receptor provides further (indirect) evidence for CXCR4 production in oral mucosa.  
Real variation in CXCR4 expression within normal epithelia may be due to true 
differences in expression in anatomically distinct sites, or potentially secondary to 
responses to the local tissue microenvironment (such as antigenic or pro-inflammatory 
stimuli).  The lack of consistent data in the literature points towards the need for 
further research. 
 
My results demonstrate surface CXCR4 staining in primary OSCC lesions.  However, 
the hypothesis that CXCR4 protein production is associated with malignant 
transformation is not supported by the observation of similar levels of cytoplasmic 
staining in normal and pTxpN0 lesions.  Staining of primary tumour cells was 
heterogeneous and findings from cultured OSCC cell lines also demonstrated that 
CXCR4 surface labelling was not ubiquitous.  It is possible that differences between 
cells within the same primary tumour or established cell line are attributable to genetic 
instability within individual cells.  Alternatively CXCR4 production may be induced 
by factors within the extracellular microenvironment.  While staining appeared 
unrelated to the proximity to the invasive front there was an appreciable difference in 
staining intensity in lymph note metastases (compared with their matched primary 
tumours).  It is not clear from these observational data at which point along the 
metastatic pathway is CXCR4 upregulated.  While some authors have commented on 
increased CXCR4 labelling at the invasive front, this area was not clearly represented 
in sufficient numbers of my specimens to be able to make a valid judgement (Ishikawa, 
Nakashiro et al. 2006; Muller, Sonkoly et al. 2006).  Recent evidence from pancreatic 
adenocarcinoma reveals a subpopulation of CXCR4-positive cancer stem cells at the 
invasive front (Hermann, Huber et al. 2007).  Abrogation of this subpopulation 
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significantly reduced metastases without affecting tumourigenicity, suggesting that 
CXCR4-mediated signalling is an early event in the metastatic pathway.   
 
CXCR4 staining was observed in all malignant specimens represented on the tissue 
arrays.  However, the strength of cytoplasmic staining in pN0 oral lesions was 
statistically indistinguishable from that of normal matched controls.  Therefore, when 
comparing to similar reports in the literature, the investigation of matched controls is 
of paramount importance.   However, for the reasons outlined in Appendix 4, direct 
comparison between different batches is subject to numerous potential methodological 
inconsistencies.    
 
The frequency of positive CXCR4 labelling of primary OSCC lesions reported in the 
literature varies from 29 to 100% (for full references see Table 1.4, Chapter 1).  One 
explanation could be the different methodologies employed.  However, it is interesting 
to note that groups reporting weak staining of normal tissues demonstrated the highest 
frequencies (57 to 100%) of positive CXCR4-labelling of primary OSCC lesions 
(Almofti, Uchida et al. 2004; Delilbasi, Okura et al. 2004). 45,46  Conversely, authors that 
described no CXCR4 staining of normal mucosa reported less frequently stained 
primary OSCC specimens (29 to 34%) (Katayama, Ogino et al. 2005; Ishikawa, 
Nakashiro et al. 2006; Muller, Sonkoly et al. 2006). 47,48  This observation is independent 
of the experimental method and assessment criteria used by each author and suggests 
that the robust comparison between these series is extremely difficult.   
 
Cytoplasmic CXCR4 staining in the primary lesions of pN+ specimens was 
significantly greater compared with pN0 samples.  This statistically significant 
relationship was observed independently in groups of lip, oral cavity and all head and 
neck SCCs on the array.  The relationship between cytoplasmic staining intensity in 
                                                     
45 Sections were defined as positive if more than 25% of tumour cells stained for CXCR4 or SDF 
respectively.  Sections with absent or less than 25% staining were classified as negative 
(Almofti, Uchida et al. 2004). 
46 The method by which staining was assessed and graded was not described in the paper 
(Delilbasi, Okura et al. 2004).  
47 Positive CXCR4 staining was defined as more than 10% of tumour cells demonstrating 
membrane and cytoplasmic staining as determined by one observer (Ishikawa, Nakashiro et al. 
2006).  
48 CXCR4 staining was categorised as strong, moderate, weak or absent as compared with 
staining in interstitial infiltrates by three independent, blinded observers (Katayama, Ogino et 
al. 2005).  
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early (Stage 1 and 2) and late (Stage 3 and 4) disease was significantly different.  
Considering early stage disease is (by definition) lymph node negative, this finding 
adds further weight to the hypothesis that lymph node status is the clinico-
pathological variable most closely associated with cytoplasmic CXCR4 production.  
There were insufficient samples on the array to investigate the relationship between 
tumour size (T stage) and CXCR4 staining while controlling for the confounding 
variable of nodal status.  This may explain the increased nuclear and cytoplasmic 
staining demonstrated with increasing T stage.  Considering that metastatic cells are 
ultimately derived from the primary focus, this association provides evidence (albeit 
indirect) supporting the hypothesis that CXCR4 mediates lymphatic metastasis in 
OSCC.  This is in agreement with the consensus of the published literature on OSCC 
(Almofti, Uchida et al. 2004; Katayama, Ogino et al. 2005; Ishikawa, Nakashiro et al. 
2006). Only one group found no consistent relationship between CXCR4 or CCR7 
staining in primary lesions and lymph node metastases (Muller, Sonkoly et al. 2006).  It 
is important to note that the statistical comparison performed in my results differs 
considerably from other authors.  My findings demonstrate a higher intensity of 
CXCR4 staining within the primary lesions with lymph node metastases compared to 
those without.  The staining intensity was measured quantitatively and compared 
statistically using tests based on the normal distribution.  In this way bias was reduced 
and the data generated was more reliable and robust.  Other authors have forced 
observations into a dichotomy and performed statistical comparisons on these ordinal 
outcomes. Together, these data suggest that lymph node metastasis is more common 
from primary OSCC lesions that demonstrate higher levels of cytoplasmic CXCR4 
staining, although this association is not ubiquitous.  What these simple analyses do 
not account for are the (biologically relevant) factors such as receptor density, 
functionality and heterogeneity amongst cells.  A more mechanistic approach in-vitro is 
required to address these questions and this is presented in Chapters 6 and 7. 
 
In a very large series of breast carcinomas, no clear association between either nuclear 
or cytoplasmic positivity for CXCR4 and lymph node metastases was demonstrated 
(Salvucci, Bouchard et al. 2006).  Statistically significant association has only been 
shown in cervical adenocarcinoma and colorectal carcinomas (Yang, Lee et al. 2007; 
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Yoshitake, Fukui et al. 2008).49  This may reflect differences in tumour biology between 
these epithelial carcinomas particularly given the not infrequent clinical observation of 
widespread breast cancer metastasis without lymphatic involvement (vide infra). 
 
Overall, CXCR4 cytoplasmic staining was greater in primary lesions that demonstrated 
lymph node metastases compared with those that did not.  From the preliminary 
examination of matched primary and secondary lesions, a tendency towards denser 
staining in the metastatic cells within the lymph nodes was observed, although this 
could not be examined statistically.  The lymphoreticular stroma constitutively 
produces SDF and this may induce, as well as bind with, tumour CXCR4 thereby 
initiating a paracrine stimulation pathway.  Co-localisation of SDF and CXCR4 staining 
has been demonstrated in up to 47% of cases conferring a spindle-shaped morphology 
to the tumour cells (Uchida, Onoue et al. 2007).  Further evidence has suggested that 
this autocrine SDF/CXCR4 pathway mediates the proliferation and motility of OSCC 
lymphatic metastases in-vivo.  Co-localisation of SDF and CXCR4 has also been 
associated with lymph node metastasis in oesophageal and colorectal carcinomas 
(Sasaki, Natsugoe et al. 2008; Yoshitake, Fukui et al. 2008). 50  This may be important in 
primary lesions where SDF is not constitutively expressed, but in the lymph node 
parenchyma, SDF is widely produced and may form a chemotactic gradient towards 
the periphery of developing lesions. 
 
As discussed in the Chapter 3, the cellular location of CXCR4 staining may be 
significant.  Only protein associated with the cell membrane will be exposed to 
extracellular ligand.  The process of ligand-mediated receptor internalisation may 
sequester functional protein within the intracellular compartments and CXCR4 has 
also been shown to undergo oligomerisation and internalisation without the presence 
of SDF (Babcock, Farzan et al. 2003).  Furthermore it has been shown that endogenous 
SDF binds to newly synthesised CXCR4, inhibiting its translocation to the cell surface 
(Zeelenberg, Ruuis-Van Stalle et al. 2003).  Conversely, CXCR4 protein within the cell 
may not be functional.  This may be due to intrinsic deficiencies preventing function or 
the inability to access the cytoplasmic membrane.  In arrestin-deficient cells, chemokine 
                                                     
49 Multivariate analysis included age (>50 years), primary tumour size, depth of stromal 
invasion, lymphovascular invasion and histological grade (Yang, Lee et al. 2007).  
50 Positive SDF staining was defined as over 10% of >1,000 tumour cells in 10 high-power fields 
as determined by two independent, blinded observers (Sasaki, Natsugoe et al. 2008).  
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receptors are unable to recycle to the cell surface and are held within the perinuclear 
recycling compartments (Vines, Revankar et al. 2003).   Consequently, one criticism of 
the literature is the inference that cellular responses to SDF are defined by the density 
of CXCR4 staining of the cell membrane.  Peri-nuclear staining may reflect receptor 
internalisation and, therefore, may be a better indicator of CXCR4 activation than cell 
membrane staining.  Strategies to address this include the analysis of CXCR4 staining 
in light of proxy markers of tumour behaviour.  For example, in a small series of 
randomly selected OSCC cases, positive CXCR4 staining was demonstrated on the cell 
membrane or in the cytoplasm in 15 out of 26 (58%) cases (Hong, Pai et al. 2009).  The 
PCNA labelling index was significantly higher in the CXCR4-positive group.   
 
What is the mechanism of CXCR4 nuclear staining?  If it is related to endogenous SDF 
release and CXCR4 internalisation then one might expect to see a difference between 
tumour cells that do and do not produce SDF.  This is not the case.  Primary colorectal 
carcinomas in which nuclear CXCR4 staining was observed were associated with 
metastatic lymph node deposits demonstrating cytoplasmic staining (Yoshitake, Fukui 
et al. 2008).  This could reflect a shift between tumour/tissue microenvironments, 
possibly mediated by hypoxia-related or pro-inflammatory factors.  My data on OSCC 
matched primary/lymph node secondary specimens were insufficient to produce a 
valid assessment.  This would need to come from investigation of a tissue array 
containing an appropriate number of suitably matched specimens.  
 
A number of authors have demonstrated a statistically significant association between 
increased CXCR4 staining of primary OSCC lesions and poor clinical outcome 
(Almofti, Uchida et al. 2004; Katayama, Ogino et al. 2005; Ishikawa, Nakashiro et al. 
2006; Lee, Jin et al. 2009).  However, multivariate analysis was employed in only two of 
these series to attempt to control for confounding variables (Katayama, Ogino et al. 
2005; Lee, Jin et al. 2009).51 In these cases, positive CXCR4 staining of the primary 
lesion was associated with significantly reduced disease-specific survival.  
Nevertheless, when calculated from the raw data, the Positive Predictive Values (PPV) 
for CXCR4 staining the clinical endpoints of lymph node metastasis, tumour 
                                                     
51 Multivariate analysis by one group included age (>60yrs), male gender, primary site (floor of 
mouth), poor tumour differentiation, advanced clinical stage (III & IV) (Katayama, Ogino et al. 
2005).  The other group included the variables of primary size, lymph node metastasis, 
recurrence and high MMP-9 expression (Lee, Jin et al. 2009).  
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recurrence, Stage IV disease and five-year survival were 66%, 66%, 66% and 57% 
respectively (Almofti, Uchida et al. 2004).52  In short, based on these data, CXCR4 
status was only marginally better than chance at defining clinically important 
outcomes. 
 
The meaningful association of SDF/CXCR4 staining patterns with clinico-pathological 
variables is fraught with methodological difficulties.  The majority of studies in the 
literature have not been powered sufficiently to determine any associations, 
particularly accounting for confounding variables associated with survival such as 
tumour stage (Scotton, Wilson et al. 2002; Burger, Glodek et al. 2003; Kato, Kitayama et 
al. 2003; Sun, Wang et al. 2003; Yasumoto, Koizumi et al. 2006; De Falco, Guarino et al. 
2007; Wen, Zhu et al. 2007; Yang, Lee et al. 2007; Zhang, Lu et al. 2007; Kajiyama, 
Shibata et al. 2008; Sasaki, Natsugoe et al. 2008; Yoshitake, Fukui et al. 2008).    These 
studies fail at two separate levels:  firstly, inherent variability in the experimental and 
assessment methodologies used precludes meaningful interpretation of the data.  
Secondly, the arbitrary numerical data produced in this way do not demonstrate a 
likelihood of a particular finding occurring at a frequency that was significantly 
different to chance alone. 
 
Interestingly, in a large series of breast carcinomas, cancers showing positive 
cytoplasmic CXCR4 staining were more likely to be high grade, hormone receptor 
negative and to overexpress HER2 (Salvucci, Bouchard et al. 2006).  A mechanism by 
which HER2-mediated breast carcinoma metastasis is dependent on CXCR4 
upregulation has been postulated (Li, Pan et al. 2004).  High nuclear and high 
cytoplasmic CXCR4 staining were independently associated with significant 
reductions in tumour-specific patient survival of 46 and 70% respectively.  These 
associations were independent of other predictors of prognosis.53  The relationship 
between increased cytoplasmic staining and decreased survival was strongest in the 
groups of patients who were lymph node negative or had not undergone 
chemotherapy.  It can be inferred from these observations that, in primary breast 
carcinoma, surface expression of CXCR4 may be more important in mediating systemic 
                                                     
52 Positive Predictive Values were calculated from the raw data by the formula (True 
Positives)/(True Positives + False Positives). 
53 Multivariate analysis included age, pT stage, BRE grade, number of positive lymph nodes, 
oestrogen receptor (ER) and progesterone receptor (PR) status (Salvucci, Bouchard et al. 2006).   
 189
metastases (and consequently patient demise)  compared with loco-regional spread.  
This is particularly seen in patients who do not undergo systemic chemotherapy.  
These clinical observations are in concordance with in-vivo studies that demonstrate 
the role of CXCR4-mediated metastatic mechanisms in murine models of breast 
carcinoma  (Muller, Homey et al. 2001). 
 
One criticism of my preliminary work was the lack of pN0 specimens examined.  
Although this was addressed with the tissue array experiments, it should be noted that 
even detailed histological examination cannot guarantee the absence of 
micrometastases.  In the clinical situation, these tiny foci of metastatic cells have 
debatable prognostic significance (Woolgar 1999).  However, for the evaluation of 
metastatic mechanisms, the ability of cells to break away and form new colonies is 
hugely important.  While the staging of the tissue arrays was done on histological 
examination of functional neck dissections, it is not known how assiduous the 
pathologists had been when examining for micrometastases.  In a study on 
oesophageal squamous carcinoma, eight out of 46 (17%) specimens assessed as lymph 
node-negative by H&E staining had detectable micrometastases by cytokeratin 
staining and all of these were CXCR4 positive (Sasaki, Natsugoe et al. 2008).  Not only 
does this highlight the limitations of current pathological investigations (developed to 
inform clinical decision making), but it also raises the intriguing observation of 
CXCR4-positive lymphatic micrometastases within SDF-rich lymph node parenchyma.  
It is not known from this “snapshot” view whether these were lesions that were 
actively growing, or if they had entered a quiescent state.  This could be tested by a 
number of complex experimental methodologies including serial animal studies or 
intra-vital microscopy. Overall, these data are consistent with the hypothesis that 
CXCR4 is not the sole mediator of metastatic progression, but rather one implement in 
the molecular “toolbox” that mediates tumour dissemination in-vivo. 
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4.6  Conclusions  
Investigation of clinical specimens offers a unique insight into the location of CXCR4-
producing cells in-vivo.  These findings presented in this chapter were consistent with 
the overall hypothesis that the SDF/CXCR4 axis plays a role in OSCC metastasis.  
However, data derived from observational studies of clinical specimens serve 
predominantly to inform in-vitro and, particularly, in-vivo experiments.  The 
localisation of a single protein belies the complexity of the tumour/tissue 
microenvironment.  Nevertheless, if CXCR4 had not been detected on primary or 
secondary tumour deposits in clinical specimens then its role in OSCC metastasis in-
vivo would have been questionable regardless of the findings from in-vitro studies.  
These data did demonstrate CXCR4 in OSCC clinical samples and the next aim was to 
investigate the role of the molecule in functional assays of cell activity associated with 
tumourigenesis.  In order to achieve this, an appropriate experimental model was 
created by overexpressing CXCR4 mRNA in an established OSCC cell line in-vitro. 
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Chapter 5:  
Establishing a stable, 
CXCR4-transfected 
OSCC cell line 
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5.1   Introduction  
Higher levels of CXCR4 mRNA have been shown in some, but not all, established 
OSCC cell lines (Chapter 3).  In cell lines with the highest expression levels, associated 
CXCR4 surface protein was also demonstrated.  This was in contrast to NOKs in which 
both CXCR4 mRNA and surface protein was barely detectable.  CXCR4 protein was 
demonstrated in archived clinical OSCC samples (Chapter 4).   The pattern of staining 
intensity appeared to correlate with histologically-confirmed lymphatic metastases.  
Together these data support the hypothesis that CXCR4 is associated with OSCC 
metastasis.   
 
Observational data can only provide evidence of association rather than causation.  
The ability to over-express CXCR4 mRNA in cells that constitutively produce the 
protein at very low levels would provide a useful experimental model in which the 
effect of CXCR4 gene upregulation on cell phenotype could be tested.  In this way, one 
element of the observed differential gene expression resulting from carcinogenesis can 
be replicated in-vitro.  Following preliminary in-vitro studies this may then be 
translated into animal models to determine the effects of single gene over-expression 
in-vivo. 
 
Genetic manipulation of cell lines can be achieved in a number of ways.  Insertion of a 
single coding sequence immediately downstream of a known promoter provides the 
most reliable mechanism of stable changes in mRNA upregulation.  Other strategies 
exist for the downregulation of genes, predominantly through the use of small 
interfering RNA (siRNA) species.  These are not applicable to gene overexpression.  
Despite the association of CXCR4 expression with a number of solid and 
haematological malignancies, there have been remarkably few reports on CXCR4-
transfection of carcinoma cell lines.  This chapter documents the development and 
investigation of the transfection of a constitutively low-expressing established OSCC 
cell line with CXCR4.   
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5.2   Chapter Hypotheses  
Stable over-expression of CXCR4 mRNA in a constitutively low-expressing established 
OSCC cell line results in significantly increased surface CXCR4 protein production. 
 
 
5.3   Chapter Aims and Objectives 
5.3.1  Overall Aim 
To produce an established OSCC cell line that produces functional surface CXCR4 
protein at high levels. 
 
 
5.3.2  Specific Objectives 
1. To select an established OSCC cell line that constitutively expressed CXCR4 
mRNA at very low levels.  
2. To transform an expression vector with the wild-type CXCR4 insert in the 
correct alignment. 
3. To transfect the H357 cell line with the CXCR4-containing vector along with 
appropriate controls. 
4. To isolate and expand positive clones using antibiotic selection. 
5. To establish the CXCR4 mRNA and protein levels produced by clones and 
their controls. 
 
 
5.4   Results 
5.4.1  Overview 
The aim of these experiments was to perform a stable CXCR4 transfection of an OSCC 
cell line that constitutively expressed the gene at low levels.  The H357 cell line was 
selected.  Data presented in Chapter 3 demonstrated that untransfected H357 cells 
expressed low levels of both CXCR4 mRNA (as determined by microarray and sqRT-
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PCR) and CXCR4 surface protein (as determined by flow cytometry analysis and 
immunocytochemistry). 
 
The methodology employed is described in Section 2.4.  A brief outline of the steps 
performed is given below: 
 
1. Isolation of the CXCR4 coding sequence 
2. Transformation of competent cells and clonal expansion 
3. Clonal screening for presence of the CXCR4 insert 
4. DNA extraction from clones 
5. Plasmid ligation 
6. Colony screening 
7. Extraction and purification of CXCR4 plasmid DNA 
8. Transfection 
9. Clonal expansion under antibiotic selection 
10. Characterisation of the transfected cell line 
 
 
5.4.2  Extraction of the CXCR4 coding sequence  
Firstly, the presence of the CXCR4 sequence in the donated pcDNA3 plasmid was 
investigated.   This was performed by transforming JM109 competent cells with the 
donated plasmid thought to contain the CXCR4 coding sequence cassette.  The 
calculated transformation efficiency of the control reaction was 6.6 x 106 cfu/μg of 
DNA added.54 
 
Single colonies were incubated overnight and then screened for the CXCR4 sequence 
by PCR.  Three strongly positive clones were identified.  To confirm the presence of the 
CXCR4 sequence, DNA was extracted from the positive clones and incubated with a 
panel of restriction enzymes (Figure 5.1).  The BamH1 restriction enzyme was 
predicted to cut the entire CXCR4 construct containing pcDNA3 plasmid twice: once in 
the pcDNA3 multiple cloning site and once in the CXCR4 cassette yielding fragments 
                                                     
54  Transformation efficiency calculated as outlined in Section 2.4.3. 
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of 6100 and 480 base pairs in length.55,56  It was also predicted that the pcDNA3 
plasmid without the CXCR4 construct would be cut only once.  Furthermore pcDNA3 
plasmids containing multiple copies of the CXCR4 construct would be cut more than 
twice.  Results showed that the BamH1 restriction enzyme digestion of the pcDNA3-
CXCR4 plasmid yields two fragments, 6100 and 480 base pairs in length, confirming 
the presence of one CXCR4 insert per plasmid.  Incubation of the pcDNA3-CXCR4 
plasmid with the restriction enzymes Xba1 and EcoR1 confirmed that they only made a 
single cut in the plasmid. 
 
 
 
  
 
Figure 5.1:  Restriction enzyme digestion of the pcDNA3-CXCR4 plasmid.  Restriction 
enzyme digestion products from pcDNA3-CXCR4 were run on a 0.75% agarose electrophoresis 
gel.  Observed band sizes were determined using the Kodak 1D Image analysis software.  
Digestion with EcoR1 and Xba1 alone resulted in a single cut with single bands at 7400bp and 
7200bp respectively.  BamH1 was shown to cut the plasmid twice giving fragments measured at 
6008bp and 524bp.  Double digestion with EcoR1 and Xba1 also resulted in two fragments with 
mean measurements of 5502bp and 1025 bp.  Gel image taken from one representative 
experiment.  Observed values are the mean from three replicates performed.  Legend: LD = 
1kbp ladder, Eco = EcoR1, Xba = Xba1, Bam = BamH1.   
 
                                                     
55  pcDNA3 plasmid sequence available at (http://www.invitrogen.com/content/sfs/vectors/ 
pcdna3_rest.htm) 
56  Restriction enzyme digests predicted using the WebCutter 2.0 software package available at 
http://rna.lundberg.gu.se/cutter2/ 
Observed & Expected band sizes 
Restriction 
Enzyme 
Eco 
Xba Xba Eco Bam 
     
Observed 5502 1025 
7200 7400 6008 
524 
     
Expected 5446 1086 
6532 6532 6100 
480 
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To isolate the CXCR4 sequence, double-digestion of the pcDNA3-CXCR4 plasmid with 
the EcoR1 and Xba1 restriction enzymes was performed.  The pcDNA3.1vB plasmid 
was digested in the same way to open the multiple cloning site at the appropriate 
locations.  Both reaction products were separated on an agarose gel, excised and the 
DNA extracted (Figure 5.2). 
 
Following DNA extraction, the CXCR4 insert and linear pcDNA3.1vB plasmid were 
ligated.  The optimum conditions for ligation were determined using a range of insert 
to vector ratios (1:3, 1:1 and 3:1).  Ligation efficiency was determined by the density of 
the PCR band for the T7forward and BGH reverse primers.  Results showed that there 
was no significant difference between the molar ratios of 1:3, 1:1 and 3:1 of insert to 
vector respectively (Figure 5.3). 
 
 
 
 
 
Figure 5.2:  Restriction enzyme digests of the pcDNA3-CXCR4 and pcDNA3.1vB plasmids.  
Restriction enzyme digestion products prior to gel extraction were run on a 1% agarose gel.  
The pcDNA3-CXCR4 and pcDNA3.1vB plasmids were double-digested with the restriction 
enzymes EcoR1 and Xba1 to yield the CXCR4 coding sequence (1086 base pairs) and open 
plasmid (5446 base pairs).  Both linear sequences were excised and extracted from this gel.  
Legend:  LD = GeneRuler 1kbp DNA ladder. 
 
 
 
1086 bp 
5400 bp 
LD pcDNA3- 
CXCR4 
pcDNA3.1vB 
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Figure 5.3:  The effect of Insert / Vector Molar Ratio on the Efficiency of CXCR4 Ligation.  
PCR products generated by the T7forward and BGH reverse primers following ligation of the 
CXCR4 insert into the open pcDNA3.1vB plasmid: the effect of variation of the insert / vector 
ratio.  Each reaction was sampled in-triplicate.  There was no obvious difference in band density 
for the three molar ratios tested.  Representative results are shown from one experiment of three 
performed.  Legend:  PC = pcDNA3-CXCR4 positive control, NC = negative control (ligation 
mixture without addition of T4 ligase), LD = GeneRuler 100bp DNA ladder, EV = pcDNA3.1vB 
empty-vector negative control, ratios = insert : vector molar ratios. 
 
 
 
5.4.3  Transformation of competent cells, clonal expansion and 
screening 
JM109 competent cells were transformed with the pcDNA3.1vB-CXCR4 plasmid with 
an efficiency of 4.3 x 106 cfu/μg of DNA added.  Twenty clones were expanded from 
single colonies and underwent PCR with CXCR4 primers.  Eleven clones demonstrated 
PCR products 232 base pairs in size, consistent with the presence of CXCR4 (Figure 
5.4).  PCR for CXCR4 was repeated on one clone which was also investigated using the 
T7 forward and BGH reverse primer pair (Figure 5.5).  Results showed that for the 
pcDNA3.1vB-CXCR4 plasmid and the pcDNA3-CXCR4 positive control, the T7/BGH 
PCR products were consistent with the 1298bp band expected.  With CXCR4 primers, 
an expected band corresponding to 232bp was demonstrated.  In the pcDNA3.1vB 
empty-vector plasmid, no CXCR4 band was seen and the T7/BGH amplicon was 
257bp, demonstrating there was no interposed CXCR4 coding sequence. 
257 bp 
1298 bp 
1 : 3 PC  NC LD EV 1 : 1 3 : 1 
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Figure 5.4:  Screening of the transformed bacterial colonies for the pcDNA3.1vB-CXCR4 
construct by PCR.  CXCR4 PCR products run by gel electrophoresis against a 100bp DNA 
ladder showing bands consistent with the predicted amplicon size of 232 base pairs.  
Representative results are shown from one experiment of three performed.  Negative control 
(DNA-free water) showed no band (data not shown).  Legend: LD = 100 base pair ladder, 1-11 = 
bacterial clones, PC = pcDNA3-CXCR4 positive control DNA. 
 
 
 
 
 
 
Figure 5.5:  Screening of a selected transformed bacterial colonies for the CXCR4 and the 
T7/BGH primer pairs.  PCR products for CXCR4 (left) and T7-BGH (right) run by gel 
electrophoresis against a 100 bp DNA ladder.  Plasmids screened: 1) pcDNA3.1vB-CXCR4 
construct (X4) showing a positive band for CXCR4 (232 bp) and the T7-BGH band at 1298 bp 
enclosing the CXCR4 coding sequence; 2) pcDNA3.1vB empty vector negative control (EV) 
showing no band for CXCR4 and the T7-NGH band and 257 bp (no interposed CXCR4 coding 
sequence); and 3) pcDNA3-CXCR4 positive control (PC) with similar results to (1).  
Representative results are shown from one experiment of three performed.  Legend: LD = 100 
base pair ladder. 
500 bp 
CXCR4 
LD   1   2    3   4   5    6   7    8   9  10  11 PC LD 
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The selected pcDNA3.1vB-CXCR4 and empty-vector clones underwent restriction 
enzyme digestion to determine the number and orientation of the CXCR4 coding 
sequences inserted (Table 5.1).  The following pattern of pcDNA3.1vB-CXCR4 plasmid 
digestion was demonstrated:  the Sal1 restriction enzyme yielded a fragment of 4500 
and 2100 base pairs (predicted 4356 and 2188 base pairs).  The EcoR1 and Xba1 
enzymes gave single fragments of 6500 and 6400 base pairs respectively (both 
predicted at 6544 base pairs).  Combined digestion with both EcoR1 and Xba1 resulted 
in two fragments of 5600 and 1153 base pairs (predicted 5458 and 1086 base pairs).  The 
Nco1 restriction enzyme was shown to cut four times giving fragments of 3500, 2200, 
842 and 360 base pairs (predicted 3345, 2069, 735 and 338 base pairs).  For the 
pcDNA3.1vB empty vector the following pattern of restriction enzyme digestion was 
shown:  the Nco1 enzyme cut three times giving fragments of 3600, 1583 and 815 base 
pairs (predicted 3347, 1415 and 735 base pairs).  Sal1 cut twice with bands at 3500 and 
2300 base pairs (predicted 3309 and 2188).  The EcoR1 and Xba1 enzymes yielded 
single fragments measuring 5600 and 5400 base pairs respectively (both predicted at 
5497 base pairs).  In combination, EcoR1 and Xba1 yielded only one fragment of 5400 
base pairs although two were predicted (5438 and 39 base pairs).  It is likely that the 
tiny 39 base pair fragment was not resolved sufficiently at the end of the gel. 
 
Finally the empty pcDNA3.1vB plasmid was transformed into competent cells as 
described above.  Single clones were incubated and screened by PCR using primers for 
the T7 promoter (forward) and BGH reverse priming site (reverse).  In an empty 
plasmid this yielded an amplicon 257 base-pairs in length. 
 
 
5.4.4  CXCR4 Transfection of H357 cells 
The optimum conditions for the transfection reaction were determined empirically 
using the pcDNA3.1-lacZ control plasmid and the β-Galactosidase reporter activity 
assay.  The effect of the three variables investigated (charge ratio, starting DNA 
concentration and exposure time) are described in Appendix 5.  The killing effect of the 
antibiotic G418 on untransfected H357 cells was determined empirically and is also 
reported in Appendix 5. 
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Table 5.1: Tabulation of observed and expected band sizes following restriction enzyme 
digestion of the pcDNA3.1vB-CXCR4 plasmid and pcDNA3.1vB empty-vector control. 
 
Observed & Expected band sizes 
 
pcDNA3.1vB-CXCR4 pcDNA3.1vB empty vector 
Restriction 
Enzyme Nco1 Sal1 EcoR1 Xba1 
EcoR1 
Xba1 Nco1 Sal1 EcoR1 Xba1 
EcoR1 
Xba1 
           
Observed 
3500 
2200 
842 
360 
4500 
2100 
6500 6400 5600 
1153 
3600 
1583 
815 
3500 
2300 
5600 5400 5400 
           
Expected 
3345 
2069 
735 
338 
4356 
2188 
6544 6544 5458 
1086 
3347 
1415 
735 
3309 
2188 
5497 5497 5438 
39 
 
Restriction enzyme digestion products from the pcDNA3.1vB-CXCR4 plasmid and 
pcDNA3.1vB empty-vector control run on 0.75% agarose gel against a 1kbp DNA ladder.  
Incubation of the pcDNA3.1vB-CXCR4 plasmid reveals excellent correlation with predicted 
fragment number and size:  Nco1 yields four bands (3500, 2200, 842 and 360 base pairs), and 
Sal1 two bands (4500 and 2100 base pairs). EcoR1 and Xba1 alone yield one band (6500 and 6400 
base pairs respectively) and in combination two bands (5600 and 1153 base pairs).  Restriction 
enzyme digestion of the pcDNA3.1vB empty-vector control also demonstrates good agreement 
with fragment predictions:  Nco1 yields three bands (3600, 1583 and 815 base pairs), and Sal1 
two bands (3500 and 2300 base pairs).  Single incubation with EcoR1 and Xba reveal one band 
each (5600 and 5400 base pairs), while in combination one band is seen (5400 base pairs) when 
two are predicted.  All experiments were performed three times and the mean observed values 
are given. 
 
 
 
In summary, H357 cells were transfected with 1.5µg of the pcDNA3.1vB-CXCR4 
plasmid (or the pcDNA3.1vB empty vector control) per well, at a charge ratio of 1:1, 
with an exposure time of one hour as described in Section 2.4.14.  Transfected cells 
were grown in non-selective media for 48 hours and then passaged, clones selected 
and expanded using selective media containing G418 at a concentration of 1600µg/ml 
(as outlined in Section 2.4.15).  Five CXCR4-containing and six empty-vector clones 
were expanded into populations large enough to permit characterisation and further 
investigation. 
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5.4.5  Characterisation of CXCR4-transfected H357 Clones 
5.4.5.1  CXCR4 mRNA expression  
To determine the effect of transfection on CXCR4 mRNA expression transfected H357 
clones (with and without the CXCR4 construct), cells were cultured under optimal 
conditions under antibiotic selection and investigated with sqRT-PCR (Figure 5.6).  
Compared with untransfected cells, CXCR4 mRNA expression was essentially 
unchanged in transfected cells lacking the CXCR4 insert.  In cells containing the 
CXCR4 insert, mRNA expression was significantly increased:  three clones (H357-X4.4, 
H357-X4.5 and H357–X4.6) demonstrated increases in CXCR4 expression of 42, 800 and 
2,000 times respectively (compared with transfected controls lacking the CXCR4 
insert).  However, in two clones (H357-X4.1 and H357–X4.2), CXCR4 mRNA species 
were over half a million times more abundant than in similarly matched controls. 
 
In a separate experiment, transfected cells with (H357-X4.1) and without (H357-EV1) 
the CXCR4 insert were cultured under varying conditions in serum-reduced media 
(0.1% FCS) for 24 hours.  Total RNA was harvested and subjected to microarray 
analysis.  CXCR4 mRNA expression was 45 to 90-fold higher (p<0.001, Student t-test) 
in the cells containing the CXCR4 insert (NEV range 4.88 – 7.34), compared with those 
that did not (NEV range 0.08 – 0.11) (Figure 5.7).  Despite variations in the 
experimental conditions (including SDF stimulation and a reduced oxygen tension) 
CXCR4 mRNA expression levels remained relatively stable in cells transfected with 
and without the CXCR4 construct.  
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Figure 5.6:  Relative expression of CXCR4 mRNA by untransfected H357 cells and transfected 
cells with and without the CXCR4 insert.  Untransfected and transfected H357 cells (five 
clones with and six clones without the CXCR4 insert) were grown under optimum conditions to 
90% confluence as determined by light microscopy.  Messenger RNA expression was 
determined by sqRT-PCR and represented as fold change relative to untransfected H357 cells.  
Bars represent the mean (range) fold change of four replicates each measured in triplicate.  All 
CXCR4 transfected clones expressed significantly more CXCR4 mRNA than the untransfected 
or empty-vector mock transfected cells (p<0.001).  There was no significant difference in CXCR4 
mRNA expression between wild-type and any of the empty-vector clones (p>0.05).  The CXCR4 
transfected clones 4.1 and 4.2 expressed significantly more (p<0.001) CXCR4 mRNA than the 
other transfected clones (4.4, 4.5 and 4.6).  No Template Controls and samples incubated 
without Reverse Transcriptase produced no signal for CXCR4 after 40 cycles.  Statistical 
comparison with expression levels in untransfected H357 cells was performed with ANOVA 
incorporating the Bonferroni correction for multiple testing.  The figure represents the 
cumulative results of two experiments performed.  Legend:  UT = Untransfected H357; EV1-
EV6 = H357 empty vector clones; X4.1-X4.6 = CXCR4-transfected H357 clones; ns = not 
significant (compared with untransfected); *** = p<0.001 (compared with wild-type). 
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Figure 5.7:  CXCR4 mRNA expression in transfected H357 cells with and without the CXCR4 
insert subject to a range of experimental conditions.  H357 cells with and without the CXCR4 
insert were seeded at known densities and grown for 24 hours in normal growth media 
supplemented with 0.1%FCS.  Cells were stimulated with varying concentrations of SDF (0, 1 
and 100 ng/ml) and varying oxygen tensions (2% and 20%).  Total RNA was harvested and 
examined with microarrays.  Figure represents the mean normalised expression value for both 
microarray CXCR4 mRNA probes for each experimental condition.  Results show that CXCR4 
expression is 45 to 90 fold higher in those clones containing the CXCR4 insert, compared with 
those that do not (p<0.001, Student t-test).  CXCR4 expression levels were independent of other 
experimental variables such as SDF and oxygen concentrations.  Legend: hypox = low (2%) 
oxygen tension; normox = high (20%) oxygen tension. 
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5.4.5.2  CXCR4 surface protein production 
To determine the production of CXCR4 surface protein by transfected cells (with and 
without the CXCR4 insert), clones were grown under optimum conditions to 90% 
confluence in selective media, dissociated and investigated with flow cytometry.  
Labelling with two unrelated anti-CXCR4 monoclonal antibodies (clones 172 and 173) 
yielded similar results (Figure 5.8).57  Two of the five clones containing the CXCR4 
insert (H357-X4.1 and H357-X4.2) demonstrated very high CXCR4 surface expression 
(MFV 93.6 and 120.8 respectively).  Some surface labelling was shown by the H357-
X4.5 clone (MFV 25.4).  Signal levels for the H357-X4.4 and H357-X4.6 clones (MFV 11.2 
and 10.1 respectively) were similar to those demonstrated by the mock-transfected 
empty-vector controls (MFV 9.45).  Background signal for the isotype antibody controls 
for all clones investigated was universally low (MFV <6).  Interestingly the two high 
CXCR4-expressing clones (H357-X4.1 and H357-X4.2) demonstrated a biphasic 
distribution of fluorescence intensity.  The density plot of cell size against granularity 
for all the clones investigated showed two distinct populations of cells. 
   
Further experiments were performed to test the working hypothesis that the biphasic 
levels of CXCR4 surface protein demonstrated in the high-expressing clones (H357-
X4.1 and H357-X4.2) were a reflection of the size of different cell populations 
represented in the size scatterplot (Figure 5.9).  Live cells were gated into two 
populations based on size.  For all clones investigated, small live cells demonstrated 
the same percentage labelling for CXCR4 as large live cells.  Consequently these data 
suggested that CXCR4 surface expression was unrelated to cell size.  Furthermore, both 
the H357-X4.1 and H357-X4.2 clones demonstrated a similar overall percentage of 
positively labelled cells (74.8% and 80.1% respectively) and mean fluorescence 
intensity within the positive population (120.4 and 124.1 respectively).  These findings 
demonstrated that a small proportion (20 to 25%) of the H357-X4.1 and H357-X4.2 
transfected clones were not expressing CXCR4 on the cell surface.  Consequently it was 
decided to select out CXCR4-labelled cells from these “mixed” populations by 
fluorescence-assisted cell sorting (FACS).  This was performed according to the 
methods outlined in Section 2.4.17.  Selected CXCR4-positive cells were cultured and 
passaged in selective growth media for use in further experiments. 
                                                     
57 Data from both antibodies (clones 172 and 173) are tabulated in Figure 5.8.  For simplicity 
mean fluorescence (MF) values quoted in the text are for the 173 clone. 
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G) Antibody Clone Mean Fluorescence 
   4.1 4.2 4.4 4.5 4.6 Empty- Vector 
 Isotype  5.04 5.19 5.19 5.24 4.25 5.63 
 172 122.89 150.09 9.35 13.82 8.20 7.40 
 CXCR4 173 93.58 120.78 11.15 25.35 10.06 9.45 
Figure 5.8: CXCR4 surface expression in transfected H357 cells.  Cells were cultured under 
optimum conditions.  Prior to analysis anti-CXCR4 monoclonal antibodies or isotype controls 
and propidium iodide were added.  Plots of cell count against fluorescence intensity are given 
for: A) H357-X4.1; B) H357-X4.2; C) H357-X4.4; D) H357-X4.5; E) H357-X4.6 and F) empty-vector 
mock transfected clones.  Mean fluorescence measurements for each monoclonal antibody in 
live cells were tabulated (G).  H357-X4.1 and H357-X4.2 cells demonstrated high levels of 
CXCR4 surface expression with both anti-CXCR4 monoclonal antibody clones.  CXCR4 surface 
labelling was not demonstrated on the remaining CXCR4-transfected cells and empty-vector 
mock-transfected controls.  Legend: Antibody labelling of cell populations:  anti-CXCR4 clone 
172 (red line); anti-CXCR4 clone 173 (green line); and isotype control (purple shading). 
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Figure 5.9: CXCR4 protein labelling in transfected H357 cells sorted by size.  Cells were 
cultured in growth media with 10% FCS until 80% confluent.  Prior to analysis cells were 
incubated with anti-CXCR4 monoclonal antibodies (MAB172 & MAB173) or isotype controls 
and propidium iodide.  For each clone two populations were gated (R1 & R2) dependent on size 
(left column) and live cells selected (R4, middle column).  Plots of cell count against 
fluorescence intensity (right column) are given for: untransfected (a); empty-vector mock 
transfected (b); H357-X4.1 (c); and H357-X4.2 clones (d).  Results show that similar CXCR4-
labelling densities are represented in the two cell populations gated by size.  Blue line = 
MAB172, Red line = MAB173. 
M1
M1
M1
a) H357 Untransfected 
R1 R2
R4
R1 R2
R4
b) H357 Empty Vector 
R1 R2
R4
R1 R2
R4
c) H357-X4.1 
d) H357-X4.2 
M1 
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Qualitative investigation was performed using immunocytochemistry.  H357 cells 
transfected with the vector including the CXCR4 insert demonstrated far greater 
staining for the protein than transfected cells lacking the CXCR4 insert (Figure 5.10).  
Using a peroxidase-based technique a strong homogeneous cytoplasmic staining was 
shown in CXCR4-transfected clones with occasional cells (approximately 5% by cell 
count) showing even denser cytoplasmic labelling.  In contrast empty-vector mock-
transfected cells demonstrated only a very weak cytoplasmic staining that was difficult 
to distinguish from background.  However, in these control clones, occasional stronger 
staining of the nucleus was also seen, suggesting that some CXCR4 protein was being 
produced but that this was not associated with the cytoplasmic membrane.  In order to 
investigate this further, confocal fluorescent immunocytochemistry on the same clones 
was performed (Figure 5.11).  These images revealed that in clones containing the 
CXCR4 insert, staining for the protein was throughout the cytoplasmic component of 
the cell (panels a and b).  In contrast, clones lacking the CXCR4 insert demonstrated 
CXCR4 protein labelling but this was predominantly associated with the perinuclear 
structures (panel c).  A similar pattern of staining was shown with untransfected cells 
from the same H357 cell line (panel d).   
 
 
5.4.6  Summary of Results 
• The CXCR4-coding sequence was excised from the donated plasmid, confirmed 
and ligated into a new vector. 
• Competent cells were transformed with the new CXCR4-containing vector 
(with appropriate controls) and amplified with clonal selection. 
• The validity, copy number and orientation of the CXCR4 sequence in the new 
vector were confirmed. 
• H357 cells were transfected with the vector (with and without the CXCR4 
insert) and clonally expanded. 
• CXCR4 mRNA was significantly upregulated in all transfected clones 
containing the CXCR4 insert. 
• Two of these clones (H357-X4.1 and H357-X4.2) demonstrated significantly 
more cytoplasmic and surface CXCR4 protein than transfected controls lacking 
the CXCR4 insert. 
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Figure 5.10:  Peroxidase-based immunocytochemistry of transfected H357 cells.  The clone 
H357-X4.1 stably transfected with CXCR4 (a, c & d) and empty-vector mock transfected controls 
(b) were cultured on glass coverslips to early confluence, fixed, permeabilised and stained for 
CXCR4 using monoclonal antibodies (clone 173) with peroxidase-based techniques.  Dense 
CXCR4 staining was revealed for transfected cells (a) compared with mock-transfected controls 
(b).  Isotype antibody (c) and no primary antibody (d) negative controls revealed no staining.  
Scale bar represents 100µm. 
 
a) b) 
c) d) 
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Figure 5.11. CXCR4 staining of transfected H357 cells.  Transfected H357 cell clones with (a&b) 
and without (c) the CXCR4 insert were grown at low density on glass coverslips along with 
untransfected controls (d).  After fixation cells were incubated with anti-CXCR4 monoclonal 
antibodies (a-d) or isotype controls (e).  Transfected cells containing the CXCR4 insert showed 
significant cytoplasmic labelling (a&b).  The majority of transfected cells without the insert (c) 
showed CXCR4 staining associated with the nuclear membrane (dashed arrow) with only 
occasional cytoplasmic staining (solid arrow).  Scale bar represents 20µm 
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5.5  Discussion 
Prior to its manipulation, the expression of CXCR4 in untransfected H357 cells was 
carefully characterised at the mRNA and protein levels using a number of 
complimentary techniques (Chapter 3).  It was demonstrated to have the lowest 
CXCR4 mRNA expression of all the OSCC cell lines investigated with levels 
comparable to NOKs.  In a similar study, Uchida et al transfected an OSCC cell line 
that expressed CXCR4 mRNA at a constitutively low level (Uchida, Begum et al. 2004).  
Subsequently it was confirmed that mock-transfected H357 cells lacking the CXCR4 
construct had similar very low levels of expression.  These were important 
observations as it confirmed that the transfection process alone did not appear to 
influence the expression of CXCR4 in the empty-vector mock-transfected H357 clones.  
Characterisation of untransfected H357 cells suggested that these cells contained the 
CXCR4 coding sequence although this was not determined directly by sequencing.  
Consequently, it was theoretically possible that CXCR4 expression could be increased 
in mock-transfected cells by incorporation of the CMV promoter contained within the 
empty vector directly upstream of the CXCR4 coding sequence.  Empirical evidence 
showed that this was not the case and confirmed the suitability of the empty-vector 
mock-transfected cells as suitable negative controls.  However, these findings are not 
universal: results from the transfection of BCC cells using a retroviral vector without 
the CXCR4 insert increased CXCR4 mRNA expression three fold (Chen, Yu et al. 2006).  
The reason for this was not clear although it was possible that the incorporation of the 
vector may have occurred upstream of the constitutive CXCR4 coding sequence 
thereby altering its basal expression compared with untransfected controls. 
 
Excising the CXCR4 construct out the donated plasmid and splicing it into a different 
vector involved a number of additional experimental steps.  However, to maximise the 
usability of the transfected cell line in subsequent investigations it was decided to 
produce a construct which could be tagged by alternative methods.   The ability to 
label the cells with other monoclonal antibodies gave the facility to mark transfected 
cells without interfering with ligand binding sites directly.  However, in retrospect, a 
vector including a green fluorescent protein (GFP) motif might have been preferable as 
this would have allowed real-time monitoring rather than the multiple fixing and 
labelling steps required for antibody-based techniques (Kawamata, Uchida et al. 1999; 
Uchida, Begum et al. 2004). 
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Untransfected H357 cells were surprisingly resistant to G418.  A concentration of 
1600µg/ml was required to achieve 90% cytotoxicity after 72 hours.  This is 
significantly higher than the concentrations used on other oral-derived cell lines 
reported in the literature which ranged from 400 to 1000µg/ml (Shintani, Mihara et al. 
2002; Uchida, Begum et al. 2004).  Consequently there was a concern that G418-
mediated cell toxicity could confound the results of subsequent protein-based and 
functional experiments.  This was addressed by maintaining transfected cells in G418-
supplemented media but then transferring them to defined, G418-free media for 24 
hours prior to exposure to experimental conditions.  
 
The validity of the sequence, its orientation and copy number could have been 
performed following transformation of competent cells without the prior excision of 
the CXCR4 insert from the donated plasmid.  Confirming the validity of the CXCR4 
sequence was performed using PCR and restriction enzyme digestion with band 
matching.  While these techniques provide evidence supporting the identity of the 
CXCR4 sequence, the data they provide are not conclusive.  One methodological 
weakness of this work is that the CXCR4 sequence was never confirmed by direct 
sequencing and this could be performed with further experiments.  Numerous CXCR4-
specific sqRT-PCR reactions and antibody binding experiments on the transfected 
clones all yielded positive results for transfected clones containing the CXCR4 insert.  
However, unexpected results – such as those from the three clones (H357-X4.4, H357-
X4.5 and H357-X4.6) in which upregulated CXCR4 mRNA was detected but produced 
no detected surface protein by flow cytometry – might be usefully analysed in this 
way, as one of the possible explanations of this finding is that the CXCR4 insert had 
been altered in a way that prevented protein translation but produced a mRNA 
sequence detectable by PCR.  Work by Zhang et al has shown that point mutations in 
the CXCR4 sequence can result in changes in constitutive activity but, as yet, no studies 
have demonstrated a difference in antibody binding resulting from point mutations 
(Zhang, Navenot et al. 2002). 
 
The magnitude of CXCR4 mRNA upregulation following transfection with the CXCR4 
insert was surprising.  By sqRT-PCR this varied from 40 to 500,000-fold.  Unfortunately 
comparative, quantitative data from the literature are not available for OSCC or 
NSCLC cells (Uchida, Begum et al. 2004; Su, Zhang et al. 2005).  However, the basal cell 
carcinoma-derived cell line BCC-1/KMC was transduced with CXCR4 which increased 
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CXCR4 mRNA expression 60-fold (Chen, Yu et al. 2006).  This may be a manifestation 
of a different experimental methodology or related to the observation that CXCR4 is 
constitutively expressed 72-fold more in BCC-1/KMC compared with other chemokine 
receptors.58  Microarray analysis of one of the highest CXCR4-expressing clones (H357-
X4.1) revealed CXCR4 upregulation 45 to 90-fold higher than in transfectants lacking 
the CXCR4 insert.  Data presented in Chapter 3 demonstrate that the relative 
magnitudes of sqRT-PCR and microarray expression data are linearly related after 
logarithmic transformation.  Applying the same formula to these results, the expected 
change in CXCR4 expression, as determined by microarray, would be approximately 
65.  This correlates well with the observed values.59   These findings suggest that 
CXCR4 is very highly expressed in all five surviving H357 clones transfected with the 
CXCR4 insert.  However, flow cytometry detected significantly increased levels (75%) 
of CXCR4 surface protein in the two highest expressing clones (H357-X4.1 and H357-
X4.2).  Similar experiments in NSCLC cell lines increased CXCR4 surface protein from 
20 to 50% (Su, Zhang et al. 2005).   
 
Clones in which CXCR4 mRNA expression was more moderately increased (42-2,116-
fold) failed to produce surface protein detectable with flow cytometry but did 
demonstrate some staining of perinuclear structures with immunocytochemistry.  
From these data alone, it is not clear why these clones did not produce surface protein.  
One possible cause could be mutation in the CXCR4 coding sequence preventing the 
translated protein reaching the cell membrane.  This could be investigated by the 
sequencing of the coding sequence of all the clones looking for discrepancies from the 
wild-type. An alternative explanation would be that significant overexpression of 
CXCR4 mRNA favours surface protein production in a similar way to that observed in 
untransfected cells.  However, evidence that the expression / translation process is 
under complex control comes from the observation that established OSCC cell lines 
which constitutively produce CXCR4 surface protein (SCC4 and SCC25) express the 
mRNA species at lower levels than several CXCR4-transfected H357 cells that do not 
demonstrate surface protein.  At what level(s) the control of surface protein production 
                                                     
58 The BCC-1/KMC basal cell carcinoma-derived cell line was transduced with CXCR4 using 
the retroviral vector pLNCX2 (Chen, Yu et al 2006).  
59 Log10 gradient was measured as 0.32 (Chapter 3).  PCR measured mean H357-X4.1 CXCR4 
upregulation as 506,370-fold.  10^((Log10(506,370)*0.32)=66.9.  Therefore, by this 
transformation, the expected upregulation of CXCR4 as measured by microarray would be 66.9.  
The observed values were 45-90. 
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is determined is not clear from these results, although its further delineation might be 
useful in the clinico-pathological context as it is this mechanism that may define the 
cell’s responsiveness to endogenous SDF and therefore the influence of CXCR4 over-
expression on cell behaviour.  However, this hypothesis assumes that the OSCC cell 
has the constitutive ability to respond to CXCR4 activation by SDF.  In order to test this 
it was necessary to derive an experimental model in which cells differed only by the 
amount of CXCR4 expressed.  The results in this chapter demonstrate that this has 
been achieved.  In the hepatoma cell line HepG2 it has been shown that although 
constitutively CXCR4 mRNA and surface protein was detectable, the receptor did not 
undergo phosphorylation or internalisation upon ligand binding (Mitra, De et al. 2001).  
However, using a pcDNA3 vector, insertion of wild-type CXCR4 restored receptor 
function suggesting that the downstream signalling machinery was already available 
within the cell (Mitra, De et al. 2001).  My flow cytometry data have demonstrated that 
CXCR4 surface protein was increased in the H357 clones containing the CXCR4 insert.   
Further functional studies were required to determine if the cells were able to respond 
to SDF gradients in-vitro without further manipulation of the cell-signalling pathways. 
 
Further transfections reducing the constitutive high CXCR4-expressing cell lines SCC4 
and SCC25 might have produced interesting experimental models.  Varying 
methodologies to decrease CXCR4 translation have been described in the literature 
including anchoring CXCR4 via KDEL-receptors in the endoplasmic reticulum 
(Zeelenberg, Ruuis-Van Stalle et al. 2003). Stable transfection with CXCR4 antisense 
RNA has been described for NSCLC (Su, Zhang et al. 2005) and nasopharyngeal 
carcinoma (Hu, Deng et al. 2005) with an associated decrease in cell surface expression 
(compared with untransfected controls).   
 
 
5.6  Conclusions 
These results have demonstrated that the stable overexpression of wild-type CXCR4 
mRNA caused a significant increase in surface protein levels.  This provided a useful 
experimental model in which to investigate the effect of SDF stimulation on OSCC cells 
which differ only by the inclusion of the CXCR4 construct.  However, constitutive 
expression of CXCR4 mRNA (as detected by sqRT-PCR) and associated protein 
production (as labeled by monoclonal antibodies) is not always indicative of functional 
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responses to SDF (Mitra, De et al. 2001).  These findings can be extrapolated to CXCR4-
transfected cells thereby confirming the importance of functional assays of cell 
behaviour.  The role of CXCR4 in OSCC tumour biology can be investigated using a 
number of in-vitro assays relevant to the metastatic process (Chapters 6 and 7).  The 
inclusion of a transfected cell line with high CXCR4 protein production (together with 
its negative control) provides a useful system with which to investigate this. 
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Chapter 6:  
The effects of CXCR4 
function on cell 
proliferation and 
apoptosis in established 
OSCC cell lines and 
CXCR4 transfectants 
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6.1 Introduction 
My results so far have demonstrated that normal oral and skin keratinocytes (NOK 
and NSK) constitutively express very low levels of CXCR4 mRNA and protein 
(Chapter 3).  However, while some established OSCC cell lines demonstrate very low 
constitutive levels of CXCR4 mRNA expression and protein production, others 
(predominantly SCC4 and SCC25) show high levels of CXCR4 mRNA expression and 
positive protein labelling in both the nuclear and cytoplasmic compartments.  
Furthermore it has been shown that the established OSCC cell line H357 can be 
induced to express high levels of CXCR4 surface protein by stable transfection with the 
coding sequence (Chapter 5).  Investigation of tissue sections has revealed an 
association between CXCR4 protein staining and lymphatic metastasis (Chapter 4). 
 
Consequently, two hypotheses might be proposed: firstly that CXCR4 upregulation 
may occur during the process of malignant transformation, although not ubiquitously 
so.  Secondly that alterations in cell phenotype produced in this way are associated 
with beneficial changes in tumour cell survival within the host/tumour 
microenvironment.  From the perspective of Paget’s “Seed and Soil” theory of tumour 
metastasis (Paget 1889; Fidler 2003), does the upregulation of functional CXCR4 
receptors convey an alteration of the tumour  “Seed”  so that it increases proliferation 
when in the environment of certain host “Soil”?    
 
One significant criticism of the published work investigating CXCR4 expression and 
metastasis in other carcinoma systems is that it has focussed on the directional 
(chemotactic) mechanisms of the process.  The potential role of CXCR4 in other 
processes within the multi-step metastatic pathway has often been overlooked.  
Consequently, observed associations between CXCR4 expression and the presence of 
metastases may really reflect a selective advantage for CXCR4-positive primary 
tumour cells before the advent of metastases. 
 
To test these hypotheses, direct human clinical evidence would be preferable.  This 
could be derived from sequential biopsies of oral mucosa that was undergoing 
transformation in-vivo from a normal phenotype through dysplasia to frank 
malignancy.  However, such material is hard to obtain, not least for the ethical 
considerations of knowingly allowing lesions to progress to carcinomas.  Furthermore, 
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it would not give information on the direct effect of CXCR4 upregulation on tumour 
cell behaviour.  To overcome these difficulties a more pragmatic empirical approach 
was employed:  data on the impact of CXCR4 expression on cell function would be 
collected using in-vitro studies (Chapters 6 and 7) to compliment the investigation of 
ex-vivo tissue sections harvested at varying stages of the disease process (Chapter 4).   
 
This chapter and the next aim to investigate the effect of the SDF-CXCR4 axis on 
molecular and cellular functions of cultured OSCC cells in-vitro.  This starts with an 
assessment of ligand-mediated receptor internalisation and continues to investigate the 
effect of SDF stimulation on proliferation and apoptosis.  The effects of CXCR4 
stimulation on cell motility (chemokinesis, chemotaxis and directed invasion) will be 
addressed in Chapter 7.   
 
 
6.2  Chapter Hypothesis 
SDF stimulation of CXCR4-expressing OSCC cell lines affects cell proliferation and 
apoptotic activity in-vitro.    
 
 
6.3  Chapter Aims and Objectives 
6.3.1  Overall Aim 
To investigate the effect of SDF stimulation on CXCR4 receptor-mediated proliferation 
and apoptosis. 
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6.3.2  Specific Objectives 
1. To determine the effect of SDF stimulation on CXCR4 receptor 
internalisation. 
2. To investigate the impact of SDF stimulation on OSCC cell proliferation. 
3. To compare the proliferation rates of untransfected and CXCR4 transfected 
H357 cells. 
4. To determine the effect of CXCR4 receptor blockade on cell proliferation 
rates. 
5. To deduce the influence of CXCR4 stimulation on apoptosis in OSCC cells. 
 
 
6.4  Results 
6.4.1  Receptor Internalisation 
6.4.1.1  Overview 
CXCR4 undergoes rapid clathrin-mediated internalisation following ligand binding.  
This results in a transient reduction in cell surface receptor levels after exposure to 
SDF.  The majority of internalised CXCR4 undergoes lysosomal degradation although 
some is recycled.  Although some ligand-activated CXCR4 signalling pathways are 
thought to be independent of receptor internalisation, the activation of CXCR4 by SDF 
triggers Gα- and β-arrestin-2-mediated signalling cascades which initiate 
internalisation (Zhang, Wang et al. 2001; Roland, Murphy et al. 2003).  It can be 
hypothesised that for CXCR4 to be fully functional in response to ligand binding it 
must be mobile within the lipid bilayer and free to internalise upon activation.  
Therefore the effect of SDF activation on CXCR4 receptor surface density was 
investigated. 
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6.4.2.1 The effect of serum-starvation and SDF stimulation on CXCR4 surface 
labelling. 
To minimise the potentially confounding effect of media supplementation with serum, 
all experiments involving stimulation with SDF were done under serum-reduced 
conditions.  Consequently, to determine the effect of serum-reduction on the surface 
expression of CXCR4 in the high expressing transfected H357 cell clones, a series of 
preliminary experiments were performed.   
 
Briefly, cells were grown in culture, dissociated using enzyme-free methods, labelled 
with monoclonal antibodies (with appropriate isotype controls), incubated with 
propidium iodide and analysed with flow cytometry.  Cells that failed to exclude 
propidium iodide were gated out. Results demonstrated that overnight incubation in a 
serum concentration reduced from 10 to 0.1% was associated with a reduction in 
CXCR4 receptor surface density (Figure 6.1).  In the H357-X4.1 clone, serum-starvation 
reduced the mean fluorescence of live cells by 21%.  In H357-X4.2 cells the change was 
approximately double this figure.  Both differences were statistically significant 
(p<0.001, Student t-test).  In both untransfected and empty-vector mock-transfected 
cells the mean fluorescence of the CXCR4-labelled cells did not differ significantly from 
that of the isotype monoclonal antibody control.   
 
In the next series of experiments the effect of SDF stimulation on the surface expression 
of CXCR4 was determined in CXCR4-transfected H357 cell clones under conditions of 
serum-starvation (Figure 6.2).  Compared with unstimulated controls, CXCR4-
transfected cells incubated with SDF (100ng/ml) for one hour demonstrated a 
significant reduction in CXCR4 surface expression (p<0.001, Student t-test).  The 
magnitude of this reduction was 48% and 23% for H357-X4.1 and H357-X4.2 cells 
respectively.  Exposure of these cells to SDF (100ng/ml) for a 16 hour period resulted 
in a further significant decrease in surface CXCR4 labelling as detected by flow 
cytometry analysis (p<0.001, Student t-test).  Compared with unstimulated controls, 
the size of this reduction was 63% and 24% for H357-X4.1 and H357-X4.2 cells 
respectively.  Untransfected and mock-transfected H357 cells lacking the CXCR4 insert 
demonstrated no significant change in CXCR4 surface expression when incubated with 
SDF. 
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  Mean Fluorescence 
Antibody FCS (%) Untransfected Empty-Vector CXCR4-transfected 
    H357-X4.1 H357-X4.2 
Isotype Control 10 5.48 5.82 4.54 5.23 
10 6.29 5.80 61.48 46.48 CXCR4 0.1 5.61 5.35 48.35 26.80 
CXCR4 
Reduction (%)  10.8 7.7 21.3 (***) 42.3 (***) 
Figure 6.1:  The effect of serum starvation on CXCR4 surface expression.  Half a million cells 
were cultured overnight in growth media supplemented with either 10% or 0.1% FCS.  Prior to 
FACS analysis cells were incubated with anti-CXCR4 monoclonal antibodies or isotype controls 
and propidium iodide.  Plots of cell count against fluorescence intensity are given for: A) 
untransfected; B) empty-vector mock transfected; C) H357-X4.1; and D) H357-X4.2 clones.  
Mean fluorescence measurements for populations of over 50,000 live cells from three 
experimental replicates were tabulated.  Overnight serum-starvation resulted in a statistically 
significant reduction of mean fluorescence of approximately 21 and 42% for H357-X4.1 and 
H357-X4.2 cells respectively.  CXCR4 expression on untransfected and empty-vector mock-
transfected cells was undetectable for all incubation conditions.  Figures are representative plots 
from one of three experiments performed; quantitative data are pooled from all three replicates.  
Legend: Antibody labelling of cell populations:  CXCR4 and 10% FCS (green line); CXCR4 and 
0.1% FCS (red line); and isotype control and 10% FCS (black line); (***) denotes p<0.001 (Student 
t-test).
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Untransfected Empty-vector 
H357-X4.1 H357-X4.2 
A) B) 
C) D) 
 
 
   Mean Fluorescence 
Antibody FCS conc (%) 
SDF time 
(hours) 
Untrans- 
fected 
Empty- 
Vector CXCR4-transfected 
     H357-X4.1 H357-X4.2 
Isotype 10 0 5.48 5.82 4.54 5.23 
0.1 0 5.61 5.35 48.35 26.80 
0.1 1  5.58 5.35 25.02 (***) 20.54 (***) CXCR4 
0.1 16 5.98 5.08 17.78 (***) 20.25 (***) 
Figure 6.2:  The effect of SDF stimulation on CXCR4 surface expression.  Half a million cells 
were cultured in growth media supplemented with 0.1% FCS and 100ng/ml of SDF for either 
one hour or overnight.  Prior to FACS analysis cells were incubated with anti-CXCR4 
monoclonal antibodies or isotype controls and propidium iodide.  Plots of cell count against 
fluorescence intensity are given for: A) untransfected; B) empty-vector mock transfected; C) 
H357-X4.1; and D) H357-X4.2 clones.  Mean fluorescence measurements for populations of over 
50,000 live cells from three experimental replicates were tabulated.  Stimulation of H357-X4.1 
and H357-X4.2 cells with SDF for 1 hour significantly reduced CXCR4 surface expression by 
approximately one half and one quarter respectively (p<0.001, student t-test).  Incubation with 
SDF overnight significantly reduced CXCR4 surface expression by approximately two-thirds 
and one quarter respectively, compared with unstimulated controls (p<0.001, student t-test). 
CXCR4 expression on untransfected and empty-vector mock-transfected cells was undetectable 
for all incubation conditions.  Figures are representative plots from one of three experiments 
performed; quantitative data are pooled from all three replicates.  Legend: Antibody labelling of 
cell populations: CXCR4 and no SDF (red); CXCR4 and SDF (100ng/ml) for 1 hour (orange); 
CXCR4 and SDF (100ng/ml) overnight (blue); and isotype control (black); (***) denotes p<0.001 
with Student t-test. 
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In conclusion the results of these simple experiments demonstrate that exposure to 
SDF reduces CXCR4 surface receptor density in high expressing transfected cell lines 
under experimental conditions including serum starvation.   
 
 
6.4.2  The effect of SDF on cell proliferation 
6.4.2.1  Overview 
The overall aim of this set of experiments was to investigate the effect of SDF 
stimulation on the proliferation rate of a range of CXCR4-positive OSCC cell lines and 
transfected clones.  A number of experimental factors that might potentially confound 
the effect of SDF stimulation on cell proliferation were identified: 
 
1. Cell seeding density 
2. Duration of incubation 
3. Cell culture supplementation with FCS  
4. Media supplementation with EGF 
 
These included the effect of basic culture conditions as well as growth media 
components (for example mitogenic factors such as EGF).  A statistical power 
calculation was also performed to determine the number of replicate wells required to 
detect likely differences in cell proliferation rates.  These factors were tested 
empirically and the results are given in Section A6.2 (Appendix 6).   
 
 
6.4.2.2  The effect of SDF stimulation on cell proliferation 
Once the optimum cell-culture parameters had been empirically defined, a series of 
experiments were performed to investigate the effect of SDF stimulation on cell 
proliferation.  Initially the effects of SDF stimulation (100ng/ml) on proliferation were 
determined for a number of established OSCC cell lines and transfected H357 cells 
with and without the CXCR4 insert (Figure 6.3). Pooled data were derived from three 
identical experiments performed on the established cell lines H357, CAL27 and SCC4. 
Only SCC4 cells demonstrated a statistically significant increase in proliferation of 26% 
(p<0.001).  Of the transfected H357 cells containing the CXCR4 insert (X4.1, X4.2 and 
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X4.4), only the X4.1 and X4.2 clones demonstrated a significant increase in proliferation 
of 22% and 23% respectively in response to SDF (p<0.01).  No effect of SDF on the 
proliferation of untransfected and empty-vector mock-transfected H357 cells was 
shown.  When the magnitude of the proliferation response to SDF was plotted against 
the availability of surface CXCR4 protein (as determined by mean fluorescence 
measurements using flow cytometry) an approximately linear relationship was 
demonstrated (Figure 6.3 panel b).  The gradient of the line of approximate best fit was 
greater for established cells than for transfected clones.  In summary, these results 
demonstrated that SDF stimulation only significantly increased proliferation in 
established cell lines or transfected H357 cells with demonstrable CXCR4 surface 
protein. 
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Figure 6.3:  The effect of SDF stimulation on the proliferation of transfected and 
untransfected OSCC cell lines.  Three established OSCC cells lines (CAL27, SCC4 and H357), 
three CXCR4-transfected H357 clones (X4.1, X4.2 and X4.4) and mock-transfected empty-vector 
cells were incubated for 72 hours under optimum conditions (10% FCS) and in serum-reduced 
conditions (0.1% FCS) with or without 100ng/ml of SDF.  The effect of serum reduction on 
proliferation is shown in Figure A6.7 in Appendix 6.  The effect of SDF treatment (compared 
with unstimulated controls) under reduced serum conditions is shown in panel (a).  Bars 
represent the mean (standard deviation) of combined data from three identical experiments 
each containing twelve replicate wells per cell treatment.  Statistical analysis was performed 
using the Student t-test.  All comparisons were not statistically significant unless indicated. Of 
the established cell lines investigated only SCC4 demonstrated a significant increase in 
proliferation in response to SDF.  A significant pro-proliferative effect of SDF was demonstrated 
in the CXCR4-transfected clones H357-X4.1 and H357-X4.2 but not in H357-X4.4, empty-vector 
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mock transfected or untransfected H357 cells.  There appeared to be a roughly linear 
relationship between surface CXCR4 levels (as determined by flow cytometry) and the 
magnitude of the proliferative effect of SDF – panel (b).  However, the gradient of the suggested 
line of best fit differed between untransfected (solid line) and transfected (dashed line) cells.  
Legend: ** = p<0.01;  *** = p<0.001.  The figure represents pooled data from three identical 
experiments. 
 
 
6.4.2.3  The effect of SDF concentration on cell proliferation 
The response of untransfected and transfected H357 cells (with and without the 
CXCR4 insert) to SDF concentrations ranging from 0.1 to 100ng/ml under serum-
reduced conditions was investigated (Figure 6.4).  H357-X4.1 cells demonstrated a 
small (5%) but significant (p<0.05) increase in proliferation following stimulation with 
SDF at 1 ng/ml, compared with unstimulated controls.  Increasing SDF concentrations 
to 100 ng/ml produced a near-linear increase in the proliferation of this clone to a 
maximal value of 17% (p<0.001).  SDF stimulation resulted in similar, significant 
increases in H357-X4.2 cell proliferation with an identical pattern of dose-response to a 
maximal value of 14% at 100 ng/ml of SDF (p<0.001).  Compared with unstimulated 
controls, untransfected and empty-vector mock-transfected H357 cells demonstrated 
no significant differences in proliferation in response to SDF stimulation (Figure 6.4 
panels a & b).   
 
The results from these two sets of experiments (represented in Figures 6.3 and 6.4) both 
showed proliferation was increased in cells that produced CXCR4 surface protein, 
either constitutively (SCC4) or following transfection (H357-X4.1 and H3457-X4.2), in 
response to SDF stimulation.  Furthermore, cells that produced little or no CXCR4 
surface protein (CAL27, H357, mock-transfected H357 and H357-X4.4) demonstrated 
no change in proliferation in response to SDF.  These data therefore support the 
hypothesis that SDF exerts a pro-proliferative effect on CXCR4-producing cells.  The 
aim of the next series of experiments was to test this hypothesis using a second and 
complimentary methodology. 
 226
 
Figure 6.4:  The effect of SDF on H357 cell clone proliferation: Dose-response.  Four H357 
clones – untransfected (H357-UT), empty-vector (H357-EV) and two CXCR4-transfected (H357-
X4.1 and H357-X4.2) were seeded at equal densities and incubated in optimum (10% FCS) and 
serum-reduced (0.1% FCS) with supplementation of SDF to final concentrations ranging from 0 
to 100ng/ml for 72 hours.  The effect of serum-reduction on proliferation in the absence of SDF 
is given in Figure A6.1 (Appendix 6).  Proliferation rates were calculated as a percentage of 
untreated (SDF 0), serum-reduced controls.  Plots represent the mean (standard error) of pooled 
data from three identical experiments each containing 12 replicate wells and five timepoints per 
treatment.  Statistical analysis was performed using the ANOVA test with post-hoc Bonferroni 
correction.  H357-X4.1 and H357-X4.2 cells demonstrated statistically significant increases in 
proliferation in response to SDF concentrations of 1 to 100 ng/ml.  No significant change in 
proliferation in response to SDF stimulation was demonstrated for either untransfected or 
empty-vector mock-transfected cells.  Legend: * = p<0.05; *** = p< 0.001.  The figure represents 
pooled data from three identical experiments. 
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6.4.2.4  The effect of SDF stimulation on BrdU incorporation 
The effect of SDF stimulation on established OSCC cell lines and transfected cells has 
been demonstrated in Sections 6.4.2.2 and 6.4.2.3 above.  However, as discussed in 
Section A6.3 (Appendix 6), resazurin-based assays measure cell viability rather than 
proliferation directly.  Consequently a series of experiments was performed to 
determine the effect of SDF stimulation on more direct measures of cell proliferation 
(BrdU incorporation).  To complement the data derived from the previous experiments 
(Section 6.4.2.2) this was firstly performed on established cell lines (H357, CAL27 and 
SCC4) and subsequently on H357 cells transfected with and without the CXCR4 insert.   
 
The effect of SDF stimulation (range 0 to 100ng/ml) on BrdU incorporation by 
established cell lines was determined and data from three identical experiments was 
combined (Figure 6.5).  In SCC4 cells, SDF concentrations of 0.1 ng/ml and 1 ng/ml 
increased BrdU uptake by 6% and 9% respectively (compared with unstimulated 
controls).  This achieved statistical significance (p<0.05, χ2 test) for the latter but not the 
former.  Increasing the SDF concentration to 10 ng/ml further increased BrdU uptake 
to 14% (p<0.01).  However, further increments of SDF concentration were not 
associated with further increases in proliferation suggesting that a maximal response 
was achieved at 10 ng/ml of SDF.  CAL27 cells and untransfected H357 cells 
demonstrated no significant effect of SDF stimulation on proliferation.   
 
In a separate series of similar experiments, the effect of SDF stimulation on BrdU 
incorporation by transfected H357 cells with and without the CXCR4 insert was 
determined (Figure 6.6).  BrdU incorporation by both the CXCR4-transfected clones 
investigated (H357-X4.1 and H357-X4.2) was increased by 5% and 8% respectively in 
response to 0.1 ng/ml of SDF, although this difference failed to achieve statistical 
significance when compared with unstimulated controls.  Increasing the SDF 
concentrations to 1 ng/ml resulted in a greater increase in proliferation in H357-X4.1 
and H357-X4.2 cells by 14% and 18% respectively.  This difference was statistically 
significant (p<0.01, χ2 test).  Further increases in SDF concentration to 10 ng/ml 
produced smaller but significant increases in BrdU incorporation compared with 
unstimulated controls.  However, stimulation with SDF at 100 ng/ml resulted in lower 
proliferation rates than observed with SDF at 10 ng/ml.  Both untransfected (H357-UT) 
and empty-vector mock-transfected (H357-EV) cells showed no significant change in 
proliferation in response to SDF stimulation.   
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In summary these experiments showed that only cells containing the CXCR4 sequence 
and expressing the surface protein either constitutively (SCC4) or following 
transfection (H357-X4.1 and H357-X4.2) demonstrated an increase in BrdU 
incorporation in response to SDF stimulation.  Maximal increases of between 14 and 
18% (compared with unstimulated controls) were seen at SDF concentrations between 
1 and 10 ng/ml.  Higher SDF concentrations did not yield further increases in 
proliferation.   Cells not expressing CXCR4 surface protein demonstrated no significant 
change in BrdU incorporation in response to SDF stimulation.  These results concur 
closely with those derived from the resazurin-based assays described in Section 6.4.2.3 
and, in combination, provide significant evidence supporting the hypothesis that the 
SDF mediates increases in proliferation in OSCC cells that demonstrate CXCR4 surface 
protein.  To test this hypothesis further a series of experiments was performed to 
determine the effect of blockade of the SDF-CXCR4 axis on cell proliferation. 
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Figure 6.5: The effect of SDF stimulation on cell proliferation in established cell lines.   
CAL27, SCC4 and untransfected H357 cells were seeded at known densities in 24 well plates 
and allowed to adhere overnight.  Cells were then stimulated in reduced-serum (0.1% FCS) 
media supplemented with varying concentrations of SDF (0, 0.1, 1, 10 and 100ng/ml) for 48 
hours.  Cells were then pulsed with SDF-free media supplemented with 10% FCS and 10µM 
BrdU for two hours then fixed, stained for BrdU incorporation and counterstained with DAPI.  
Each well was photographed in three positions.  The total cell count and number of BrdU 
labelled nuclei were recorded (a minimum of 1,000 cells were counted per experimental 
condition per replicate).  The dose-response of each cell type to SDF (expressed as a percentage 
of unstimulated controls) was plotted.  BrdU incorporation by SCC4 cells was significantly 
increased (p<0.05, χ2 test) by stimulation with SDF at concentrations ranging between 1 and 
100ng/ml.  CAL27 and untransfected H357 cell proliferation did not change significantly in 
response to SDF stimulation.   Legend: * = p<0.05 ; ** = p<0.01.  The figure represents pooled 
data from three identical experiments. 
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Figure 6.6: The effect of SDF stimulation on CXCR4-transfected H357 cell proliferation.   
Untransfected, empty-vector mock-transfected and two clones containing the CXCR4 insert and 
producing surface protein (H357-X4.1 and H357-X4.2) were seeded at known densities in 24 
well plates and allowed to adhere overnight.  Cells were then stimulated in reduced-serum 
(0.1% FCS) media supplemented with varying concentrations of SDF (0, 0.1, 1, 10 and 
100ng/ml) for 48 hours.  Cells were then pulsed with SDF-free media supplemented with 10% 
FCS and 10µM BrdU for two hours then fixed, stained for BrdU incorporation and 
counterstained with DAPI.  Each well was photographed in three positions for both BrdU 
labelling and DAPI.  No signal was detected when an isotype primary antibody was compared 
with the DAPI control.  Representative raw data images are presented in Figure A6.2 
(Appendix 6).  The total and number of BrdU labelled nuclei were recorded (a minimum of 
1,000 cells were counted per treatment per replicate).  The panel represents the dose-response of 
each cell type to SDF (expressed as a percentage of unstimulated controls) derived from 
cumulative data from three identical experiments.  Untransfected and transfected cells lacking 
the CXCR4 insert showed no significant response to SDF stimulation.  Clones containing the 
CXCR4 insert demonstrated a clear response to SDF with maximum proliferation at SDF 
concentrations between 1 and 10ng/ml of SDF (p<0.05, χ2 test).  Further increases in SDF 
concentration did not increase BrdU incorporation rates.  Overall Chi-squared testing for trend 
revealed no significant relationships.  Legend: * = p<0.05; ** = p<0.01.  Panel represents 
cumulative data from three identical experiments. 
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6.4.2.5  The effect of CXCR4 blockade on cell proliferation 
The effect of AMD3100 (a pharmacological CXCR4 antagonist) on the SDF-induced 
proliferation of transfected H357 cells (with and without the CXCR4 insert) was 
determined by a fluorescence-based proliferation assay (Figure 6.7).  Results showed 
that incubation with AMD3100 (1µg/ml) alone had no statistically significant effect on 
the proliferation of transfected or untransfected cells (compared with untreated 
controls).    Stimulation of cells with SDF (10ng/ml)60 alone resulted in statistically 
significant (p<0.001) increases in proliferation for H357-X4.1 and H357-X4.2 cells of 
13% and 15% respectively (compared with untreated controls).  Proliferation of H357-
X4.1 and H357-X4.2 was significantly reduced (p<0.001) by the combined incubation of 
cells with SDF (10 ng/ml) and AMD3100 (1µg/ml).  Co-culture of these CXCR4-
transfected clones with both SDF and AMD3100 abrogated proliferation to levels 
statistically indistinguishable from those of untreated controls and cells cultured with 
AMD3100 alone.  Untransfected (H357-UT) and empty-vector mock-transfected (H357-
EV) cells demonstrated no statistically significant change in proliferation in response to 
SDF alone, AMD3100 alone or combined treatment with SDF and AMD3100 
(compared with untreated controls).  In summary, these data demonstrate that the pro-
proliferative effect attributed to SDF stimulation in previous experiments was 
abrogated by blockade of the SDF-CXCR4 axis using the receptor antagonist 
AMD3100. 
 
                                                     
60 The SDF concentration of 10 ng/ml was used as it had been previously shown to exert the 
maximal effect on cell proliferation in transfected H357 cells containing the CXCR4 insert.  
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Figure 6.7:  The effect of AMD3100 treatment on H357 cell proliferation.  Four H357 clones 
(untransfected, empty-vector and two CXCR4 transfectants – H357-X4.1 and H357-X4.2) were 
incubated with 10ng/ml with and without additional treatment with 1µg/ml AMD3100 for 72 
hours in conditions of 0.1% FCS.  Serial fluorescence measurements were taken and the 
proliferation rate in each experimental condition was calculated.  Bars represent mean 
(standard deviation) percentage change in proliferation compared with untreated controls 
(0.1%FCS only) from three identical experiments each with 12 replicate wells per treatment.  
Statistical analysis using the Student t-test was performed.  Treatment with AMD3100 alone 
resulted in no change in cell proliferation.  Stimulation with SDF alone resulted in a significant 
increase in proliferation in H357-X4.1 and H357-X4.2 cells but not mock- or un-transfected cells.  
Combined treatment with both SDF and AMD3100 reduced proliferation to levels statistically 
indistinguishable from treatment with AMD3100 alone.  Legend: AMD = AMD3100 at 1µg/ml; 
SDF = SDF at 10 ng/ml; UT = untransfected; EV = empty-vector; *** = p< 0.001.  The figure 
shows cumulative data from three identical experiments performed. 
 
 
6.4.2.6  Summary of proliferation assay data 
These results have clearly demonstrated that SDF stimulation increases proliferation in 
cells that produce CXCR4 surface protein either constitutively (SCC4) or following 
transfection (H357-X4.1 and H357-X4.2).  The magnitude of the response appears to be 
dependent on both the availability of CXCR4 surface protein and the concentration of 
SDF in the culture media.  Further supportive evidence was derived from blockade of 
the SDF-CXCR4 axis which resulted in abrogation of the SDF-mediated pro-
proliferative effects in normally responsive cells. 
 
Similar findings were demonstrated using techniques based on BrdU incorporation (a 
direct measure of DNA synthesis) and fluorescence-based assays of cell viability.  
While data derived from BrdU incorporation were suggestive that the SDF-CXCR4 axis 
mediated increases in cell proliferation, it was possible that the results of the cell 
viability assays were a combination of cell growth (proliferation) and cell death 
(apoptosis and necrosis).  To investigate this further the effect of CXCR4 stimulation on 
cell death was determined. 
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6.4.3  The effect of SDF stimulation on cell death 
Data demonstrating the pro-proliferative effect of SDF on cells bearing the CXCR4 
receptor have been outlined in Section 6.4.2.  What is not clear from cell viability assays 
alone is the mechanism by which SDF exerts this effect.  One possibility was that cell 
apoptosis was reduced by SDF stimulation resulting in a net increase in the 
accumulation of cellular material detected by cell viability assays.  Data derived from 
direct measurements of cell proliferation (BrdU incorporation) have suggested that this 
effect is small.  However, several techniques exist by which apoptotic activity can be 
evaluated.  An assay of caspase 3/7 activity was selected as this measures the 
“executioner arm” of the apoptotic pathway.  Initially the caspase assay was validated 
and optimised using H357 cells incubated with varying concentrations of 
staurosporine, a known inducer of apoptosis (Figure A6.3, Appendix 6).   
 
Once the caspase 3/7 assay had been validated it was necessary to determine the effect 
of serum-reduction on H357 cell apoptosis.  Preliminary experiments were performed 
to determine the effect of serum reduction on apoptosis in untransfected H357 cells 
(Figure A6.4, Appendix 6).   Further experiments were then performed to determine 
the effect of SDF stimulation on the caspase 3/7 activity in transfected H357 clones 
cultured under reduced-serum conditions (0.1% serum (Figure 6.8)).   Stimulation with 
SDF (100ng/ml) had no statistically significant effect on caspase 3/7 activity in 
untransfected H357 cells compared with untreated controls.  Treatment with AMD3100 
(1μg/ml), either alone or in combination with SDF (100ng/ml), also produced no 
statistically significant difference in caspase 3/7 activity in untransfected H357 cells 
compared with untreated controls.  A similar pattern of results was obtained for 
transfected H357 cells both with and without the CXCR4 insert.  In summary, 
AMD3100 and SDF (either alone or in combination) had no significant effect on 
apoptotic activity in transfected or untransfected H357 cells.  
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Figure 6.8:  The effect of SDF stimulation on H357 cell apoptosis.   Four H357 cell clones 
(untransfected, empty-vector mock-transfected and two CXCR4-transfected – H357-X4.1 and 
H357-X4.2) were incubated in 0.1% FCS for 24 hours.  Cells were either left untreated in 0.1% 
FCS (controls) or stimulated with AMD3100 (1µg/ml) or SDF 100ng/ml either alone or in 
combination.  Caspase 3/7 activity was measured after 24 hours.  Bars represent mean 
(standard deviation) of cumulative data derived from two identical experiments each with 12 
replicate wells.  Data are expressed as a percentage of untreated controls (0.1% FCS alone).  
Statistical comparison between groups was performed with the ANOVA test.  There was no 
statistically significant difference between the treatment groups (SDF or AMD either alone or in 
combination) compared with controls.  Legend: AMD = AMD3100 1µg/ml; UT = untransfected 
H357 cells; EV = empty-vector mock-transfected H357 cells; X4.1 and X4.2 = CXCR4-transfected 
H357 clones.  Figure represents cumulative date derived from two identical experiments. 
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6.4.4 Summary of experimental results 
6.4.4.1  Receptor internalisation 
• CXCR4 surface expression in CXCR4-transfected H357 cells was reduced by 20 
to 40% following incubation in low-serum (0.1%) media (Figure 6.1).  
• Exposure of CXCR4-transfected H357 cells to SDF (100ng/ml) for one hour 
decreased CXCR4 surface expression by 25 to 50% with no further change after 
16 hours (Figure 6.2). 
 
 
6.4.4.2  Proliferation and Apoptosis 
• SDF stimulation (100ng/ml) produced a significant 26% increase in the 
proliferation of the constitutively CXCR4-expressing cell line SCC4 (Figure 6.3). 
• SDF stimulation (100ng/ml) produced significant increases (22-23%) in the 
proliferation of transfected H357 with (but not without) the CXCR4 insert 
(Figure 6.3). 
• A clear dose-response between SDF concentration and increases in proliferation 
was demonstrated for H357 cells transfected with (but not without) the CXCR4 
insert (Figure 6.4). 
• Increasing concentrations of SDF produced significantly increased levels of 
BrdU incorporation for cells that did constitutively express CXCR4 (SCC4) but 
not for those that did not (Figure 6.5). 
• Increasing concentrations of SDF produced increased levels of BrdU 
incorporation in CXCR4-transfected H357 cells with a maximum response at 
10ng/ml (Figure 6.6). 
• Co-stimulation with the CXCR4 antagonist AMD3100 significantly abrogated 
the SDF-mediated increases in cell proliferation of CXCR4-transfected H357 
cells (Figure 6.7). 
• SDF and AMD3100 stimulation (alone or in combination) had no significant 
effect on the apoptotic activity of untransfected H357 cells or those transfected 
with or without the CXCR4 insert (Figure 6.8). 
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6.5  Discussion  
Before interpreting the results of the experiments presented in this Chapter it is useful 
to reflect upon the relative strengths and weakness of the methodologies employed 
and the statistical analysis performed on the data generated.  This can be found in 
Section A6.3 (Appendix 6).   Ligand-induced receptor internalisation is a key feature of 
chemokine (and cytokine) signalling mechanisms.  Response to SDF gradients by 
CXCR4-expressing haematopoietic stem cells has been shown to be associated with the 
incorporation of the receptor and the GTPase Rac-1 into membrane lipid rafts 
(Wysoczynski, Reca et al. 2005).  Consequently it would be possible to hypothesise that 
the response to SDF gradients is dependent on factors controlling intracellular lipid 
biochemistry.  Direct evidence to support this notion comes from in-vitro observations 
that depletion of membrane cholesterol reduces the response to SDF by CXCR4 
positive tumour cells (Kucia, Reca et al. 2005).  Evidence that indirectly supports this 
hypothesis may be drawn from the in-vivo observations that coincident treatment with 
the “statin” family of compounds (that inhibit the intracellular synthesis of cholesterol) 
appears to be associated with an anti-tumour effect.  Furthermore, some authors have 
suggested that other drugs (such as polyene antibiotics) that alter the formation of 
intracellular lipid rafts may also have an anti-cancer action (Kucia, Reca et al. 2005).  
Membrane-expressed haematopoietic phosphatase (CD45) associates with CXCR4 
within lipid rafts and this can be blocked by β-cyclodextrin (which inhibits lipid raft 
formation) (Fernandis, Cherla et al. 2003). 
 
The activated SDF-CXCR4 complex undergoes rapid internalisation through a 
mechanism involving G-protein-coupled receptor kinases.  This is followed by the 
binding of β-arrestin (Cheng, Zhao et al. 2000).  Although internalised CXCR4 may be 
re-expressed on the surface (blocking de novo synthesis), this process may be blocked 
in haematopoietic stem-cells by heparin (Kucia, Reca et al. 2005) or by cross-linking of 
L-selectin (Ding, Issekutz et al. 2003).  CXCR4 in the plasma membrane can undergo 
internalisation in both a constitutive and a ligand-dependent fashion.  It has recently 
been demonstrated that these two internalisation pathways are mediated by separate 
mechanisms (Futahashi, Komano et al. 2007).  Evidence in the literature is inconclusive 
with regards to the hypothesis that CXCR4 internalisation is a requirement for all its 
signalling activity.  It has been shown that SDF-induced phosphorylation of 
MAPKp42/44 still occurs using a mutant receptor that does not undergo 
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internalisation (Zhang, Wang et al. 2001).  Furthermore, MAPKp42/44 
phosphorylation is mediated by the third intracellular domain of the receptor which is 
not involved in receptor internalisation (Roland, Murphy et al. 2003). 
 
Studies have been performed using mutant receptors to identify which part of the 
CXCR4 molecule is responsible for signalling (Roland, Murphy et al. 2003).  These have 
shown that only the third intracellular loop is involved in the binding of Gαi proteins, 
calcium mobilisation and MAPKp42/44 activation but not receptor internalisation.  
SDF-mediated chemotaxis was dependent on the second, third and C-terminal 
intracellular domains, suggesting that migration is dependent on several 
complementary signalling events rather than one particular pathway.  WHIM 
syndrome (warts, hypogammaglobulinaemia, immunodeficiency and myelokathexis) 
is associated with an activating mutation of CXCR4 characterised by truncations in the 
C-terminus region (Hernandez, Gorlin et al. 2003; Kawai, Choi et al. 2005).  Following 
stimulation with SDF (100nM for 30 minutes) a reduction in surface CXCR4 levels of 
approximately 60% in wild-type and 30% in mutant receptor was observed.  Receptor 
recovery after 120 minutes was twice as great in the mutant group compared to wild-
type.  Lymphoblastoid cells from these donors demonstrate greater calcium flux in 
response to SDF compared with normal controls (Kawai, Choi et al. 2005). 
 
In cells constitutively producing detectable CXCR4 surface protein (SCC4), stimulation 
with SDF (100ng/ml) resulted in significantly increased proliferation.  CAL27 cells 
(which demonstrated small amounts of CXCR4 surface protein by flow cytometry) 
showed a small increase in proliferation in response to SDF but this failed to reach 
statistical significance.  Transfected H357 cells containing the CXCR4 insert 
demonstrated significant increases in proliferation in response to SDF (up to 
100ng/ml) in a dose dependent manner.  This effect was abrogated by co-incubation 
with the pharmacological CXCR4 antagonist AMD3100.  The magnitude of the 
response to maximal stimulation with SDF (100ng/ml) was positively associated with 
the abundance of CXCR4 surface protein (as measured by the MFV determined by flow 
cytometry).  The gradient of this association differed between transfected and non-
transfected cells.  This may be explained by differences in the binding capacity, 
downstream signalling or phenotypic responses of the different cell lines.  Further 
experiments could be aimed at investigating these possible confounding variables. 
 
 238
From the observations that SDF-mediated increased proliferation, further experiments 
were performed to determine if the magnitude of this effect was dependent on factors 
associated with the SDF-CXCR4 axis (such as surface levels of CXCR4 or SDF 
concentrations) or just reflected differences between cell lines.  It might be expected 
that untransfected cell lines producing surface CXCR4 protein at higher levels might 
show greater increases in proliferation in response to SDF compared with H357 cells.  
However, this is not the case.  SCC4 cells demonstrated increased SDF-mediated 
proliferation by both fluorescence assay and BrdU incorporation, but CAL27 cells did 
not (despite demonstrating CXCR4 surface protein with flow cytometry).  This may be 
an inherent feature of the different cell lines.  However, it must be remembered that the 
statistical power of the BrdU incorporation studies was relatively low and further work 
may demonstrate a small, but statistically significant effect.  Dose-response for SCC4 
cells was maximal at 10 to 100ng/ml of SDF.  Further work could be performed to 
investigate the effect of bio-neutralising antibodies or pharmacological antagonists on 
the SDF-mediated increase in SCC4 proliferation.  These findings were consistent with 
the only other published results which demonstrated no further increase in 
proliferation with SDF concentration in excess of 10 to 25ng/ml in untransfected OSCC 
(Katayama, Ogino et al. 2005), hepatoma  (Sutton, Friand et al. 2007), cervical (Zhang, 
Lu et al. 2007) and gastric carcinoma (Yasumoto, Koizumi et al. 2006) cell lines; and 
abrogation of the effect with anti-CXCR4 antibodies. 
 
As mentioned earlier, the magnitude of the pro-proliferative effect of SDF in 
untransfected cells was associated with the availability of surface CXCR4 protein as 
measured by flow cytometry.  The maximal response ranged from 5-8% for CAL27 
cells and 15-26% for SCC4 cells.   Other authors have demonstrated a range of changes 
in maximal response to SDF in untransfected gastric (10%) (Yasumoto, Koizumi et al. 
2006), hepatoma (10%) (Sutton, Friand et al. 2007), breast (25%) (Wendt, Cooper et al. 
2008), ovarian (40%) (Scotton, Wilson et al. 2002; Kajiyama, Shibata et al. 2008), thyroid 
(40%) (Castellone, Guarino et al. 2004; De Falco, Guarino et al. 2007), pancreatic (40%) 
(Marchesi, Monti et al. 2004), cervical (50-100%) (Yang, Lee et al. 2007; Zhang, Lu et al. 
2007), oral (50%) (Katayama, Ogino et al. 2005) and basal cell (125%) (Chen, Yu et al. 
2006) carcinomas.  Does this represent changes in CXCR4-mediated signalling (surface 
density, ligand concentration or down-stream signalling), variation between carcinoma 
cell lines or differences in assay systems?  It is difficult to make substantive conclusions 
when comparing data between cell lines or between tumour types.  The most robust 
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data come from studies using cell lines in which single-gene transfections have been 
made.  Nevertheless, in my experiments on untransfected cells there was good 
correlation between fluorescence-based and BrdU incorporation assays.  In the 
literature the proportional changes in measurements of DNA synthesis were much 
greater than the variation in cell counts (Scotton, Wilson et al. 2002; De Falco, Guarino 
et al. 2007).  This is due to methodological differences: changes in cell count over time 
are calculated relative to a baseline value whereas measures of DNA synthesis are 
“snapshot” views.  MTT assays offer similar snapshot views and, indeed, studies using 
this technique tended to report greater differences in proliferation rates in response to 
SDF.  In my experiments it would have been possible to perform MTT assays once the 
final fluorescence-based measurements had been made.  This would provide a dataset 
complimentary to the first and a more accurate reflection of what was happening at the 
end of the incubation period.  These combined techniques might be useful in further 
work. 
 
The pro-proliferative effect of SDF stimulation on the transfected H357 cells containing 
the CXCR4 insert was significant (20-44%).  Mock-transfected H357-EV cells lacking the 
CXCR4 insert did not demonstrate significant proliferative responses to SDF 
stimulation.  Interestingly, both CXCR4-containing clones (H357-X4.1 and H357-X4.2) 
demonstrated similar levels of surface CXCR4 by flow-cytometry (Chapter 5) and 
proliferative responses to SDF stimulation that were statistically indistinguishable 
from each other (compared with untreated controls).  However, transfection (with or 
without the CXCR4 insert) increased proliferation rates in unstimulated cells under 
serum-starved conditions compared with untransfected controls (Figure A6.1, 
Appendix 6).  The influence of transfection on proliferation is discussed below.  The 
shape and magnitude of the SDF dose-response curves for H357-X4.1 and H357-X4.2 
proliferation were similar for each technique used.  However, with fluorescence-based 
assays, 100ng/ml of SDF achieved maximal responses (approximately 14-17%) in 
H357-X4.1 and H357-X4.2 cells respectively.  However, dose-response curves based on 
BrdU incorporation revealed maximal responses (approximately 15-18%) at 1-10ng/ml 
of SDF for both clones.   Other experiments investigating the effect of SDF on the 
proliferation of OSCC-derived cells transfected with and without the CXCR4 insert are 
not described and comparison with the literature is not possible. 
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The inconsistency between the different assay systems regarding the SDF dose 
producing the maximal proliferative effect may be real or artefact.  As discussed above, 
methods measuring DNA synthesis offer a snapshot view at the end of the incubation 
period while techniques comparing growth rates over time may be unduly influenced 
by early readings.  To exclude methodological artefact, comparison with MTT 
measurements may be more useful.  Transfected cells containing the CXCR4 insert 
demonstrated higher levels of surface CXCR4 protein (Chapter 5) and consequently 
may be more sensitive to exogenous SDF ligand.  This may explain the greater 
response of transfected cells to low SDF concentrations compared with untransfected 
cells (Figure 6.6).   Furthermore, it might be possible that these cells produce SDF in-
vitro thereby exerting a direct proliferative effect via autocrine stimulation.  
Consequently, it might be expected that incubation with AMD3100 alone would 
reduce cell proliferation by blockade of the autocrine SDF/CXCR4 signalling pathway.  
Data from these experiments demonstrated that AMD3100 alone did not produce a 
statistically significant change in cell proliferation (Figure 6.8).  Furthermore, the 
hypothesis of autocrine SDF production was not supported by evidence from assays of 
soluble protein level (data not shown).  However, it is possible that ligand-mediated 
receptor internalisation may reduce soluble SDF protein levels below the detection 
threshold of commercial ELISA kits.  Further studies using probes for SDF mRNA and 
Western blotting techniques would reveal insights into SDF gene transcription and 
levels of post-translational control of protein production by cells and could be included 
in further work.  Investigation of prostate carcinoma cell lines demonstrated a 
reduction in proliferation following treatment with anti-CXCR4 antibodies (Sun, Wang 
et al. 2003).  CXCR4 silencing in SDF-secreting breast and Mc3 salivary 
mucoepidermoid carcinoma cells resulted in reduced growth compared with controls 
(Lapteva, Yang et al. 2005; Wen, Zhu et al. 2007).  In combination, these findings 
suggest that stimulation of the SDF-CXCR4 axis by either autocrine or paracrine ligand 
results in increased proliferation of some, but not all, tumour systems.   
 
As discussed above, the effect of stimulation of the SDF-CXCR4 axis on tumour cell 
proliferation is the subject of much debate in the literature.   There remains a paucity of 
published evidence regarding its effects on OSCC-derived cell lines and the data 
presented here would make a substantial contribution to this.  The majority of recent 
reports that include proliferation studies (using a range of complimentary 
methodologies) suggest that SDF stimulation increases growth in cells producing 
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functional CXCR4.  However, this conclusion is not ubiquitous.  SDF (up to 100ng/ml) 
had no effect on the proliferation of SAS-H1 cells derived from an OSCC primary 
lesion (K Muraoka, poster communication, IADR annual scientific congress [Brisbane] 
2006).  No effect of SDF stimulation on proliferation was demonstrated in non-small 
cell lung carcinoma (NSCLC) (Phillips, Burdick et al. 2003), glioma (Zhou, Larsen et al. 
2002), renal (Pan, Mestas et al. 2006), hepatocelluar (Schimanski, Bahre et al. 2006) and 
laryngeal SCC cells (Tan, Chu et al. 2008).  Consequently it seems likely that the 
magnitude of the effect of SDF on cell proliferation is mediated by the availability of 
surface CXCR4 receptors, ligand concentration and intrinsic factors within the cell 
lines.  What is not completely clear from the literature is whether these are 
idiosyncrasies between cell lines or features of different tumour tissues.  An answer to 
the question might be derived by a better understanding of the signalling pathways 
involved in modulating CXCR4-mediated changes in proliferation rate. 
 
While there is increasing empirical evidence that SDF stimulation augments cell 
proliferation there is little data available to delineate the mechanisms involved.  
Indirect effects of SDF on cell proliferation will be discussed below.  However, it has 
been proposed that SDF binding exerts a direct proliferative effect by altering the 
intracellular balance between the activated p38 stress kinase negative regulator and the 
PI-3K/AKT axis positive regulator (Vlahakis, Villasis-Keever et al. 2002).  It has been 
well documented in oral and other carcinomas that binding of SDF to the CXCR4 axis 
activates a G-protein mediated cascade (Bonavia, Bajetto et al. 2003) resulting in rapid 
phosphorylation of the PI-3K/Akt and ERK1/2 pathways (Zhou, Larsen et al. 2002; 
Katayama, Ogino et al. 2005; Muller, Sonkoly et al. 2006; Yasumoto, Koizumi et al. 
2006).  However, although there is a significant volume of literature that demonstrates 
the effect of both of these pathways on cell proliferation, the only direct evidence 
pertaining to CXCR4 is from Yang, Lee et al, 2007. They showed that the ERK1/2 
inhibitor PD98059 and the PI3K/Akt inhibitor LY294002 independently reduced 
CXCR4-mediated proliferation in BCC cells in culture (Yang, Lee et al. 2007).   
Interestingly, deletion of the –COOH terminal from the CXCR4 protein resulted in 
constitutional activation of ERK (Ueda, Neel et al. 2006).  However, it is not clear 
whether this increased proliferation observed in these cells was due to ERK activation 
or a reduction in cell-adhesion molecule mediated signalling (vide infra). 
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Reduction of serum concentration was associated with a decrease in cell viability and 
an increase in apoptotic activity.  Serum deprivation at 0.1% FCS doubled caspase-3/7 
activity in untransfected and transfected H357 cells equally (Figure A6.4, Appendix 6).  
The magnitude of this effect was slightly greater than that described in the literature 
where increases in apoptotic activity were approximately 20% and 30% in ovarian and 
pancreatic carcinoma cells respectively (Marchesi, Monti et al. 2004; Kryczek, Lange et 
al. 2005).  These differences may be due to variation in the absolute concentrations of 
serum used, characteristics of the carcinoma cells or features of the assay systems used.  
Variations in serum concentration appear an unlikely explanation as final FCS levels 
varied between 3% and 0% (Marchesi, Monti et al. 2004; Kryczek, Lange et al. 2005).  
Consequently it seems most likely that the differences may be due to intrinsic 
properties of the cells.  Increased caspase-3/7 activity can be induced in OSCC-derived 
cell lines by incubation with cisplatin (R Damerau, poster communication, IADR 
annual scientific congress [New Orleans] 2007) and further work could investigate the 
effects of chemotherapy agents and radiation on apoptosis in these cells.   
 
No reports on the effect of SDF stimulation on apoptosis in OSCC-derived cells are 
available in the literature.  However, a reporting bias may be present as authors may 
choose not to present negative findings.  In other carcinoma systems opinion is 
divided.  No effect of SDF stimulation on low-serum induced apoptosis was 
demonstrated in breast (Wendt, Cooper et al. 2008), small-cell (Hartmann, Burger et al. 
2005), or non small-cell lung carcinomas (Phillips, Burdick et al. 2003).  However, 
chemical or radiation-induced apoptosis was significantly reduced by SDF, albeit at 
high concentrations (100-500ng/ml), in hepatoma (Sutton, Friand et al. 2007), cervical 
(Yang, Lee et al. 2007), adenoid cystic (Muller, Sonkoly et al. 2006), pancreatic 
(Marchesi, Monti et al. 2004), papillary thyroid (Castellone, Guarino et al. 2004) and 
basal cell carcinomas (Chen, Yu et al. 2006).  In ovarian carcinoma cell lines VEGF has 
been shown to potentiate the SDF-mediated reduction in low-serum induced apoptosis 
(Kryczek, Lange et al. 2005). 
 
Considering the stages of metastasis within the “Seed and Soil” hypothesis, 
proliferation is important for neoplastic progression at both the primary and secondary 
sites.  Increased tumour cell growth confers a selective advantage to clones of 
neoplastic cells.  On the one hand, it is possible that the SDF-CXCR4 axis provides an 
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additional mechanism by which cancer cells may respond in the tumour-tissue 
microenvironment.  On the other, as some of these and other published results have 
suggested, there is indirect evidence for autocrine pathways that influence SDF-CXCR4 
signalling.  The differing effects of endogenous and exogenous sources of SDF on 
CXCR4-positive OSCC cells has been recently postulated (Uchida, Onoue et al. 2007).  
They argue that exogenous SDF within the lymph nodes mediates regional OSCC 
metastasis whereas endogenous production of SDF by OSCC cells facilitates 
haematogenous spread.  Although distant metastasis is an uncommon, late occurrence 
in OSCC, there is increasing evidence that OSCC cells enter the systemic circulation 
(either directly or via lymphatic efferents) at an early stage in disease progression.  If 
this is the case then clinical observations show that the vast majority of tumour emboli 
fail to establish themselves as distant metastases of a clinically detectable size.  This 
failure of tumour proliferation at distant sites may be due to a reduced efficiency at a 
number of stages of the metastatic process including extravasation and angiogenesis 
(Fidler 2003).  However, early work with OSCC-derived cell lines in animal models 
suggests that the SDF-CXCR4 axis may play a role (Uchida, Onoue et al. 2007) and the 
data presented here suggest that stimulation of this pathway exerts a pro-proliferative 
effect, at least in-vitro.  However, rapid tumour growth without associated 
angiogenesis results in a hypoxic microenvironment.  The interrelation between 
hypoxia and CXCR4 signalling is beginning to be unravelled, with particular focus on 
Hypoxia-inducible Factor-1α (HIF-1α).  It has been demonstrated that HIF-1α is a 
potent regulator of both SDF (Ceradini and Gurtner 2005) and CXCR4 (Staller, 
Sulitkova et al. 2003 ; Pan, Mestas et al. 2006) expression under hypoxic conditions.  
Tissue hypoxia also induces VEGF production which has been shown to potentiate the 
effects of SDF on increased proliferation and reduced apoptosis in ovarian carcinoma 
cells (Kryczek, Lange et al. 2005).  The effect of VEGF and SDF co-stimulation on the 
proliferation and apoptotic activity of OSCC-derived cells has yet to be investigated 
but may form a mechanism co-ordinating tumour growth and neo-angiogenesis at 
primary and secondary sites. 
 
The effect of SDF stimulation on cell proliferation may not be (entirely) a direct 
consequence of CXCR4-mediated signalling.  Evidence comes from haemotopoeitic 
progenitor cells that SDF may induce other autocrine growth factors directly (Grafte-
Faure, Leveque et al. 2000) (Hodohara, Fujii et al. 2000) or, through increased cell 
motility, expose cells to paracrine factors secreted nearby (Kucia, Reca et al. 2005).  
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Finally, the apparent pro-survival effect of SDF may act through CXCR4-mediated 
changes in cell-cell adhesion.  Ueda et al demonstrated that deletion of the –COOH 
terminal domain from CXCR4 resulted in a substantial increase in cell proliferation 
(Ueda, Neel et al. 2006).  This increase occurred in the absence of SDF, suggesting that 
this was not a direct SDF-mediated effect on proliferation but, perhaps, a manifestation 
of a down-regulation of cell-to-cell contact and anchorage-dependence as evidenced by 
associated changes in the cell phenotype.  In separate work on OSCC-derived cell lines 
producing wild-type CXCR4 surface protein, endogenous SDF production 
(approximately 1ng/ml) significantly increased anchorage-independent cell growth 
(soft agar assay) but not anchorage-dependent cell growth compared with controls 
(Uchida, Onoue et al. 2007).  The effect of CXCR4 signalling on cell adhesion and its 
indirect effect on cell proliferation remains intriguing and would be a potential 
direction for further work.  Possible strategies include the use of selective signalling 
pathway inhibitors, CXCR4-transfection of adhesion molecule deficient OSCC cells 
lines (such as E-cadherin negative H376 cells) or selective adhesion molecule gene 
silencing in the CXCR4-transfected H357 cells.   
 
 
6.6  Conclusions 
The results presented in previous chapters have demonstrated that transfection 
including the CXCR4-insert significantly increases production of the protein on the cell 
surface in-vitro.  CXCR4 staining has also been demonstrated on clinically-derived 
specimens of OSCC metastasis.  The data presented in this chapter demonstrated the 
functional response of CXCR4-producing cells to SDF stimulation.  Stable transfection 
with the CXCR4 coding sequence significantly increases cell proliferation in response 
to SDF suggesting that the downstream signalling cascade mediating these effects is 
already present.  Similarly, CXCR4 blockade was shown to attenuate these responses. 
As discussed in Chapter 1, metastatic mechanisms in-vivo encompass a number of 
additional cell processes including survival, angiogenesis, migration and invasion.  
Data presented here have demonstrated that CXCR4 production has no significant 
effect on cell apoptosis in-vitro.  However, much of the early work on homeostatic 
chemokine receptors focussed on their role in selective leukocyte homing and a role for 
CXCR4 in cell migration and invasion is suggested.  This will be investigated in 
Chapter 7. 
 245
Chapter 7:  
The effects of CXCR4 
function on cell motility 
in established OSCC cell 
lines and CXCR4 
transfectants 
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7.1  Introduction 
The characterisation of established OSCC-derived cell lines and CXCR4 transfectants 
has provided the background material to investigate the function of CXCR4 in these 
cells.  Data presented in the previous chapter have demonstrated that SDF stimulation 
of CXCR4-expressing cells results in increased cell proliferation without a significant 
effect on apoptotic activity. 
 
From its role in developmental biology it is clear that CXCR4 has an important effect 
on stem cell positioning (cell migration) and organogenesis (proliferation and 
survival).   The role of the SDF/CXCR4 axis in lymphocyte homeostasis is also reliant 
on similar pathophysiological processes.  Metastasis is a multistep process 
incorporating not only cell growth and survival, but also angiogenesis, migration and 
invasion.  The association of CXCR4 expression with directed cell movement within 
the developing embryo and the immune system has stimulated a number of studies 
into its expression in carcinoma systems.  Functional CXCR4 has been demonstrated in 
a number of tumours (reviewed in Section 1.5, Chapter 1).  Furthermore, constitutive 
production of the ligand has been shown in a number of organs that are the common 
metastatic destinations for these cancers.   
 
Clinically relevant OSCC metastases are often present in the cervical lymph nodes and 
less frequently at distant sites.  However, the micrometastatic burden of this disease 
may be greater than the clinical picture suggests.  What is not clear from the emerging 
literature on CXCR4 expression by OSCC-derived cell lines is the effect of SDF 
stimulation on directed and undirected cell movement.  This chapter presents 
conclusive evidence that the SDF/CXCR4 axis mediates chemokinesis, chemotaxis and 
invasion in OSCC cell in-vitro. 
 
 
7.2  Chapter Hypothesis 
SDF stimulation of CXCR4-expressing OSCC cells mediates increased chemokinesis, 
chemotaxis and invasion in-vitro. 
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7.3  Chapter Aims and Objectives 
7.3.1  Overall Aim 
To investigate the effect of SDF stimulation on CXCR4 receptor-mediated OSCC cell 
motility.   
 
 
7.3.2  Specific Objectives 
6. To optimise laboratory assays for the determination of chemokinesis, 
chemotaxis and directed cell invasion. 
7. To investigate SDF-induced chemokinesis in CXCR4-expressing OSCC cells. 
8. To determine SDF-induced chemotaxis in CXCR4-expressing OSCC cells. 
9. To analyse the role of the SDF-CXCR4 axis in directed OSCC cell invasion in 
vitro. 
 
 
7.4  Results 
7.4.1  The effect of SDF on cell movement. 
The aim of these experiments was to investigate the effect of SDF on cell movement.  
This was to test the hypothesis that: 
 
a) Motility in CXCR4-positive cells would be increased by stimulation with SDF in 
a dose-dependent manner.   
b) Maximal cell movement would be achieved when a SDF gradient was present. 
 
In order to test these hypotheses complimentary methodologies were employed to 
differentiate between cell motility in the presence or absence of a ligand gradient 
(chemotaxis and chemokinesis respectively). 
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7.4.1.1  The effect of SDF on chemokinesis (Gold colloid assays) 
Gold colloid assays were performed to investigate the effect of direct SDF stimulation 
on undirected cell movement (chemokinesis) in the absence of a chemotactic gradient.  
To overcome the possible confounding effect of intercellular interactions on cell 
movement, the motion of single cells was analysed using this methodology.   
 
Preliminary experiments were performed to establish the validity of the technique.  
The hypothesis that, within a particular time frame, the area cleared of gold colloid 
represents the perimeter of the excursion of the cells was tested.   The relationship 
between the surface area covered by the cytoplasm and the area of gold colloid cleared 
from around the cells at the end of the incubation period was determined using H357-
X4.1 cells exposed to 100ng/ml of SDF for 20 hours (Figure 7.1).  The results 
demonstrated an area of gold colloid clearance over four-fold larger than the area 
defined by the cytoplasmic membrane at the time of fixation (Figure 7.1 panel d).  
From this finding it was concluded that the cells had undergone movement over the 
surface of the coverslip during the incubation period and that the boundary seen did 
not represent the cytoplasmic membrane of a single cell.  Similar data were derived 
from H357-X4.2 cells (data not shown).  Consequently it was assumed that a measure 
of gold colloid clearance could be used as an indicator of cellular chemokinesis.   
 
A second series of experiments (10 replicates per condition) investigated the effect of 
SDF concentration on the chemokinesis of solitary transfected H357 cells with and 
without the CXCR4 insert (Figure 7.2).  Without SDF stimulation both H357-X4.1 and 
H357-X4.2 cells demonstrated more motility (23% and 44% respectively, p<0.01) than 
H357-EV cells lacking the CXCR4 insert.61  Upon stimulation with SDF at 
concentrations of 1, 10 and 100ng/ml H357-X4.1 cells showed an increase in 
chemokinesis of 23%, 25% and 42% respectively (p<0.01) compared with unstimulated 
(SDF 0) controls.   A similar pattern of response to SDF stimulation was seen with 
H357-X4.2 cells although the magnitude of the increased chemokinesis was less (8%, 
7% and 20% more chemokinesis in response to 1, 10 and 100ng/ml SDF respectively).  
In H357-X4.2 cells only the highest concentration of SDF (100ng/ml) produced an 
increase in chemokinesis that achieved statistical significance (p<0.05).  Furthermore, 
H357-EV cells demonstrated an increase in chemokinesis in response to SDF 
                                                     
61  All statistical comparisons were performed using a two sample, homoscedastic Student t-test. 
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stimulation in a pattern similar to H357-X4.1 cells.  Compared with unstimulated (SDF 
0) controls, H357-EV motility was increased by 35%, 29% and 44% in response to 1, 10 
and 100ng/ml SDF respectively (p<0.05).  However, in absolute terms, the motility of 
H357-EV cells exposed to 100ng/ml SDF was the same as unstimulated H357-X4.2 
cells; while the chemokinesis of H357-X4.1 and H357-X4.2 cells stimulated with 
100ng/ml SDF was also identical.  Finally, all three cell types demonstrated a similar 
degree of motility in response to 1ng/ml SDF as with 10ng/ml. 
 
In summary, this small set of experiments investigated the effect of SDF stimulation on 
the chemokinesis of transfected H357 cells with and without the CXCR4 insert.  Results 
suggest that increasing concentrations of SDF do increase chemokinesis.  However, 
from the response of H357-EV cells it appears that overexpression of CXCR4 is not 
required to modulate SDF-mediated chemokinesis in this assay system.  What is not 
clear from these experiments is the effect of directional vectors on cell movement.  
These “vectors” can either be defined by cell-cell interactions or extracellular gradients 
and further experiments were performed to investigate these respectively. 
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Figure 7.1:  Determination of area covered in gold colloid assays.  H357-X4.1 cells were 
incubated for 20 hours on sterile coverslips coated with gold colloid at a density of 4,000 cells 
per well.  Cells were labelled with an anti-CXCR4 monoclonal antibody, a Texas Red-
conjugated secondary antibody and counterstained with DAPI.  Confocal fluorescence and 
brightfield microscopy was performed at x400 magnification and analysed using Zeiss LSM 
image software.  Panels show images from the blue channel (a), red channel (b), brightfield (c) 
and overlaid red channel plus brightfield (d).  Results demonstrate that the area of gold colloid 
cleared by the cells (panel c) is greater than the area occupied by the cytoplasmic membrane 
(panel b) which is, in turn, greater than the area of the cell nuclei (panel a).  Scale bar represents 
50µm. 
 
 
a) 
d)c) 
b)
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Figure 7.2:  The effect of SDF on cell chemokinesis.  Transfected cells with (H357-X4.1 & 
H357-X4.2) and without (H357-EV) the CXCR4 insert were incubated for 20 hours on sterile 
coverslips coated with gold colloid at an initial density of 4,000 cells per well.  Growth media 
was supplemented with SDF to yield final concentrations varying between 0 and 100ng/ml.  
Cells were washed, fixed, mounted and photographed under oil immersion.  Raw data are 
given in Figure A7.1 (Appendix 7).  Areas were recorded for 10 cells per experimental condition 
and the mean and standard deviations represented in a histogram (a).  The same mean values 
were plotted against SDF concentration on a logarithmic scale (b), standard deviations were 
omitted for clarity.  Statistical analysis was performed using the Student t-test.  Legend: 
EV=H357 Empty Vector, X4.1= H357-X4.1, *=p<0.05, **=p<0.01 and ***=p<0.001.  Scale bar 
represents 50µm. 
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7.4.1.2  The effect of SDF on directed chemokinesis (Scratch assays) 
The results from the gold colloid assays demonstrate that single transfected cells with 
or without the CXCR4 insert increase their chemokinesis in response to SDF.  
However, this methodology does not investigate cells in contact with each other as is 
found in-vivo.  An in-vitro model of this (the scratch assay) was used to analyse further 
the effect of SDF on chemokinesis. 
 
Preliminary experiments were performed to optimise the cell seeding density, 
photographic intervals and incubation times (data not shown).  Photomicrographs 
were taken at defined intervals (Figure 7.3, panels a, c & e) and a robust and 
reproducible method for measuring the distance between cells on either side of the 
scratch was tested empirically (Figure 7.3, panels b, d & f).  For each experimental 
condition eight replicates were measured. 
 
The effect of SDF concentration on scratch wound closure against time was determined 
for untransfected as well as transfected H357 cells with and without the CXCR4 insert 
(Figure 7.4).  In the absence of SDF, all cell lines tested demonstrated no significant 
differences in the percentage of scratch wound closure over the 28 hour period 
investigated (range 41% to 51%).  For all experiments positive controls using growth 
media supplemented with 10% FCS showed complete or near complete closure of 
wounds at 28 hours (mean remaining wound distance ranging from 0% to 18%).  When 
pre-incubation with mitomycin C was omitted, all cell lines demonstrated complete or 
near complete wound closure at 20 hours.  Statistical comparison of all cell lines tested 
under positive and negative control conditions demonstrated no significant 
differences. 62 
 
Following supplementation of the growth media with SDF, H357-X4.1 cells 
demonstrated significantly faster closure of scratch wounds:  the mean percentage 
wound distance remaining at 28 hours was 51%, 23%, 27% and 6% for SDF 
concentrations of 0, 1, 10 and 100ng/ml respectively.  A similar pattern of response 
was exhibited by H357-4.2 cells at 28 hours although with a reduced magnitude: mean 
percentage wound distances were 43%, 37%, 37% and 25% for SDF concentrations of 0, 
1, 10 and 100ng/ml respectively.  Interestingly, both untransfected (H357-UT) and 
                                                     
62 p>0.05, ANOVA 
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mock transfected (H357-EV) cells which lacked CXCR4 overexpression showed no 
response to SDF supplementation regardless of concentration.  These findings suggest 
that SDF mediates faster scratch wound closure in growth-arrested H357 cells which 
have been modulated to overexpress CXCR4.   
 
To test this hypothesis further a series of experiments was performed on responsive 
cell lines (H357-X4.1 and H357-X4.2) in which the SDF-CXCR4 axis was blocked by 
either pharmacological antagonists (AMD3100) or bioneutralising monoclonal 
antibodies (Figure 7.5).  As before, unstimulated (SDF 0), growth-arrested cells from 
both cell lines demonstrated similar rates of scratch wound closure (range 45% to 48% 
at 28 hours).  Supplementation with 100ng/ml SDF resulted in complete H357-X4.1 cell 
wound closure and reduced the remaining distance to 28% for H357-X4.2 cells at 28 
hours.  For both H357-X4.1 and H357-X4.2 cells incubation with either AMD3100 or 
anti-CXCR4 monoclonal antibodies completely abrogated the effect of SDF stimulation 
(100ng/ml) to the level of unstimulated (SDF 0) negative controls.  However, the 
addition of isotype control monoclonal antibodies had no detrimental effect on the 
response to SDF supplementation. 
 
In summary, these data provide compelling evidence that CXCR4 overexpression 
confers a response to SDF that mediates faster wound closure in the scratch assay 
system.  The confounding effects of proliferation were excluded by initiating growth 
arrest prior to SDF exposure.  Consequently, in assays in which the vector of cell 
movement was defined by an asymmetry in intercellular contacts, it can be 
hypothesised that the changes in wound closure rate observed were due to SDF-
mediated chemokinesis.  What is not clear from these results is whether the SDF-
CXCR4 axis can mediate directed cell movement along chemotactic gradients.  Further 
experiments using an alternative assay system were required to determine this.  
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Figure 7.3: The effect of SDF on scratch wound closure: determination of experimental 
procedure.  Confluent wells of mitomycin-treated, growth-arrested cells were scratched to 
produce 8 replicates per well and subsequently incubated with varying concentrations of SDF 
as outlined in Section 2.9.2 (Chapter 2).  In this representative experiment an SDF concentration 
of 1ng/ml was used.   Photomicrographs (a, c & e) were taken at varying time and the distance 
between cell edges measured at a set distance from the intersection (as represented by “x” and 
“m” respectively in panels b, d & f).  The mean percentage decrease in each distance (compared 
with baseline T0) and standard deviation was then calculated for each experimental condition.  
Scale bar represents 400µm. 
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Figure 7.4: The effect of SDF on scratch wound closure.  Confluent wells of growth-arrested 
untransfected (H357-UT) and transfected cells with (H357-X4.1 and H357-X4.2) and without 
(H357-EV) the CXCR4 insert were prepared and scratched as previously described to produce 8 
replicates per experimental condition.   Growth media were supplemented with varying 
concentrations of SDF (0, 1, 10 and 100ng/ml). Photomicrographs were taken at varying time 
points (0, 5, 20 & 28 hours) and the distance between cell edges measured and expressed as a 
percentage of baseline (T0).  Data from three identical experiments were combined and the 
mean distances were plotted against time (error bars were omitted for clarity).  Statistical 
comparisons were performed using ANOVA.  Legend:  SDF concentration (0-100ng/ml), FCS 
M+ = Fetal Calf Serum with mitomycin, FCS M- = Fetal Calf Serum without mitomycin, 
*=p<0.05 and **=p<0.01.   
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Figure 7.5: The effect of SDF-CXCR4 blockade on scratch wound closure in responsive cell 
lines.  Confluent wells of growth-arrested CXCR4-transfected cells (H357-X4.1 and H357-X4.2) 
were prepared and scratched as previously described to produce 8 replicates per condition.   
Growth media were supplemented without or with 100ng/ml SDF. Wells containing SDF were 
further supplemented with AMD3100, bioneutralising anti-CXCR4 monoclonal antibodies or 
isotype controls.  Photomicrographs were taken at varying time points (0, 5, 20 & 28 hours) and 
the distance between cell edges measured and expressed as a percentage of baseline (T0). Data 
from three identical experiments was combined and the mean distances were plotted against 
time (error bars were omitted for clarity).  Statistical comparisons were performed using 
ANOVA.  Legend: AMD=AMD3100, mAb=anti-CXCR4 monoclonal antibodies, iso Ab=isotype 
control monoclonal antibodies, *=p<0.05 and **=p<0.01. 
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7.4.1.3  The effect of SDF on chemotaxis (Transwell assays) 
Gold colloid and scratch assays were previously performed to determine the effect of 
the SDF-CXCR4 axis in undirected and directed chemokinesis respectively.  To 
investigate cell movement in response to SDF gradients the Transwell assays system 
was optimised and used.  Preliminary empirical data (in conjunction with reports from 
the literature) revealed that keratinocytes adhered poorly to untreated polycarbonate 
membranes (data not shown).  Therefore initial experiments were performed to 
investigate the effect of membrane coating on cell migration.  The effects of pre-coating 
the polycarbonate membranes with type 1 collagen or fibronectin were compared 
against no pre-treatment.  Cells were prepared in low-serum media (0.1% FCS) with 
and without the addition of a positive chemotactic stimulus (10% FCS) added to the 
lower chamber (Figure 7.6).  Results demonstrated that without pre-coating there was a 
limited migratory response to 10% FCS but this was potentiated threefold by pre-
treating with collagen.  The difference between collagen coating on both surfaces and 
only the lower was negligible for both 10% FCS and negative controls.  Interestingly, a 
significantly increased (p<0.001, Student t-test) migratory response was demonstrated 
when the lower surface was coated with fibronectin, even with FCS absent from the 
lower chamber.  In the absence of FCS, coating of both surfaces with fibronectin 
decreased the number of migrating cells by approximately 60% (p<0.001).  These 
results are suggestive that fibronectin alone acts as a significant haptotactic stimulus 
for these cells.  Type 1 collagen facilitates adhesion (compared with no treatment) but 
does not act as an independent chemoattractant.  All further experiments were 
performed with Type 1 collagen coating of the lower polycarbonate surface only. 
 
The effect of transfection (with and without the CXCR4 insert) and SDF stimulation on 
the adhesion of cells was investigated using Transwell membranes pre-incubated with 
Type 1 collagen on the lower surface only (Figure 7.7).  Results revealed that 
transfection had no effect on adhesion compared with untransfected controls.  
Addition of SDF (100ng/ml) to both the upper and lower chambers increased the 
numbers of migrating cells between two and threefold.  While this increase was 
greatest in cells containing the CXCR4 insert (H357-X4.1 and H357-X4.2) the numbers 
of migrated cells was small and difference was not statistically significant.  Addition of 
FCS to the lower chamber only was used as a positive control. 
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Figure 7.6:  The effect of membrane coating on cell migration.  CXCR4-transfected H357 cells 
were plated at known density in the upper chamber of a Transwell assay.  Type 1 collagen or 
fibronectin had been used to pre-coat the polycarbonate membranes on either on either the 
upper and lower, or lower surfaces only.  Media containing either 10% FCS or migration buffer 
(negative control) were added to the lower chambers.  Three replicate wells per experimental 
condition were included.  Cells were incubated overnight, fixed, stained and counted.  Data 
from three identical experiments were combined and the mean (standard deviation) cell count 
per high power image was plotted against treatment type.  Statistical analysis was performed 
with the Student t-test.  In membranes with no pre-treatment, cells only migrated towards 10% 
FCS.  Collagen coating potentiated this effect approximately threefold.  However, it stimulated 
no significant migration when migration buffer was added to the lower chamber.  Fibronectin 
coating resulted in the most cell migration towards 10% FCS.  However, when there was no 
chemotactic stimulus in the lower chamber, fibronectin stimulated the migration of cells when 
applied to the lower surface alone.  This effect was attenuated when both surfaces were pre-
coated with fibronectin.  Legend: MB = migration buffer, *** = p<0.001. 
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Figure 7.7:  The effect of CXCR4 transfection and SDF stimulation on cell chemokinesis.  
Untransfected H357 cells (H357-UT) and H357 cells transfected with (H357-X4.1 & H357-X4.2) 
and without (H357-EV) the CXCR4 insert were prepared in migration buffer and known 
numbers were seeded in upper Transwell assay chambers which had been pre-incubated with 
Type 1 collagen on the lower surface.  SDF (to a final concentration of 100ng/ml) was added to 
both upper and lower chambers of some wells.  FCS (to a final concentration of 10%) was added 
to the lower chamber only of some wells to act as a positive control.  Three replicate wells per 
experimental condition were prepared.  Plates were incubated for 3 hours under optimal 
conditions.  The numbers of cells on the lower surface were counted per high power image.  
Data from three identical experiments were pooled and the cumulative means (standard 
deviations) were calculated and plotted.  Statistical comparison was performed using the 
Student t-test.  SDF stimulation but not transfection (with or without CXCR4) demonstrated a 
significant increase on cell adhesion.  Legend: MB = migration buffer, ** = p<0.01. 
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Figure 7.8:  The chemotactic and chemokinetic effect of SDF.  CXCR4-transfected H357 cells 
were seeded at a known density in the upper chamber of a Transwell assay.  Migration buffer 
was added to the lower chamber and supplemented with either recombinant SDF (to a final 
concentration of 100ng/ml), 10% FCS (positive control) or nothing (negative control).  An equal 
concentration of SDF was added to the upper chamber of one group of wells.  Three replicate 
wells per experimental condition were prepared.  Cells were incubated for 3 and 12 hours.  Data 
from three identical experiments were pooled and the mean (standard deviation) cell count per 
high power image were plotted against treatment type and incubation period.  Statistical 
analysis was performed using ANOVA with the Bonferroni post-hoc correction for multiple 
testing.  There was some movement (chemokinesis) of cells in the negative control wells and 
this was increased approximately twofold by the addition of SDF to both upper and lower 
chambers.  A chemotactic gradient of SDF dramatically increased the number of cells migrating 
to the lower chamber.  This was about 65% of the number migrating towards 10% FCS.  The 
pattern of results was similar for the 3 and 12 hour time points although values were 
approximately 50% greater after the longer incubation.  Legend: MB = migration buffer, ** = 
p<0.01. 
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Figure 7.9:  CXCR4-transfected H357 cell migration towards SDF: Time course.   CXCR4-
transfected cells were seeded at known densities in the upper chamber of Transwell assays.  
Migration buffer with or without SDF at 100ng/ml was added to the lower chambers and 
inserts were incubated for a variety of durations from 1 to 8 hours.  Three replicate wells per 
experimental condition were performed.  Data were pooled from three identical experiments.  
Mean (SD) cell number per high-powered image was plotted against time.  Addition of 
migration buffer (MB) alone to the lower chamber resulted in a slow increase in cell migration 
to the lower surface of the membrane (red line).  This relationship was linear (R-squared = 
0.924, dotted line).  Addition of SDF to the lower chamber significantly increased cell migration 
(blue line).  This increase was greatest over the earlier time points and plateaued later. This 
relationship was best modelled with a logarithmic function (R-squared = 0.988, solid black line).  
Legend: MB = migration buffer, *** p<0.001, Student t-test. 
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Initially, the effects of recombinant SDF on chemokinesis and chemotaxis were 
determined (Figure 7.8).  Results demonstrated that CXCR4-transfected H357 cells do 
demonstrate random chemokinesis when cultured in migration buffer alone for 3 
hours.  When 100ng/ml of SDF was added to both upper and lower chambers 
(obviating the effect of any chemotactic gradient), chemokinesis was approximately 
doubled.  Creation of a chemotactic gradient across the membrane by the addition of 
100ng/ml of SDF to only the lower chamber increased cell migration by approximately 
100% percent (compared with the chemokinetic effect previously described).  Addition 
of 10% FCS to the lower chamber resulted in the greatest migratory response 
(approximately 50% greater than towards 100ng/ml SDF).  Incubation of cells under 
similar conditions for 12 hours yielded a similar pattern of results, although the 
numbers of migrating cells were approximately 50% greater than for the 3 hour time 
point.  This is suggestive that some, but not all, cell migration occurs within the first 3 
hours of incubation.  Consequently, a time-course experiment was performed to 
determine the effect of incubation duration on migration. 
 
Results demonstrated that when no chemotactic gradient was present there was a 
gradual increase in cell migration to the lower surface with time (Figure 7.9).  This 
relationship was best modelled with a linear function (R-squared = 0.924).  When cells 
were exposed to a chemotactic gradient of 100ng/ml of SDF across the membrane, 
there was a statistically significant increase in cell migration at all time points (p<0.001, 
Student t-test).  At one hour, three times more cells had moved in response to SDF than 
with migration buffer alone.  The rate of change of SDF-induced cell migration was 
greatest between the early time points and plateaued after approximately 5 hours.  The 
relationship with time was best modelled with a logarithmic function (R-squared = 
0.988). 
 
The dose-response of CXCR4-transfected H357-X4.2) to varying chemotactic gradients 
of SDF was determined (Figure 7.10).  Consistent with earlier findings, H357-X4.2 cells 
demonstrated some migration to the lower surface of the Transwell assay even in the 
absence of SDF (negative control).  The greatest number of migrated cells was 
demonstrated towards 10% FCS (positive control).  However, with an increase in SDF 
concentration in the lower chamber up to 50ng/ml, there was a concomitant 150% 
increase in the number of cell migrating through (p<0.001, Student t-test).  The number 
of cells that migrated towards 50ng/ml of SDF was approximately 70% of the size of 
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the response to the 10% FCS positive control.  Interestingly, increasing the SDF 
concentration in the lower chamber from 50 to 100ng/ml decreased the number of 
migrating cells by 30% but this change failed to achieve statistical significance.  The 
control wells also yielded interesting results:  Firstly, transfected H357 cells lacking the 
CXCR4 insert (H357-EV) demonstrated a similar number of migrating cells to the 
negative controls.  The migratory response of H357-X4.2 cells to 100ng/ml of SDF was 
also significantly reduced (p<0.01) to baseline levels by the addition of the 
pharmacological CXCR4 antagonist AMD3100 at concentrations of 1µg/ml to the 
upper chamber.  Similar attenuation was demonstrated by the addition of 
bioneutralising anti-CXCR4 monoclonal antibodies (but not isotype controls) to the 
upper chamber.  Finally, the addition of 50ng/ml of SDF to the upper chamber also 
significantly reduced (p<0.01) the migratory response towards 100ng/ml of SDF (in the 
lower chamber) back to baseline levels. 
 
A similar experiment was performed to investigate the effect of SDF gradient on SCC4 
cell migration (Figure 7.11).  A small number of SCC4 cells migrated to the lower 
surface of the membrane over the 8 hour time period.  This was significantly increased 
(p<0.001, Student t-test) by the addition of SDF to the lower chamber in a dose-
dependent fashion over the concentration range tested (25-100ng/ml).  Increasing the 
SDF concentration from zero to 100ng/ml increased the number of migrating SCC4 
cells fivefold.  The maximum elicited response to SDF was approximately 45% of the 
size of the response to the positive control (10% FCS).  Addition of SDF to the upper 
chambers reduced the chemokine gradient across the membrane and significantly 
reduced (p<0.05) the number of migrating cells:  For low concentrations (12.5ng/ml) 
the reduction in the migratory response was proportional to the reduction in the 
chemotactic gradient across the membrane.  However for greater concentrations added 
to the upper chamber (50ng/ml) there was a greater decrease in migratory response 
than would be predicted by a linear proportion.  Addition of AMD3100 (1µg/ml) to the 
upper chamber abrogated the response to SDF back down to baseline (unstimulated) 
levels (p<0.001).  A similar significant reduction was demonstrated with the incubation 
of cells with bioneutralising anti-CXCR4 monoclonal antibodies, but no significant 
change was demonstrated with their isotype controls. 
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Figure 7.10:  CXCR4-transfected H357 cell migration towards SDF: Dose-response.  Known 
densities of CXCR4-transfected H357 cells (clone X4.2) were seeded into the upper chambers of 
Transwell inserts.  SDF at given concentrations were added to the lower chambers and the wells 
were incubated under optimum conditions for 8 hours.  Three replicate wells per experimental 
condition were performed and data from three identical experiments were pooled.  Bars 
represent mean (SD) cell counts per high-power field expressed as a percentage of positive 
control (FCS only).  Statistical comparisons were performed using the Student t-test.  
Significantly more (p<0.001) cells migrated towards the SDF stimulus in a dose-dependent 
fashion up to concentrations of 50ng/ml.  Further increases in SDF concentration did not yield 
significant further increases in migration.  The chemotactic response was significantly 
attenuated (p<0.01) by the addition to the upper chamber of SDF (50ng/ml), AMD3100 
(1µg/ml), bioneutralising anti-CXCR4 monoclonal antibodies (25µg/ml), but not by an isotype-
control monoclonal antibody.  Compared with unstimulated controls, empty-vector mock 
transfected H357-EV cells showed no significant migratory response to 100ng/ml SDF.  Legend: 
all SDF concentrations given in ng/ml; EV = empty vector mock-transfected H357 cells; AMD = 
AMD3100 at 1µg/ml; Ab = bioneutralising anti-CXCR4 monoclonal antibodies at 25µg/ml; iso 
= isotype control monoclonal antibodies at 25µg/ml; FCS = 10% FCS; *** = p<0.001, ** = p<0.01, 
ns= not significant (Student t-test). 
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Figure 7.11:  SCC4 cell migration towards SDF:  Dose-response.  Wild-type SCC4 cells were 
seeded at known densities into the upper chambers of Transwell inserts.  SDF at varying 
concentrations was added to the lower chambers and the wells were incubated for 8 hours 
under optimum conditions.  Three replicate wells per experimental condition were performed 
and data from three identical experiments were pooled.  Bars represent mean (SD) cell counts 
per high-power field expressed as a percentage of positive control (FCS only).  Statistical 
comparisons were made using the Student t-test.  Some cells migrated to the lower surface in 
the absence of SDF (negative control). The greatest migratory response was to 10% FCS 
(positive control).  Significantly more (p<0.05) cells migrated in response to increasing SDF 
gradients across the membrane to the maximum value tested (100ng/ml). Further addition of 
SDF to the upper chambers significantly reduced (p<0.05) the migratory response.  Incubation 
of cells with AMD3100 (1µg/ml) or bioneutralising anti-CXCR4 monoclonal antibodies (25 
µg/ml) significantly reduced migration (p<0.001) to levels similar to unstimulated (negative) 
controls.  Addition of isotype control antibodies to the upper chamber yielded no significant 
change in migration pattern.  Legend: All SDF concentrations in ng/ml; AMD = AMD3100 at 
1µg/ml; Ab = bioneutralising anti-CXCR4 monoclonal antibodies at 25µg/ml; iso = isotype 
control monoclonal antibodies at 25µg/ml; FCS = 10% FCS; *** = p<0.001, * = p<0.05, ns= not 
significant (Student t-test). 
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7.4.2  The effect of SDF on cell invasion 
Preliminary experiments were performed to determine the optimum duration for the 
incubation of invasion assays (Figure 7.12).  Results showed that very few cells 
invaded through the Matrigel to reach the lower surface of the membrane in the 
absence of a chemotactic gradient.  With SDF, however, the invasive response of H357-
X4.2 cells showed three phases:  Initially, there was a latent phase in which no cells 
were seen on the lower membrane until 8 hours had elapsed.  Secondly, between 8 and 
16 hours, there was a linear phase in which the numbers of invading cells rose 
proportionally with time.  Finally, after 24 hours, there was an exponential phase 
where the number of cells counted on the lower membrane exceeded what would have 
been predicted from a continuation of the linear phase.   Interestingly, the morphology 
of the cells on the membrane surface after 24 hours was different to that seen at 
previous time points:  Small clusters of dividing cells could be seen in the former but 
not in the latter (data not shown).  This is suggestive that, after 24 hours, early 
invading cells were proliferating.  Consequently, in order to negate this confounding 
effect, invasion assays were run for 16 hours overnight. 
 
The invasive response of CXCR4-transfected H357 cells to varying concentrations of 
SDF was determined (Figure 7.13).  Some cells invaded through the Matrigel to reach 
the lower surface of the membrane in the absence of SDF (negative control), although 
when 10% FCS was added to the lower chamber (positive control) the number of 
invading cells increased approximately sixfold.  H357-X4.2 cells (a high CXCR4-
expressing clone) demonstrated a linear dose-response to SDF in concentrations from 
zero to 100ng/ml with significantly more (p<0.001, Student t-test) cells invading with 
each increment SDF gradient tested (25, 50 and 100ng/ml).  The number of invading 
cells was increased nearly sixfold over this range of concentrations.  The numbers of 
invading cells towards 100ng/ml of SDF was statistically indistinguishable to that 
towards 10% FCS.  Interestingly, addition of 50ng/ml of SDF to the upper chamber 
significantly reduced H357-X4.2 invasion (towards 100ng/ml of SDF) to levels similar 
to negative controls (p<0.001, Student t-test).  Invasion of transfected H357 cells lacking 
the CXCR4 insert (H357-EV) was statistically indistinguishable from unstimulated 
(negative) H357-X4.2 controls despite the presence or absence of SDF.  Incubation of 
cells with AMD3100 (1µg/ml) or anti-CXCR4 monoclonal antibodies (25µg/ml) 
significantly attenuated the invasive response towards 100ng/ml of SDF (p<0.001, 
Student t-test).  This attenuation was not complete; residual invasion greater than 
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negative controls by about 25 and 35 percent respectively (although this failed to 
achieve statistical significance).  The addition of isotype control monoclonal antibodies 
to the upper chambers had no effect on invasion. 
 
 
 
 
 
 
Figure 7.12:  CXCR4-transfected cell invasion towards SDF:  Time course.  Known densities of 
H357-X4.2 cells were added to the upper chamber of Transwell assays supplemented with 
Matrigel.  Migration buffer with or without 100ng/ml SDF was added to the lower chambers.  
Wells were incubated for between 2 and 24 hours.  Three replicate wells per experimental 
condition were performed and data were pooled from three identical experiments.  Mean (SD) 
cell number per high power field was plotted against time.  No cells were seen on the lower 
membrane until the 8 hour time point.  Very few cells demonstrated invasion in the absence of a 
chemotactic gradient.  In response to SDF significantly more cells demonstrated invasion 
compared with migration buffer alone. A linear increase in invasion with time over the 8 to 16 
hour time period (R-squared = 0.962, dotted line) was demonstrated.  The most cells were seen 
on the lower membrane after 24 hours.  Legend: MB = migration buffer, *** = p<0.001, Student 
t-test. 
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Finally, the invasive response of SCC4 cells towards SDF was determined (Figure 7.14).  
Very few SCC4 cells invaded through the Matrigel in the absence of SDF.  The creation 
of a chemokine gradient by the addition of SDF to the lower chambers resulted in a 
significant increase (p<0.001, Student t-test) in invasion in an approximately linear 
dose-response up to a concentration of SDF of 50ng/ml.  Further increasing the SDF 
gradient to 100ng/ml produced no statistically significant increase in invasion.  The 
invasive response towards 100ng/ml of SDF was approximately fifteen times greater 
than that demonstrated in the absence of SDF (p<0.001, Student t-test) but about two-
thirds of the response to the 10% FCS positive control (p<0.01, Student t-test).  
Interestingly, addition of SDF to the upper chambers almost completely attenuated 
(p<0.001, Student t-test) the invasion of SCC4 cells towards 100ng/ml of SDF.  This 
effect was similar for the addition of 12.5 and 50ng/ml of SDF to the upper chamber.  
Incubation of cells with the pharmacological CXCR4 antagonist AMD3100 (1µg/ml) or 
anti-CXCR4 monoclonal antibodies (25µg/ml) also significantly reduced (p<0.001, 
Student t-test) SCC4 cell invasion.  For a SDF gradient of 100ng/ml across the Matrigel-
coated membrane, the addition of isotype control antibodies demonstrated no 
significant effect on invasion. 
 
In summary, these results demonstrate that both the constitutively CXCR4-producing 
cell line SCC4 and the transfected H357 cells containing the CXCR4 insert both migrate 
and invade across the Matrigel extracellular matrix analogue in response to SDF.  The 
magnitude of this response appears to be related to the concentration gradient of SDF 
and the CXCR4 surface receptor density (as determined in Chapters 3 and 4).  
Furthermore these chemotactic responses were significantly attenuated by the addition 
of either SDF to the upper chamber (reducing the chemokine gradient) or by 
incubation with pharmacological (AMD3100) or bio-neutralising anti-CXCR4 
monoclonal antibodies.  
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Figure 7.13:  CXCR4-transfected H357 cell invasion towards SDF: Dose-response.  Known 
densities of CXCR4-transfected H357 cells (clone X4.2) were seeded into the upper chambers of 
Transwell inserts supplemented with Matrigel.  SDF at given concentrations were added to the 
lower chambers and the wells were incubated for 16 hours under optimum conditions.  Three 
wells per experimental condition were prepared and the data from three identical experiments 
were pooled.  Bars represent mean (SD) number of cells per high-powered field expressed as a 
percentage of positive control (10% FCS).  Statistical comparisons were performed using the 
Student t-test.  Significantly more (p<0.001) cells invaded through Matrigel towards the SDF 
stimulus in a dose-dependent fashion across the range of concentrations tested.  The 
chemotactic response was significantly abrogated (p<0.001) by the addition to the upper 
chamber of SDF (50ng/ml).  The addition of AMD3100 (1µg/ml) or bioneutralising anti-CXCR4 
monoclonal antibodies (25µg/ml) demonstrated a significant attenuation (p<0.001) of the 
invasive response.  Isotype-control monoclonal antibodies had no significant effect on invasion. 
Transfected H357 cells lacking the CXCR4 insert (H357-EV) showed a similar invasive response 
with and without 100ng/ml SDF which was statistically indistinguishable from unstimulated 
(negative) controls. Legend: All SDF concentrations given in ng/ml; EV = empty vector mock-
transfected H357 cells; AMD = AMD3100 at 1µg/ml; Ab = bioneutralising anti-CXCR4 
monoclonal antibodies at 25µg/ml; iso = isotype control monoclonal antibodies at 25µg/ml; 
FCS = 10% FCS; *** = p<0.001, ns = not significant (Student t-test). 
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Figure 7.14:  SCC4 cell invasion towards SDF:  Dose-response.  SCC4 cells were seeded at 
known densities into the upper chambers of Transwell inserts supplemented with Matrigel.  
SDF at varying concentrations was added to the lower chambers and the assays incubated for 
16 hours under optimum conditions.  Three wells per experimental condition were prepared 
and the data from three identical experiments were pooled.  Bars represent mean (SD) number 
of cells per high-powered field expressed as a percentage of positive control (10% FCS).  
Statistical comparisons were performed using the Student t-test.  Very few cells invaded 
through the Matrigel in the absence of SDF (negative control).  Significantly more (p<0.001) 
SCC4 cells invaded towards SDF added to the lower chamber in a dose dependent fashion up to 
a SDF concentration of 50ng/ml.  Further increasing the SDF gradient to 100ng/ml did not 
produce a statistically significant increase in invasion.  Cell invasion was significantly reduced 
(p<0.001) to levels of the negative control by the addition to the upper chamber of SDF (12.5 or 
50ng/ml), AMD3100 (1µg/ml) or anti-CXCR4 monoclonal antibodies (25µg/ml).  The addition 
of isotype control monoclonal antibodies to the upper chamber did not reduce cell invasion 
significantly.  The greatest number of invading cells was demonstrated towards 10% FCS 
(positive control).  Legend: SDF concentrations in ng/ml; AMD = AMD3100 at 1µg/ml; Ab = 
bioneutralising anti-CXCR4 monoclonal antibodies at 25µg/ml; iso = isotype control 
monoclonal antibodies at 25µg/ml; FCS = 10% FCS; *** = p<0.001, ** = p<0.01, ns = not 
significant (Student t-test). 
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7.4.3  Summary of experimental results 
 
• Solitary, transfected H357 cells containing the CXCR4 insert demonstrated the 
most chemokinesis in response to SDF stimulation (Figures 7.1 & 7.2). 
• CXCR4-transfected H357 cells in confluent culture demonstrated the quickest 
healing of scratch wounds in response to SDF gradients (Figures 7.3 & 7.4).  
This relationship was attenuated by CXCR4 receptor blockers (Figure 7.5). 
• FCS and fibronectin gradients potentiated the migration of H357 cells across 
Transwell membranes (Figures 7.6 & 7.7). 
• CXCR4-transfected H357 cells demonstrated chemotaxis in response to SDF 
gradients (Figure 7.8) that was maximal at 8 hours (Figure 7.9).  Cell invasion 
increased over a period of 24 hours (Figure 7.12). 
• SCC4 cells that constitutively produce CXCR4 protein migrated (Figure 7.11) 
and invaded (Figure 7.14) towards SDF in a dose-dependent manner. 
• Similar responses were demonstrated by CXCR4-transfected H357 cells for both 
migration (Figure 7.10) and invasion (Figure 7.13). 
• SDF-mediated responses in migration and invasion were attenuated by 
blockade of CXCR4 receptors. 
 
 
7.5  Discussion  
Before considering the implications of these results it is prudent to review the strengths 
and weaknesses of the experimental methodologies employed.  These are discussed in 
Appendix 7.  Proliferation and migration in the OSCC cell lines studied were 
anchorage dependent.  In the absence of Type 1 collagen, cells adhered poorly to the 
polycarbonate Transwell membranes.  It has been reported that SDF stimulation 
mediates increased adhesion extracellular matrix (ECM) proteins by CXCR4-producing 
head and neck squamous cell carcinomas (HNSCC) (Samara, Lawrence et al. 2004), 
small-cell lung (Burger, Glodek et al. 2003; Hartmann, Burger et al. 2005), ovarian  
(Kajiyama, Shibata et al. 2008), prostate (Taichman, Cooper et al. 2002) but not salivary 
mucoepidermoid carcinoma (Wen, Zhu et al. 2007) cell lines.  There is little consensus 
in the literature with regards to the precise signalling mechanisms that modulate 
adhesion although in all cases blockade of the CXCR4 receptor abolishes the effect.  
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Downstream, it is likely that multiple integrin subunits are involved, mediated by Rho 
GTPases or ERK but not receptor-associated G-proteins (Taichman, Cooper et al. 2002; 
Burger, Glodek et al. 2003; Samara, Lawrence et al. 2004; Hartmann, Burger et al. 2005).  
While my results suggested that fibronectin also promoted CXCR4-transfected H357 
cell adhesion, the effect of SDF stimulation on this was not examined. 
 
The influence of cell adhesion on the metastatic process is complex.  However, at a 
very simplistic level, it might be thought that increased adhesion may favour tumour 
proliferation and extravasation from the circulation, while reduced attachment may 
promote cell migration and invasion.  The expression of adhesion molecules during 
different phases of the neoplastic process is likely to vary significantly.  Preliminary 
findings suggest that CXCR4 may play a role in the increase or decrease of cell 
adhesion in response to endogenous or exogenous sources of SDF.  It has been shown 
that SDF stimulation reduces ECM adherence by confluent colorectal carcinoma cells 
undergoing anoikis (Wendt, Cooper et al. 2008).  While my preliminary experiments 
(performed to optimise the Transwell assays) demonstrated that cells were attracted to 
fibronectin, their design did not allow further comment on the influence of the 
SDF/CXCR4 axis on OSCC cell adhesion.  This could be studied using simple ECM 
attachment assays (with blockade of various cell signalling pathways) or more complex 
assays of cell-cell adhesion (for example with endothelial cells).  These methodologies 
would be potential avenues of further work.    
 
The hypothesis that the SDF-CXCR4 axis mediates increased motility in OSCC cells in-
vitro is supported by the data presented in this chapter.  As discussed in the previous 
chapter, the magnitude of the effect may be due to a number of different factors 
including ligand concentration, ligand source, surface protein density, cell line motility 
and assay type.  In three different assay systems, exposure of CXCR4-overexpressing 
cells to media supplemented with SDF produced an increase in both chemokinesis and 
chemotaxis.   However, a simple relationship between dose and response was not 
observed.  In the gold colloid and scratch wound assays, H357-X4.1 and H357–X4.2 
cells showed significant increases in motility when the SDF concentration was 
increased from 0 to 1ng/ml, and from 10 to 100ng/ml, but no difference between SDF 
concentrations of 1 and 10ng/ml.     In high expressing OSCC cell lines a similar dose-
response pattern was observed in some (Almofti, Uchida et al. 2004) but not all 
(Uchida, Begum et al. 2003; Katayama, Ogino et al. 2005) Transwell invasion assays.  
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However, comparative data from invasion assays should be interpreted with caution 
(vide infra).  Similar data from gold colloid and scratch wound assays are not available 
in the literature. 
 
Chemokinetic (gold colloid) assays demonstrated that cell motility was increased by 
20-40% with SDF stimulation (100ng/ml) in transfected H357 cells with and without 
the CXCR4 insert.  This suggests that SDF increases random cell movement in cells 
with high and low levels of CXCR4 surface protein even in the absence of a directional 
stimulus.  One similar published study demonstrated that one cell line (out of two 
tested) demonstrated a doubling of random cell movement in response to SDF despite 
both producing CXCR4 mRNA and functional protein (Ishikawa, Nakashiro et al. 
2006).  However, protein production in these cell lines was investigated with Western 
Blotting and not flow cytometry (hence its location inside or outside the cell membrane 
could not be determined).  Recent work on human mesenchymal stem cells (MSCs) has 
demonstrated that SDF-1 stimulation activates Jak2/STAT3 as well as MEK/ERK1/2 
signalling, which promotes migration of MSCs toward tumour cells. Focal adhesion 
kinases and paxillin were significantly activated which correlated with reorganization 
of F-actin filaments in MSCs (Gao, Priebe et al. 2009). 
 
In the Transwell migration assays, the dose-response relationship for both H357-X4.2 
and SCC4 cells demonstrated a similar pattern but a differing magnitude.  SCC4 cells 
demonstrated an increase in chemotaxis proportional to SDF concentration across the 
range investigated (0 to 100ng/ml).  It is possible that, at SDF concentrations below 
100ng/ml, the magnitude of response was determined by ligand availability rather 
than downstream signalling.  Further evidence supporting ligand concentration as a 
determinant of migratory response is available in the literature: Similar peak 
chemotactic responses at 100ng/ml SDF were reported by groups investigating cell 
lines constitutively expressing CXCR4 derived from head and neck SCC (Katayama, 
Ogino et al. 2005), nasopharyngeal (Hu, Deng et al. 2005), breast (Muller, Homey et al. 
2001; Helbig, Christopherson et al. 2003) and non-small cell lung (Phillips, Mestas et al. 
2005) carcinomas.  Breast carcinoma cells transfected with wild-type CXCR4 
demonstrated a peak migratory response to 12.5ng/ml SDF with migration decreasing 
with further increases in SDF concentration up to 250ng/ml (Ueda, Neel et al. 2006).  
SDF-induced invasion was abrogated by co-culture with AMD3100 or neutralising 
anti-CXCR4 monoclonal antibodies.  Similar antibody concentrations produced 
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identical results in 3 other OSCC cell lines (Katayama, Ogino et al. 2005).  Only in 
adenoid cystic carcinoma cells has it been shown that increasing SDF concentrations to 
supra-physiological levels (up to 1500ng/ml) produces any further increase in 
chemotaxis in the Transwell system (Muller, Sonkoly et al. 2006).    
 
SDF concentrations measured in-vitro range from 1 to 10ng/ml for SDF-transfected 
OSCC cell lines and gingival fibroblasts respectively (Almofti, Uchida et al. 2004; 
Uchida, Onoue et al. 2007).  In breast carcinoma cells transfected with modulated 
CXCR4, SDF concentrations of 0.1ng/ml were demonstrated in complete serum but not 
serum-free media (Ueda, Neel et al. 2006).  Measurements in-vivo have found SDF 
concentrations of 25ng/ml have been found in malignant ascites (Kryczek, Lange et al. 
2005).  Significantly faster rates of scratch wound closure have been demonstrated by 
CXCR4-producing OSCC cells endogenously expressing SDF (approximately 1ng/ml) 
compared with controls (Uchida, Onoue et al. 2007).  However, these experiments ran 
for 48 hours without the induction of growth arrest and therefore the confounding 
effect of cell proliferation cannot be determined.  In contradistinction, increased 
endogenous production of SDF in breast carcinoma cells was associated with reduced 
cell chemotaxis towards exogenous SDF stimuli and vice versa (Wendt, Cooper et al. 
2008).  The quantitative effects of mechanisms such as ligand-mediated chemokine 
receptor internalisation and the tumour-tissue microenvironment on SDF 
concentration gradients in-vivo are difficult to determine.   
   
In assays of scratch wounded, growth-arrested monolayers, the effects of SDF 
stimulation on the motility of CXCR4-transfected H357 cells were clear.   The rate of 
wound closure differed significantly between clones and was reproducible across 
experiments.  This was due to variation in cell motility rather than cell proliferation, 
although the reasons for the former are not clear.  CXCR4 blockade abrogated the SDF-
mediated response suggesting that the receptor remains functional in both clones.  
However, the more motile clone (H357-X4.1) constitutively produced higher levels of 
surface protein and enhanced ligand-mediated receptor-internalisation compared with 
H357-X4.2 cells.  If this explanation is valid then it might be expected that the efficacy 
of the SDF/CXCR4 signalling mechanisms would vary between clones.  The 
hypothesis of altered receptor sensitivity could be investigated by measurements of 
calcium flux and the effect of signalling pathway blockade on cell function.  The effects 
of altered CXCR4 receptor cycling on cell motility have been demonstrated in breast 
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carcinoma cells (Ueda, Neel et al. 2006). Cells transfected with COOH-truncated 
CXCR4 closed scratch wounds quicker than wild-type controls.  However, 
demonstrated changes in proliferation rate were not controlled for and this truncation 
has wide ranging effects on cell adhesion and epithelial-to-mesenchymal transition.  
Furthermore, while COOH-truncated CXCR4 cells demonstrated faster basal migration 
levels there was no clear dose response to SDF.  While the two clones I investigated 
demonstrated different receptor sensitivities it seems unlikely that this was due to 
similar terminal deletions.  It is also possible that the transfection process had resulted 
in other differences in the transcriptomes between the clones (for example an effect of 
the plasmid gene promoter upon genes modulating cell motility).  This would require 
a more in-depth analysis to determine the exact insertion site although its effect on 
gene expression could be investigated by microarray analysis of stimulated cells. 
 
Does the evidence support the hypothesis that SDF-mediated cell migration and 
invasion is proportional to CXCR4 receptor surface density independent of cell line?  
Compared with SCC4 cells, increased CXCR4 surface receptor density (as 
demonstrated by mean fluorescence intensity measurements by flow cytometry), a 
maximal chemotactic response to lower concentrations SDF (25-50 ng/ml) and a 
threefold increase in the numbers of migrating cells at this concentration were all 
demonstrated empirically by H357-X4.2 cells.  Furthermore, pre-incubation of cells in 
the upper Transwell chamber with SDF significantly reduces chemotaxis possibly due 
to a diminution of available CXCR4 secondary to ligand-induced receptor 
internalisation.   Invasive response has been shown to vary in association with levels of 
CXCR4 mRNA and protein in different constitutively expressing OSCC cell lines 
(Uchida, Begum et al. 2003; Almofti, Uchida et al. 2004; Ishikawa, Nakashiro et al. 
2006). 
 
Surface CXCR4 protein (as detected by flow cytometry) may not mediate chemotaxis in 
response to SDF in all cell lines.  Hu et al demonstrated that only two out of seven 
CXCR4-producing nasopharyngeal carcinoma cell lines migrated towards an SDF 
gradient in-vitro (Hu, Deng et al. 2005).  This suggests that CXCR4 receptor function 
and signalling is not ubiquitous.  However, it is not clear whether this is due to defects 
in the CXCR4 protein, deficits in the SDF/CXCR4 signalling pathways or due to 
variations in other associated characteristics of the cells (such as invasiveness, cell 
adhesion or proliferation).  Transfected H357 cells lacking the CXCR4 insert (H357-EV) 
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were responsive to increasing concentrations of SDF as determined by the gold colloid 
assay.  The pattern of response was similar to transfected cells that did contain the 
CXCR4 insert.  H357-EV cells do demonstrate very low levels of constitutive CXCR4 
surface labelling and it is tempting to attribute this observed behaviour to this.  An 
alternative hypothesis is that it is the incorporation of the transfection plasmid that 
confers enhanced chemokinesis in these cells irrespective of the inclusion (or not) of the 
CXCR4 insert.  However, in both scratch wound and Transwell assays no chemotactic 
response of H357-EV to SDF was observed.  One possibility is that the data generated 
for H357-EV cells in the gold colloid assay is not truly representative although the 
results are averaged from 10 replicate cells and the experiment was repeated twice.  
Further work to investigate this effect could compare transfected with untransfected 
cells and also focus on the blockade of the CXCR4-SDF axis with pharmacological 
antagonists, monoclonal antibodies or inhibitors of the signalling pathways discussed 
above.  In this way the validity of the observed data could be tested. 
 
Despite their frequency in the literature, comparisons of invasive potential between cell 
lines are fundamentally flawed (Almofti, Uchida et al. 2004; Uchida, Begum et al. 2004; 
Katayama, Ogino et al. 2005).  Matrix degradation is a key mechanism in neoplastic 
invasion.  OSCC cells have been shown to produce matrix metalloproteinases (MMPs) 
and urokinase plasminogen activators (uPAs) constitutively in culture (Kawamata, 
Nakashiro et al. 1997).   While some authors have established an association between 
SDF stimulation and production of activated MMP-9 by HNSCC cells (Samara, 
Lawrence et al. 2004), the majority of the published literature disagrees for OSCC 
(Onoue, Uchida et al. 2006) and other carcinomas including ovarian (Scotton, Wilson et 
al. 2002).  It has been suggested that matrix degradation is an independent feature of 
tumour cell behaviour and chemokine stimulation merely defines the directional 
component (Scotton, Wilson et al. 2002).  My data suggest that SDF stimulation 
mediates more than just directed chemotaxis alone due to the demonstrable effect on 
chemokinesis.  This is supported in the OSCC literature (Ishikawa, Nakashiro et al. 
2006).  My results clearly demonstrate the ability of CXCR4-transfected H357 cells to 
invade through Matrigel.  A clear dose-response relationship between SDF 
concentration and invasiveness was demonstrated in CXCR4 expressing cells in 
concordance with other published studies on OSCC-derived cell lines (Uchida, Begum 
et al. 2003; Rehman and Wang 2008). 
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While invasion may be greatly increased in highly expressing (transfected) cell lines it 
should be remembered that the functional endpoint measured is a manifestation of 
many mechanisms within the cell line under investigation.  The signalling pathways 
that modulate these functions have been investigated by some authors.  Both the 
ERK1/2 and Akt/PKB pathways are thought to be involved in migration mediated by 
the SDF-CXCR4 axis (Uchida, Begum et al. 2003; Uchida, Begum et al. 2004; Katayama, 
Ogino et al. 2005).  More recently Rehman et al have suggested that NF-κB signalling 
has a role in SDF-mediated Matrigel invasion via a TNFα-independent mechanism 
(Rehman and Wang 2008).  This finding is replicated in breast carcinoma cells and 
raises the intriguing prospect of an autocrine loop as NF-κB has been shown to induce 
CXCR4 expression in these cells (Helbig, Christopherson et al. 2003).  Further 
experimental investigation might have focussed on the selective blockade of the MEK, 
P13K, SFK and NF-κB pathways with the synthetic inhibitors PD098059, LY294002, PP1 
and IKKβVI respectively.  The disadvantage of using such inhibitors is that they have a 
far ranging effect on cell function which is not restricted to the migratory endpoint of 
the pathway under investigation.  Careful control experiments must be performed to 
ensure that, for example, changes in migration or invasion are not secondary to 
changes in proliferation (Rehman and Wang 2008).  Consequently, the observed 
changes in cell phenotype may not always be attributable to the effect on single 
pathways. 
 
Perhaps the most informative line of further work would be to investigate differences 
between a single cell line transfected with and without the CXCR4 insert.  This would 
allow direct comparison of the effects of CXCR4 overexpression in different aspects of 
chemokinesis, chemotaxis and invasion while controlling for other characteristics of 
the cell line.  My data have demonstrated functional differences between clones 
containing the CXCR4 insert suggesting that insertion site may influence phenotype.  It 
is also possible that certain cell lines may not be appropriate to use in particular assay 
systems.   My preliminary findings using H357 cells on dermal collagen in organotypic 
culture showed no significant invasion.  This may be due to a reduced MMP/uPAs 
activity produced by the cell line which has been shown to be poorly tumourigenic in-
vivo (Prime, Eveson et al. 2004).   Consequently, an alternative cell line with greater 
constitutive MMP activity but low CXCR4 expression may be suitable for transfection. 
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Transfection with or without the CXCR4 insert made no significant impact on the 
response of H357 cells to wounding in the absence of SDF.  However, H357-X4.1 cells 
were considerable more responsive to SDF to stimulation than H357-X4.2.  As the 
CXCR4 mRNA expression and surface receptor labelling were similar for both clones, 
this suggests that where the gene was incorporated into the host cell line genome may 
have a significant effect on the change in phenotype arising.  Nevertheless such 
changes are not universally demonstrated as the response of both clones to SDF 
stimulation in the gold colloid assays was almost identical.  It is likely that the 
overexpression of the CXCR4 sequence does not ubiquitously lead to increases in cell 
chemotaxis but the functional response measured is dependent on other factors within 
the cellular microenvironment.  These might include intracellular binding, adhesion to 
extracellular matrix molecules (such as fibronectin and heparin sulphated 
proteoglycans) and possibly the effect of these on SDF ligand binding efficiency 
(Mbemba, Gluckman et al. 2000; Sbaa-Ketata, Vasse et al. 2001). 
 
Hu, Deng et al (2005) demonstrated that, of two CXCR4-producing nasopharyngeal 
carcinoma cell line subclones produced, only one of which demonstrated SDF-
mediated chemotaxis in-vitro.  While both subclones formed primary lesions following 
orthotopic injection into nude mice but only the SDF-responsive one metastasised to 
local lymph nodes and the lungs.  Anti-sense CXCR4 abrogated the in-vitro chemotaxis 
and reduced lymphatic and lung metastases in-vivo (Hu, Deng et al. 2005).  These data 
demonstrate that blockade of SDF/CXCR4 signalling decreases, but does not abolish, 
metastasis in-vivo, suggesting that the metastatic process is dependent on more 
pathways than CXCR4 alone. 
 
 
7.6  Conclusions 
The results presented in previous chapters have demonstrated that SDF stimulation 
results in increased proliferation of OSCC cells bearing the CXCR4 receptor in-vitro.  
Data presented in this chapter supports the hypothesis that CXCR4 mediates directed 
cell movement in-vitro.  This was demonstrated in response to SDF stimulation both 
with and without a directional gradient.  Transfected cells containing the CXCR4 insert 
demonstrated a greater response than those without, suggesting that the CXCR4 
downstream signalling cascade that mediates cell motility in these cells was present 
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and functional prior to transfection.  Similarly, blockade of the SDF-CXCR4 axis 
attenuated these responses in-vitro.  In combination with the results presented in 
previous chapters, these data support the hypothesis that CXCR4-mediated responses 
play a role in OSCC cell metastasis through effects on proliferation, chemotaxis and 
invasion. 
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Chapter 8:  
Conclusions 
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8.1  Clinical context 
Oral squamous cell carcinoma is a dismal disease.  Overall, approximately one third of 
patients diagnosed with the condition in the United Kingdom will die as a result of it.   
Recent publications have shown that disease-specific 5-year survival has changed little 
in the last decade (Woolgar, Rogers et al. 1999; Rogers, Brown et al. 2009).  Modern 
therapeutic regimes are still associated with significant morbidity and mortality 
despite the advent of new strategies including microvascular reconstruction and 
Intensity-Modulated Radiotherapy (IMRT).  Independent clinicopathological features 
associated with poor prognosis are positive primary tumour resection margins, the 
presence of lymph node metastases, extracapsular spread from lymph node deposits 
and metastatic dissemination (Woolgar 2007).  All of these features represent the ability 
of the tumour to invade locally and spread to distant sites.  Clinicians planning 
individual treatment algorithms face the difficulty of estimating the likelihood of 
disseminated disease based on clinical, radiological and histological investigation.  The 
sensitivity and specificity of these combined assessments still fall far short of perfect 
and, at best, treatment recommendations are based on informed estimates (Weiss, 
Harrison et al. 1994; Okura, Aikawa et al. 2009).  Consequently, the ability to predict 
accurately the likelihood of metastatic dissemination from analysis of the primary 
OSCC lesion would be extremely beneficial to clinicians and their patients.   
 
With the advent of modern laboratory techniques the focus of predicting metastases 
has fallen on the characterisation of molecular biomarkers.  Numerous single markers 
have been statistically associated with OSCC lymph node metastases.  However, 
sensitivity and specificity data have been universally disappointing with the 
conclusion that these molecular analyses yield little clinical benefit at present.  Gene 
arrays have offered the ability to profile multiple markers from single tumours  with 
the associated benefits in statistical prediction (O'Donnell, Kupferman et al. 2005; 
Hunter, Thurlow et al. 2006).  However, again their findings are based on retrospective 
analyses of association and are limited by the methods of mRNA extraction from 
tissues.  As previously discussed, tumour/tissue homogenates offer little insight into 
the specific gene signatures of tumours (compared with the surrounding stroma).  For 
molecules such as CXCR4 this is a significant handicap due to its physiological 
expression in the peri-tumour infiltrate.  One strategy to overcome this would be to use 
laser-capture microdissection with multiplexed semi-quantitative RT-PCR.  This was 
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attempted in this thesis but found to be technically very difficult with confounding 
influences (such as tissue preparation and preservation) impossible to control for 
without the prospective collection of specimens.  Further work using LCMD/sqRT-
PCR with fresh clinical material would provide an interesting insight into the 
expression of CXCR4 and other markers in OSCC ex-vivo. 
 
 
8.2  A novel, quantitative method for using 
immunohistochemistry 
In this thesis, immunohistochemistry (IHC) was used to investigate the pattern of 
CXCR4 staining in archived clinical OSCC specimens.  Traditional IHC is subject to the 
limitations of methodological reproducibility and inter-observer variation discussed in 
Chapter 4.  The most common faults in the reported literature are the failure to include 
appropriate positive and negative controls, and the (often arbitrary) grading systems 
used to convert qualitative images into quantitative results.  The lack of consistency in 
the latter precludes comparison between published series.  To address these issues I 
developed a novel method by which the intensity of IHC cell staining could be 
examined.  It also produced robust and reproducible, quantitative data that could be 
examined with appropriate statistical tests.  In this way the inherent biases associated 
with the conventional assessment of IHC specimens were addressed.  However, this 
method alone was not able to control for the possible confounding effects of variable 
staining intensities caused by the processing of individual samples in batches.  To 
overcome this I used tissue arrays of suitable clinical material.  In this way, all 
specimens were exposed to identical incubation conditions and any variability between 
batches was eliminated.  For this reason the use of tissue arrays has significant 
advantages.  One limitation of my work was that there were insufficient samples 
represented on the array to permit the independent examination of the association of 
CXCR4 staining intensity with possibly interrelated variables such as tumour site, 
tumour size/thickness, histological differentiation and nodal metastasis.  This could be 
overcome by creating larger arrays containing more specimens (Salvucci, Bouchard et 
al. 2006).  As far as I am aware this method of IHC, which combines the use of tissue 
arrays and an independent, quantitative assessment of staining intensity, has not been 
previously described in the literature. 
 
 283
My results demonstrated a statistically significant increase in CXCR4 staining of the 
cytoplasm in primary OSCC lesions that demonstrated lymph nodes metastases (pN+) 
compared with primary lesions in which no lymph node metastases were detected 
(pN0).  No difference in cytoplasmic staining intensity between normal tissue and pN0 
primary OSCC lesions was shown.  These data suggest that CXCR4 staining of the 
cytoplasm is positively associated with lymph node metastasis but not with neoplastic 
transformation.  However, nuclear CXCR4 staining was significantly increased in 
primary oral and other head and neck SCCs compared to case-matched normal 
controls.  This suggests that CXCR4 staining in the nucleus is positively associated 
with neoplastic transformation (but not lymph node metastasis). 
 
These IHC results highlight the critical importance of including matched normal 
controls in IHC analyses as, without these, no comment can be made on the level of 
staining intensity observed in the primary lesions.  The prevalence of positive CXCR4 
staining in normal oral mucosa varies widely in the literature (reviewed in Section 4.5, 
Chapter 4).  This is probably a reflection of the variety of IHC methodologies 
employed.  My preliminary investigations suggested a positive but lower level of 
staining in case-matched normal mucosa (Figure 4.1, Appendix 4).  However, using the 
quantitative methodology accounting for background staining, a similar intensity of 
specific CXCR4 staining in normal mucosa and pN0 primary OSCC was demonstrated.  
This has not been previously described.  This may be due to the methodological 
inadequacies in other published studies as previously discussed.  Alternatively it may 
be due to sampling error resulting from the small numbers of case-matched normal 
controls available on the tissue arrays.  Further work using this novel, quantitative 
methodology to investigate CXCR4 staining in normal mucosa would be 
recommended.  Prospectively-harvested, non-inflamed, normal oral mucosa from 
young individuals without significant exposure to environment risk factors for OSCC 
(heavy alcohol and tobacco use) would be of particular interest.   It is questionable 
whether pericoronal tissue taken at the time of the removal of symptomatic 3rd molar 
teeth provides a suitable normal control. 
 
As discussed above, there are severe limitations to the combined techniques of 
LCMD/sqRT-PCR.  My results have shown that novel analysis of conventional IHC 
can yield significant insights into the distribution of CXCR4 staining in primary OSCC 
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lesions.  These data serve to inform in-vitro experiments where CXCR4 (and other 
chemokine receptors) production and function can be investigated. 
 
 
8.3  Insights from in-vitro investigations. 
In this study, microarrays were used to perform a wide ranging screen of chemokine 
receptor mRNA expression in six established OSCC cell lines.  CXCR4 was found to be 
the most highly expressed chemokine receptor.  Data derived from in-vitro experiments 
using microarrays and sqRT-PCR demonstrated a significant increase in CXCR4 
mRNA expression in some (but not all) OSCC cell lines compared with normal oral 
keratinocytes.  CXCR4 mRNA was expressed in normal oral keratinocytes, but at very 
low levels.  Examination of CXCR4 protein production revealed very low levels in 
normal oral keratinocytes (Figure 3.9, Chapter 3).  In OSCC cells with low levels of 
CXCR4 mRNA expression, the protein staining was weak (Figures 3.11 & 3.12, Chapter 
3) and limited predominantly to the perinuclear structures (Figure 3.15, Chapter 3).  
Established cell lines with high constitutive levels of CXCR4 mRNA expression and 
cells transfected with the CXCR4 insert demonstrated stronger surface protein staining 
(Figure 3.13, Chapter 3 and Figure 5.11, Chapter 5 respectively).   
 
Observational data from established OSCC cell lines (Chapter 3), clinical specimens 
(Chapter 4) and transfected OSCC cells containing the CXCR4 insert (Chapter 5) were 
consistent in demonstrating low levels of CXCR4 in normal cells, increased levels in the 
perinuclear structures in low-expressing OSCC cells and significant cytoplasmic 
staining in high-expressing OSCC cells.  IHC data suggested that cytoplasmic staining 
was associated with lymph node metastasis.  What was unclear from these 
observations was the role of CXCR4 in OSCC cell function.  This marked the second 
part of the thesis in which attention was focussed on CXCR4 through the production of 
a stably-transfected cell line and the assessment of the SDF/CXCR4 axis on cell 
proliferation, apoptosis, migration and invasion. 
 
The microarray data presented here have demonstrated a significant diversity in the 
transcriptomes of the established OSCC cell lines investigated.  This underpins the key 
limitation of comparing the results of functional assays in a variety of cell lines: there 
are a number of genetic factors that may explain any significant differences that are 
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detected.  Consequently a more robust method of investigating the effect of the 
expression of one particular gene is to manipulate its transcription.  The method 
chosen in this thesis was over-expression in a constitutively low-expressing established 
OSCC cell line by stable transfection with a vector including the CXCR4 insert 
(together with appropriate controls).  An alternative method would have been to select 
a high-expressing cell line and knock-down CXCR4 using small, interfering RNA 
(siRNA).  From the literature, CXCR4 appears to confer a positive effect on certain cell 
functions.  Therefore the advantage of the former technique compared with the latter is 
that experiments can be designed looking for an increase in effect, rather than a 
decrease or absence.  However, the two techniques are complimentary and further 
work targeting CXCR4 for gene silencing in the SCC4 cell line could produce another 
model for investigation with functional assays. 
 
One criticism of functional assays performed in-vitro is that they do not represent the 
complexity of the in-vivo tumour/tissue microenvironment.  This can be universally 
applied to all cell culture-based experiments.  However, these techniques offer the 
unique opportunity to analyse specific characteristics and to record any changes in 
response to the manipulation of environmental conditions.  In the planning of this 
study, observational data derived from clinical specimens and cell culture experiments 
were used to focus the aim of functional assays of OSCC tumour behaviour in-vitro.  
The ability of tumours to metastasise is dependent on a number of cellular processes 
(summarised in Table 1.1, Chapter 1) (Fidler 2003).  However, changes in cell 
behaviour required to establish lymph node metastases are likely to be different to 
those required for distant dissemination.  This may explain the pattern of OSCC 
disease observed clinically where spread to the cervical lymph nodes is seen 
commonly, but sizeable systemic deposits are only rarely encountered.   
 
Previous studies in the literature have focussed on the ability of CXCR4 and other 
chemokine receptors to mediate cell migration in OSCC and other carcinomas 
(reviewed in Sections 1.6.2.2 and 1.5.4, Chapter 1 respectively).  My results 
demonstrated that transfected OSCC cells containing the CXCR4 insert showed 
significant increases in chemokinesis, chemotaxis, migration and invasion, compared 
with transfected cells lacking the CXCR4 insert (Chapter 7).  Established OSCC cell 
lines constitutively expressing relatively high amounts of CXCR4 also migrated and 
invaded towards SDF gradients through pathways that could be attenuated by 
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blockade of the SDF/CXCR4 axis.  The methodologies of previously published studies 
have been inadequate, predominantly due to lack of appropriate controls (reviewed in 
Section 1.6.2.2, Chapter 1).  Therefore the data presented here are the first to provide 
conclusive evidence that CXCR4 over-expression causes an increase in OSCC cell 
migration and invasion in-vitro.  It was also demonstrated (using scratch wound 
assays) that a concentration gradient of SDF was not essential for CXCR4-mediated 
chemotaxis in growth-arrested cells.  While it has been shown that SDF can bind ECM 
moieties such as heparin sulphate, clear chemokine gradients are difficult to 
demonstrate within the tissue/tumour microenvironment.  Cell-cell interactions, 
including the expression of cell-adhesion molecules and the release of MMPs, may play 
a significant role in defining the direction of cell movement while SDF promotes 
tumour cell chemokinesis.  Further investigation of these mechanisms could be 
performed using organotypic culture models.  In this way the delivery of exogenous 
SDF stimulation could be controlled through either supplementation of the growth 
media or pre-incubation of the collagen/ECM matrix.  One particular facet of CXCR4 
function that could be explored using this method is the role of fibroblasts (or 
fibroblast-conditioned media) to induce EMT.  However, one limitation of the 
organotypic model is its inability to recreate the effect of cell-cell interactions.  This is 
only achievable in co-culture experiments or animal models, although the latter 
preclude the precise manipulation of single constituents of the cell microenvironment. 
 
The parallels between the mechanisms of tumour dissemination and physiological 
lymphocyte homing are probably over-simplistic.  The release of activated 
lymphocytes via lymphatic channels to the venous circulation facilitates their systemic 
delivery.  However, these cells can pass freely through the lung beds and the post-
capillary venules of tissue in which the signals for selective re-circulation are not 
present.  This is not the same for the much larger carcinoma cells that may undergo 
mechanical arrest in the microcirculation and are targeted for destruction by the host 
immune system if they are not equipped to evade it.  However, the role of chemokine 
receptors in lymph node metastasis may mirror more closely the multi-step mechanism 
of dendritic cell recruitment to lymph nodes (Table 1.3, Chapter 1).  Defined 
anatomical pathways deliver cells down afferent lymphatic channels to the first 
echelon of draining lymph nodes.  In this way tumour cells are able to disseminate to 
the lymph node parenchyma that is rich in chemokines.  Functional chemokine 
receptors on the carcinoma cell surface may then mediate changes in cell behaviour in 
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response to this new microenvironment.  Metastatic deposits may then develop within 
the lymph node if the tumour is able to proliferate while avoiding destruction by the 
host immune system.  It is possible that immune-mediated mechanisms that promote 
tumour growth may confer a particular survival advantage to metastatic cells. 
 
The results presented here provide clear evidence of a role for CXCR4 in OSCC cell 
proliferation but not apoptosis (Chapter 6).  SDF concentration and CXCR4 availability 
were found to be independent factors that determined the magnitude of the pro-
proliferative response.  Consequently, cells bearing functional, surface CXCR4 might 
be expected to access lymph nodes where they would be stimulated to proliferate, 
migrate and invade.  Despite the positive relationship between CXCR4 staining and 
poor clinical outcome described in the literature, the possible association between 
CXCR4 and extracapsular spread outside the lymph node has not been tested.  This 
might yield further evidence regarding the role of the SDF/CXCR4 axis in the 
progression of lymph node disease, one of the major determinants of patient outcome. 
 
  
8.4  Limitations and suggestions for further work 
One of the features of CXCR4 is its ability to signal through a variety of different 
cellular pathways.  The results presented here have focussed on the functional 
responses of high-expressing CXCR4 cells to SDF.  No examination of the signalling 
pathways mediating each response was made.  This could be achieved using a number 
of different, complimentary techniques including Western Blotting to determine the 
activated, phosphorylated form of signalling kinases, or co-incubation with 
pharmacological antagonists against selected pathways.  The elucidation of the phases 
of kinase phosphorylation is critically dependent on the duration between stimulation 
and measurement.  This may vary for each of the pathways involved which may be 
multiple for the function observed.  The strength of data generated following single 
gene transfection (compared with appropriate controls) is that the native, potential 
signalling pathways within the recipient cells are left unaffected.  Therefore, while 
pathway analysis may yield useful information on CXCR4-mediated mechanisms, the 
translational benefit is limited to defining which pharmacological pathway antagonists 
may be of use clinically.  
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The in-vitro evidence presented here strongly suggests that CXCR4 over-expression 
mediates a number of cell functions required for carcinoma cell metastasis.  However, 
as mentioned above, one of the limitations of culture-based experimental data is that it 
may poorly represent conditions in-vivo.  Therefore, orthotopic inoculation of the 
transfected OSCC cell line containing the CXCR4 insert could be performed in nude 
mice along with appropriate mock-transfected controls.  The mouse model would then 
reveal data on the effect of CXCR4 upregulation on the development of primary and 
metastatic lesions both in the cervical lymph nodes and distant sites.  However, the 
H357 cell line has been shown to be poorly tumourigenic in nude mice (Prime, Eveson 
et al. 2004).  If tumour growth could not be demonstrated (with or without the CXCR4 
insert) then it is likely that this would be a representation of features of the cell line 
rather than the over-expression of CXCR4.  One strategy would be to select and 
transfect an alternative established OSCC cell line, or alternatively select a 
constitutively high expressing cell line and transfect them with a construct that 
produced anti-CXCR4 siRNA.  One limitation of the transfection vector selected in this 
study was the reliance on antibody labelling to determine surface protein levels.  Other 
methods exist to make quicker, real-time assessments of construct expression.  These 
include the incorporation of a green fluorescent protein (GFP) marker which would 
allow investigation of tumour dissemination without immunofluorescence.  This could 
be performed on sacrificed tissue in the conventional way, or in live animals using 
intra-vital microscopy.  An alternative technique to determine the pattern and volume 
of tumour burden without sacrificing the animal would be to use PET/CT scanning, 
potentially with a co-transfected marker. 
 
One of the most surprising findings from the characterisation of established OSCC cell 
lines was that significant levels of CCR7 mRNA or protein were not demonstrated.  
CCR7 appears to be the predominant chemokine receptor involved with the uptake of 
activated dendritic cells to peripheral lymph nodes.  The CCR7 -/- knockout mouse 
lacks this ability, although comparison with CXCR4 -/- knockouts is not possible as the 
latter is fatal.  There is some evidence in the literature that some OSCC cell lines 
produce functional CCR7 protein in-vitro and that CCR7 staining in clinical specimens 
is associated with advanced disease and lymph node metastasis (reviewed in Section 
1.6.1, Chapter 1).  One limitation of the work presented in this thesis is that 
investigation of CCR7 was restricted to established OSCC cells.  With more time it 
would be necessary to optimise the IHC staining protocol for CCR7 and investigate the 
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same preliminary specimens and tissue arrays using the novel, quantitative IHC 
method described.  In this way correlation between in-vitro and clinical findings could 
have been made.  If positive CCR7 staining was not demonstrated in clinical samples 
then this would not preclude investigation of its functional role in cell culture.  
However, this work would be limited to the study of a transfected cell line in which 
CCR7 mRNA was over-expressed.  Additionally any functional activity demonstrated 
could not be readily translated to the in-vivo situation where the protein had not been 
shown to exist. 
 
CXCR7 (RDC1) was only recently discovered as a second receptor for SDF (Balabanian, 
Lagane et al. 2005).  While it was initially thought to play a role predominantly in 
organogenesis, a number of groups have described CXCR7-mediated changes in 
tumour cell proliferation in-vitro (reviewed in Section 1.5.5, Chapter 1).  The function of 
CXCR7 appears to vary between carcinomas and, unfortunately, retrospective 
examination of the microarray data presented here shows that RDC1 was not 
represented on the array.  Consequently it would be interesting to investigate archived 
cDNA for CXCR7 expression levels and to determine protein levels using flow 
cytometry and IHC.  From the literature, CXCR4 production is poorly predictive of 
CXCR7 levels and their co-expression and interaction would be important to delineate.  
Further manipulation of this could be performed by performing transfection of a 
constitutively low-expressing cell line with a single insert or both in combination. 
 
 
8.5  Translational considerations 
The ability of carcinoma cells to invade locally, disseminate widely and then proliferate 
at distant anatomical sites is unlikely to be due to a change of expression of a single 
gene.  This fact explains why individual biomarkers are universally poor at predicting 
metastases.  However, physiological processes (such as the uptake of activated 
dendritic cells by lymph nodes) are attractive targets for subversion by neoplastic cells.  
Over-expression of the molecules that mediate such mechanisms expose the carcinoma 
cell to pathophysiological processes (such as the inflammatory response) that may 
further promote tumour progression (Balkwill and Mantovani 2001).  From the 
tumour’s perspective, a further, indirect benefit of subverting physiological pathways 
is that therapeutic strategies aimed at blocking these mechanisms may have substantial 
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and debilitating side effects that preclude their use in patients.  This phenomenon has 
been demonstrated in patients with HIV who have been administered pharmacological 
antagonists to CXCR4. 
 
If the role of individual biomarkers is clinically limited and the development of anti-
CXCR4 therapies handicapped by systemic toxicity, is there any translational benefit in 
studying the role of CXCR4 in OSCC metastasis?  The answer is clearly yes.  Current 
treatment strategies for early stage disease (in which no involvement of the CLN can be 
felt or imaged) focus on an assessment of risk of occult, subclinical tumour deposits in 
the neck.  While the results of prospective, randomised, clinical trials are still a decade 
away the accepted yardstick remains an arbitrary threshold (Weiss, Harrison et al. 
1994; Okura, Aikawa et al. 2009).  Any method of assessing the diagnostic biopsy taken 
from the primary tumour that would inform the decision-making process with regards 
to the prospective treatment of the N0 neck would be clinically beneficial.  In this way 
a panel of validated biomarkers with defined sensitivity and specificity could help 
clinicians and their patients decide on the best course of treatment in situations where 
the decision is not clear-cut.  Data presented here demonstrate an association between 
cytoplasmic CXCR4 protein and lymph node metastasis.  This assessment could be 
performed in the clinical situation by conventional IHC of the diagnostic biopsy taken 
from the primary lesion. 
 
Other ways in which anti-CXCR4 therapies may be helpful without the burden of 
systemic toxicity include the use of radio-sensitising agents.  These compounds do not 
cause side effects themselves but potentiate the anti-tumour effect of external beam 
radiotherapy on cells that have taken them up.  Limitations of this technique include 
the effects on the physiological upregulation of surface CXCR4 within the parenchyma 
of the cervical lymph nodes targeted in the radiation field.  Involvement of the 
SDF/CXCR4 axis in induction of apoptosis was not demonstrated by my results.  This, 
combined with their systemic side-effects, suggests that the role of CXCR4 antagonists 
in adjuvant chemotherapy is likely to be extremely limited. 
 
Finally there are distinct benefits in studying the mechanisms by which CXCR4 may 
mediate lymph node and distant metastasis.  Although sequential involvement of the 
CLN is the most common pattern of OSCC tumour spread, the prevalence of lymph 
node skipping has been reported by a number of authors (reviewed in Section 1.2.1, 
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Chapter 1).  This is particularly important when more minimally invasive techniques 
of CLN assessment and treatment are considered.  These include sentinel node biopsy 
(SNB) in which the first echelon of draining lymph nodes are identified and sampled.  
The rationale of this treatment is that only patients with a positive sentinel node 
progress to formal neck dissection.  The danger with this treatment algorithm is the 
false negative SNB in which tumour has spread to the CLN but the screening 
investigation (SNB) fails to predict it.  
 
The metastatic process is highly inefficient, suggesting that, of the huge number of 
genetic variants created, only a few cells develop the ability to access and grow at 
distant sites.  Detailed autopsies of patients with OSCC have demonstrated that small, 
subclinical distant metastases may be relatively common, but they rarely progress to 
form clinically significant lesions.  This failure to enlarge may be due to properties 
inherent within the tumour metastases, or due to the confounding effect of rapid 
progression of loco-regional disease precipitating early demise of the patient.  Clinical 
observation supports (at least in part) the former hypothesis.  Therefore investigation 
of the mechanisms controlling tumour growth arrest (despite CXCR4 bearing cells 
disseminating to tissue microenviroments with abundant SDF) may yield interesting 
insights into the control of metastatic pathways. 
 
In conclusion, the results presented in this thesis demonstrate that CXCR4 protein 
levels on the cell membrane of primary OSCC lesions are associated with CLN 
metastases.  This may be mediated by the positive effects of CXCR4 activation on 
proliferation, migration and invasion.  While individual biomarkers may lack 
significant statistical power in predicting clinical metastases, these data support the 
inclusion of CXCR4 protein in a prognostic panel.  This would be amenable to 
investigation of diagnostic biopsies by IHC.  However, the complexity of multiple IHC 
testing precludes its current use in the clinical setting.  Further prospective work 
focussing on the specific removal of tumour cells (for example by LCMD) followed by 
multiplexed sqRT-PCR might automate this procedure, albeit at an mRNA level.  
While this work would provide significant insights into the metastatic mechanisms of 
OSCC, its clinical application remains limited (at least in the short-term). 
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 A1.1  Supplementary Tables and Figures 
 
Table A1.1:  International Statistical Classification of Diseases and Related Health Problems 
(10th Revision 2007):  Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)  
Site & Code Sub-Code Sub-site Definition 
In
cl
ud
ed
 
Ex
cl
ud
ed
 
C00  
Lip 
C00.0 to 
C00.9 
   x 
C01 
Malignant 
neoplasm of 
base of tongue 
  Dorsal surface of base of tongue  
Fixed part of tongue NOS  
Posterior third of tongue 
x  
C02.0  Dorsal surface of 
tongue 
Anterior two-thirds of tongue, dorsal 
surface 
C02.1  Border of tongue Tip of tongue 
C02.2  Ventral surface of 
tongue  
Anterior two-thirds of tongue, ventral 
surface  
Frenulum linguae 
C02.3 Anterior two-
thirds of tongue, 
part unspecified 
Middle third of tongue NOS  
Mobile part of tongue NOS 
C02.4 Lingual tonsil  
C02.8  Overlapping 
lesion of tongue 
 
C02 
Malignant 
neoplasm of 
other and 
unspecified 
parts of 
tongue 
C02.9  Tongue, 
unspecified 
 
x  
C03.0 Upper gum alveolar (ridge) mucosa  
gingiva 
C03.1 Lower gum alveolar (ridge) mucosa  
gingiva 
C03 
Malignant 
neoplasm of 
gum 
C03.9 Gum,  unspecified 
x  
C04.0  Anterior floor of 
mouth 
Anterior to the premolar-canine 
junction 
C04.1  Lateral floor of 
mouth 
 
C04.8  Overlapping 
lesion of floor of 
mouth 
 
C04 
Malignant 
neoplasm of 
floor of mouth 
C04.9  Floor of mouth,  unspecified 
x  
C05.0  Hard palate  
C05.1 Soft palate  
C05.2  Uvula  
C05.8  Overlapping 
lesion of palate 
 
C05 
Malignant 
neoplasm of 
palate 
C05.9  Palate,  Roof of mouth unspecified 
x  
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Table A1.1 (cont’d) 
Site & Code Sub-Code Sub-site Definition 
In
cl
ud
ed
 
Ex
cl
ud
ed
 
C06.0  Cheek mucosa  Buccal mucosa NOS  
Internal cheek 
C06.1  Vestibule of 
mouth 
Buccal sulcus (upper)(lower)  
Labial sulcus (upper)(lower) 
C06.2  Retromolar area  
C06.8  Overlapping 
lesion of other 
and unspecified 
parts of mouth 
 
C06 
Malignant 
neoplasm of 
other and 
unspecified 
parts of 
mouth 
C06.9  Mouth, 
unspecified 
Minor salivary gland, unspecified site 
/ Oral cavity NOS 
x  
C07 
Malignant 
neoplasm of 
parotid gland 
   
 x 
C08 
Malignant 
neoplasm of 
other & 
unspecified 
major salivary 
glands 
C08.0 to 
C08.9  
Submandibular 
gland,  
Sublingual Gland 
 
 x 
C09.0  Tonsillar fossa  
C09.1  Tonsillar pillar 
(anterior)(posterio
r) 
 
C09.8  Overlapping 
lesion of tonsil 
 
C09 
Malignant 
neoplasm of 
tonsil 
C09.9  Tonsil, 
unspecified 
Tonsil:  
· NOS / faucial / palatine 
  
C10.0  Vallecula  
C10.1  Anterior surface 
of epiglottis 
Epiglottis, free border [margin]  
Glossoepiglottic fold(s) 
C10.2  Lateral wall of 
oropharynx 
 
C10.3 Posterior wall of 
oropharynx 
 
C10.4  Branchial cleft Branchial cyst [site of neoplasm] 
C10.8  Overlapping 
lesion of 
oropharynx 
Junctional region of oropharynx 
C10 
Malignant 
neoplasm of 
oropharynx 
C10.9  Oropharynx, 
unspecified 
 
x  
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Table A1.1 (cont’d) 
Site & Code Sub-Code Sub-site Definition 
In
cl
ud
ed
 
Ex
cl
ud
ed
 
C11.0  Superior wall of 
nasopharynx 
Roof of nasopharynx 
C11.1  Posterior wall of 
nasopharynx 
Adenoid  
Pharyngeal tonsil 
C11.2  Lateral wall of 
nasopharynx 
Fossa of Rosenmüller  
Opening of auditory tube  
Pharyngeal recess 
C11.3  Anterior wall of 
nasopharynx 
Floor of nasopharynx  
Nasopharyngeal surface of soft palate 
(anterior)(posterior) Posterior margin 
of nasal:  
· choana / septum 
C11.8  Overlapping 
lesion of 
nasopharynx 
 
C11 
Malignant 
neoplasm of 
nasopharynx 
C11.9  Nasopharynx, 
unspecified 
Nasopharyngeal wall NOS 
 x 
C12 
Malignant 
neoplasm of 
piriform sinus 
  Piriform fossa 
x  
C13.0 Postcricoid region  
C13.1  Aryepiglottic 
fold, 
hypopharyngeal 
aspect 
Aryepiglottic fold:  
· NOS marginal zone 
C13.2  Posterior wall of 
hypopharynx 
 
C13.8  Overlapping 
lesion of 
hypopharynx 
 
C13 
Malignant 
neoplasm of 
hypopharynx 
C13.9  Hypopharynx, 
unspecified 
Hypopharyngeal wall NOS 
x  
C14.0 Pharynx, 
unspecified 
 
C14.2  Waldeyer's ring   
C14 
Malignant 
neoplasm of 
other and ill-
defined sites 
in the lip, oral 
cavity and 
pharynx 
C14.8  Overlapping 
lesion of lip, oral 
cavity and 
pharynx 
Malignant neoplasm of lip, oral cavity 
and pharynx whose point of origin 
cannot be classified to any one of the 
categories C00-C14.2 
 x 
C15 
Oesophagus 
    x 
C32 Larynx     x 
C33 Trachea     x 
C43.0 Upper   x C43 & C44 
Skin of Lip C44.0 Lower   x 
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A2.1 Supplementary Tables & Figures  
 
Table A2.1: Components of Specialised Growth Media for Cell Culture 
 
Cell 
Line(s) 
Base Media Supplements (final concentrations) 
357 
3:1 Dulbecco’s 
Modified Eagle 
Medium (DMEM) with 
sodium pyruvate and 
1000mg/ml glucose 
(31885-023, Invitrogen) 
to Ham F-12 (N-4888, 
Sigma), (Formanek, 
Millesi et al 1996) 
Hydrocortisone 0.4μg/ml, (H0135, Sigma) 
Transferrin 5μg/ml, (T5391, Sigma)  
Insulin 5μg/ml,  (I-1882, Sigma) 
Cholera Toxin 1 x 10-10M, (C-3012, Sigma) 
Epidermal cell Growth Factor (EGF) 10ng/ml, 
(E1257, Sigma) 
Adenine 1.8 x 10-4 M, (A3159, Sigma) 
Penicillin/Streptomycin 50u/ml & 50μg/ml 
Fungizone 2.5μg/ml 
10% FCS 
FADU 
CAL27 
RPMI 1640 with 25mM 
Hepes & L-Glutamine  
(BE12-115F) 
Penicillin/Streptomycin 50u/ml & 50μg/ml 
Fungizone 2.5μg/ml 
10% FCS 
TR146 
HGF 
3T3 
 (DMEM)  
(BE12-604F) 
 
Penicillin/Streptomycin 50u/ml & 50μg/ml 
Fungizone 2.5μg/ml 
10% FCS 
SCC4 
SCC25 
1:1 DMEM :  
Ham F-12 with 15mM 
Hepes & L-Glutamine  
(BE12-719F) 
Penicillin/Streptomycin 50u/ml & 50μg/ml 
Fungizone 2.5μg/ml 
Hydrocortisone 400ng/ml 
10% FCS 
SVpgC2a 
Defined Keratinocyte 
SFM medium (Gibco) 
Penicillin/Streptomycin 50u/ml & 50μg/ml 
Insulin 4μg/ml 
Hydrocortisone 0.5μg/ml 
EGF 25ng/ml 
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Table A2.2: Determination of growth kinetics of OSCC & 3T3 cell lines 
 
 Doubling Time 
(Hours) 
Time to end of 
log growth 
phase / hr * 
No. of Cell 
divisions to 
end of Log 
Growth Phase 
Accuracy of the 
modelling of 
the Exponential 
Phase (RSQ) 
H357 19.9 112 5.6 0.972 
TR146 20.6 88 4.3 0.979 
CAL27 43.3 136 4.9 0.914 
FaDu 24.3 112 3.6 0.971 
SCC4 23.1 88 3.8 0.979 
SCC25 20.3 88 4.3 0.960 
3T3 20.9 112 5.3 0.999 
Legend: * = Based on seeding density of 5x103 per well 
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Table A2.3:  Pathology Report Summary of ten preliminary cases of tongue OSCC 
selected for CXCR4 immunohistochemistry. 
 
Sample 
Number 1 2 3 4 5 
Specimen 126/01 815/01 1189/01 501/01 1010/02 
Type FFPE FFPE FFPE FFPE FFPE 
Year taken 2001 2001 2001 2001 2002 
Patient Age 48 76 49 36 50 
Sex M F M M M 
Pathological 
Staging T2N1M0 T2N2bM0 T4N2b T2N0M0 T2N0M0 
Primary 
tumour site Tongue Tongue 
Tongue & 
FoM Tongue Tongue 
Primary 
tumour size 
(cm)* 
2.1 3.4 5.0 1.6 2.1 
Maximum 
depth of 
invasion (cm) 
1.0 1.1 2.2 1.6 0.9 
Differentiation Moderate Moderate Moderate Poor Well 
Invasive front Non-cohesive Cohesive Cohesive 
Non-
cohesive Cohesive 
Total number 
of lymph 
nodes excised 
24 18 N/A 6 23 
Number of 
positive neck 
lymph nodes 
1 2 3 0 0 
Anatomical 
level of 
positive lymph 
nodes 
2 2 2 N/A N/A 
Lymph node 
metastasis size 
(cm)* 
0.7 1.1 1.3 N/A N/A 
Extracapsular 
spread Yes Yes Yes N/A N/A 
 
Continued on the next page 
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Table A2.3 (continued) 
Sample 
Number 6 7 8 9 10 
Specimen 1111/02 2055/01 445/03 1133/03 299/03 
Type FFPE FFPE FFPE FFPE FFPE 
Year taken 2002 2001 2003 2003 2003 
Patient Age 52 72 66 59 48 
Sex M M M M F 
Pathological 
Staging T1N0M0 T2N1M0 T2N2M0 T2N2M0 T3N2M0 
Primary 
tumour site Tongue Tongue Tongue Tongue Tongue 
Primary 
tumour size 
(cm)* 
1.3 2.5 2.8 2.8 4.5 
Maximum 
depth of 
invasion (cm)** 
0.4 0.9 1.3 1.5 1.5 
Differentiation Moderate Moderate Poor Moderate Moderate 
Invasive front Cohesive Non-cohesive Cohesive Cohesive 
Non-
cohesive 
Total number 
of lymph 
nodes excised 
19 17 36 34 38 
Number of 
positive neck 
lymph nodes 
0 1 4 4 1 
Anatomical 
level of 
positive lymph 
nodes 
N/A 2 2, 3 & 4 2 & 3 2 
Lymph node 
metastasis size 
(cm)* 
N/A 0.5 3.7 2.0 1.0 
Extracapsular 
spread N/A Yes Yes Yes Yes 
 
Legend:  FFPE = formalin-fixed paraffin-embedded;  FoM = Floor of Mouth;  * = maximum 
dimension as measured in the plane of section; ** = maximum depth of invasion as measured 
from estimated epithelial surface. 
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Figure A2.1:  Diagram of the layout of the Head & Neck Tissue Array (A219II, Accumax) 
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Figure A2.2: Restriction Enzyme digest of pcDNA3-CXCR4 with Xba1, EcoR1 and BamH1.  A 
schematic representation of the restriction enzyme binding sites for Xba1, EcoR1 and BamH1 in 
the pcDNA3 plasmid containing the CXCR4 insert.  Fragment sizes are given in base pairs (bp). 
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Figure A2.3: PCR primers for T7F/BGH-R and CXCR4 on pcDNA3-CXCR4 and pcDNA3.  
Schematic representation of the binding sites for the PCR primer pairs for T7F/BGH-R and 
CXCR4 on the pcDNA3 plasmids with (panel a) and without (panel b) the CXCR4 insert.  
Fragment sizes are given in base pairs (bp). 
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a)  
  
b)  
      |     T7 promoter / priming site      | 
861 ATTAATACGA  CTCACTATAG  GGAGACCCAA  GCTGGCTAGT  TAAG  
CTT 
  
                                                                                                                            EcoR1 
905 GGT  ACC  GAG  CTC  GGA  TCC  ACT  AGT  CCA  GTG  TGG  TGG | AAT 
  
                                                                                                                           Xba1 
944 TCT  GCA  GAT  ATC  CAG  CAC  AGT  GGC  GGC  CGC  TCG  AG | T  CTA 
  
  
983 GAG  GGC  CCG  CGG  TTC  GAA  CAA  AAA  CTC  ATC  TCA  GAA  GAG 
  
                                                                            |              Polyhistidine tag            | 
1022 GAT  CTG  AAT  ATG  CAT  ACC  GGT   CAT  CAT  CAC  CAT  CAC  CAT 
  
                                                                     |  BGH Reverse Priming Site  | 
1061 TGA  GTTT  AAACCCGCTG  ATCAGCCTCG  ACTGTGCCTT  CTAGTTGCCA 
 
Figure A2.4:  pcDNA3.1 plasmid map.  A diagram of the pcDNA3.1 plasmid (a) and detail of 
the binding site (b) showing the CXCR4 insertion site following restriction enzyme digestion 
with EcoR1 and Xba1. 
CXCR4
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Figure A2.5.  Tests for the consistency of cell seeding density prior to Alamar Blue assays.  96 
well plates were seeded with cells at a known density and incubated overnight with 5% Alamar 
Blue.  Fluorescence measurements were taken and an observed against expected cumulative 
probability (P-P) plot was produced (A).  Subsequently, the baseline fluorescence 
measurements of future experimental groups were compared (B).  Bars represent mean 
(standard deviation) of twelve replicate wells.  ANOVA reveals no significant difference 
between groups (p>0.05). 
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A2.2  Protocol for Mycoplasma testing 
Cells were taken and grown in parallel with flask cultures on sterile glass coverslips in 
a 24-well plate at an initial density of 1x104 cells/well under standard conditions for 72 
hours.  They were washed twice with sterile PBS and then incubated with 50μl of 
10μg/ml 4',6-Diamidino-2-phenylindole dimethylsulfoxide (DAPI) nuclear fluorescent 
stain for ten minutes in the dark.  The coverslips were mounted in aqueous 
Immunomount (ThermoShandon, 9990402), allowed to dry and viewed under the 
fluorescence microscope.  Speckled staining of the cytoplasm was taken as evidence of 
mycoplasma infection.  Mycoplasma positive cell lines were treated as outlined in 
Section 2.1.5 (Chapter 2) and were rechecked at the end of the treatment regimen. 
 
An additional ELISA-based method was employed to screen the transfected H357 cells 
prior to their use in observational or functional experiments.  Briefly, aliquots from cell 
culture supernatants were taken at confluence, spun at 8,000g for 1 minute and 
incubated according to the manufacturer’s instructions (Roche).  Colour was allowed 
to develop for a standardised period (30 minutes) and the plates were then read in a 
standard microplate reader.  Transfected cells with and without the CXCR4 insert were 
tested with antibodies raised against four common mycoplasma species.  Results show 
levels generated by the cell lines were equivalent to negative control levels and well 
below the response levels of internal positive controls (Figure A2.6). 
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Figure A2.6: ELISA-based mycoplasma screening of transfected H357 cells.  Transfected H357 
cells with and without the CXCR4 insert were cultured and the supernatant was sampled.  
Analysis using an ELISA-based protocol was performed according to the manufacturer’s 
instructions.  Samples were incubated with antibodies raised against four common mycoplasma 
species.  Absorbance recordings for cell supernatants were similar to those recorded for internal 
negative controls.  Readings from internal positive control samples were substantially higher. 
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A3.1  Statistical processing of array data  
For each array, histogram plots of the log(10) transformation of each normalised gene 
expression values for all represented genes were produced.  These plots were shown to 
be similar in shape between arrays and graphically followed a normal distribution 
(Figure A3.1).  A normal distribution of each log(10) transformed (but not the 
untransformed) normalised expression values was confirmed using P-P plots. 
 
 
 
Figure A3.1:  Histogram plots of the log(10) transformation of all genes represented on the 
microarrays.  Microarrays (U133A, Affymetrix) were hybridised against cDNA manufactured 
from NOK, NSK and established OSCC cell lines (as outlined in Section 2.2, Chapter 2).  
Internal quality-control genes demonstrated that 17 arrays had hybridised correctly.  The 
normalised expression values (NEV) of all genes represented on the micoarrays were plotted 
against frequency for the 17 arrays (each represented by an individual line).  Each curve 
conformed to the normal distribution centred on the value 1.00. 
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A phylogenetic tree of all the samples mapping all genes on the array demonstrated that each 
sample duplicate most closely matched to its reciprocal pair (Figure A3.2).  The concordance 
values between sample replicates from each cell line ranged from 0.92 to 0.97 
compared with a maximum value of 0.798 for the concordance between samples 
derived from different cell lines (SCC4 and SCC25).  These results confirmed that there 
was a high reproducibility of results between sample replicates.  Consequently, the 
validity of the mathematical amalgamation of data for the cell line replicates is 
supported by the biological correlation of cell line type with these phylogenetic and 
concordance analyses. 
 
 
Figure A3.2:  Phylogenetic gene tree of all microarray samples.  The gene expression 
profile of all genes represented on the microrrays were compared for samples that had 
hybridised correctly (n=17).  Where appropriate the results from duplicate samples 
were combined. 
 311
A3.2  Raw data tables for chemokine receptor mRNA 
expression as determined by microarrays 
 
Table A3.1:  Chemokine Receptor mRNA expression raw data for NOK and NSK 
microarrays.   
 NEV  mean (min , max) 
 NOK NSK 
CCR1 0.88 (0.54, 1.88) 
0.83 
(0.14 , 1.45) 
CCR2 0.65 (0.28, 1.93) 
0.89 
(0.43, 2.02) 
CCR3 0.84 (0.34, 2.11) 
0.37 
(0.36, 0.37) 
CCR4 0.60 (0.23, 1.57) 
1.46 
(1.29, 1.66) 
CCR5 1.45 (1.01, 2.08) 
0.76 
(0.64, 0.91) 
CCR6 0.76 (0.74, 0.78) 
0.22 
(0.19, 0.26) 
CCR7 1.20 (1.02, 1.41) 
0.79 
(0.63, 0.98) 
CCR8 0.60 (0.43, 0.84) 
1.93 
(1.55, 2.41) 
CCR9 1.19 (1.09, 1.29) 
1.68 
(1.66, 1.70) 
CCR10 0.81 (0.80, 1.20) 
0.73 
(0.71, 0.90) 
CXCR1 0.31 (0.31, 0.32) 
2.04 
(1.14, 2.95) 
CXCR2 0.98 (0.83, 1.15) 
1.37 
(0.83, 1.52) 
CXCR3 0.85 (0.34, 2.69) 
1.19 
(0.50, 1.79) 
CXCR4 0.96 (0.53, 1.22) 
0.80 
(0.56, 1.15) 
CXCR5 0.70 (0.32, 1.53) 
0.39 
(0.23, 0.53) 
CXCR6 1.34 (0.76, 2.09) 
1.05 
(0.49, 2.50) 
XCR1 1.70 (0.95, 3.05) 
0.98 
(0.56, 1.72) 
CX3CR1 0.96 (0.55, 1.69) 
0.85 
(0.66, 1.08) 
 
Raw data for Figure 3.1 (Chapter 3) 
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Table A3.2:   Chemokine Receptor mRNA expression raw data for established OSCC Cell 
Lines.   
 
 Mean Normalised Expression Value (NEV) 
 SCC4 SCC25 CAL27 H357 FADU TR146 SV 
CCR1 0.926 0.764 0.661 0.646 1.777 0.450 0.564 
CCR2 0.760 0.847 1.292 1.171 0.991 0.684 0.727 
CCR3 0.882 1.129 1.905 0.716 0.353 0.469 0.502 
CCR4 1.582 0.893 0.802 0.790 0.568 1.370 0.289 
CCR5 3.867 1.289 1.790 0.578 0.805 0.706 0.854 
CCR6 0.918 0.937 0.614 0.686 0.427 1.027 1.169 
CCR7 0.746 0.226 1.342 0.940 1.953 1.017 1.072 
CCR8 1.226 1.152 0.236 1.206 0.274 1.846 0.959 
CCR9 0.909 0.703 0.623 1.058 1.409 0.768 0.887 
CCR10 0.634 1.188 0.559 0.975 1.329 1.199 1.549 
CXCR1 0.817 1.097 0.256 1.833 1.473 0.978 0.189 
CXCR2 0.675 0.540 1.089 0.614 2.466 1.189 0.287 
CXCR3 0.489 1.220 0.759 1.011 0.478 0.653 1.123 
CXCR4 8.326 10.118 0.610 0.762 0.807 0.857 0.835 
CXCR5 0.703 1.199 0.358 0.482 0.712 0.792 1.633 
CXCR6 0.980 0.646 0.743 1.019 0.807 1.115 1.293 
XCR1 0.256 0.298 0.690 0.794 0.578 0.429 0.974 
CX3CR1 0.483 0.842 1.368 0.727 1.032 0.591 0.341 
 
Raw data for Figure 3.2 (Chapter 3) averaged for duplicate samples were appropriate. 
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A3.3  Chemokine mRNA expression by Primary Cultures of 
NOK, NSK and Established OSCC cell lines. 
The Affymetrix U133A microarray contains probes for all known chemokines (CCL1-
27, CXCL1-14, XCL1 and CX3CL1) with the exception of CCL6, CCL9, CCL10, CCL12 
and CCL26.  The normalised expression values (NEV) of chemokines for normal oral 
and skin keratinocytes were calculated (as outlined in Section 2.2.13) and plotted 
(Figure A3.3). 
 
These results show a considerable degree of variability in the expression of chemokine 
mRNA (compared with the normalised mean) for normal oral keratinocytes.  In the 
majority of cases the duplicate values were highly concordant.  Out of the C-X-C 
family of chemokines, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6 and CXCL8 were 
expressed at high levels (NEV 5.6, 3.9, 18.5, 37.3, 19.1 and 6.5 respectively).  CXCL13 
was the only C-X-C chemokine expressed at low levels in NOK (NEV 0.20).  Only three 
members of the C-C chemokine family were highly expressed by NOK: CCL14, CCL20 
and CCL22 (NEV 2.9, 8.9 and 2.7 respectively).  However, seven C-C chemokines were 
expressed at low levels by these cells: CCL1, CCL2, CCL3, CCL5, CCL23, CCL25 and 
CCL27 (NEV 0.17, 0.29, 0.26, 0.49, 0.25, 0.43 and 0.29 respectively).  Finally, the 
chemokine CX3CL1 was highly expressed in NOK (NEV 5.1). 
 
There were a number of similarities between the chemokine expression profiles in 
keratinocytes from the skin and the mouth:  Normal skin keratinocytes showed high 
expression of CXCL5, CXCL6 and CX3CL1 (NEV 8.2, 6.1 and 5.3 respectively) and low 
expression of CXCL13 (NEV 0.14).  However, some differences in the expression of C-
X-C chemokines between NSK and NOK were also demonstrated:  In NSK the 
chemokines CXCL1, CXCL3 and CXCL8 were not highly expressed and CXCL2 was 
only expressed at low levels (NEV 0.46).  Finally, CXCL7 was highly expressed in NSK 
(NEV 20.2) but at normal levels in NOK.   
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Figure A3.3:  Normalised expression of chemokine mRNA by normal oral and skin 
keratinocytes.  Solid bars represent the NEV of chemokine mRNA for normal oral (NOK) and 
skin (NSK) keratinocytes (averaged for duplicate samples).  For description of results see text. 
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Figure A3.4a:  C-C Chemokine mRNA Expression by Established OSCC Cell Lines.  Solid 
bars represent the chemokine NEV (averaged for duplicate samples where applicable).  For 
description of results see text.  
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Figure A3.4b:  C-X-C, X-C and C-X3-C Chemokine mRNA Expression by Established OSCC 
Cell Lines.   Solid bars represent the chemokine NEV (averaged for duplicate samples where 
applicable).  For description of results see text.  
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The C-C and X-C chemokines were less variably expressed by NSK and demonstrated 
fewer similarities with the pattern of expression in NOK.  The chemokines CCL2, 
CCL8, CCL17, CCL18, CCL21 and XCL1 were expressed at low levels in NSK (NEV 
0.23, 0.31, 0.42, 0.45, 0.47 and 0.33 respectively).  Interestingly, no chemokines of the C-
C family were expressed at high levels in NSK.  The mean normalised expression 
values for all chemokines represented on the microarrays were calculated for the cell 
lines tested (as outlined in section 2.4.2.13).  These NEVs are represented for C-C 
chemokines (Figure A3.4a) and for C-X-C, X-C and C-X3-C chemokines (Figure A3.4b).  
 
The pattern of chemokine mRNA expression by oral cell lines was complex and highly 
variable.  However, several trends can be identified from analysis of significant 
differences in expression of greater than twofold from the normalised mean:  Firstly, 
the majority of changes in chemokine expression were shown to be associated with 
their downregulation.  However, only CCL1 was ubiquitously downregulated in all 
the oral cell lines tested (NEV range 0.12 to 0.37).  Secondly, when chemokine 
expression in individual cell lines was compared some patterns emerged.  Both SCC4 
and SCC25 demonstrated low expression of CCL1, CCL2, XCL1 and particularly 
CXCL1, while showing upregulation of CXCL2 and CXCL3.  In addition, SCC25 
demonstrated downregulation of CCL3, CCL4, CCL7, CCL8, CCL11, CCL16, CCL18, 
CCL21, CXCL5 and CXCL7; while SCC4 showed low expression of CCL17, CCL23, 
CXCL11, CXCL12 and CXCL13.  The CAL27 cell line demonstrated some similarities 
with SCC25 cells, for example the low expression of CCL1, CCL2, CCL4, CCL7, CCL8, 
CCL21 and CXCL7.  However, CAL27 cells showed the greatest upregulation of 
chemokines including CCL3, CCL11, CCL16, CCL17, CCL18, CXCL10, XCL1, and 
particularly CXCL11 and CX3CL1.  In contrast, H357 cells showed few changes in 
chemokine expression but was the only cell line in which CCL21 was highly expressed 
(NEV 2.3).  The expression pattern in FADU cells showed some similarities with 
CAL27, notably downregulation of CCL1, CCL4, CCL8, CCL14, CXCL13, CXCL14 and 
upregulation of CCL18 and XCL1.  TR146 cells also showed some similarities to CAL27 
cells particularly in their C-X-C chemokine profile: both cell lines showed low 
expression of CXCL7 and CXCL13, with high expression of CXCL10 and CXCL11.  
Again the SV cell line demonstrated a unique pattern of chemokine expression: CCL1, 
CCL4, CCL7, CCL17, CCL18, CCL22, CCL24, CXCL7, CXCL8, CXCL13, XCL1 and 
particularly CCL20, CXCL1, CXCL2 and CXCL3 were all downregulated.  SV was the 
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only cell line to show high expression of CCL2.  A summary of these changes is given 
in Table A3.3. 
 
 
Table A3.3:   Summary of Significant Changes of Chemokine Normalised Expression 
Values in Oral Cell Lines 
 SCC4 SCC25 CAL27 H357 FADU TR146 SV 
CCL1 ▼ ▼ ▼ ▼ ▼ ▼ ▼ 
CCL2 ▼ ▼ ▼ ▼   ▲ 
CCL3  ▼▼ ▲     
CCL4  ▼ ▼  ▼ ▲ ▼ 
CCL5     ▲   
CCL7  ▼ ▼    ▼ 
CCL8  ▼ ▼  ▼   
CCL11  ▼ ▲  ▼ ▼  
CCL13     ▼   
CCL14   ▼  ▼   
CCL15        
CCL16  ▼ ▲     
CCL17 ▼  ▲   ▼ ▼ 
CCL18  ▼ ▲  ▲  ▼ 
CCL19   ▼ ▼    
CCL20     ▲  ▼▼ 
CCL21  ▼ ▼ ▲    
CCL22   ▼    ▼ 
CCL23 ▼   ▼    
CCL24  ▲ ▼ ▼  ▼ ▼ 
CCL25        
CCL27      ▼  
CXCL1 ▼▼ ▼▼     ▼▼ 
CXCL2 ▲ ▲    ▼ ▼▼ 
CXCL3 ▲ ▲     ▼▼ 
CXCL4     ▼   
CXCL5  ▼  ▲ ▼   
CXCL6        
CXCL7  ▼ ▼   ▼ ▼ 
CXCL8     ▲ ▼ ▼ 
CXCL9        
CXCL10   ▲   ▲  
CXCL11 ▼  ▲▲  ▼ ▲  
CXCL12 ▼       
CXCL13   ▼  ▼ ▼ ▼ 
CXCL14 ▼  ▼  ▼   
XCL1 ▼ ▼ ▲  ▲  ▼ 
CX3CL1   ▲▲  ▼   
 
Representation of changes in NEV in oral cell lines.  This table is derived from data presented in 
Figures A3.4a&b (Appendix 3).  Legend: ▲ = upregulation 2-5 fold, ▲▲ = upregulation greater 
than fivefold, ▼= downregulation 2-5 fold, ▼▼ = downregulation greater than fivefold. 
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A3.4  Discussion of experimental techniques 
A3.4.1  Selection of established cell lines 
The derivation of the established OSCC cell lines used in these experiments is 
reasonably well documented in the literature (details given in Chapter 2.1.1).  It is 
tempting to hypothesise that cell lines derived from primary tumours and metastases 
show changes in gene expression levels principally attributable to either these 
phenotypic characteristics or their anatomical location of origin (or both).  However, 
this supposition is flawed for a number of reasons:  Firstly, the accuracy of 
representation of the original tumour by the cell line is unclear.  While some authors 
maintain that cell lines are well representative of (at least specific fractions of) the 
tumours they were derived from (Mackenzie 2005), not all literature is in agreement 
(Prime, Nixon et al. 1990).  Secondly, an investigation of a large number of tumours 
would be required to determine any consistent patterns of gene expression.  While this 
experiment investigated six established OSCC cell lines other authors have been more 
ambitious using lines derived from OSCC clinical specimens (Hunter, Thurlow et al. 
2006).   
 
It is tempting to attribute changes in gene expression to clinico-pathological 
parameters relating to the index patient for each cell line.  However, this reasoning is 
flawed for the reasons given above.  Consequently, now that the in-vitro gene 
expression profile for these established OSCC cell lines has been determined, the 
logical progression would be to investigate their associated in-vivo phenotype using a 
suitable animal model.  Interestingly some data are available in the literature:  Prime et 
al inoculated athymic mice (Balb/C, nu/nu) with the H357 cell line and found it to be 
non-tumorigenic (possibly due to Smad3-mediated TGFβ1-induced growth inhibition) 
(Prime, Eveson et al. 2004; Pring, Prime et al. 2006).  However, as the H357 cell line 
demonstrates, cells may grow well in culture but not in-vivo.  This is most likely due to 
changes in their transcriptome (and consequently in their phenotype) induced by 
factors in the tumour/tissue microenvironment such as cytokines and hypoxia.  These 
variables are easier to control in-vitro than in-vivo but investigation by the former may 
allow better planning of the latter.  An interesting experiment to perform using the 
H357 cell line would be observation of the invasive/metastatic patterns of clones with 
and without the CXCR4 construct.  This would allow a more direct measure of the 
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influence of CXCR4 on the multistep process of metastasis (Fidler 2003).  Studies with 
similar methodologies have recently been performed on other carcinomas including 
oral squamous (Uchida, Begum et al. 2004), pancreatic (Saur, Seidler et al. 2005), non-
small cell lung (Phillips, Burdick et al. 2003; Su, Zhang et al. 2005) and prostate (Sun, 
Schneider et al. 2005) as well as melanoma (Murakami, Maki et al. 2002).   
 
An alternative approach has also been described in which nude mice have been 
orthopically inoculated with OSCC cell lines and then tumour cells harvested from 
resultant metastatic deposits (Zhang, Liu et al. 2002; Chen, Zhang et al. 2003; Wang, Xi 
et al. 2004).  This process was repeated several times thereby creating a form of in-vivo 
“passaging” of OSCC cells.  The authors argue that subsequent “passages” should 
increase the expression of genes associated with metastasis.  However, this 
methodology is flawed because it cannot distinguish between association and 
causation.  What would be more informative is insertion of candidate genes identified 
in these experiments into cell lines and a comparison made between their metastatic 
behaviours. 
 
 
A3.4.2  Cell culture methodologies 
The aim of these experiments was to determine the expression of chemokines and their 
receptors in established OSCC cell lines and to compare them with primary cultures 
derived from normal keratinocytes.  The validity of this comparison is dependent on 
two biological assumptions:  Firstly that the NOK sample was really representative of 
normal oral mucosal tissue.  Secondly that the total RNA extracted from the primary 
cultures was representative of the keratinocyte population (rather than the fibroblast 
feeder layer).   
 
The primary NOK culture used was derived from gingival tissue excised during the 
routine removal of human lower third molar teeth.  Clinical information regarding the 
indications for dental extraction was not available.  However, it is possible that either: 
i) pathological processes (for example inflammatory conditions such as recurrent 
pericoronitis) were present in the soft tissues around these teeth at the time of tissue 
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harvesting;63 or ii) that the gene expression profile of the NOK sample might have been 
changed from its in-vivo state by the selection and expansion in-vitro over a couple of 
passages.  If these were the case then it might be hypothesised that inflammatory 
changes present in the donor tissues would be represented in the transcriptomes of the 
primary keratinocyte cultures derived from them.  However, a couple of levels of 
empirical microarray data do not support this:  Firstly, expression of pro-inflammatory 
chemokines was low in the NOK sample.  Secondly, a similar pattern of gene 
expression was shown for NOK and NSK (harvested from normal skin during breast 
reduction) both overall (Figure A3.2, Appendix 3) and particularly for chemokines 
(Figure A3.3, Appendix 3) and their receptors (Figure 3.1, Chapter 3).  A third method 
would be to use pathways analysis to investigate expression levels of mediators of pro-
inflammatory signalling pathways in the NOK (or NSK) samples.  The latter method is 
limited by the fact that gene transcription (measured by the microarray) does not 
always accurately represent protein translation or kinase activation, both of which 
require carefully timed analysis with Western blotting to determine their precise 
activity. 
 
Two complimentary methods were used to minimise 3T3 fibroblast genetic 
contamination: Firstly microscopic examination was performed to determine the 
impact of mitomycin treatment on cell attachment with time.  Secondly as the feeder 
layer was originally derived from an albino Swiss mouse embryo its reactivity with the 
human cDNA array was likely to be reduced.  One limitation was that this cross-
reactivity could not be determined empirically and no data were available from the 
manufacturer.  FACS methodologies (used elsewhere in this thesis) were considered as 
adjuncts in the process of cell separation.  Basic FACS analysis could be used to sort 
cell populations based on differences in cell size / granularity.  However, complete 
separation based on these parameters alone requires distinct populations of cells or 
otherwise the intermediate group will be discarded.  This may be overcome by 
labelling with monoclonal antibodies against fibroblast-specific cell surface markers.  
However, this technique is dependent on a number of incubation and wash steps 
during which gene expression profiles may alter in an unpredictable fashion.  
Consequently the methodology used was a compromise between cell selectivity and 
                                                     
63 According to the 2001 NICE guidelines for the removal of third molar teeth the only 
indication for the removal of asymptomatic wisdom teeth in the absence of pathology is prior to 
orthognathic surgery (http://guidance.nice.org.uk/TA1/guidance/pdf/English) 
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maintaining the cells in optimal growing conditions until the total RNA was harvested.  
The use (and ultimate concordance) of the duplicate samples provided evidence that 
this strategy was reasonable and reproducible. 
 
Factors such as serum supplementation can have a significant effect on global gene 
expression profiles (Iyer, Eisen et al. 1999).  Consequently, in order to minimise the 
effect of potentially confounding variables, the culture conditions used were 
standardised. 
 
 
A3.4.3  Comparison of microarray and sqRT-PCR data 
When a comparison is made between the relative expression values of mRNA species 
generated by sqRT-PCR and microarray it is important to consider that each data set 
have been normalised in different ways.  Semi-quantitative RT-PCR data is calculated 
relative to expression in a defined species (in this case normal oral keratinocytes) and 
the data transformation is simple.  However, expression levels for individual genes 
derived from microarray data are calculated relative to a normalised mean for each 
array.  This value is determined from the expression levels of all the genes represented 
on the array.  Microarray expression data for individual genes can be viewed as 
quantitative (rather than semi-quantitative).  This is based on one of the key 
assumptions of microarray data processing: that global expression profiles for each 
sample are both similar and normally distributed.  Analysis of these data shows that 
both these conditions are met (Figure A3.1).  Therefore it is assumed that variations in 
signal strength between samples are due to variations in hybridisation efficiency.  
Internal controls within the microarray methodology lend validity to this assumption 
by measuring hybridisation efficiency across the entire surface of the array.  Therefore 
comparing quantitative microarray data with sqRT-PCR results for single genes can be 
misleading if mRNA expression in the normalising sample for PCR (in this case NOK) 
does not equal 1 as determined by microarray.  This was demonstrated with all genes 
compared although the greatest difference was found with XCR1 where the microarray 
NEV in NOK was 1.70.  This problem can be addressed by redefining the NEV in NOK 
is as equal to 1.00 and performing the simple mathematical transformation to the other 
expression data to generate relative NEVs.  When this is performed there is a 
significant linear correlation between the data obtained by microarray and sqRT-PCR, 
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but only when the log of each value is plotted.  Why this is dependent on a logarithmic 
function is not obviously clear.  It seems most likely that, due to technical constraints 
and the post-hoc mathematical transformations involved, the dynamic range available 
to microarray data does not match that of the sqRT-PCR system.  What is irrefutable is 
that the pattern of gene expression derived from each technique is similar.  
Furthermore this occurs across a variety of genes tested and across a wide range of 
values (Figure 3.7, Chapter 3). 
 
One criticism of the methodologies used to determine mRNA expression is the reliance 
on commercial products.  It was assumed that the primer/probe sets for both the 
microarrays and sqRT-PCR reactions were appropriate and correct.  This could have 
been tested using conventional RT-PCR reactions using self-designed primers and 
subsequent sequencing of the reaction product.  In this way the results could have been 
confirmed by comparison to known sequences, although relative quantification of the 
results would have been more difficult. 
 
 
A3.4.4  Flow cytometry and FACS 
Flow cytometry was used with the specific aim to study chemokine receptor protein 
located on the surface of cells.  Specific methodologies were used to maximise the 
validity of the results:  Firstly, non-enzymatic dissociation was performed to ensure 
surface proteins were minimally disturbed.  Secondly, all incubation steps were 
performed on ice to maintain cellular integrity and minimise chemokine receptor 
internalisation.  And finally, a DNA fluorochrome (propidium iodide) was used to 
enable the gating out of cells that did not have an intact cell membrane. 
 
The results from the flow cytometry experiments were represented as histograms of 
cumulative frequency comparing labelled and unlabelled (isotype control antibody) 
populations.  There is debate in the literature regarding the presentation of data in this 
format.  Certainly these histograms do not represent variations in size, granularity and 
variations in propidium iodide staining.  However, as the cell populations are 
previously gated on these variables, the use of histograms is justified to represent the 
single variable under investigation.  In certain established cell lines, CXCR4 surface 
expression is clearly detectable in excess of levels of cell autofluorescence.  However, 
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while some authors would advocate the use of subtraction histograms in these 
situations (Overton 1988; Lampariello 1994), these have not achieved widespread 
acceptance in the literature. 
 
Flow cytometry yields data pertaining to the frequency of positive cells (percent 
positive) and the density of surface staining (mean fluorescence).  For comparison 
between cell lines I have used the latter variable.  This is because both the fluorescence 
distribution determined by flow cytometry and the qualitative findings of 
immunocytochemistry suggested that the staining within cell lines was homogenous.  
However, not all of the published literature is in agreement with other authors quoting 
the overall percentage of positive cells.  My criticism of this is that these data condense 
the large number of cells analysed into one figure.  The calculation of this figure is 
dependent on the (arbitrary) threshold of surface protein labelling at which a cell is 
termed “positive”.  This does not take into account of variation in surface receptor 
density and the biological significance of this.  Condensing these values into a single 
variable (mean fluorescence) is also highly reductionist, however, the histogram plots 
clearly better represent the biological variation between individual cells within the 
population examined.   No summary data are perfect, but I felt that mean fluorescence 
was a better tool than percentage positive for descriptive purposes.  However, 
comparison with published data using other variables is more difficult to interpret. 
 
Regarding the choice of monoclonal antibody, the 12G5 clone was one of the first 
described and has been the most widely used.  Recently its use in routine clinical 
practice for the staging of haematological malignancies has been advocated (Burger 
and Burkle 2007).  However, binding of the 12G5 clone to the first and second 
extracellular loops of CXCR4 is conformation dependent (Brelot, Heveker et al. 1997).  
Consequently, as CXCR4 exists in at least two conformational subtypes, it has been 
argued that the 12G5 clone underestimates monoclonal antibodies and that clone 44717 
(MAB#173, R&D Systems), which binds to many conformational shapes exclusive to 
CXCR4, is better suited to flow cytometry (Baribaud, Edwards et al. 2001).  From these 
findings it was decided to use clone 44717 in these experiments. 
 
Not all published studies routinely gate out cell without an intact cell membrane 
(Samara, Lawrence et al. 2004; Hosokawa, Hosokawa et al. 2005).  However, omission 
of this step potentially skews results by the incorporation of non-viable cells.  As 
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chemokine receptors are actively cycled to and from the surface membrane, when this 
membrane integrity is lost measurement of the intracellular “reservoir” of receptor 
protein may confound results.  Several compounds have been used to probe membrane 
integrity: propidium iodide, ethidium homodimer-1, the cyanine Yo-Pro and the 
bizbenzimidazole Hoechst 33258.  Of these, propidium iodide is the most common 
technique described in the literature with widespread use in flow cytometry associated 
with apoptosis assays (Smolewski, Grabarek et al. 2002) and fertility assessment 
(Gillan, Evans et al. 2005). 
 
FACS techniques were employed to select transfected cells producing high levels of 
CXCR4 surface protein.  This had the double benefit of ensuring that a “clean” 
population of high expressing cells was being used in the experiments (particularly 
important when performing functional assays) and speeding up the time required to 
create a pool of such cells (rather than wait for clonal expansion).  One methodological 
modification might have been to include a GFP reporter in the transfection cassette.  
This would have allowed direct sorting by FACS (without the need for antibody 
labeling) and direct viewing of cells containing the cassette in culture.  In this way cells 
that had expelled the transfection vector could be identified and excluded by a 
mechanism complimentary to antibiotic selection.  However, in a mixed population of 
transfected cells with and without the CXCR4 construct, this methodology would be 
unable to distinguish between the populations. 
 
 
A3.4.5  Immunocytochemistry and Immunohistochemistry 
While tissue culture techniques are excellent tools by which individual experimental 
parameters may be manipulated, they do not provide data on the complex spatial 
arrangement between living cells in-vivo.   Cell-cell relationships in-vitro can be 
investigated at the protein level using immunocytochemistry or at the mRNA level 
using in-situ hybridization.   However, while potentially providing good quality 
qualitative data, both techniques have their limitations. 
 
One drawback of immunocytochemistry is that the resultant image is inevitably a two-
dimensional representation of a three-dimensional structure.  To address this issue two 
strategies were employed: Firstly counterstains were used to delineate the nuclear 
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compartment of the cells.  This allows a comparison of the distribution of protein 
staining throughout the cell with the outline of the nuclear structures.  However, their 
relative relationship cannot be absolutely determined in this way using conventional 
microscopy.  Consequently a second strategy using confocal microscopy was 
performed to divide the image into separate slices optically.  The pattern of staining in 
images generated using this technique were less likely to suffer from the confounding 
effect of overlay and were therefore likely to be more representative of the actual 
intracellular protein distribution.   
 
While this technique yields extraordinary optical clarity it still depends on visual 
resolution to determine the spatial relationship between CXCR4 localisation and cell 
ultrastructure.  Further methodologies could have been used to define this relationship 
more clearly.  For example, double-labelling of sections with antibodies against 
components of the cell membrane, nuclear membrane and other cell organelles would 
permit accurate visual co-localisation of CXCR4 staining within the cell.  While the 
methodologies of these multi-labelling studies are well described, the precise protocols 
require meticulous optimisation of preparation and antibody incubation steps.  
However, once achieved, it is reasonable to suggest that the protocols would be similar 
for most cultured cells and the multi-channel image data generated would yield 
powerful results.  This limitation of the current work is one that would lend itself well 
to further study. 
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A4.1  Preliminary investigation of CXCR4 staining in OSCC 
clinical specimens using immunohistochemistry 
Preliminary experiments were carried out with tissue blocks selected from the clinical 
resection specimens of ten patients (Table A2.3, Appendix 2).  Each specimen 
comprised of matched primary tumour and lymph node metastases excised from the 
same patient in continuity.  Matched, adjacent, histologically normal mucosa was also 
examined where available.  Lymph node parenchyma served as an internal positive 
control.   
 
Three representative cases are reproduced here.  Results from a pT2N1Mx tumour 
originating at the lateral border of the tongue are shown in Figure A4.1.64  CXCR4 
staining of occasional basal keratinocytes together with some intra-epithelial and 
stromal cells (which had a lymphocytic morphology) was demonstrated in adjacent 
normal tissue (panels a & c).  Endothelial cells within the adjacent normal mucosa were 
also stained positively (compared with isotype controls - panel e).  Heterogeneous, 
moderate CXCR4 staining within the primary tumour (panels g, i & k) was found with 
a predominantly nuclear distribution.  Some tumour islands demonstrated more 
intense cytoplasmic staining (black arrows, panel i).   Within the associated lymph 
node metastases tumour cells of varying differentiation were seen.  While the 
pathology report comments on the extracapsular spread of tumour from this lymph 
node, this is not represented on these sections.  Once again a similar heterogeneous 
pattern of moderately intense nuclear CXCR4 staining of tumour cells (panels h, j, & l) 
was observed, although some cytoplasmic staining was also identified (black arrow, 
panel j).  The intensity of CXCR4 staining did not obviously vary with the degree of 
tumour cell differentiation within the lymph node.  Intense CXCR4 staining within the 
lymph node lymphocyte population was demonstrated (panel n). 
 
                                                     
64 pT2N1Mx denotes that the TNM staging was informed by histopathological examination of 
the resection specimen (primary lesion and associated modified radical neck dissection). 
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Figure A4.1:  CXCR4 immunohistochemistry of a T2N1 OSCC clinical specimen (continued 
overleaf).  Tissue sections taken from a single surgical specimen were stained with monoclonal 
antibodies to CXCR4 (a, c, g - l & n) or isotype controls (b, d - f, m) as outlined in Section 2.7.  
Sections from adjacent normal mucosa (a, c & e), primary tumour (b, g, i & m) and 
corresponding lymph node metastasis (d, f, h, j, l & n) are shown.  Black arrows (panels i & j) 
demonstrated cytoplasmic staining of tumour cells in the primary lesion and lymph node 
secondary.  For further details see text.  Scale bar represents 100μm (a, b, d – h & m) or 50μm (c, 
i – l & n). 
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Figure A4.1 (continued) 
  
For legend see previous page. 
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Sections from a pT2N2bMx lateral tongue OSCC with extracapsular lymphatic spread 
were also stained for CXCR4.  Representative images are shown from the primary 
lesion and a lymph node metastasis in Figures A4.2a and A4.2b respectively.  Within 
the primary lesion a heterogeneous CXCR4 staining pattern was observed with cells 
variably demonstrating predominantly cytoplasmic (black arrows), nuclear (white 
arrows) or no CXCR4 labelling. Within the associated lymph node metastasis 
(demonstrating extracapsular spread) CXCR4 staining was again observed in both the 
cytoplasmic and nuclear compartments. Staining with isotype control antibodies 
demonstrated no non-specific binding for either the primary lesion or associated 
lymph node metastasis (panels e, f, k & l).   
 
Examination of a larger and locally invasive primary tumour was made.  Results from 
the pT4N2bMx tumour originating from tongue and floor of mouth are shown in 
Figure A4.3.  In a similar fashion to before, isotype controls demonstrated no evidence 
of non-specific binding (panel d).  Nuclear and cytoplasmic CXCR4 staining was 
evident in tumour cells (panels a and b).  The vascularity of the tumour was 
demonstrated on H&E staining (panel c) and CXCR4 labelling was noted in the 
endothelial cell cytoplasm.  A number of cells in the epithelium overlying the tumour 
stained positive for CXCR4.  Similar results were observed in the other seven cases 
examined. 
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Figure A4.2a:  CXCR4 immunohistochemistry of a T2N2b OSCC specimen showing the 
primary lesion (A4.2a) and associated lymphatic metastases (A4.2b) with extracapsular 
spread.  Tissue sections taken from a single surgical specimen were stained with monoclonal 
antibodies to CXCR4 (a - d) or isotype controls (e & f) as outlined in Section 2.7.  Sections from 
the primary tumour (a - f) and corresponding lymph node (g - l) were prepared.  For details see 
text.  White and black arrows highlight areas of nuclear and cytoplasmic staining respectively.  
Scale bar represents 100µm (a, c, e, f, g, k & l ) or 50µm (b, d, & h -j). 
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Figure A4.2b:  CXCR4 immunohistochemistry of a T2N2b OSCC specimen showing the 
primary lesion (A4.2a) and associated lymphatic metastases (A4.2b) with extracapsular 
spread.  Tissue sections taken from a single surgical specimen were stained with monoclonal 
antibodies to CXCR4 (a - d) or isotype controls (e & f) as outlined in Section 2.7.  Sections from 
the primary tumour (a - f) and corresponding lymph node (g - l) were prepared.  For details see 
text.  White and black arrows highlight areas of nuclear and cytoplasmic staining respectively.  
Scale bar represents 100µm (a, c, e, f, g, k & l ) or 50µm (b, d, & h -j). 
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Figure A4.3:  CXCR4 immunohistochemistry of a locally invasive T4N2bMx OSCC specimen.  
Tissue sections taken from a primary tumour resection specimen were stained with monoclonal 
antibodies to CXCR4 (a & b), isotype control (d) or H&E counterstain (c) as outlined in Section 
2.7.    For details see text.  Scale bar represents 250µm (c), 100µm (a & d) or 50µm (b). 
 
 
b) 
d) c) 
a) 
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A4.2   Design, validation and discussion of a semi-
quantitative method for analysing immuno-
histochemistry images. 
A4.2.1  Methodology 
The aim of these experiments was to compare immunohistochemistry staining using a 
robust, reproducible and unbiased method of assessment.  Tissue arrays were taken 
and stained for CXCR4 expression as per the optimised protocol outlined in Section 
2.7.  All sections were examined using a PC-driven conventional light microscope with 
dry and oil-immersion lenses (Zeiss).  Computer-controlled algorithms for focus, 
illumination and shutter speed were selected.  Photomicrographs of tissue array 
specimens were taken sequentially under standardised conditions and a 5µm graticule 
was photographed at all magnifications to define scale.  Images were assigned a 
randomised study number, carefully labelled, transferred to computer database and 
analysed using the Photoshop CS suite of software (Adobe).  All computer-based 
analysis was performed blind to the pathological diagnosis to obviate observer bias.   
 
A methodology was developed to standardise the measurement of staining intensity to 
permit comparison between specimens located on the same slide.  Firstly all 
photomicrographs were taken under standard conditions of magnification, colour 
balance and illumination (Figure A4.4a).  Secondly all isotype control slides were 
reviewed to ensure that no background or non-specific binding had occurred (Figure 
A4.4c).  Thirdly each immunostained photomicrograph was enlarged to a full screen 
size and nine separate locations were defined using a grid overlay (Figure A4.4b).  The 
single tumour cell on (or nearest) to each intersection point was selected and the 
nuclear and cytoplasmic components defined.  The yellow and magenta colour 
saturations for each selected cell (nucleus and cytoplasm) were assessed using the 
software colour analysis tool and tabulated in Microsoft Excel.  Nine areas of 
background (no tissue present) were selected using the grid system and analysed in a 
similar way.  In this way yellow and magenta colour saturations were obtained in a 
standardised fashion for nucleus, cytoplasm and background from 9 positions on each 
photomicrograph (sample data is represented in Figure A4.4d).  The variability of the 
raw data obtained was compared with the normal distribution using P-P plots to 
determine its suitability for summarisation and analysis with parametric statistical 
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methods.  Finally the mean background colour saturations for each slide were 
subtracted from each measured variable to give a background corrected score. 
 
Preliminary analysis revealed that the correlation between magenta and yellow colour 
saturation across the entire array was high: for background, cytoplasmic and nuclear 
staining R2 linear regression values were 0.521, 0.731 and 0.640 respectively (Figure 
A4.5).  For cytoplasmic and nuclear staining the mean ratio of yellow/magenta 
saturation was calculated to be 1.532 and 1.367 respectively suggesting that yellow 
saturation was the most sensitive marker of peroxidase activity.  The robustness and 
reproducibility of this method was tested in two ways:  Firstly observer consistency 
was measured by the selection of twenty slides at random.  Data were collected in the 
same manner as described previously and the results paired with their original 
counterparts.  For each variable recorded a scatterplot was generated linear regression 
performed and a R2 value calculated.  Secondly each clinical tumour sample was 
represented by two sections on the array.  A plot was made of the mean and standard 
deviation of the data derived from each replicate to give an indication of how robust 
the technique was.  To interpret the results, the blinding of samples was removed and 
background-corrected yellow saturation data was combined for each replicate pair.  
The mean and standard deviation was calculated for both nuclear and cytoplasmic 
components for each sample.  A scatterplot of nuclear staining against cytoplasmic 
staining was produced.  Subgroups were identified according to their tissue / tumour 
stage of origin.  
 
Data were generated from all of the images and P-P plots confirmed that these 
conformed to the normal distribution.  The repeat analysis of 20 images selected at 
random showed high levels of correlation (R2 > 0.95 for all variables).  When the 
blinding of samples was removed, data from those represented twice on the array were 
used to generate a scatterplot and regression line (Figure A4.6).  There was an excellent 
correlation between replicate data sets for both the cytoplasmic and nuclear 
compartments with R2 values of 0.85 and 0.68 respectively.   
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Figure A4.4: Image analysis and data tabulation for a semi-quantitative method of 
immunohistochemistry results.  Standardised individual images from CXCR4-stained tissue 
arrays were obtained as outlined in Sections 2.7 and A4.1 (panel a) and compared with isotype 
controls (panel b).  A grid with 9 intersections was overlaid and the magenta and yellow 
saturations were recorded for the background, cytoplasm and nuclear components nearest each 
intersection (panels b & d).  The mean background saturation was calculated and subtracted 
from each measured component.  Legend: M = % saturation of magenta; Y = % saturation of 
yellow; scale bar represents 250µm. 
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Figure A4.5: Scatterplots of magenta and yellow colour saturations.  Areas were selected on 
each slide on the tissue array (as outlined in Section 2.7).  Measurements of magenta and yellow 
colour saturation were made using a software colour analysis tool, tabulated and a scatterplot 
prepared for background (a), cytoplasm (b) and nuclear (c) components.  The conformity to a 
regression line was analysed and the gradient, intercept and R2 values calculated for each 
component (d). 
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Figure A4.6:  Scatterplot of colour saturations from replicate samples represented on tissue 
arrays.  Colour saturation data were collected blind to tissue of origin as described in Section 
2.7.  Mean values (points) and standard deviations (error bars) from replicate samples were 
plotted for the cytoplasmic (a) and nuclear (b) compartments.  R2 values were 0.85 and 0.68 
respectively.  The respective line gradients were 0.912 and 0.993. 
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A4.2  Discussion of Experimental Procedures 
A4.2.1  Selection of techniques 
Although complex in-vivo monitoring techniques (such as intravital microscopy) are 
described and available, immunohistochemistry remains the mainstay of investigative 
techniques that focus on tissue morphology and the cellular interactions within it.  To 
build up a robust “picture” it is necessary to examine a number of repeat samples with 
this technique.  However, there are a number of methodological difficulties associated 
with immunohistochemistry that may significantly bias the results it generates.  These 
can be broadly grouped into two main categories: 1) experimental methodology; and 2) 
interpretation of results.   
 
 
A4.2.2  Immunohistochemical experimental methodology 
Methodological problems associated with immunohistochemistry are predominantly 
due to the wide number of experimental factors that may influence the pattern and 
intensity of colour generation.  These include variations in specimen selection, sample 
processing, slide preparation, antigen unmasking, antibody concentration, wash 
efficiency and duration of colour development.  For repeat experiments these variables 
can be difficult to standardise precisely.  
 
One of the limitations of using archived tissue is that the investigator must make 
several assumptions that cannot be tested empirically.  These include methodological 
steps such as tissue processing and handling, as well as clinical and pathological 
diagnoses.  For example, is tissue labelled as “normal oral mucosa” really normal oral 
mucosa?  It is possible that this tissue was derived from specimens taken for diagnostic 
purposes (probably with a visible lesion) but in which no histological abnormality 
could be detected by conventional light microscopy.  However, short of harvesting 
control tissue from healthy, age- and sex-matched consenting adults, this limitation is 
difficult to overcome.  Assumptions regarding the processing of tissues must also be 
made.  Including the provision of research samples in routine patient management 
would help standardise this process and facilitate access by more sensitive techniques 
such as laser-capture microdissection with sqRT-PCR or in-situ hybridisation.  
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Although immunohistochemistry techniques are not so sensitive to variations in tissue 
handling, the standardisation of surgical sample processing will undoubtedly reduce 
variability in the results (Werner, Chott et al. 2000).65 
 
Immunohistochemistry slides derived from formalin-fixed paraffin-embedded (FFPE) 
tissue blocks are often dependent on techniques of antigen retrieval.  These require 
careful optimisation against known positive and negative controls.  From the early 
literature pertaining to CXCR4 many techniques of antigen retrieval were described 
including microwave heating (Schrader, Lechner et al. 2002), pressure cooking (Sun, 
Wang et al. 2003; Katayama, Ogino et al. 2005) or other unspecified methods (Muller, 
Homey et al. 2001).  Using tonsillar sections it was determined empirically that the 
pressure cooking method using commercially available antigen-unmasking solutions 
produced the most reproducible results for antigen retrieval.  One method employed 
to reduce variability in this stage was to prepare samples in batches.  This has the 
benefit that separate slides were exposed to identical conditions but would not 
overcome variations in the later stages of washing, antibody incubation or staining.  To 
achieve this multiple samples must be mounted on single slides.  The presentation of 
samples in this format is provided by tissue arrays.  
 
The majority of my immunohistochemical results were derived from tissue arrays.  The 
processing of multiple tissue samples on one slide removes the effect of the majority of 
potentially confounding experimental factors listed above.  The problem of sample 
processing (the transfer from patient to stabilization in fixative) remains difficult to 
address in samples not specifically taken for research purposes.   
 
 
A4.2.3  Interpretation of immunohistochemistry 
The interpretation of immunohistochemistry results has been the subject of much 
debate within the literature.  Numerous methodologies have been described regarding 
the assessment and grading of CXCR4 immunohistochemistry results although these 
are predominantly for tumour tissues other than OSCC.  Unfortunately, not all authors 
are assiduous with their description of their experimental methodologies: particularly 
                                                     
65 Derived from the report of the first meeting of the International Consensus Group on 
Standardisation and Quality Control (ICGSQC), Nice, France, 2000 
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the immunohistochemical protocols, rationale for interpretation, justification of scaling 
system and minimisation of observational bias.  Most of the published work on CXCR4 
in OSCC falls into this category which makes its credibility difficult to establish 
(Uchida, Begum et al. 2003; Delilbasi, Okura et al. 2004; Uchida, Begum et al. 2004).  
Other work defines a dichotomy (either positive or negative) dependent on whether 
greater than a defined percentage of cells demonstrate visible staining (Ishikawa, 
Nakashiro et al. 2006).  My criticisms of this approach are that it is over-simplistic and 
the threshold is completely arbitrary.   
 
My in-vitro results have shown that different OSCC cell lines demonstrate variable 
degrees of CXCR4 protein production in their nuclear and cytoplasmic compartments 
as well as on the surface membrane.  Whether this reflects normal protein assembly 
and transport, receptor cycling or pathological processes is unclear from these data.  
However, at a simplistic level, it can be hypothesised that the cell responsiveness to 
exogenous SDF is, at least partly, defined by the density of functional CXCR4 protein 
on the cell surface membrane.  While immunohistochemistry does not give insight into 
protein functionality, it does yield qualitative data on protein localisation.   
 
Many authors have described systems by which immunohistochemical image data can 
yield quantitative results.  These scoring systems range from a simple four-point scale 
(Katayama, Ogino et al. 2005) to complex systems that attempt to combine parameters 
for both staining location (nuclear versus cytoplasmic) and intensity (Cabioglu, Yazici 
et al. 2005; Retz, Sidhu et al. 2005; Su, Zhang et al. 2005; Su, Wu et al. 2005).  All of these 
scoring systems can be criticised due to their subjective interpretation.  Using multiple 
observers either concurrently or consecutively is a strategy by which the subjectivity is 
shared but not eliminated (Maxwell and McCluggage 2000).  The system I have 
described was developed to try and address this lack of objectivity and allow these 
biological systems to be analysed with parametric (rather than categorical) variables.  
Objective measurements of colour saturation were determined using points defined by 
a standardised grid.  The mean and standard deviation were calculated for each data 
set.  One drawback of this technique might be if the staining pattern was highly 
heterogeneous.  This would result in data sets that did not conform to the normal 
distribution and had wide variability relative to the mean.   Probability plots suggested 
that all data sets conformed to the normal distribution although it is important to stress 
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that the numerical results generated are complimentary to (but do not replace) the 
qualitative interpretation of the slides. 
 
Concerns regarding the reproducibility of the technique were tested using a second 
random sample set of 20 images.  R-squared66 values exceeding 0.95 for all variables 
tested suggested the method was both robust and highly reproducible.  Some authors 
aim to address the issue of subjectivity by multiple assessments by “independent” 
observers (Katayama, Ogino et al. 2005)67 and this technique could have been used to 
test for inter-observer variation in these experiments.  Another potential source of bias 
(especially in more subjective methods) is awareness of the clinicopathological details 
when assessing the staining pattern.  Most authors describe blinding techniques to 
overcome this and this was also performed in these experiments.  
 
 
A4.2.4  Alternative techniques 
Techniques to identify mRNA species within histological sections of clinical tissues are 
well described.  These include in-situ hybridization and laser-capture microdissection 
(LCMD) in association with sqRT-PCR.  The former yields qualitative data on the 
spatial distribution of mRNA transcripts and is a useful compliment to 
immunohistochemistry.  The latter can be used to identify multiple transcripts (with 
the use of multiplexed PCR) and provides (semi) quantitative data on cellular subsets 
identified visually.   
 
It was my intention to perform LCMD with multiplexed sqRT-PCR on the same 
archived FFPE sections of OSCC investigated with immunohistochemistry.  However, 
preliminary experiments revealed that the yield of housekeeping gene mRNA was too 
small and too variable to allow meaningful comparison or further investigation in 
combination with laser-capture.  Although these techniques are well described in the 
literature (Stanta, Bonin et al. 1998; Lehmann and Kreipe 2001; Macabeo-Ong, 
Ginzinger et al. 2002), they are highly dependent on the speedy handling of the clinical 
                                                     
66 Linear regression was selected as the technique to investigate measurement reproducibility 
because of the parametric nature of the data.  Kappa statistics are inappropriate in this case for 
two reasons: Firstly the data are not categorical; and secondly it examines observer 
independence (not valid in this case because the same person did the evaluation both times).. 
67 No kappa-correlation coefficients were published in this paper. 
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samples ex-vivo to prevent degradation of mRNA species by RNases.  The most likely 
interpretation of my preliminary results was that the timing of tissue fixation was 
highly variable between specimens.  It was therefore likely that in-situ hybridisation 
techniques would be difficult to optimise in these FFPE specimens.   
 
Without doubt clinical material is fundamental to the interpretation of results derived 
from in-vitro experiments.  However, ethical and tissue storage issues aside, the 
interface between clinican and laboratory investigator is key in securing material of use 
to researchers.  The potential conflict between diagnostic interpretation and the early 
stabilisation of research samples must be addressed at a local level if highly technique 
sensitive methodologies (such as LCMD and microarrays) are to be able to produce 
meaningful results. 
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A5.1  Transfection optimisation 
A5.1.1  Characterisation of the donated plasmid 
Experiments were performed using the methodology outlined in Section 2.4.11.  
Optimisation of the transfection reaction was performed using the pcDNA3.1-lacZ 
control plasmid.  Initially, JM109 competent cells were transformed with the plasmid 
with a calculated efficiency of 5.8 x 106 cfu/μg of DNA added.  Single colonies were 
selected on the basis of blue staining and the DNA was extracted following overnight 
incubation.  Restriction enzyme digestion was performed to confirm the presence of 
the pcDNA3.1-lacZ plasmid (Figure A5.1).  A panel of restriction enzymes were used: 
BCl1 was predicted to cut once at 8540 base pairs although two bands were seen on the 
gel at 9333 and 25600 bp.  It is likely that the former represents plasmid that has been 
cut once and made linear, while the latter, smaller band would be consistent with 
plasmid that has either retained or re-annealed to form its original circular structure.   
EcoR1 was expected to cut the plasmid twice, yielding fragments of 3023 and 5517 base 
pairs.  Sal1 was also predicted to cut twice (fragments 2188 and 6352 base pairs) and 
Nco1 was expected to cut three times (fragments 735, 3347 and 4458 base pairs).  
Results obtained correlated very closely with predicted values confirming the presence 
of the correct plasmid in the clone tested. 
 
 
A5.1.2  Charge Ratio 
The effect of charge ratio on transfection efficiency was investigated.  For the charge 
ratios 1:1, 1.5:1 and 2:1 (TransFast reagent volume to DNA volume) there was a trend 
towards the 1:1 ratio being the most efficient, although the difference was not 
statistically significant (Figure A5.2).  This occurred over a range of DNA 
concentrations between 0.2 and 0.8 µg per well.  Consequently the 1:1 TransFast to 
DNA ratio was used for further experiments.  Interestingly, an approximately linear 
relationship between β-Galactosidase reporter activity and DNA added was noted for 
the concentration range used in this experiment.  Further experiments were performed 
to investigate the effect of adding more than 0.8 µg of DNA per well. 
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5.1.3  Amount of DNA added 
Further experiments were performed to determine the relationship between the 
amount of DNA added per well and the overall efficiency of the transfection reaction 
(Figure A5.3).  From a range of starting DNA concentrations (0 to 2.0 µg per well) it 
was shown that β-galactosidase reporter activity was approximately linear over the 
range of 0.2 to 1.5 µg of DNA per well.  Further addition of DNA did not result in 
significantly greater transfection efficiency (p>0.05).  Qualitative evidence supporting 
this finding is provided by direct visualisation of β-galactosidase reporter activity in 
H357 cells transfected with pcDNA3.1-lacZ DNA in concentrations ranging from 1.0 to 
2.0 µg per well (Figure A5.4).  A very low level of background or endogenous β-
galactosidase activity as seen in pcDNA3.1vB transfected negative controls confirms 
the results from the quantitative methods used. 
 
 
5.1.4  Exposure Time 
A final set of experiments were done to determine the relationship between 
transfection incubation time and transfection efficiency (Figure A5.5).  A range of 
incubation times from 30 minutes to 2 hours were investigated.  Greatest β-
Galactosidase reporter activity was shown for one hour incubations.  Shorter or longer 
incubation steps resulted in significant reductions in transfection efficiency (p<0.05). 
 
 
A5.2  Antibiotic Selection 
The antibiotic G418 was found to be toxic to wild-type H357 cells in a dose-dependent 
manner (Figure A5.6).  At lower concentrations (<800 µg/ml) the effects on wild-type 
H357 cells were less at 72 hours than at 48 hours when compared with no-treatment 
controls.  However, at concentrations of 1200 µg/ml and above further reductions in 
cell survival were seen at the 72 hour time point.  A G418 concentration of 1600 µg/ml 
achieved the aim of 90% wild-type cell killing after 72 hours.  Consequently, 1600 
µg/ml was the concentration of G418 used to apply positive selection towards the 
transfected clones. 
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Figure A5.1:  Gel electrophoresis and tabulation 
of observed and expected band sizes following restriction enzyme digestion of the 
pcDNA3.1-lacZ plasmid.  Restriction enzyme digestion products from the pcDNA3.1-lacZ 
plasmid run on 0.75% agarose gel against a 1kbp DNA ladder.  Results show two bands for the 
restriction enzyme BCl at 25600 and 9333 base pairs (predicted one band at 8540 bp).  The 
remaining digestions are as predicted: EcoR1 reveals two bands (5300 and 3200 base pairs), 
Nco1 three bands (4214, 3233 and 717 base pairs), and Sal1 two bands (5500 and 2181 base 
pairs).  All fragments correspond closely in size with those predicted in-silico.  Legend:  LD = 
GeneRuler 1 kbp DNA ladder, BCl = BCl1, Eco = EcoR1, Nco = Nco1, Sal = Sal1.  
 
Observed & Expected band sizes 
Restriction 
Enzyme 
BCl Eco Nco Sal 
Observed 
25600 
9333 
5300 
3200 
4214 
3233 
717 
5500 
2181 
     
Expected 
8540 5517 
3023 
4458 
3347 
735 
6352 
2188 
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Figure A5.2:  The effect of Charge Ratio on Transfection Efficiency over a range of DNA 
concentrations:  Plot of Beta-Galactosidase activity against the amount of DNA added per well.  
Beta-galactosidase activity was measured as a reporter of transfection efficiency.  Wild-type 
H357 cells were incubated with 1:1, 1.5:1 and 2:1 charge ratios of TransFast reagent volume to 
pcDNA3.1-lacZ volume for one hour over a range of DNA amounts added per well.  Bars 
represent the mean (standard deviation) of β-Galactosidase activity from six wells each 
measured in duplicate.  The 1:1 ratio appears to give the greatest transfection efficiency over a 
range of DNA concentrations, although statistical significance was not achieved (p>0.05, 
ANOVA with Bonferroni correction).  The graph shows one representative experiment of three 
performed.  
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Figure A5.3:  The effect of DNA concentration on Transfection Efficiency:  Plot of Beta-
Galactosidase activity against the amount of DNA added per well.  Beta-galactosidase activity 
was measured as a reporter of transfection efficiency following incubation of wild-type H357 
cells for one hour with a range of pcDNA3.1-lacZ DNA amounts added per well.  A 1:1 charge 
ratio of TransFast reagent to DNA volume was used.  Bars represent mean (standard deviation) 
of β-Galactosidase activity from six wells each measured in duplicate.  Transfection efficiency 
increases approximately linearly with the amount of DNA added up to 1.5 µg/well.  Further 
increases in DNA concentration do not result in statistically significant increases in transfection 
efficiency (p>0.05, ANOVA with Bonferroni correction).  The graph shows one representative 
experiment of three performed.  
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Figure A5.4:  The effect of starting pcDNA3.1-lacZ concentration on transfection efficiency:  
Visualisation of Beta-galactosidase reporter activity in H357 cells.  Beta-galactosidase activity 
was visualised in H357 cells transfected with the pcDNA3.1-lacZ plasmid compared with mock-
transfected pcDNA3.1vB negative controls.  The effect of starting DNA concentration per well 
on β-galactosidase reporter activity is demonstrated.  Cells were transfected with pcDNA3.1-
lacZ DNA at concentrations of: a) 1.0 µg per well; b) 1.5 µg per well; and c) 2.0 µg per well.  A 
qualitative increase in reporter activity can be appreciated with an increase in starting DNA 
concentration up to, but not above, 1.5 µg per well.  The pcDNA3.1vB negative control well (d) 
confirms little background or endogenous β-galactosidase reporter activity.  Scale bar 
represents 100µm. 
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Figure A5.5:  The effect of Incubation Time on Transfection Efficiency:  Plot of Beta-
Galactosidase Activity against Incubation Time.  Beta-galactosidase activity was measured as a 
reporter of transfection efficiency following incubation of wild-type H357 cells with 1.5 µg/well 
of pcDNA3.1-lacZ DNA for periods varying from 30 minutes to 4 hours.  A 1:1 charge ratio of 
TransFast reagent to DNA volume was used.  Bars represent mean (standard deviation) of β-
Galactosidase activity from six wells each measured in duplicate.  Transfection efficiency is 
maximal after one hour incubation.  Incubation for shorter (30 minutes) and longer (4 hour) 
periods results in a statistically significant reduction in transfection efficiency (p<0.05, ANOVA 
with Bonferroni correction).  The graph shows one representative experiment of three 
performed.  
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Figure A5.6:  The Effect of G418 Concentration and Time on the Killing of wild-type H357 
Cells as determined by MTT Cell Viability Assay:  Plot of Percentage Survival (compared 
with untreated control) against G418 Concentration by time point.  Wild-type H357 cell survival 
after exposure to varying concentrations of G418 (100 to 1600 µg/ml) for periods of 24,48 and 72 
hours.  Bars represent mean (standard deviation) cell survival as determined by MTT assay for 
each G418 concentration (n=12) and time point calculated as a percentage of untreated control 
(n=12).  Exposure of untransfected H357 cells to 1600 µg/ml of G418 resulted in the required 
90% cell killing in 72 hours.  The graph shows one representative experiment of three replicates 
performed. 
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Appendix 6:  
Supplement to Chapter 6 
- The effects of CXCR4 
function on cell 
proliferation and 
apoptosis in established 
OSCC cell lines and 
CXCR4 transfectants 
 355
A6.1  Supplemental figures  
 
 
 
Figure A6.1:  The effect of serum-starvation on transfected and untransfected OSCC cell 
lines.  Three established OSCC cells lines (CAL27, SCC4 and H357), three CXCR4-transfected 
H357 clones (H357-X4.1, H357-X4.2 and H357-X4.4) and mock-transfected empty-vector cells 
(H357-EV) were incubated for 72 hours under optimum conditions (10% FCS) and in serum-
reduced conditions (0.1% FCS) with or without 100ng/ml of SDF.  This figure represents the 
effect of serum reduction on proliferation in the absence of SDF.  The effect of SDF stimulation 
is represented in Figure 6.3 (Chapter 6).  Bars represent the mean (standard deviation) of 
combined data from three identical experiments each containing twelve replicate wells per cell 
treatment.  Statistical analysis was performed using the Student t-test.  All comparisons were 
not statistically significant unless indicated.  Serum reduction significantly reduced 
proliferation in SCC4 and untransfected H357 cells.  No significant effect was demonstrated in 
transfected H357 cells with or without the CXCR4 insert.  Legend: ** = p<0.01.  The figure 
represents pooled data from three identical experiments. 
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FigureA6.2: Representative raw data for Figure 6.6.  Each well was photographed in three 
positions for both BrdU labelling (panels a), c) and e)) and DAPI (panels b), d) and f)).  No 
signal was detected when an isotype primary antibody (panel (g)) was compared with the 
DAPI control (panel (h)).  Scale bar represents 250µm.    
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Figure A6.3:  The effect of staurosporine on apoptosis.  Results demonstrated that caspase 3/7 
activity was proportional to staurosporine concentration over the range of concentrations tested 
and that the enzyme kinetics of the fluorescence assay were stable over a wide time window 
ensuring robust and reproducible findings.     
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Figure A6.4:  The effect of serum starvation on apoptosis in H357 cells.  Untransfected H357 
cells were incubated with varying concentrations of FCS supplementation (0.1, 0.5 and 10%) for 
24 hours.  Caspase 3/7 activity and MTT absorbance were measured.  Bars represent mean 
(standard deviation) of 12 replicate wells calculated as a percentage of the positive control (10% 
FCS).  Cell viability was reduced in 0.5% and 0.1% FCS (p=0.016 and p<0.001 respectively) 
compared with positive controls.  Apoptosis was significantly increased in conditions of 0.1% 
FCS (p=0.011), but not 0.5% FCS, compared with positive controls.  Legend: * = p<0.05, *** = 
p<0.001 (Student t-test).  Figure represents cumulative data from two identical experiments. 
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A6.2  Determination of the optimal experimental conditions 
for the investigation of the effect of SDF on cell 
proliferation 
A6.2.1  Overview 
The overall aim of this set of experiments was to investigate the effect of SDF 
stimulation on the proliferation rate of CXCR4-positive OSCC cells and transfected 
clones.  A number of potentially confounding variables were identified.   
 
5. Cell seeding density 
6. Duration of incubation 
7. Cell culture supplementation  
8. SDF concentration  
9. Variability across cell lines 
 
These included the effect of basic culture conditions as well as growth media 
components (for example mitogenic factors such as EGF).  In order to investigate these 
variables simple and repeatable assays were required.  For this purpose the MTT and 
resazurin-based assays were performed (as outlined in Chapter 2, Sections 2.8.2 and 
2.8.3 respectively).  However, both these techniques require the enzymatic conversion 
of a substrate to a detectable end-product.  Therefore these techniques are, more 
accurately, determinants of cell viability rather than proliferation per se.  Consequently, 
once the experimental conditions had been optimised, results were obtained using 
measurements of BrdU incorporation as a direct measure of cellular proliferation.  A 
statistical power calculation was also performed to determine the number of replicate 
wells required to detect likely differences in cell proliferation rates. 
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A6.2.2  Determination of Replicate Numbers 
In order to determine suitable replicate numbers for further experiments using a 
statistical power calculation a sample data set was generated by a preliminary series of 
experiments that investigated the effect of cell media supplementation and SDF 
concentration on cell proliferation (Figure A6.5).  The data generated conformed to the 
normal distribution and was therefore amenable to statistical tests for parametric 
variables.68   Results showed the trend that CAL27 cells were responsive to SDF 
gradients (in a roughly dose-dependent manner) when cultured with supplementation 
with FCS, but not BSA.  Although overall proliferation was greater in cells cultured in 
10% FCS, compared with 0.5% FCS, the response to SDF concentration was 
demonstrated in both arms of the experiment.  However, multiple statistical testing 
revealed that only the comparison between cells treated with 100 ng/ml of SDF and 
untreated controls reached significance in the 0.5% FCS arm (p=0.007) but not the 10% 
FCS group (p=0.101).69   
 
From these preliminary experiments, the data were suggestive of a trend but were not 
statistically conclusive.  At this point, for the purposes of a statistical power 
calculation, it was assumed that SDF stimulation altered cell proliferation but that the 
direction (positive or negative) was unknown.70  Consequently (based on the data 
derived from the FCS arm) it was calculated that twelve replicates per treatment would 
give the experiment sufficient statistical power.71  Interestingly if similar assumptions 
were made for the results for 1% BSA, then it was calculated that a sample size of over 
100 would be required to power the experiment to the same degree. 
  
                                                     
68 A P-P plot of expected against observed cumulative probability for data from the three 
experimental conditions investigated conformed well to a straight line confirming that the data 
were normally distributed (as outlined in Figure A2.5, Appendix 2). 
69  ANOVA with Bonferroni corrections for multiple testing. 
70 The working hypothesis was that SDF stimulation increased cell proliferation.  However, if 
the power calculation was altered to a one-way test to reflect this assumption there was a risk 
that the experimental arms would have insufficient replicates to demonstrate an effect either 
way. 
71 The statistical power calculation was performed as outlined in Chapter 2, Section 2.8.5.  
Briefly, variances were compared and found to be equal (Levene’s test) and the number of 
replicates calculated to detect differences of p<0.05 on 90% of occasions using a two-way test. 
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Figure A6.5:  Preliminary experiment to determine proliferation assay replicate numbers.  
CAL27 cells were seeded at equal density and grown for 24 hours under optimal conditions 
with supplementation of the basal growth media with: 1) 10% FCS; 2) 0.5% FCS; and 3) 1% BSA.  
Cells were also treated with SDF in concentrations of 0, 10, 50 and 100 ng/ml.  Relative 
proliferation at 24 hours was determined by MTT assay.  Bars represent the mean (standard 
deviation) of relative proliferation from six replicate wells per treatment.  Statistical 
comparisons were performed using one-way ANOVA with Bonferroni correction for multiple 
testing.  Cells grew best in media supplemented with 10% FCS and lest well in 1% BSA.  There 
was a trend that increasing concentrations of SDF were associated with increasing proliferation 
of cells grown in 10% and 0.5% FCS (compared with untreated controls).  These results did 
achieved statistical significance in latter group (p=0.007) but not the former (p=0.101).  No 
difference in proliferation with SDF stimulation was demonstrated in cells grown in 1% BSA. 
 
0
0.4
0.8
1.2
1.6
10% FCS 0.5% FCS 1%BSA
Cell culture media supplements
R
el
at
iv
e 
Pr
ol
if
er
at
io
n 
at
 2
4 
ho
ur
s
0 ng/ml
10 ng/ml
50 ng/ml
100 ng/ml
ns 
ns 
** 
 362
A6.2.3  Determination of Incubation parameters 
A preliminary study was performed to determine if the compounds used to 
supplement the growth media in future experiments would interfere with the 
fluorescence-based resazurin assay.  It was found that growth media, FCS, and all 
compounds used in the cell stimulations (including SDF, AMD3100 and 
desferrioxamine) did not cause reduction of resazurin in the absence of cells.  A second 
experiment was performed to determine the effect of resazurin on intracellular 
fluorescence: Cells incubated overnight in resazurin-supplemented growth media 
showed similar background fluorescence readings when the media was removed 
compared with cells grown in normal media.  Finally, a very slow auto-reduction of 
resazurin with time was noted in cell-free culture and this was accounted for by the 
subtraction of media-only blanks from each reading for each time point. 
 
Although not contact inhibited, the proliferation of OSCC cells is influenced by the 
physical constraints of the culture environment.  A series of experiments were 
performed to optimise seeding density by allowing the cells to proliferate unhindered 
over the duration of the experiment.  The effect of seeding density on H357 cells is 
shown in Figure A6.6(A).  Increases in starting cell densities up to 5 x 103 per well were 
associated with a proportional increase in fluorescence measured at the 48 hour time 
point.  Similar proportionality was not demonstrated with further increases in seeding 
density.  These data suggested that wells initially seeded with more than 5 x 103 cells 
demonstrated a confounding limitation on proliferation within a 48 hour time period.  
This was possibly due to the accumulation of toxic waste products and/or the 
generation of over-confluent cultures caused by the physical constraints of the 96-well-
plate.  The latter was confirmed by visual inspection using light microscopy. 
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Figure A6.6:  The effect of cell seeding density and incubation time on cell proliferation.  
Untransfected H357 cells were seeded at densities ranging from 1.25 to 20 x 103 per well and 
incubated for 48 hours (A).   Mean (standard deviation) fluorescence values were plotted 
against seeding density.  A starting density of 5 x 103 cells per well or less resulted in a 
proportional increase in proliferation at 48 hours.  This was not the case for seeding densities 
greater than 5 x 103 cells per well.  A proliferation time course was performed for the same cell 
line (B).  Cells were seeded at 2.5 x 103 (red line) and 5 x 103 (blue line) cells per well and 
incubated for 72 hours.  Mean (standard deviation) relative fluorescence values multiplied by 
the number of cells seeded per well (for twelve replicate wells) were plotted against time.  The 
rates of fluorescence accumulation (black lines) remained linear up to 48 hours in both cases (R2 
>0.995).  The accumulation rate for wells seeded with 5 x 103 cells was 2.04 times (95% CI 2.03-
2.05) that for wells seeded with 2.5 x 103 cells.  Legend:  RFV = Relative Fluorescence Value; Cw 
= Cells seeded per well; AU = arbitrary units.  Both figures present data from a single 
representative experiment of three performed. 
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The relationship between the accumulation of fluorescence and time was determined 
for the same cell line seeded at two different starting densities (Figure A6.6-B).  Results 
showed that, for cells seeded initially at either 2.5 x 103 or 5 x 103 per well, proliferation 
proceeded at a linear rate for the first 48 hours with excellent correlation of the 
multiple readings taken (R2 value >0.995).  For wells initially seeded with 5 x 103 cells, 
the rate of fluorescence accumulation reduced between the 48 and 72 hour time points 
and the relationship with time became non-linear.  This was not demonstrated in the 
replicate wells seeded with 2.5 x 103 cells.  Overall, these findings were consistent with 
the results from the experiments investigating the effect of cell seeding density and 
proliferation (demonstrated in Figure A6.6-A).   The rate of accumulation of 
fluorescence in wells starting with 5 x 103 cells was 2.04 (95% CI 2.03 - 2.05) times 
greater than in those seeded with 2.5 x 103 cells.  This is very close to the twofold 
increase predicted by the numerical relationship between the starting densities.   
 
Consequently, as shown in Figure A6.6(B), the difference in rates of fluorescence 
accumulation correlates closely with the amount of cellular material present.  When 
care is taken to ensure that all replicates start with similar cell numbers, changes in the 
rates of fluorescence accumulation can be assumed to represent variation in the rates of 
cellular viability.72  In these experiments it was assumed that this was due to changes 
in proliferation rates although this was tested empirically using a complimentary 
BrdU-based technique (vide infra).  Therefore, for fluorescence-based assays using time-
series data, it was decided to measure proliferation rates over the first 48 hours of 
culture for wells with seeding density of 5 x 103 cells per well.   
 
 
                                                     
72 As outlined in Chapter 2, Section 2.8.3 all experimental plates were analysed at the start of the 
experiment (T0) for parity of cellular material.  Plates that did not conform to this quality control 
measure were discarded. 
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A6.2.4  The effect of cell culture supplementation on cell proliferation. 
Another series of preparatory experiments were performed to investigate the influence 
of culture media supplementation on cell proliferation.  Initially the influence of serum 
was determined (Figure A6.7).  Results demonstrated that the proliferation of CAL27 
and SCC4 cells, and to a lesser extent H357 cells, was dependent on FCS concentration.  
For CAL27 and SCC4 cells a reduction of serum supplementation below 10% (final 
concentration) resulted in a significant decrease in cell proliferation after 72 hours, 
compared with baseline controls.  Interestingly, a plot of absorbance value against 
log10[FCS concentration] for CAL27 and SCC4 cells suggest that the relationship is 
linear (R2>0.95) over the range of values tested.  In contradistinction, the relationship 
between H357 cell proliferation and FCS concentration was less clear-cut:  FCS 
concentrations of 1% and 0.5% resulted in no significant difference in proliferation 
compared with 10% FCS.  Only incubation with 0.1% FCS significantly reduced H357 
proliferation compared with 10% FCS.  Furthermore, plots of absorbance value against 
log [FCS concentration] did not produce a linear relationship for H357 cells.  Finally, 
over 72 hours, H357 cells demonstrated significantly more growth in serum-free 
conditions than both CAL27 and SCC4 cells.  Collectively, these findings demonstrate 
that all three OSCC cell lines tested proliferated better with serum supplementation to 
a final concentration of 0.5% or greater.   
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Figure A6.7:  The effect of FCS on OSCC cell proliferation.  Cells from three OSCC cell lines 
(CAL27, SCC4 and H357) were seeded at 5 x 103 cells per well and incubated in normal growth 
media supplemented with varying concentrations of FCS (0, 0.1, 0.5, 1.0 and 10% by total 
volume).  MTT assay was performed after 72 hours.  Bars represent mean (standard deviation) 
of twelve replicate wells per treatment.  Statistical comparisons were performed using one-way 
ANOVA with Bonferroni correction for multiple testing.  The proliferation of CAL27 and SCC4 
cells demonstrated a dramatic response to FCS concentration with a significant (p<0.001 
respectively) reduction in proliferation with decreasing FCS.  However, the proliferation of 
H357 cells was less responsive to FCS concentration, with changes from 10 to 0.5% showing no 
significant reduction in MTT absorbance.  H357 cells grown in 0.1% FCS showed significantly 
less proliferation than those grown in 10% (p<0.001).  Interestingly, H357 cells demonstrated 
significantly more growth than CAL27 and SCC4 cells in serum-free conditions (p<0.001, 
Student t-test).  Legend: ns = not significant; * = p<0.001.  Figure shows pooled data from three 
identical experiments performed. 
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The results from the previous experiment (Figure A6.7) are suggestive that, while 
CAL27 and SCC4 cells are highly dependent on FCS concentration for growth, H357 
cells are able to proliferate more independently of serum supplementation.  This 
important finding was investigated further with a time-course of cell proliferation 
against FCS concentration for H357 cells (Figure A6.8-A) and the SCC4 cell line (Figure 
A6.8-B).  The results obtained were consistent with earlier findings: The reduction of 
serum concentration in SCC4 cells was associated with a significant reduction in 
absorbance values at the later time points of 48, 72 and 96 hours.  However, after 
incubation for only 24 hours there was no statistically significant difference in SCC4 
proliferation in conditions of reduced FCS compared with controls cultured with 10% 
FCS.  Towards the end of the time course, SCC4 cells in 0.1% and serum-free 
environments demonstrated a loss of cellular material from the wells.  One explanation 
was that, under these conditions, cells were dying and becoming detached from the 
culture surface:  Aspirates of the media taken just prior to performing the MTT assay 
and inspected by light microscopy showed that this was indeed the case.   
 
The behaviour of H357 cells (Figure A6.8-A) under similar conditions was quite 
different.  Compared with controls cultured with 10% FCS, H357 cells demonstrated no 
statistically significant reduction in proliferation when the serum supplementation was 
reduced to 0.5% or 1% (final concentration).  Only incubation in 0.1% and serum-free 
conditions resulted in a significant reduction in proliferation (p<0.01) when compared 
with 10% FCS control wells.  Furthermore, H357 cells grown in media supplemented 
with 0.1% or no FCS also demonstrated a significant increase (p<0.01) in absorbance 
values over the entire 96 hour time course of the experiment.  This is suggestive that a 
slow rate of proliferation was still occurring with a net accumulation of total cellular 
material (confirmed by light microscopy). 
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(A) H357 cells 
(B) SCC4 cells 
Figure A6.8:  The effect of FCS on the proliferation of H357 and SCC4 cells.  Five thousand 
(A) H357 and (B) SCC4 cells per well were incubated in normal growth media supplemented 
with varying concentrations of FCS.  MTT assay was performed at 5 time points up to 96 hours.  
Bars represent mean (standard deviation) of twelve replicate wells per treatment.  Statistical 
comparisons were performed against the 10% FCS group for each time point using ANOVA 
with the post-hoc Bonferroni correction.  FCS concentration was a clear determinant of SCC4 cell 
proliferation with significant differences demonstrated at the later time points (p<0.01).  
However, the proliferation of H357 cells in FCS concentrations ≥ 0.5% was statistically 
indistinguishable in the later time points.  While H357 cells incubated in serum-free conditions 
continued to grow over the 96 hour time period, SCC4 cells did not.  All statistical results were 
not significant (p>0.05) unless indicated (* = p<0.01).  Figure represents pooled data from three 
identical experiments. 
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The results from the previous experiment (Figure A6.8) demonstrate that untransfected 
H357 cells are more resistant to serum-starvation than SCC4 cells.  It was hypothesised 
that differences in the basal growth media used for H357 and SCC4 cells were 
responsible for the effect shown.  H357 growth media (outlined in Table A2.1, 
Appendix 2) contains additional factors (such as Epidermal Growth Factor, EGF) that 
are pro-proliferative.  A time-course experiment was performed to determine the effect 
of EGF stimulation on transfected and untransfected H357 cell proliferation with and 
without serum-starvation.  For clarity the results for the 72 hour time point are 
represented in Figure A6.9.  The results showed that EGF supplementation had no 
significant effect on untransfected, empty-vector or CXCR4-transfected H357 cells 
grown under conditions of 0.1% FCS concentration.  Interestingly, the only statistically 
significant comparison was found in the 10% FCS control group where CXCR4-
transfected H357 cells showed reduced proliferation in response to EGF 
supplementation.  However, this difference was not reproduced across the time points 
and it was felt that this finding had statistical but not biological significance.  Given 
that the aim of the experiment had been to determine the effect of EGF at the low 
serum concentrations to be used in the chemokine stimulation experiments, it was 
concluded that EGF was not a significant influence on H357 proliferation at FCS 
concentrations of 0.1%. 
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Figure A6.9:  The effect of EGF supplementation on H357 cell proliferation.  Three H357 
clones (wild-type, empty-vector and CXCR4-transfected) were seeded at equal densities and 
incubated with or without EGF supplementation in media either supplemented with 10% or 
0.1% FCS.  Serial fluorescence measurements were taken, of which only the 72 hour time point 
is represented for the sake of clarity.  Bars represent mean (standard deviation) of twelve 
replicate wells per treatment.  Statistical analysis was performed using the Student t-test.  
Essentially, EGF supplementation had no significant effect on the proliferation of any of the 
three H357 clones tested, except for CXCR4-transfected cells in conditions of 10% serum 
(p<0.05).  This finding was replicated at both 10% and 0.1% FCS concentration.  Legend:  WT = 
wild-type; EV = empty-vector mock transfected; X4 = CXCR4 transfected; ns = not significant; * 
= p<0.05.  Figure represents pooled data from three identical experiments performed. 
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A6.3  Discussion of Experimental Methodologies 
A6.3.1 Proliferation assays 
A6.3.1.1 Resazurin-based assays 
The use of resazurin-based assays for the determination of cytotoxicity in real-time was 
originally described in 1993 (Fields and Lancaster 1993).  However, their usefulness in 
monitoring cell growth and survival is greater than that for measuring the toxic effect 
of particular compounds (Carter, Ericsson et al. 1998).  This is due to the fact that the 
fluorescence measurements obtained by the assay are due to the accumulation of the 
reduced substrate with time.  Consequently, although the experiments reported here 
initially incubated cells with 5% resazurin and 10% FCS overnight, this was removed 
and replaced with fresh media at the time of the addition of cell treatments.  However, 
considering the hypothesis that the pre-incubation of cells with resazurin may affect 
subsequent results, this experimental design might attract criticism.  Importantly, the 
findings from preliminary experiments determined that this was not the case; and 
evidence from the literature supports this finding by describing that very little 
fluorescence is retained intracellularly (O'Brien, Wilson et al. 2000)   Another criticism 
of these fluorescence assays, described by the same authors, is that possible redox 
reactions between resazurin and cell treatments may yield confounding effects if these 
are not initially determined empirically (O'Brien, Wilson et al. 2000).  Meticulous 
preliminary experiments were performed to ensure the accuracy of these experimental 
procedures by the empirical determination of any interference between cell treatments 
and resazurin.  
 
Another consideration is the impact of the experimental methodology on cell growth.  
Serial measurements requiring prolonged removal of cultures from optimal conditions 
for growth might have a confounding effect on results.  Consequently it was decided to 
measure at spaced time-points over the duration of the experiment to reduce the effect 
of cooling and atmospheric change on growth profiles.  Other authors describe 
techniques using similar principles although the effect of multiple measurements is 
impossible to quantitate (Katayama, Ogino et al. 2005).   
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A6.3.1.2 Selection of complimentary assays 
Many techniques are described in the literature under the loose heading of 
“proliferation assays”.  These include fluorescence-based real-time assays, measures of 
DNA synthesis (such BrdU incorporation), single measures of cellular activity (such as 
MTT assays) and cell counts either performed manually or by flow cytometry 
(Murdoch, Monk et al. 1999).  It is important to remember what these assays actually 
measure and, consequently, their relative strengths and weaknesses.  BrdU, [3H]-
thymidine and MTT assays provide a single measure of DNA synthesis or cellular 
activity over a short, defined period of time at the end of treatment.  Cell counts 
provide serial measurements over time, but not of the same wells.   Many authors use 
cell counting to substantiate results derived by other methods (Scotton, Wilson et al. 
2002; Chen, Yu et al. 2006; De Falco, Guarino et al. 2007; Yang, Lee et al. 2007; Zhang, 
Lu et al. 2007).  However, the inherent assumption (as with the other single 
measurement techniques) is that all replicate wells are set up with exactly the same 
amount of starting material.  Results from my real-time, resazurin-based assays have 
demonstrated that this premise is not valid.  The experimental data showed that, 
despite assiduous technique, individual wells varies by as much as 10%.  
Consequently, a comparison of data from two or more techniques provides the most 
robust and reliable results. 
 
 
A6.3.1.3 Incubation times 
For anchorage-dependent cells there is an inverse relationship between seeding density 
and incubation duration in vessels of fixed volume.  To reduce the accumulation of 
waste products within the media the protocol of an optimum number of cells 
measured serially over 48 hours was adopted.  These time-course data could be 
represented graphically; replicates checked against a normal distribution and 
compared statistically using parametric tests.  Other authors opted for lower seeding 
densities and prolonged incubation (Katayama, Ogino et al. 2005; Ueda, Neel et al. 
2006; Yasumoto, Koizumi et al. 2006; Wen, Zhu et al. 2007; Zhang, Lu et al. 2007; 
Kajiyama, Shibata et al. 2008).  The concern with these methodologies would be the 
confounding effects of waste accumulation within the media or the effect of contact-
inhibition inhibiting growth.  Attempts to address the former by changing the media at 
regular intervals were described by some authors, although the effects of these changes 
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on cell growth were not investigated.  My preliminary data suggested that changing 
the cell media has a significant impact on cell growth kinetics. 
 
 
A6.3.1.4 Serum supplementation 
The influence of culture media supplementation on cell proliferation is an important 
question to address.  This is because FCS has a significant impact on cell growth and 
contains many soluble factors that may impact on cell behaviour and thereby act as 
confounding variables when investigating the impact of cytokines and chemokines on 
cell function.  Consequently the ability to minimise FCS concentration while still 
maintaining cell viability is key, not only to proliferation assays, but also to all assays 
of cell function. 
 
My results show the profound effect of serum supplementation on cell growth.  Other 
groups have reported proliferation data derived from experiments in which serum 
supplementation varied greatly.  Results in two pancreatic cell lines demonstrated a 
proliferative effect of SDF in the presence of serum in one cell line but not another 
(Marchesi, Monti et al. 2004).   This suggests that the interaction between SDF and 
serum is idiosyncratic.  However the majority of papers reporting a positive 
association between SDF concentration and cell proliferation incubated cells in base 
media supplemented with low concentrations of either BSA (Scotton, Wilson et al. 
2002; Katayama, Ogino et al. 2005; Yasumoto, Koizumi et al. 2006) or FCS (Chen, Yu et 
al. 2006).  Interestingly a number of studies reporting no effect used either full (10% 
FCS) or no supplementation at all (Uchida, Begum et al. 2003; Pan, Mestas et al. 2006).  
Supplemental serum has a permissive effect on cell growth and low levels are required 
by all cells.  However, high levels may mask the (subtle) effects of SDF. 
 
 
A6.3.2 Apoptosis Assays 
The process of apoptosis involves highly regulated intracellular processes that may be 
triggered by intrinsic or extrinsic events.  Consequently there are a number of 
methodologies by which apoptosis can be measured – each focussing on different 
elements of these pathways.  The caspase 3/7 assays system used for these 
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experiments was selected for two principal reasons: Firstly, the mechanism by which 
SDF might affect apoptosis was unknown and so measurement of the final 
“executioner” steps was necessary.  Secondly, in order to ensure that quantitative 
results were not skewed by cell number, an apoptosis assay that used the cell 
supernatant was preferred as it allowed contemporaneous measurements of cell 
viability.  Therefore methodologies such as labelling of cell proteins (such as PARP or 
cytochrome C), plasma membrane components (Annexin V) or DNA fragmentation 
would not have permitted the concurrent measurement of cell viability. 
 
The caspase 3/7 assay system used was validated empirically using staurosporine-
induced apoptosis in untransfected H357 cells.  It was evident from this preliminary 
work that, because of the enzyme kinetics, cell measurements should take place in 
batches.  Consequently, this technique was dependent on having hardware that could 
acquire the data sufficiently quickly so as to negate the impact of delay in 
measurement between samples.  Formatting the experiments in opaque 96-well plates 
facilitated this.  According to the manufacturer’s instructions, the resazurin-based 
viability assay and the apoptosis assay could be multiplexed within the same well.  
However, this was not done due to the complex set of preliminary experiments that 
would be required to ensure that no interactions between the cell treatments and the 
assay components would confound the results. 
 
 
A6.3.3 Data handling and statistical tests 
A fluorescence-based assay of cell proliferation has several advantages and some 
disadvantages.  Although it might be thought that the acquisition of readings at 
multiple time points affords greater accuracy through sheer volume of data, this is not 
necessarily the case.  Statistical handling of “time series” data has attracted much 
debate.  However, there is general consensus that, if the multiple readings for a single 
replicate can be represented by a single value, then the data from experimental 
replicates can be combined using simple statistical methods (Matthews, Altman et al. 
1990).  In these experiments, fluorescence values (reflecting the accumulation of 
cellular material) from each single replicate (represented by individual wells on the 96 
well plate) could be collected at different time points and plotted against time.  It was 
found that, using certain empirically-derived setup parameters (such as cell seeding 
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density and incubation duration), the rate of accumulation of fluorescence was linear 
with time over an initial 48 hour period.  Consequently, for each individual well, it was 
appropriate to summarise the time series data generated as a rate (defined by the 
gradient of the line) and handle the calculated slopes from each replicate as parametric 
data as long as they fitted the normal distribution (as tested by P-P plots).   
 
At the outset the effect of SDF stimulation on cell proliferation was unknown.  
Consequently, calculations of statistical power were based on the possibility of 
distinguishing two-tailed (bi-directional) responses each with equal variance.  
However, from the preliminary data it was possible to hypothesise that SDF 
stimulation would increase proliferation rather than decrease it.  The experimental 
model was then changed to investigate a unidirectional response for which a one-tailed 
comparison was sufficient.  Maintaining twelve replicates per treatment therefore 
increased the statistical power of the experiment. 
 
Resazurin-based assays of cell viability have the advantage that multiple replicates can 
be performed with ease.  In this way a large volume of parametric data was produced 
yielding significant statistical power.  Conversely, statistical handling of the categorical 
data generated by BrdU incorporation assays (cells label positive or not) is more 
problematical.  At the simplest level a chi-squared test for each individual comparison 
may be performed.  This has the significant disadvantage that the statistical power of 
multiple testing (dose-response) is lost.73  One test covering the range of SDF 
concentrations would be preferred to serial comparisons of individual results.  
However, in agreement with data from the cell viability experiments, the relationship 
between SDF concentration and proliferation is not linear.  Consequently, as the dose 
increases (and the biological response plateaus) the effect is to reduce the statistical 
significance of the result.  An alternative would be to apply the Mantel Haenzsel trend 
test or to calculate the Kendall rank correlation coefficient.  However, again, arbitrary 
values of significance for the effect of dose would have to be tested for fit. 
 
 
 
                                                     
73 The Chi-squared test employed for BrdU incorporation assays requires a difference of 
approximately 12% to reach statistical significance at the p<0.05 threshold.  This was 
approximately the magnitude of the effect observed. 
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A7.1  Supplementary Figures 
 
Figure A7.1:  The effect of SDF on cell chemokinesis: Raw data for Figure 7.1 (Chapter 7).  
Transfected cells with (H357-X4.1 & H357-X4.2) and without (H357-EV) the CXCR4 insert were 
incubated for 20 hours on sterile coverslips coated with gold colloid at an initial density of 4,000 
a) EV 
SDF 0 
g) EV 
SDF 100 
c) EV 
SDF 1 
e) EV 
SDF 10 
b) X4.1 
SDF 0 
d) X4.1 
SDF 1 
f) X4.1 
SDF 10 
h) X4.1 
SDF 100 
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cells per well.  Growth media was supplemented with SDF to yield final concentrations varying 
between 0 and 100ng/ml.  Cells were washed, fixed, mounted and photographed under oil 
immersion.  Panels represent H357-EV (a, c, e & g) and H357-X4.1 cells (b, d, f & h) exposed to 
SDF at concentrations of 0 (a & b), 1 (c & d), 10 (e & f) and 100 ng/ml (g & h).  Areas were 
recorded for 10 cells per experimental condition and the mean and standard deviations 
represented in a histogram and the same mean values were plotted against SDF concentration 
on a logarithmic scale (Figure 7.2, Chapter 7).  Legend: EV=H357 Empty Vector, X4.1= H357-
X4.1, Scale bar represents 50µm. 
 
 
 
A7.2  Discussion of Experimental Methodologies 
Three complimentary methodologies were performed to determine the effect of SDF 
stimulation on cell movement.  Chemokinesis (with and without directional stimuli) 
and chemotaxis were investigated using gold colloid, scratch and Transwell assays 
respectively.  Gold colloid assays provided an indirect measurement of chemokinesis 
(without directional stimuli) by tracking the total surface area covered by single cells at 
the end of a defined time point.  More recent, fluorescence-based adaptations of this 
phagokinetic assay have been described to investigate the motility of tumour cell lines 
(Gu, Pellegrino et al. 2007).  An alternative technique would to be to collect real-time 
data using time-lapse photography.  This would also obviate the need for pre-coating 
with gold colloid, the ingestion of which may impact on cell motility.  Time-lapse 
photography would also be a useful technique by which to ascertain the movements of 
individual cells in the scratch assay system.  In this way the direction and velocity of 
cell movements could be defined and compared.  Data collected using this technique 
would provide a useful adjunct to the results already achieved and therefore could be 
usefully included in the scope of further work.  Time-lapse photography would also 
allow chemotaxis chambers to be used for the investigation of chemokinetic and 
chemotactic responses.  The mechanism by which SDF stimulation mediates increased 
cell motility was not addressed in this work.  It has been demonstrated that immediate 
actin polymerisation and cytoskeletal rearrangement with the formation of stress fibres 
in SCLC (Burger, Glodek et al. 2003) and hepatoma (Sutton, Friand et al. 2007) cell 
lines.  Similar methods could be applied to OSCC-derived cell lines using conventional 
and confocal immunofluorescence microscopes. 
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Cell proliferation was a potential confounding variable for all three methodologies 
employed.  Previous results have shown that SDF does influence the rate of cell 
proliferation (Chapter 6).  Various techniques were therefore employed to minimise the 
effect of this confounding variable:  In gold colloid assays the movements of single 
cells were analysed.  In scratch assays, growth arrest was induced by pre-incubation 
with mitomycin C.  Results showed that scratch wounds healed under both mitomycin 
C treated and untreated conditions.  The closure rate was greater without mitomycin C 
treatment, providing indirect evidence that proliferation contributes to wound healing 
under these conditions.  In the Transwell assays, although incubation times were kept 
short to minimise the effect of proliferation, no direct steps were taken to induce 
growth arrest prior to SDF stimulation.  This would be an interesting line of further 
work but these experiments would require careful controls to ensure that the methods 
used to induce growth arrest had no direct effect on cell motility or adhesion. 
 
Other in-vitro methodologies investigating cell motility and invasion were considered.  
Preliminary experiments using organotypic cultures of H357 cells on dermal 
fibroblasts were performed.  The aim of these assays was to determine the feasibility of 
the technique and to ascertain the usefulness of the H357 model under these 
conditions.  The technique was found to be robust and reproducible although its time-
consuming nature conferred a long lag time between replicates.  Transfected and 
untransfected H357 cells were established on the dermal collagen and stimulation with 
SDF was performed.  However, unlike the Transwell Matrigel assays, no striking 
differences between treatments were observed in the preliminary experiments and it 
was decided that subsequent use of this technique should be restricted to further 
works.  
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Table A8.1:  Associated presentations and published abstracts 
 
Year Conference Title and Abstract Reference 
2009 BAOMS 
Bournemouth 
 
A role for CXCR4 in OSCC cancer stem cells 
 
2007 QMUL  
William 
Harvey Day 
 
Overexpression of the receptor CXCR4 results in an 
aggressive OSCC tumour phenotype in-vitro 
2007 BAOMS 
Aviemore 
Overexpression of the chemokine receptor CXCR4 is 
associated with lymph node metastasis in patients with 
HNSCC.  BJOMS 2007 45(7) e60 
 
Characterisation of chemokine receptor expression by oral 
squamous cell carcinoma cells in-vitro. BJOMS 2007 45(7) e3 
 
Overexpression of the receptor CXCR4 results in an 
aggressive OSCC tumour phenotype in-vitro, BJOMS 2007 
45(7) e3 
 
Winner of the BAOMS research poster prize 
 
2006 IADR 
Brisbane 
The role of the chemokine receptor CXCR4 in OSCC tumour 
biology 
http://iadr.confex.com/iadr/2006Brisb/techprogram/abst
ract_82598.htm 
 
2005 ICOOC 
Crete 
Chemokine receptor profiling of oral squamous cell 
carcinoma by microarrays: a possible role for CXCR4 in 
lymph node metastasis.  Oral Oncology 2005: 1 (1): 104 
 
2005 BSDR 
Dundee 
The functional role of CXCR4 in oral carcinoma invasion 
http://iadr.confex.com/iadr/bsdr05/techprogram/abstrac
t_ 65957.htm 
 
Winner of the Junior Colgate Prize 
 
2004 BSDR 
Birmingham 
Expression of the chemokine receptor CCR7 in oral 
squamous cell carcinoma cell lines 
http://iadr.confex.com/iadr/bsdr04/techprogram/abstrac
t_49383.htm 
 
Legend: BAOMS = British Association of Oral & Maxillofacial Surgeons Annual Scientific 
Meeting;  BJOMS = British Journal of Oral & Maxillofacial Surgery;  IADR = International 
Association for Dental Research Annual Scientific Meeting;  BSDR = British Society for Dental 
Research Annual Scientific Meeting;  ICOOC = International Congress on Oral & 
Oropharyngeal Cancer; QMUL = Queen Mary University London. 
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